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Abstract 
Multiple Sclerosis (MS) is a chronic progressive disease which presents with a variety of cognitive, 
motor and sensory deficits. Rehabilitation strategies to help manage some of these deficits include 
increasing physical activity and undertaking therapeutic exercise. A literature review begins this 
thesis and where relevant gaps are highlighted. These include; minimal literature on the long-term 
effects of therapeutic exercise, the views of those with MS taking part in therapeutic exercise and 
the characteristics of outcome measures used to assess those with MS. To address these areas three 
studies are presented related to therapeutic exercise for those moderately affected with MS (defined 
as an Expanded Disability Status Score of 5 to 6.5). 
In the first study, a 12-week therapeutic exercise programme was delivered to twenty people with 
MS, whilst 12 people acted as controls who received usual care. Clinical outcomes were assessed at 
five time points over the intervention and 12-month follow-up period of the study. No statistically 
significant results emerged to suggest the intervention was effective, however calculated effect 
sizes indicated the intervention had a positive effect on areas related to the physiological (strength, 
mobility, fatigue and body composition), functional (mobility, balance and activity participation) 
and psychological (mood and quality of life) status of participants.  
The second study sought to establish the views and opinions of participants, who had attended the 
exercise intervention. Three inter-related themes emerged. These were (1) the Exercise Class, 
which developed as a bridge to allow participants to realise (2) the Benefits of the Class, helping 
them to overcome (3) Barriers to Exercise. Results suggested the benefits to participating in 
exercise and the exercise intervention included social support and symptom improvement. Barriers 
to exercise included perceived psychosocial factors, symptoms and lack of service. 
A third study investigated the test re-test reliability of four outcome measures used in the first 
study, calculations were done to establish the clinically significant change and precision of the 
outcome measures. The test re-test reliability of the outcome measures was good, with the 
calculated clinical change and precision of the outcome measures in those moderately affected with 
MS highlighting the problems of assessing those with MS.  
The overall investigation suggests that therapeutic exercise and monitoring its effect in MS is good. 
Clinical and research recommendations emerged from this work, these include that the 
heterogeneity of symptoms presented in MS should be considered in future research designs and 
that group therapeutic exercise may improve physiological, functional and psychological status of 
those with MS, with the social benefits important to participants. 
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1 Introduction 
Multiple Sclerosis (MS) is a chronic progressive disease which presents with a variety of cognitive, 
motor and sensory deficits (Compston and Coles 2008). Rehabilitation strategies to help manage 
some of these deficits include increasing physical activity and undertaking therapeutic exercise. A 
thorough review of the current literature surrounding therapeutic exercise in MS is provided in this 
thesis as is information on three studies undertaken regarding therapeutic exercise in MS. These 
studies were designed to gather information on the impact of a therapeutic exercise programme and 
to gather information on the reliability of outcome measures commonly used to assess motor 
deficits in MS. 
1.1 Therapeutic exercise in Multiple Sclerosis 
Therapeutic exercise, is described as the “prescription of a physical activity program that involves 
the client undertaking voluntary muscle contraction and/or body movement with the aim of 
relieving symptoms, improving function or improving, retaining or slowing deterioration of health” 
(Taylor et al 2007). Therapeutic exercise is therefore an important treatment modality in MS and is 
the major topic of this thesis. 
1.2 The investigations central to this thesis 
This thesis included studies regarding therapeutic exercise for people moderately affected with MS, 
i.e. people who had an Expanded Disability Status Score (EDSS) of 5 (ambulatory without aid or 
rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20m without 
resting (Kurtzke 1983).  
The main investigation (Study 1) involved a randomised control trial (RCT) to assess the impact of 
a 12-week therapeutic exercise intervention in people moderately affected with MS. This exercise 
intervention took a combined approach (i.e. included aerobic, resistance and balance exercises), 
was undertaken in groups, it was held in community leisure facilities and was led by a 
physiotherapist and an exercise professional. Two smaller studies were undertaken, to complement 
this main investigation;   
Study 2 was a qualitative analysis of participants’ views on the exercise class whilst Study 3 was an 
assessment of the reliability of the mobility and balance  outcome measures which were used in 
Study 1. 
Introduction 
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The overall investigation was a collaboration between The University of Glasgow and National 
Health Service (NHS) Ayrshire and Arran with assistance from KA Leisure and East Ayrshire 
Leisure Services. The majority of funding was provided by NHS Ayrshire and Arran (Bevan 
Endowment) and the University of Glasgow. Additional financial support was provided by KA 
Leisure, East Ayrshire Leisure Services and the Ayrshire and Arran Branch of the Multiple 
Sclerosis Society. 
1.3 Contribution to knowledge 
In undertaking this thesis, additional knowledge has been added to the growing body of literature 
surrounding therapeutic exercise in MS. The impact of a group exercise programme for people 
moderately affected with MS is established using quantitative analysis, as are the views and 
opinions on therapeutic exercise of those taking part in the exercise intervention. In addition, the 
reliability, clinical significance and precision of clinically relevant outcome measures used in the 
assessment of people moderately affected with MS are established. These are important areas for 
the healthcare management of people with MS, and offer insight into therapeutic exercise and 
assessment of outcome measures in this population. 
1.4 Aims of this investigation 
The overall aim of this investigation was to explore the impact of therapeutic exercise on those 
moderately affected with MS.  
1.5 Research questions  
Primary research question: 
What is the effect of a group therapeutic exercise class on the physiological, functional or 
psychological status of people with MS who have moderate disability? 
Research questions of individual projects: 
• What are the short and longer term effects of a 12-week community based group exercise 
class in people moderately affected with MS, against controls with MS of a similar age, 
gender and disability level who received usual care? 
• Is a 12-week community based group exercise class effective in improving the 
physiological, functional or psychological status of people moderately affected by MS? 
Introduction 
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• What are the participants’ views on exercise and the therapeutic exercise intervention  
• What are the reliability, clinically significant minimal detectable change and standard error 
of measurement scores of outcome measures used in people with moderate MS? 
To answer these questions three studies were undertaken: 
1. The quantitative analysis of the impact of a 12-week leisure centre-based, group exercise 
intervention for people moderately affected with Multiple Sclerosis. 
2. A qualitative analysis of a 12-week group exercise intervention for people with Multiple 
Sclerosis. 
3. The quantitative analysis of the reliability, clinical significance and precision of mobility 
and balance assessments in Multiple Sclerosis. 
The studies, their individual aims and results are discussed within Chapters 4, 5 and 6 of this thesis. 
1.6 Dissertation Guidance 
It is the intention of the author that the information contained within this dissertation be accessible 
and interesting to a broad range of readers; health professionals, exercise professionals, academics, 
researchers and those who are interested in finding out about management strategies for MS. As 
such, sections of this thesis are published as individual projects within their own right. 
The dissertation provides a great depth of information and to guide the reader Figure 1.1 provides 
possible paths through. Chapter 4, 5 and 7 assume knowledge of strategies used to manage and 
assess patients with neurological problems, and are written to be understood by healthcare 
professionals. Those interested in establishing strategies to manage MS sufferers may be most 
interested in the methods and results described in Chapters 4 and 5. Academics and researchers 
may find value in the findings of Chapter 4-6, dependant on their research interests. Although 
Chapters 4-6 can be read in any order, Chapters 4 and 5 and Chapters 4 and 6 complement one 
another. Clinical and research recommendations from the overall investigation are provided in 
Chapter 7.  
Introduction 
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2 Literature review 
Multiple Sclerosis (MS) is a chronic progressive autoimmune disease which impacts the 
neurological system. The condition involves intermittent immune mediated inflammatory changes 
within the myelin sheath, the protective coating around nerve fibres. These changes are often 
associated with new symptoms and are recognised as a relapse in the disease. This damage is 
cumulative and will result in the loss of integrity within the underlying nerve axon with subsequent 
axonal degeneration, this damage is the main determinant of disability progression (Compston and 
Coles 2002).  Different patterns of MS (Section 2.2.1) follow a slightly different pathological 
process; one which is characterised by progressive primary axonal loss, and manifests in 
progressive deterioration, without relapse (Compston and Coles 2002). 
Symptoms commonly involve deficits in motor function leading to major disability (Compston and 
Coles 2008). Rehabilitation therapy and in particular therapeutic exercise can help manage some 
symptoms related to motor function (Rietberg et al 2004). The main aim of this thesis was to 
explore the impact of therapeutic exercise on the physiological (strength, mobility, fatigue and 
body composition), functional (mobility, balance and activity participation) and psychological 
(mood and quality of life) status of people moderately affected with MS.  
This chapter describes the current literature related to MS and therapeutic exercise providing the 
background for the thesis. 
2.1 Introduction 
The literature review provides the background and justification for the research (Bruce 1994), 
allowing a comparison of the past research in therapeutic exercise for those with MS. Establishing 
the status quo within the current MS exercise literature allowed the investigation to develop from 
the work of others. By obtaining a detailed knowledge of the topic, it was possible to design 
relevant studies to fill the literature gap.  
This section will begin with a description of the key features of, and therapies for, MS, before 
expanding on the therapeutic exercise literature in MS, providing a background to therapeutic 
exercise interventions and qualitative data related to therapeutic exercise in MS. In Chapter 3 a 
literature review of the outcome measures used in this study will be presented, where further 
explanation of the reliability of outcome measures will be given. 
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2.2 Multiple Sclerosis 
2.2.1 Pathophysiology, Classification and Diagnosis 
Multiple Sclerosis (MS) has been described for many years as an inflammatory disorder resulting 
in widespread demyelination and axonal degeneration within the central nervous system (CNS). 
This manifests clinically as increased neurological deficit. Inflammation occurs in various regions 
of the brain and CNS, most commonly adjacent to the lateral ventricles within the corpus callossum 
of the cortex, subcortical white matter, optic nerves, brainstem and throughout the CNS. It can 
result in blockages to action potentials travelling through the axons of the CNS and axon 
transection or damage to the axon’s myelin sheath (demyelination), as illustrated in Figure 2.1 
(Compston and Coles 2008). Remyelination and repair can occur, resulting in lesions, visible under 
magnetic resonance imaging (MRI Figure 2.2), however this tissue repair may be limited, and 
results in the clinical features associated with MS. Diagnostic criteria are shown in Table 2.1.  
 
Figure 2.1 Nerve fibre (neuron) from a healthy individual and person with MS  
(Nucleus Medical Media 2011). 
 
 
In the majority of cases clinical symptoms indicate the involvement of motor, sensory and 
autonomic systems which can be used for diagnosis. Empirical evidence of more widespread 
cerebral involvement can be found through MRI, where lesions indicate areas of damage; either T1 
Gadolinium-enhanced brain lesions, showing currently active areas of MS, or T2 lesions which 
may, in addition, show older or inactive lesions (van Waesberghe et al 1998). With evidence of 
elevated immunoglobulin G in the cerebrospinal fluid also a notable indicator (Polman et al 2011) 
of the disease. 
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Figure 2.2 Magnetic Resonance Imaging of damaged MS brains. 
Arrows indicating Gadolinium enhancing; T1 (left) T2 (right) lesions  (EMD Serono 2012) 
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Table 2.1 Diagnostic criteria for MS 
Clinical Presentation Additional Data Needed for MS Diagnosis 
 Two or more attacks 
(relapses) 
Two or more objective 
clinical lesions 
None; clinical evidence will suffice (additional evidence desirable but must be 
consistent with MS) 
Two or more attacks 
One objective clinical 
lesion 
Dissemination in space, demonstrated by: 
MRI  
 or a positive CSF and two or more MRI lesions consistent with MS 
 or further clinical attack involving different site 
2010 Amendment:  Dissemination in Space (DIS) can be demonstrated by the 
presence of 1 or more T2 lesions in at least 2 of 4 of the following areas of the 
CNS: Periventricular, Juxtacordial, Infratentorial, or Spinal Cord. 
One attack 
Two or more objective 
clinical lesions 
Dissemination in time, demonstrated by: 
MRI 
or second clinical attack 
2010 Amendment:  No longer a need to have separate MRIs run; 
Dissemination in time, demonstrated by: Simultaneous presence of 
asymptomatic gadolinium-enhancing and nonenhancing lesions at any time; or a 
new T2 and/or gadolinium-enhancing lesion(s) on follow-up MRI, irrespective 
of its timing with reference to a baseline scan; or Await a second clinical attack. 
 One attack 
* One objective clinical 
lesion 
(clinically isolated 
syndrome) 
2010 Amendment:  Dissemination in space demonstrated by: 
For Dissemination in Space: 1 or more T2 lesion in at least 2 of 4 MS-typical 
regions of the CNS (periventricular, juxtacortical, infratentorial, or spinal cord); 
or Await a second clinical attack implicating a different CNS site; and  
Dissemination in Time: Simultaneous presence of asymptomatic gadolinium-
enhancing and nonenhancing lesions; or a new T2 and/or gadolinium-enhancing 
lesion(s) on follow-up MRI, irrespective of its timing with reference to a 
baseline scan; or a second clinical attack. 
Insidious neurological 
progression 
suggestive of MS 
(primary progressive 
MS) 
One year of disease progression (retrospectively or prospectively determined) 
and Two or three (2010 Amendment) of the following:     
Positive brain MRI (nine T2 lesions or four or more T2 lesions with positive 
VEP)     
Positive spinal cord MRI (two focal T2 lesions) or  Positive CSF 
 
Adapted from McDonald et al(2001) and Polman et al (2011).  
MRI – Magnetic Resonance Imaging, CSF – Cerebrospinal Fluid, T2 – Lesion indicating evidence of MS, 
VEP - Visual Evoked Potentials (evidence on brain activity) 
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MS is commonly described as one of several clinically defined types, which describe the course of 
the disease. However, it is not necessarily a natural progression from one to the next, and often a 
clear classification of type of MS cannot be made. Relapsing-remitting MS, is the most common 
(80% of people at onset, National Institute for Health and Clinical Excellence; NICE (2003)), 
manifesting in a relapse of symptoms followed by periods of remission. Secondary progressive MS 
describes cases where fewer periods of remission occur and neurological deficits progressively 
worsen. NICE (2003) indicates that about 50% of people diagnosed with relapsing remitting MS 
develop the secondary progressive form within 10 years. Primary progressive MS is the least 
common (10-15% of people at onset, NICE (2003)), in this form neurological deficits progressively 
worsen from the onset (Talbot 2010). Primary progressive MS may differ to other types of MS in 
the underlying damage within the immune system. Whereby milder inflammatory damage occurs 
overtime, with the accumulation of disability being ultimately more progressive, rather than the 
clear relapsing pattern more commonly seen (Compston and Coles 2002). However some people 
with more progressive MS may also experience occasional relapses, and thus a subsidiary form of 
Primary progressive MS, which has no clear definition, is Progressive relapsing MS,  whereby 
relapse occurs alongside progression of the disease, and subsequent disability (Lublin and Reingold 
1996). Another form of MS, when there has been no change in any neurological systems for 15 
years or more is known as benign MS (Lublin and Reingold 1996). The pattern of clinical 
symptoms and descriptors is complex, variable and unpredictable; however, the types are displayed 
in Figure 2.3. 
 
. 
Figure 2.3 Clinical types of  MS  
(adapted from Lublin and Reingold (1996)) 
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2.2.2 Epidemiology and prevalence  
MS is the most common progressive neurological disease affecting young people, it is more than 
twice as common in women than men, with disease onset usually in the third or fourth decade of 
life (Compston and Coles 2002). Life-expectancy is around 25 years following diagnosis, but is 
nearing that of the general population (Confaxreux & Compston, 2004),  with most people dying of 
unrelated causes (Compston and Coles 2002).  
The cause of the disease is unknown, despite a genetic predisposition (Compston and Coles 2002). 
Environmental factors such as infections, diet, country of birth and country of residence are also 
amongst the most common risk factors and are discussed in detail by Ascherio and Munger  
(2007a; 2007b) and Handel et al (2010a; 2010b). Linked with both the genetic and environmental 
risk factors, the prevalence of MS varies around the world, found most commonly in countries 
populated by those of primarily European ancestry, such as Ireland, the United Kingdom, South 
East Australia, New Zealand, Sweden, Finland and Southern Canada/Northern United States 
(Compston and Coles 2008). In Europe the UK is estimated to have the highest prevalence , with 
up to 250 cases per 100, 000 people having been reported in a past Scottish study  (Poskanzer et al 
1980).  This is high since the prevalence of MS is deemed to be high if there are more than 60 cases 
of MS in a population of 100,000 people (Olek 2008). 
It was first observed by Dr Bramwell in 1903, that there was an unusually high rate of MS within 
his Edinburgh practice in comparison with America (McDonald 1986). Since then many studies 
have looked at this interesting observation. Scotland, in particular, has reportedly high prevalence 
rates. With reports of 127-250 cases per 100,000, in different studies around the country (cited in 
Rothwell and Charlton (1998)), compared to studies in England and Wales where prevalence rates 
are lower, ranging from 99 cases per 100,000 (Roberts et al 1991) to 146 cases per 100,000 (Hirst 
et al 2009). The primary study by Rothwell and Charlton (1998) found a prevalence rate in the 
Scottish region of Lothian to be 203 cases per 100,000. Researchers have had difficulty explaining 
the higher rates of MS found in Scotland, however there has been an increased interest in this area 
in recent years, with tentative explanations surrounding Vitamin D deficiency, lower levels of 
sunlight and diet (Ebers 2008; Handel et al 2010b) in addition to genetics. 
2.2.3 Clinical features 
Clinical features and symptoms vary amongst those who have MS. Clinical features may include; 
fatigue, mobility impairments, weakness, balance impairments, stiffness and spasms, memory and 
other cognitive problems, bladder and bowel problems, pain and unpleasant sensations, emotional 
problems, visual changes, and dizziness (Motl et al 2008b). Symptoms can be heterogenic, for 
Literature Review 
23 
 
example mobility impairments may range from slight leg weakness to being fully wheelchair 
dependant. 
A study of 301 people with MS living in Wales provided information on the frequency of 
symptoms  (Matthews 1998) displayed in Table 2.2. This table not only highlights the most 
common symptoms (weakness, sensory symptoms, ataxia, bladder symptoms, and fatigue), 
amongst those with MS whilst indicating that not all symptoms may be present throughout the 
course of the disease.  
 
Table 2.2 Frequency of symptoms  
Symptom Ever (n (%)) At onset (n (%)) 
Weakness 268 (89) 66 (22) 
Sensory Symptoms 263 (87) 103 (34) 
Ataxia 248 (82) 32 (11) 
Bladder Symptoms 213 (71) 5 (2) 
Fatigue 171 (57) 5 (2) 
Cramps 156 (52) 2 (0.6) 
Diplopia  155 (51) 25 (8) 
Visual symptoms 148 (49) 38 (13) 
Bowel Symptoms 126 (44) 0 
Dysarthria 110 (37) 2 (0.6) 
Vertigo 107 (36) 13 (4.3) 
Facial pain 106 (35) 5 (2) 
Poor memory 96 (32) 1 (0.3) 
Headache 90 (30) 6 (2) 
Mental symptoms 68 (23) 1 (0.3) 
Deafness 51 (17) 2 (0.6) 
Facial weakness 48 (16) 4 (1) 
Dysphagia 40 (13) 1 (0.3) 
Data from Matthews (1998) 
 
2.2.4 Predicting prognosis 
The Expanded Disability Status Scale (EDSS) (Kurtzke 1983) is the most widely used measure of 
disability for MS. It describes both neurological and functional aspects of the disease. The scale 
quantifies neurological impairments, in each of eight neurological functional systems (FS); 
pyramidal, cerebellar, brainstem, sensory, bowel and bladder, visual, cerebral and other. These are 
combined with ambulation ability/mobility and give a measure of disability on a scale from 0 
(normal) to 10 (death due to MS) (See Appendix 9.1). In general, as the number of symptoms 
increases so will the EDSS level. 
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The EDSS has, for many years attracted criticism (Section 3.7.2), despite this it is still a commonly 
used tool clinically and in research allowing for comparison between study populations. Authors 
have noted a poor response to change (Sharrack et al 1999) and that scores are clustered around 3/4 
and 5/6 (Whitaker et al 1995; Jacobs et al 1999). Grades above three are heavily reliant on 
mobility, thus at the higher end of the scale a newly acquired FS problem may not necessarily 
modify the EDSS score.  
The definitions of mild, moderate and severe MS are often  linked with the EDSS, however the 
original author (Kurtzke 1983) did not use these definitions. Moderate MS, defined in the present 
study as 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance 
required to walk about 20m and without resting) was the description used by Freeman et al (1997) 
and Hammond et al (2000). However there is a discrepancy in the literature as moderate MS has 
been described by others as an EDSS score of 5-7 (Filipi et al 2011),  4-6 (Craig et al 2003) or 3-4  
(Goldman et al 2008).  
Higher levels of disability have been associated with a poorer prognosis, and faster disease 
progression (Cottrell et al 1999). A prevalence study showed that persons with milder  MS (EDSS 
0-3) at initial disease diagnosis, have a much better prognosis than  those with moderate or severe 
MS (EDSS 4-9) (Hammond et al 2000). These authors also found that an increased number of 
multiple symptoms at disease onset  had a negative effect on prognosis.  
Brain imaging (MRI) is also increasingly used to predict prognosis. It has been shown in a 20 year 
follow-up study that more damage to the brain at baseline (number of T2 lesions) is associated with 
a higher disability score after 20 years (Fisniku et al 2008). However brain imaging is not utilised 
within this thesis and thus will not be explored in any depth. 
2.2.5 Treatments for Multiple Sclerosis symptoms 
As has been discussed MS symptoms and prognoses vary widely, and thus there is no one specific 
treatment, although many options are available. These will be discussed in brief and taken from the 
National Institute for Health Clinical Excellence (2003) guidelines of acute exacerbations and long-
term management in MS, with updates to these guidelines acknowledged as appropriate. 
Management of acute exacerbations 
When a severe exacerbation or attack of symptoms occurs medical treatment such as 
corticosteroids are often administered, and hospitalisation may be necessary dependent on the 
severity of the exacerbation. Corticosteroids will often be administered (intravenous or high dose 
oral methylprednisolone) for 3-5 days. Rehabilitation will target the sudden increase in disability, 
with referral to the appropriate specialist within the rehabilitation service.  
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Long-term management 
Where relapses are the predominant feature of the disease, as in Relapsing-remitting MS, National 
Institute for Health and Clinical Excellence (2003) guidelines suggest that patients are offered 
disease modifying therapy (DMT), either interferon beta or glatiramer acetate under the guidance 
of their neurologist. Other medical treatments which include azathioprine, mitoxantrone, 
intravenous immunoglobulin, plasma exchange and intermittent methyprednisolone should be 
prescribed judiciously if appropriate. Updates to these guidelines suggest that natalizumab be 
prescribed to rapidly evolving cases of severe relapsing remitting MS (National Institute for Health 
and Clinical Excellance 2007) . Whilst fingolimod has recently been recommended for those with 
highly active relapse-remitting MS  (National Institute for Health and Clinical Excellence 2012). 
Maintaining functional activities and social participation is important and can be managed through 
rehabilitation. Assessment and access to a multidisciplinary neurological rehabilitation service is 
important. This will offer early intervention of any change in symptoms, whilst offering disease 
management to minimise the impact of disease progression.  
It is advised by National Institute for Health and Clinical Excellence (2003) that as a minimum the 
following specialists are involved in a multidisciplinary neurological rehabilitation service: 
• Doctors  
• Nurses 
• Physiotherapists 
• Occupational Therapists 
• Clinical Psychologists  
• Social workers
These services will aim to maintain the person with MS in their chosen vocational activity, 
encourage leisure and social interaction, maintain mobility, maintain activities of daily living and 
help manage symptoms (such as those referred to in Table 2.2). 
2.2.6 Symptom management in Multiple Sclerosis 
Within this thesis, the role of therapeutic exercise will be the primary focus related to symptom 
management. The medical and pharmacological treatments for managing MS symptoms will 
therefore not be discussed in great depth, however the interested reader is referred to the following 
texts. 
Khan et al (2008b) provides a comprehensive review of the common multidisciplinary therapy 
approaches to management in MS, finding that multidisciplinary approaches are effective in 
managing MS, although no recommendations on optimum dose or type of therapy to guide best 
practice emerged.   
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Thompson et al (2010) provides a good source of reference for multidisciplinary therapy 
approaches (including occupational therapy and physiotherapy),  pharmacological and surgical 
treatments in MS to address symptoms such as; spasticity, ataxia, impaired mobility, bladder/bowel 
and sexual dysfunction, fatigue, cognitive problems, mood disturbance, visual and brainstem 
symptoms. The authors conclude that a diverse range of management options are available and 
should be utilised when appropriate. They acknowledge that although there are promising 
treatments on the horizon, improvement in study design is required before recommendations in 
clinical practice can be made.  
Freedman et al (2002) provide a consensus statement on the use of DMTs in MS, with other 
authors updating these guidelines  (Wiendl et al 2008; Goodin 2008). The recommended DMTs for 
MS are interferon beta, glatiramer acetate, mitoxantrone, natalizumab and fingolimod (National 
Institute for Health and Clinical Excellence 2003; National Institute for Health and Clinical 
Excellance 2007; National Institute for Health and Clinical Excellence 2012). These treatments can 
positively influence the signs and symptoms of the disease, reduce the frequency and severity of 
relapse rates and minimise accumulation of brain lesions, as evidenced through MRI. Each 
medication does however have known side effects, which must be considered.  
However there is a consensus in all of the above works that a multimodal approach is taken 
towards management in MS, combining medical, pharmacological and therapeutic intervention. 
One of which, therapeutic exercise, is the focus of this thesis. 
2.2.7 Therapeutic exercise for Multiple Sclerosis 
Therapeutic exercise is an integral therapeutic intervention to help manage those with MS (Doring 
et al 2011), thus it is an important treatment for MS, recommended by health professionals such as 
physiotherapists.  
Physiotherapy is therapy delivered by a qualified physiotherapist, to promote physical, 
psychological and social wellbeing, based on the needs of the patient/participant established 
through the physiotherapist’s focussed assessment (Thornton 1996; Chartered Society of 
Physiotherapy 2005). This may include therapeutic exercise or other therapies or modalities such as 
hands-on treatment, aquatic-based therapy or assisted mobility aids.  
Therapeutic Exercise is the “prescription of a physical activity program that involves the client 
undertaking voluntary muscle contraction and/or body movement with the aim of relieving 
symptoms, improving function or improving, retaining or slowing deterioration of health” (Taylor 
et al 2007) . 
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Within this context Physical Activity is any bodily movement produced by skeletal muscles 
resulting in energy expenditure. Exercise is a planned, structured and repetitive  physical activity 
with a goal of maintaining or improving physical fitness (Caspersen and Christenson 1985). There 
is reason to believe that exercising specifically to improve symptoms of MS is worthwhile and, as 
will be explained during the literature review, may offer a management approach to the 
deconditioning associated with the disease over time. In addition to managing symptoms, exercise 
and increased physical activity may go some way to preventing age-related health conditions 
associated with a sedentary lifestyle.    
There are reports in the literature to suggest that those with MS are more sedentary than their 
healthier peers (Mostert and Kesselring 2002; Motl et al 2005; Sandroff et al 2012). Therefore, 
those with MS may be at the same, or perhaps greater, risk of age-related health conditions 
associated with a sedentary lifestyle   (Bronnum-Hansen et al 2004; Marrie et al 2008). 
Consequently increasing the burden on health services and increasing mortality rates, as the 
combination of inactivity and ageing not only increases the general risk of osteoporosis, diabetes 
and coronary problems in those with MS, but may worsen the impact of more disease-specific 
problems, such as fatigue, mobility impairment, balance deficits, weakness and stiffness. All of 
which are common problems in MS (Ponichtera et al 1992; Matthews 1998; Frzovic et al 2000; 
Compston and Coles 2008; Motl et al 2008b).  
Therefore increased physical activity and exercise should be promoted throughout all stages of the 
disease, which has not always been the case. 
2.2.8 A historical look at therapeutic exercise for Multiple Sclerosis  
Historically the importance of therapeutic exercise was not always acknowledged in MS 
management. McAlpine et al (1955) stated that physiotherapy had previously been prescribed as a 
placebo until rehabilitation was found to have a “remarkable effect” during the war years in those 
with traumatic paraplegia, and thus it was used for other causes of paraplegia, such as MS. The 
progression towards active rehabilitation through therapeutic exercise seen today can be charted by 
the writings of Douglas McAlpine, Nigel Compston and Charles Lumsden, arguably recognised as 
the most authoritative authors in MS.  In early writings the advice to patients supported healthy 
activity, with the authors commenting that “on common-sense grounds alone” a normal weight 
should be maintained (McAlpine et al 1955). Furthermore they acknowledged that routine exercise 
contributed to maintaining good health, however bed rest (for up to two weeks) during symptom 
relapse was recommended. Rehabilitation advice for those with more ongoing symptoms was 
limited to spasticity management, such as positional changes, standing with abducted legs and 
lying prone (McAlpine et al 1955). Similar to today’s practice it was acknowledged that patients 
should be discharged from hospital with instructions to help them carry out daily activities; these 
may have included maintenance exercises.   
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In the late 1960s Russell and Palfrey (1969) gave specific details of an MS exercise programme, 
tailored to the individual patient and provided guidance to other therapists and patients on carrying 
out exercise. Admitting the obvious weakness of assessing short-term improvements of a relapsing 
remitting disease and chronic progressive disease these authors took a long-term approach to their 
intervention. Over a period of eight years they encouraged 69 patients with many differing types of 
MS to exercise daily, provided record cards for them to maintain, and assessed their progress 
yearly. Their sole outcome measure, a six scale mobility assessment taken from McAlpine & 
Compston (1955), showed improvement in 41 participants, with no change in the remainder. This 
study lacked controls, blinding, statistical strength and validated outcome measures and would not 
withstand contemporary reviewers, nevertheless it illustrates the success of therapeutic exercise 
treatment of at least one specialist neurorehabilitation centre during the 1960s. 
By the 1980s a short section in the McAlpine series of books was dedicated to physiotherapy, with 
the lack of published data on the merits of physiotherapy treatment being acknowledged (Matthews 
1985). 
More recently Noseworthy et al (2006) writing in the latest McAlpine publication, acknowledged 
the importance of exercise in MS management:  
“Patients should be encouraged to enter a graded exercise programme to optimize 
fitness” (p718)  
 “…the introduction of drug treatment in parallel with neurorehabilitation offers a 
better chance for the rehabilitation intervention to result in sustained benefits to the 
patients” (p727).  
In summary although therapeutic exercise has not always been recommended for those with MS, its 
importance is becoming increasingly recognised to both manage the symptoms of the disease 
whilst also addressing the long-term general health of those with MS.  
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2.3 Therapeutic exercise for Multiple Sclerosis today 
Physiotherapy is one of the main health professions involved in the rehabilitation of MS (Khan et 
al 2008b), with qualitative findings suggesting people with MS would feel more confident 
exercising with support from a physiotherapist (Dawes et al 2010).  Indeed UK-based survey 
studies suggest that between 21% and 44% of people with MS have contact with a physiotherapist  
(Freeman and Thompson 2000; Vazirinejad et al 2008). Although it is accepted, that physiotherapy 
treatment is not only exercise based (see below), prescribing therapeutic exercise is a large aspect 
of physiotherapy treatment. Furthermore, there is evidence that those with MS want to learn more 
about exercise options (Somerset et al 2001; Hepworth and Harrison 2004), suggesting a 
therapeutic exercise intervention may be well received by people with MS. 
There is growing evidence and support for therapeutic exercise to be delivered not only by 
physiotherapists but also other exercise professionals. Indeed cross-organisational options for 
patient management are encouraged by current guidelines on MS care and general health guidelines 
(National Institute for Health and Clinical Excellence 2003; Scottish Executive 2007; Scottish 
Government 2007). With physiotherapy and the fitness industry both playing a role in symptom 
management and improving the health of those with MS (Figure 2.4). Furthermore, the current 
social, political and economical landscape encourages community-based rehabilitation where 
therapeutic exercise can be done in a non-hospital setting (Romberg et al 2004; Romberg et al 
2005).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Relationship between physiotherapy and the exercise profession in MS management 
 
The following sections review and describe the available evidence for therapeutic exercise 
interventions in MS.  
Symptom 
management 
 and health 
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2.3.1 Identification of studies in the literature review 
A systematic method was adopted to identify therapeutic exercise studies discussed in this review 
of the literature. In addition to relevant textbooks and government publications, online databases 
including the Cochrane database of Systematic reviews, Ovid-Medline, Ovid-Embase and Google 
Scholar were searched for published articles.  
Key words searched included were Multiple Sclerosis, Rehabilitation, Exercise, Exercise-therapy, 
Physiotherapy, Physical Therapy, Aerobic, Strength, Resistance, Balance, Focus Groups, 
Qualitative and Reliability. These were combined and truncated versions of the key words were 
also used. The main search covered most recent papers (2005 – March 2012), however older papers 
of interest were also included.  
The above searches were carried out on a three-monthly basis throughout the time of the PhD 
study. Email updates were sent to the thesis author from relevant journals and from Ovid related to 
the keywords. Social media (i.e. Twitter posts) was also utilised to remain updated on the current 
literature, by following researchers and charities who posted examples of new research related to 
MS. 
2.3.2 Studies not included in the literature review.  
To focus the literature review only studies involving therapeutic exercise with 1) an aerobic 
exercise intervention, 2) a resistance exercise intervention or 3) a combined exercise intervention 
methodology were reviewed. As a group and community based methodology was adopted in the 
study this was also important in the review of the research. As such the following criteria were 
adopted for exclusion of studies from the literature review. 
• Any study involving in-patient therapy, which is classified as any stay over 24 hours in 
either a specialist rehabilitation centre or hospital ward. 
• Any study including an intervention of only one day. 
• Any study involving health professionals visiting and delivering interventions in the 
participants’ own home. 
• Any study where the intervention was delivered over the internet. 
• Any study involving evaluation of a multidisciplinary approach (e.g. physiotherapy, 
occupational therapy, speech therapy and input from a neurologists and nurses). 
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• Any study where a hands-on/passive therapeutic approach (when the therapist moves the 
patient’s body whilst they are inactive) was the main component of the intervention. 
• Any study where the intervention was mainly pharmacological. 
• Any study where the intervention was primarily of a didactic/educational nature.  
• Any study whereby the intervention was mainly aquatic based exercise or based on 
breathing exercises. 
• Any study which did not assess functional or psychological outcome measures. 
2.3.3 Quality of the literature 
Ranking the studies against standardised criteria offers some comparison of quality for researchers 
and clinicians to use when carrying out evidence based research/practice.  
To help establish the quality of the quantitative evidence base, all literature which included a 
randomised control design was entered into the Physiotherapy Evidence Database PEDro which 
assesses trials independently for methodological quality. The PEDro is an online tool based on The 
Delphi List for assessing the quality of randomised clinical trials (Verhagen et al 1998) which can 
be accessed at (www.pedro.org.au). The PEDro system considers the methodological quality of the 
study based on “believability” (internal validity) and whether enough detail is provided to interpret 
the outcome of the study.  
For internal validity, criteria are; acknowledging eligibility, random allocation, concealed 
allocation, similarity at baseline, subject blinding, therapist blinding, assessor blinding, analysis of 
intention to treat and adequacy of follow-up (85% for at least one key outcome). For 
interpretability, criteria are; between group statistical comparisons of at least one key outcome and 
reports of point and variability measurements for at least one key outcome. Together these criteria 
provide a total of 11 points.  
Utilising the PEDro system has two direct benefits, firstly it allows comparison of the 
methodological quality across similar studies and secondly it will help in the developmental stage 
of any new study of an  intervention based randomised control trial, to improve methodological 
quality and reporting. Thus the PEDro system was referred to when developing the main study in 
this thesis. The PEDro system has been shown to adequately measure methodological quality of 
clinical trials (de Morton 2009) and to display acceptable reliability of the total score (Maher et al 
2003). The total scores for the randomised clinical trials included in this literature review are given, 
providing comparable evidence on the quality of the background literature. 
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To help establish the quality of the qualitative evidence, relevant studies were critically appraised 
using the Critical Appraisal Skills Programme (CASP) qualitative research appraisal tool (available 
online at www.caspinternational.org). This helps to consider; validity of the results, the results 
themselves and the relevance of results. Ten questions cover these areas; study aims, 
appropriateness of methodology, appropriateness of research design, recruitment, data collection, 
relationship between the researcher and participant, ethical considerations, data analysis, findings 
and relevance (value) of the research. Unlike the PEDro system, scoring is not absolute and it is not 
necessary to score the research, however the tool allows comparison of quality between studies.  
2.3.4 Systematic reviews and meta-analysis of therapeutic exercise  
Many review articles have been written which evaluate therapeutic exercise in MS (Rietberg et al 
2004; Karpatkin 2005; Heesen et al 2006a; Dalgas et al 2008; Motl and Gosney 2008; Garrett and 
Coote 2009; Hogan and Coote 2009; Snook and Motl 2009; Andreasen et al 2011; Dalgas and 
Stenager 2011). 
This section will summarise the reviews of the studies related to exercise therapy. A summary of 
the reviews, and the reviewed studies discussed within them can be found in Table 2.3. During this 
section any study included in the reviews, which is not thought relevant to this thesis will not be 
discussed (refer to Section 2.3.2). 
General reviews on the effects of exercise in MS have been written (Karpatkin 2005; Heesen et al 
2006b). However Rietberg et al (2004) carried out a review on general therapeutic exercise in MS. 
In this review only RCT’s which concerned rehabilitation, physical therapy, training and home 
physiotherapy in MS were included (Table 2.3), to ascertain the effects of these on activities of 
daily living and/or quality of life. All study participants were mild to moderately disabled (EDSS 
≤6.5). Rietberg et al’s (2004) review concluded that exercise based rehabilitation which covers 
many forms of interventions/exercise types, including more traditional impairment and mobility 
physiotherapy approaches, as well as aerobic and resistance training can be beneficial for those 
with MS. 
Since then various authors have built on the work of Rietberg and colleagues. Snook and Motl 
(2009) carried out a meta-analysis of therapeutic exercise related to walking mobility. Interventions 
and exercise types varied, and included physiotherapy based, aerobic exercise based and resistance 
exercise based (Table 2.3). The mean effect size of the included studies varied widely. Reporting 
effect size is becoming more common in studies in MS, they are a scale free measure of the relative 
size of the effect of an intervention (Coe 2002). Snook and Motl (2009) found the combined 
estimate of the effect size from the meta-analysis (g=0.19) showed a trend toward exercise being 
beneficial for mobility, which, at the 95% confidence interval level,  which suggests a small effect 
size.  
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Studies of physiotherapy interventions  (Hogan and Coote 2009) and aerobic and resistance 
exercise interventions   (Hogan and Coote 2009; Garrett and Coote 2009) have been reviewed in 
people with wide ranging mobility problems. These researchers used the Cochrane criteria for 
assessing the quality of the literature, but unlike a traditional Cochrane review they aimed to 
include all studies with a view to reporting on clinical applicability. Hogan and Coote (2009) 
reported on therapeutic interventions for those more disabled (EDSS≥6); aerobic exercise, 
resistance exercises and physiotherapy were included (Table 2.3). They reported similar findings to 
the other reviews; that these interventions have positive benefits for those with MS with mobility 
problems. Hogan and Coote (2009) highlight the need to carry out similar research in MS, 
specifically, looking at the effects stratified to level of mobility and disability.  
Garrett and Coote  (2009) reviewed studies of exercise interventions which included participants 
who had milder disability (EDSS ≤6). With a focus on making the review clinically relevant, the 
studies were presented using Frequency, Intensity, Type and Time (FITT) a common acronym used 
in exercise training (Franklin et al 2000).  Garrett and Coote  (2009) found that, similar to other 
reviews, exercise interventions are beneficial for those with MS, who have milder disabilities. 
To establish recommendations for the application of resistance, endurance (aerobic) and combined 
exercise training in MS, Dalgas et al (2008) reviewed many therapeutic exercise studies (Table 
2.3). The majority of their reviewed trials looked at aerobic exercise (endurance) (Table 2.3). By 
choosing to look at exercise as a health promoting intervention, and not a therapeutic approach, 
Dalgas et al’s (2008) review actively excluded physiotherapy. Strict inclusion criteria were also 
applied to this review; only studies using a longitudinal evaluation of an exercise intervention were 
included, and only those whose interventions could be categorised as either endurance, resistance 
or combined exercise were included, in addition this review included one qualitative study.  
The authors did not state what the criteria for a longitudinal design were, although trials ranging 
from 4 – 26 weeks were included. As length of programme was important within Dalgas et al’s 
(2008) review, it is disappointing that the authors failed to comment on the longer term effects of 
the intervention, following completion of the intervention. However, they did provide information 
on training regimes studied and basic results. In general the findings suggest that patients mildly to 
moderately affected by MS can safely tolerate low to moderate endurance training and moderate 
resistance training; however more evidence is required for combined training. This information 
however can only be applied to those mildly to moderately affected with MS, as no trials included 
any participant with an EDSS score of greater than seven. A narrative stance was present 
throughout the review; some critique was present with the authors concluding that the quality of 
evidence is poor. However no attempt was made to rank the quality of the studies, which allows 
more objective comparisons. 
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Motl and Gosney (2008) took a different stance in an earlier meta-analysis of exercise studies. 
They looked at the effects of exercise on health-related quality of life and fatigue in those with MS. 
The majority of trials which were included involved aerobic training for three months or less 
(Table 2.3). Overall a small improvement in quality of life was found, with more improvement in 
shorter interventions. When the effect size was calculated and compared with similar meta-
analyses, the effect of exercise training was comparable (in magnitude) with the effects of DMTs 
on reducing exacerbations of MS (Filippini et al 2003). It was also comparable to  the effects of 
long term exercise on mental health outcomes (Colcombe et al 2006) and fatigue ( Puetz et al 2006 
cited in Motl & Gosney (2008)). However it is unknown which type/level of MS this information 
applies, as the authors failed to report this, or any demographic data on the participants in the 
analysed trials. It is disappointing that the disease type was unreported, as direct comparison 
between DMTs (not given to those with secondary progressive MS) cannot be made without this 
information.  
Asano et al (2009) also carried out a meta-analysis, with the aim of establishing the strength of 
current evidence guiding regular exercise prescription. One feature of this review different from 
that of Motl and Gosney (2008) was that only trials whose main outcome was quality of life were 
included. The benefits of focusing like this mean that, if included trials are statistically powered to 
show changes in quality of life (as the main outcome) then stronger statements can be made about 
the overall results. Unfortunately of all the trials included in this meta-analysis none were 
sufficiently powered to show these effect changes. Two of the trials (Oken et al 2004; Storr et al 
2006) attempted to recruit enough patients to show meaningful changes in quality of life, however 
neither achieved their target recruitment. The remaining five trials did not acknowledge power in 
relation to quality of life.  
A problem, present throughout all the MS exercise literature is the variety of outcome measures 
used (discussed in more depth in Chapter 3). This is highlighted in the work of Asano et al (2009) 
which found, across the included trials, seven different tools used to measure quality of life. 
Realistic comparison, and any attempt to meta-analyse the results across different trials is difficult 
if numerous different outcome measures are used. Ideally, if a consensus were made on which 
outcome measures should be used in future trials in MS then true effect changes could be 
confirmed by the exercise interventions. However with the available data Asano and colleagues 
could only show that although there is evidence of symptoms improvement after exercise there is 
insufficient evidence to offer clinical guidelines. With the available evidence only applicable to 
those mildly affected by MS (EDSS ≤ 5). This is not only due to the differing outcome measures 
but also due to the varying methodologies and interventions which make it difficult to recommend 
any specific training guidelines. 
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However when reviewing the impact of exercise on self-reported fatigue levels in MS Andreasen et 
al (2011) found more agreement in the fatigue outcome measures used. Only four different 
outcome measures were used across the 20 reviewed studies; the Fatigue Severity Scale (FSS) was 
the most common fatigue outcome measure. The review took a descriptive narrative, with limited 
discussion on the quality of the studies; furthermore the authors did not attempt to calculate the 
effect of the interventions on fatigue. Two qualitative studies were also included in the descriptions 
of past studies (Table 2.3). Andreasen et al (2011) concluded that exercise had the potential to 
improve fatigue, but were unable to draw conclusions as the appropriate FITT of exercise to best 
help manage fatigue 
More recently Dalgas et al (2011) reviewed the potential of exercise to alter the disease progression 
in MS, much of the work reviewed is based on empirical non-clinical outcomes (such as MRI 
analysis, relapse rate) or animal studies beyond the realms of this thesis. However the accumulated 
evidence discussed within the review paper supports a possibility that there is a disease modifying 
potential to therapeutic exercise in MS. 
There is much overlap between the reviews; however no trial appears in all reviews (Table 2.3). 
This not only reflects the variety of studies in this area, but also the different aims and methodology 
of the reviews/meta-analyses. The description of the interventions vary slightly throughout the 
reviews, with some providing more depth of information than others, resulting in some disparity as 
to the form of exercise. However in general all reviews agree that exercise has been found to be 
effective, to a certain extent, for those with mild to moderate MS symptoms. 
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Table 2.3 Chronological summary of reviews and reviewed articles  
Author Short aim Reviewed studies 
Rietberg et 
al (2004) 
Exercise on daily 
living and quality 
of life in MS  
Petajan et al (1996)p a 
Mostert and Kesselring (2002)a r 
O’Connell et al (2003)a 
Debolt and McCubbin (2004)r 
Heesen et 
al (2006) 
General 
discussion on 
exercise in MS 
Petajan et al (1996)p a 
Mostert and Kesselring (2002)a r 
Carter and White (2003) a r c 
O’Connell et al (2003)a 
Debolt and McCubbin (2004)r 
Oken et al (2004)a 
Schulz et al (2004)a 
Romberg et al (2005)a r  
Karpatkin 
(2006) 
General 
discussion on 
exercise in MS 
Petajan et al (1996)p a 
Mostert and Kesselring (2002)a 
Rodgers et al (1999)a 
Harvey et al (1999)r 
Kraft et al (1996)r 
Dalgas et 
al (2008) 
Exercise 
recommendations 
in MS 
Schapiro et al (1988)a 
Kasser and McCubbin (1996)r 
Kraft et al (1996)r 
Petajan et al (1996)p a 
Ponichtera-Mulcare et al (1997)a 
Harvey et al (1999)r 
Fisher et al (2000)r 
Mostert and Kesselring (2002)a 
O’Connell et al (2003)a 
Carter and White (2003)a r c 
Debolt and McCubbin (2004)r 
Oken et al (2004) a 
Romberg et al (2004)a r c 
Romberg et al (2005)a r c 
Schulz et al (2004)a 
White et al (2004)r 
Gutierrez et al (2005)r 
Kileff and Ashburn (2005)a 
Rasova et al (2006)a 
van den Berg (2006)a 
Dodd et al*(2006)r 
Taylor et al (2006)r 
Motl and 
Gosney 
(2008) 
Exercise on 
quality of life in 
MS 
Petajan et al (1996)p a 
Mostert and Kesselring (2002)a 
White et al (2004)r 
Oken et al (2004)a 
Schulz et al (2004)a  
Romberg et al (2005)a r  
van den Berg (2006)a 
Rasova et al (2006)a 
Asano et al 
(2009) 
Exercise on 
quality of life in 
MS  
Petajan et al (1996)p a 
Harvey et al (1999) r 
Schulz et al (2004)a 
Oken et al (2004)a 
Romberg et al (2004)a r  
Debolt and McCubbin (2004)r 
van den Berg (2006)a 
Storr et al (2006)p 
Rampello et al (2007)a  
Garrett and 
Coote 
(2009) 
Exercise in less 
disabled MS 
Oken et al (2004)a 
Schulz et al (2004)a 
Romberg et al (2004)a r  c 
Romberg et al (2005)a r c 
White et al (2004)r 
Gutierrez et al (2005)r 
Kileff and Ashburn (2005)a 
van den Berg (2006)r 
Taylor et al (2006) r  
Bjarnadottir et al (2007)p c  
 Newman et al (2007)a 
Rampello et al (2007)a 
McCullagh et al (2008)a  
Ayan Perez et al (2007)r  
Hogan and 
Coote 
(2009) 
Therapeutic 
interventions in 
more disabled MS 
Harvey et al (1999)r 
Rodgers et al (1999)a 
Mostert and Kesselring (2002)a 
Debolt and McCubbin (2004)r 
Oken et al (2004)a  
van den Berg (2006)a 
Rasova et al (2006)p a c 
 
Snook and 
Motl 
(2009) 
Exercise on 
walking in MS 
Petajan et al (1996)p a 
Rodgers et al (1999) a  
Debolt and McCubbin (2004)r 
Freeman and Allison (2004)p 
Oken et al (2004)a 
Romberg et al (2004)a r 
Schulz et al (2004)a 
White et al (2004)r 
Gutierrez et al (2005)r 
Kileff and Ashburn (2005)a 
Romberg et al (2005)a r 
van den Berg (2006)a 
Rasova et al (2006)a 
Taylor et al (2006) r 
Ayan Perez et al (2007)r 
Bjarnadottir et al (2007)p  
Newman et al (2007)a 
Rampello et al (2007)a 
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Author Short aim Reviewed studies 
Andreasen 
et al 
 (2011) 
Exercise on 
fatigue in MS 
Petajan et al (1996)p a 
Mostert and Kesselring (2002)a 
Oken et al (2004)a 
Schulz et al (2004)a 
White et al (2004)r 
Gutierrez et al (2005)r 
Kileff and Ashburn (2005)a 
Dodd et al*(2006)r 
van den Berg et al (2006)a 
Rasova et al (2006)a  
Newman et al (2007)a 
Rampello et al (2007)a 
Fragoso et al (2008) a r c 
McCullagh et al (2008)a r c 
Geddes et al (2009)a 
Plow et al*(2009b) a r c 
Smith et al*(2009) a r c 
Cakt et al (2010)c 
Dalgas et al (2010)r 
Dalgas et 
al (2011) 
Disease 
modifying 
potential of 
exercise  
Petajan et al (1996)p a 
Rodgers et al (1999) a 
White et al (2004)r 
Romberg et al (2004)a r c 
Romberg et al (2005)a r c 
Kileff and Ashburn (2005)a  
van den Berg et al (2006)a  
Bjarnadottir et al (2007)p  
Dalgas et al (2009) r 
Pilutti et al (2011) a 
 
*Qualitative studies  aaerobic/endurance exercise, ccombined exercise, pphysiotherapy  rresistance exercise 
pphysiotherapy intervention, as described by the authors of the review. Please note, due to exclusion of 
studies as explained in Section 2.3.2 not all studies included in the reviews appear in the above table. 
 
 
2.4 Therapeutic exercise programmes in MS 
The following sections will attempt to place in context the trials pertaining to the studies contained 
within this thesis, and not replicate the works of previous reviewers. The interested reader is 
directed to the reviews in the preceding section for greater detail. 
Studies involving therapeutic exercise will be discussed in relation to aerobic exercise, resistance 
exercise and combined exercise (which involves aerobic exercise, resistance exercise and/or 
another form of exercise). A discussion will then follow on the qualitative literature surrounding 
therapeutic exercise in MS. 
The following literature review discusses many studies; within this, a variety of different outcome 
measures were used for assessment. Table 2.4 provides a summary of the discussed outcome 
measures, and a reference to where further information can be found. As can be seen in Table 2.4 
physiological, functional and psychological status of participants have been measured in different 
assessments in past MS therapeutic exercise studies.  
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Table 2.4 Outcome measures used in the relevant studies. 
Outcome Measure (Abbreviation) Primary outcome 
assessed 
Relevant citation 
10-metre Walk Test (10MWT) Mobility Collen et al (1991) 
3-minute Step Test (3MWT) Mobility White et al (2004) 
500m Walk Test (500MWT) Mobility Schwid et al (1999) 
Dynamic Gait Index (DGI) Mobility Shumway-Cook and Woolacott 
(1995) 
Multiple Sclerosis Walking Scale 
(MSWS) 
Mobility Hobart et al (2003) 
Rivermead Mobility Index (RMI) Mobility Collen et al (1991) 
Six-minute Walking test  (6MWT) Mobility Butland et al (1982) 
Timed 25 Foot Walk Test (T25FW) Mobility Kalkers et al ( 2008) 
Timed Up and Go (TUG) Mobility Podsiadlo and Richardson 
(1991) 
Two-minute Walking Test (2MWT) Mobility Butland et al (1982) 
Activities-specific Balance 
Confidence (ABC) 
Balance Powell and Myers (1995) 
Berg Balance Scale (BBS ) Balance Berg (1989) 
Dizziness Handicap Inventory (DHI) Balance Jacobson and Newman (1990) 
Equiscale Balance Tesio et al  (1997) 
Falls Efficacy Scale (FES) Balance Yardley et al (2005) 
BAECKE Activity Questionnaire 
(BAQ) 
Physical activity Baecke et al (1982) 
PhoneFITT (PF) Physical activity Gill et al (2008) 
Chalder’s Fatigue Scale (CFS) Fatigue Chalder et al (1993) 
Fatigue Impact Scale (FIS) Fatigue Schwartz (1993) 
Fatigue Severity Scale (FSS) Fatigue Krupp  (1988) 
Modified Fatigue Impact Scale 
(MFIS) 
Fatigue Tellez et al (2005) 
Multidimensional Fatigue Inventory 
(MFI) 
Fatigue Smets et al (1995) 
Beck Depression Inventory (BDI) Mood/depression Beck et al (1961) 
Centre of Epidemiological Studies 
Depression Scale (CES-D) 
Mood/depression Hann et al (1999) 
Coopersmith Self-Esteem Inventory 
(CSEI) 
Mood/self-esteem Coopersmith (1989) cited in 
Navipour et al (2006) 
Hospital Anxiety and Depression 
Scale (HADS) 
Mood/anxiety and 
depression 
Zigmond and Snaith (1983) 
Major Depression Inventory (MDI) Mood/depression Olsen et al (2003) 
Multiple Sclerosis Self-Efficacy-Scale 
(MSSES) 
 
Mood/self-efficacy Rigby et al (2003) 
Profile of Mood States (POMS) Mood Oken et al (2004) 
State-trait Anxiety Inventory (SAI) Mood/anxiety Spielberger et al (1970) 
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Outcome Measure (Abbreviation) Primary outcome 
assessed 
Relevant citation 
Functional Assessment of MS 
(FAMS) 
Quality of Life Cella et al (1996) 
Hamburg Quality of Life 
questionnaire (HQOL) 
Quality of Life Gold et al (2001) 
Leeds Multiple Sclerosis Quality of 
Life scale (LMSQOL) 
Quality of Life Ford et al (2001) 
Multiple Sclerosis  Quality of Life 54 
(MSQOL) 
Quality of Life Morris (2000) 
Short-Form 36 Health Questionnaire 
(SF-36) 
Quality of Life Ware Jr and Sherbourne (1992) 
Sickness Impact Profile (SIP) Quality of Life Bergner et al (1981) 
World Health Organization Quality of 
Life-Bref (WHOQOL) 
Quality of Life Skevington et al (2004) 
Goal Attainment Scale (GAS) Goal attainment Kiresuk and Sjherman (1968) 
Barthel Index (BI) Disability Morris (2000) 
Environmental Status Scale (ESS) Disability Morris (2000) 
Expanded Disability Status Scale Disability Kurtze (1983) 
Functional Independence Measure 
(FIM) 
Disability Keith et al (1987) 
Guy’s Neurological Disability Scale 
(GNDS) 
Disability Sharrack and Hughes (1999) 
Multiple Sclerosis Functional 
Composite  (MSFC) 
Disability Cutter et al (1999) 
Mini Mental Status Examination  
(MMSE) 
Cognition Folstein et al (1975) 
Multiple Sclerosis Spasticity Scale – 
88 (MSSS) 
Spasticity Hobart et al (2006) 
Borg’s Rating of Perceived Exertion 
Scale (RPE) 
Exercise capacity Borg (1982) 
Modified Ashworth Scale (MAS) Spasticity Bohannon and Smith (1987) 
Multiple Sclerosis Impact Scale 
(MSIS) 
Physiological and 
psychological impact of 
disease 
Hobart et al (2001) 
Multiple Sclerosis Related Symptom 
checklist (MSRS) 
Disease symptoms Gulick (1989) 
Physiological Cost Index (PCI) Energy use Bailey and Ratcliffe (1995) 
 
A discussion follows on therapeutic exercise programmes in MS; aerobic exercise, resistance 
exercise and combined exercise. Due to the large volume of literature in this area a summary of the 
general literature will be made with depth of detail provided in Table 2.5-Table 2.7. However for 
those studies with similar methodology to the intervention in this thesis, primarily a combined-
exercise class for those with MS, a greater discussion will be undertaken. The RCTs included were 
compared against the PEDro criteria (Section 2.3.3) for trial quality and their scores, along with 
other key information and notable limitations of each study are displayed in Table 2.5-2.8.  
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2.4.1 Aerobic exercise  
A focus on studies involving aerobic exercise follows, first, a short explanation of aerobic exercise 
and aerobic capacity. 
Aerobic exercise is used to increase aerobic capacity and aerobic endurance. With aerobic exercise 
being; any activity that uses large muscle groups, which is maintained continuously and is 
rhythmical in nature, designed to overload the cardiorespiratory system (Pollock et al 1998).  
Aerobic capacity describes the functional ability of the cardiorespiratory system to circulate blood 
around the body, with maximal oxygen consumption, resting heart rate and blood pressure all 
indicators of aerobic capacity (Katch et al 2001), whilst aerobic endurance; the ability to maintain a 
continuous rhythmical activity, can be monitored with continuous activities (Dalgas et al 2009), 
such as walking tests.  
Reduced aerobic capacity and reduced aerobic endurance are not clinical features of MS, however 
may result as secondary symptoms, with reduced aerobic capacity and endurance commonly found 
in the MS population (Dalgas et al 2009). Thus, strategies designed to improve aerobic capacity 
and aerobic endurance , such as aerobic exercise are important in MS management. Many studies 
have looked at the effect of aerobic exercise in MS. These will be briefly summarised, highlighting 
potential gaps in the literature, with more detail available in Table 2.5. Interventions which utilise 
mainly aerobic based exercise are the most common in the MS therapeutic exercise literature; they 
have found that this type of exercise intervention may improve participants’ mobility, endurance 
and aerobic capacity, with fatigue and disability status also showing improvement. 
Disability level is not always reported by authors however the majority of studies include 
participants of milder disability levels (EDSS<4). With some studies stating that they included 
participants with an EDSS higher than 4, however they did not recruit many participants at this 
disability level.  Two small studies (n=8) (Kileff and Ashburn 2005; Geddes et al 2009) included 
participants up to EDSS level 6. Another study, which utilised body weight supported treadmill 
training in six people with MS, recruited participants with a mean EDSS of 6.9 (Pilutti et al 2011). 
These small trials indicated aerobic training is feasible in those with more disability, however 
overall the available results are only applicable to those with milder disease, with further, larger 
studies required in more disabled groups. Interestingly some studies have stratified their results 
based on disability level, finding that those less disabled have either a better baseline 
exercise/fitness capacity (Schapiro et al 1988) or an improved exercise capacity, following an 
aerobic exercise intervention,  more so than more disabled study participants (Ponichtera-Mulcare 
et al 1997). 
The majority of studies utilised a static cycle to achieve an aerobic effect in their participants. 
However other studies have utilised treadmill training (O'Connell et al 2003; van den Berg et al 
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2006; Pilutti et al 2011), home walking (Geddes et al 2009) or other forms of achieving aerobic 
exercise, such as an elliptical trainer. There is no evidence to suggest that one aerobic exercise 
modality is better than another to achieve improvements in MS; however there is no study which 
compares different aerobic modalities. In the only known aerobic exercise study to be undertaken 
within a community leisure centre Collett et al (2011) compared different intensities of static 
cycling in 55 people with MS over 12 weeks. Like other studies the intervention improved mobility 
compared with baseline results, yet there was no difference found in mobility, strength, quality of 
life or fatigue between the different intensities of aerobic exercise.  
In general, outcome measures and assessments have been taken before and after the intervention, 
but, as the length of interventions varied from between 4 and 24 weeks, and was delivered one to 
three times per week, it is difficult to establish the optimal length of intervention to elicit symptom 
change, with no length of time showing any clear benefit over another.  
A small number of studies took measurements at different time points throughout their 
interventions (Ponichtera-Mulcare et al 1997; Collett et al 2011) but they failed to show any 
significant changes over time. It may be important to know the optimal number of weeks of 
training participants would undertake before expecting to see symptom improvements, highlighting 
a need for further work in this area to better inform the participant and clinician.  
Few studies carried out a follow-up, by re-assessing their participants a set period of time after the 
end of the intervention. However of those that did, symptoms which had shown improvement 
immediately following the intervention such as walking speed, fatigue levels, exercise capacity and 
quality of life remained improved at follow-up compared with before the intervention (McCullagh 
et al 2008; Collett et al 2011). Whilst other improvements such as functional mobility showed 
decline without the intervention (Collett et al 2011). However, with minimal data on the carry over 
effect of therapeutic exercise, there is a need for further work reporting on participants’ symptoms 
following completion of an intervention. Establishing the longer term effect of therapeutic exercise 
is important, particularly as the optimal goal for any therapeutic exercise programme is to improve 
the health of those with MS and avoid decline of their symptoms and health status long-term, 
making it beneficial to ascertain the follow-up effects of an aerobic intervention. 
In general the interventions were delivered either 2 or 3 times per week, with each session lasting 
around an hour, which is similar to current exercise guidelines of five 30 minute sessions of aerobic 
exercise per week (Durstine and Moore 2003). There is no evidence to suggest this is an optimal 
time for delivering aerobic exercise in MS. 
Most exercise interventions have been carried out on an individual basis, supervised by either 
physiotherapists or exercise professionals. This however may not be the optimal mode of delivery, 
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particularly in the current healthcare climate, where budgets often drive service provision. Group 
exercise interventions are another logical option, which may be less costly than individual personal 
sessions. A group intervention, was carried out by McCullagh et al (2008) who employed a 
randomised control methodology to investigate the effect of 12 weeks of twice weekly 30 minute 
aerobic circuit exercises (10 minutes of each of four aerobic machines), these were performed in 
classes of 4-6 people, led by one physiotherapist. In O’Connell et al’s (2003) small randomised 
control study the aerobic circuit classes were completed in groups, although it is unclear either how 
many participants were in each group or the level of supervision. There are benefits to both 
individual and group exercise (particularly regarding level of supervision), however there is a need 
to establish whether group aerobic exercise is feasible in people with MS, across different disability 
ranges. 
Aerobic intervention studies have taken place in a variety of different venues, from hospital gyms, 
leisure centres to clinical research laboratories. There is no indication as to whether one is more 
beneficial than another, and these may be chosen based on the methodology and ease of access. 
However the work undertaken by Collett et al  (2011) has shown aerobic exercise interventions for 
those with MS can be undertaken in a community leisure setting. 
Many different outcome measures have been used across the studies making comparison and 
review of findings difficult. Mobility, endurance and aerobic capacity have been assessed most 
frequently in aerobic exercise studies. With the majority of studies finding improvements in these 
areas, regardless of length of intervention or modality of exercise (treadmill, static cycling etc). 
Fatigue has often been assessed and although significant improvements have been seen in some 
studies (McCullagh et al 2008; Huisinga and Stergiou 2011), other studies have reported no change 
in fatigue (Petajan et al 1996; Schulz et al 2004). Equally, studies including outcome measures to 
assess disability status and quality of life have found that aerobic exercise may have a significant 
effect on improving disability (O'Connell et al 2003; Kileff and Ashburn 2005; 2011) and quality 
of life (Huisinga and Stergiou 2011), whilst Pilutti et al (2011) reported no change in disability 
with the intervention. Strength, range  of movement, spasticity and mood have also been assessed 
in studies adopting an aerobic exercise methodology however there is little evidence to 
acknowledge that the intervention is beneficial in these areas. Balance, a common impairment in 
people with MS, was not assessed in any aerobic exercise study. Furthermore physical activity 
levels were only monitored in one study (Mostert and Kesselring 2002). 
There have been few reported decline in symptoms related to aerobic exercise. However this may 
be due to reporting bias, whereby authors do not publish negative findings. In the study by Mostert 
and Kesselring (2002), two participants dropped out due to increased lower limb spasticity during 
the static cycling intervention. Whilst in Rodgers et al (1999) study the disability levels (as 
measured with the EDSS) declined in six of their 19 participants following a 24-week cycling 
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intervention, although overall the study had found non-significant improvements in disability 
levels, mobility and range of movement in the participants.  
Of the studies that included a control group a decline in some symptoms has been noted in the 
control participants, although not evident in the intervention group; suggestive of the maintenance 
aspect of therapeutic interventions. Schulz et al (2004) found decline in their control group’s 
mobility after eight weeks, whilst Ponichtera-Mulcare et al (1997) noted reduced exercise capacity 
in their control group over the 24 weeks of the study (however since only four participants acted as 
controls, compared with 19 in the intervention group, this is limited evidence). Related to longer 
term maintenance of symptoms the 12-week follow-up findings from Collett et al’s  (2011)  study 
suggest many symptoms in MS may be preserved after an intervention, it may be important to 
highlight the symptom maintenance component  of therapeutic exercise in light of the evidence 
from the above studies. 
The quality of the literature in aerobic exercise varies, some studies taking an experimental 
approach, with no control group (Rodgers et al 1999; Kileff and Ashburn 2005; Newman et al 
2007; Huisinga and Stergiou 2011; Pilutti et al 2011). In other studies, a control group was 
included however these were non-randomised control trials (Ponichtera-Mulcare et al 1997; Rasova 
et al 2006). Other trials adopted a randomised control design (Schapiro et al 1988; Petajan et al 
1996; Mostert and Kesselring 2002; O'Connell et al 2003; Schulz et al 2004; Rampello et al 2007; 
McCullagh et al 2008; Geddes et al 2009; Collett et al 2011). In these studies the PEDro scores 
which can be used as a marker of quality vary from five to seven out of a possible eleven. Studies 
were marked down for not including blinding in their design, not concealing group allocation, not 
using intention to treat analysis, not including adequate follow-up or not having comparable 
baseline scores. The benefit of a RCT is that, fundamentally, the design minimises the risk of 
allocation bias (randomisation) whilst balancing for known prognostic factors, such as 
demographic details, which may impact on results (controlled) and by doing so more conclusive 
results emerge. Including a control group may also help balance for unknown prognostic factors 
(Moher et al 2010).  
However, demographic details (e.g. age, gender, disability level)  in many past aerobic exercise 
studies are not always explicitly stated, making comparison between studies difficult. There is also 
risk of bias in these studies, noted from the PEDro score reported in Table 2.5; generally 
researchers have been unable to achieve “blinding” of participants and therapists. Other sources of 
bias include not matching control and intervention groups (based on areas such as gender, age, time 
since disease onset and disability level),  not providing follow-up data or not using intention to treat 
analysis, which would involve including results from all participants initially recruited into the 
study (Hollis and Campbell 1999). These are areas which good methodology should aim to 
overcome. 
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Aerobic training has been assessed in a number of MS therapeutic exercise studies, where in 
general it offers benefits to those taking part in the exercise programme with improvements 
primarily in mobility and exercise capacity. However there is a need for further research in this 
area particularly regarding; 
• Evaluating the effect of aerobic exercise in a more disabled population 
• Establishing the feasibility of different exercise modalities to achieve an aerobic training 
effect 
• Establishing the optimal length of time of exercise intervention for change to be seen 
• Establishing the optimal frequency of sessions 
• Establishing whether a group class delivery is feasible and effective (and what is the 
optimal modality/equipment to use) 
• Standardisation of outcome measures, to allow comparison across studies 
o Utilising outcomes to assess the impact of the intervention on balance and physical 
activity levels. 
• Improved methodology to reduce the risk of bias. 
• Undertaking follow-up assessment, a period of time after the intervention, to ascertain the 
longer term effect of interventions. 
• Determining if the venue, where the intervention takes place, or the profession of the 
exercise instructor is influential on results. 
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Table 2.5 Aerobic exercise intervention studies  
Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ potential 
bias 
Lead author, publication 
date 
Country 
Type of study (PEDro score 
where relevant) 
Follow-up (if included) 
Number of participants (in each group, 
where relevant) 
EDSS – Disability score 
Type – MS Diagnosis 
Sex – number of each 
Age – of participants 
Years diagnosed – years since diagnosis 
with MS 
Completed study – how many participants 
completed study (reasons for drop out if 
known) 
Form of training 
 
Frequency and time of training 
Venue –where the intervention took 
place 
Trained – whether participant 
trained individually or as part of a 
group 
Led by – Profession of the 
supervising researcher 
Outcome measures 
used (please refer to 
Table 2.4) 
The main findings Where appropriate critique 
was based on; 
Potential areas of bias 
indicated by PEDro 
scores.(RCT only) 
Study size, sample 
description, intervention 
description and follow-up  
 
Collett et al 2011 
UK 
RCT  (PEDro 7/11) 
 
12 week follow-up. 
55 MS participants (20 continuous, 
18 intermittent, 17 combined) 
EDSS - Unclear 
Type - All 
Sex F/M – 16/39 
Age mean 52 
Years diagnosed mean– 13 
 
Completed study – 45 (due to  variety of 
reasons) 
Cycling 
Comparison of continuous, 
intermittent and combined aerobic 
cycling. 
12 weeks, twice weekly, 20 minute 
sessions 
Venue – Community leisure centres 
Trained – Individually 
Led by – Exercise professionals 
2MWT 
TUG 
BI 
SF 36 
FSS 
MVC quadriceps 
Significant increase in 
2MWT and non 
significant improved 
MVC of quadriceps 
after 6 weeks.  
Non-significant 
improved MVC of 
quadriceps between 
weeks 6-12. 
At follow-up  2MW 
returned toward 
baseline scores 
No clear difference 
between groups 
No; 
Concealed group allocation  
Subject blinding 
Therapist blinding 
Assessor blinding 
Follow-up (PEDro requires 
this to be in 85% of 
participants) 
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Geddes et al 2009 
USA 
RCT (PEDro 5/11) 
12 MS participants (8 home exercise, 4 
control) 
EDSS range–  ≤6 (unclear) 
Type – All 
Sex F/M – All F 
Age range (mean) – 22-64 (95) 
Years diagnosed  – Unclear 
 
Completed study – Unclear  All 
Home walking programme 
12 week, thrice weekly for 30 
minutes (Intensity 60-80% 
maximum HR) 
Venue – Home 
Trained - Individually 
Led by – Self-managed 
FSS 
6MWT 
PCI 
Non-significant 
improvement in 6MWT 
and PCI in intervention 
group 
No; 
Concealed group allocation  
Subject blinding 
Therapist blinding 
Assessor blinding 
Intention to treat 
Follow-up 
Kileff and Ashburn 2005 
UK 
Experimental  
 
 
8 MS participants 
EDSS range 4-6 
Type – Unclear 
Sex F/M – All F 
Age range (mean) – 33-61 (45) 
Years diagnosed; range (mean) – Unclear 
 
Completed study – Unclear  (one dropped 
out due to knee injury, one due to relapse – 
unclear if data used) 
Cycling 
12 week twice weekly 30 minute 
session 
Venue - Hospital gym 
Trained – Individually 
Led by – Physiotherapist 
 
10MWT 
6MWT 
Functional reach 
MSRS  
GNDS 
FSS 
MAS 
Significant 
improvement in 6MWT 
and GNDS. Non 
significant improvement 
in FSS and 10MWT 
Small sample size 
Unclear demographic data 
No follow-up 
Huisinga et al 2011 
USA 
Experimental 
26 MS participants  
EDSS mean -  2.7 
Type – Unclear 
Sex F/M – 21/5 
Age mean –45.5 
Years diagnosed – Unclear 
 
Completed study –  All 
Elliptical trainer. 
6 week on 15 occasions, 30minute 
sessions 
Venue – University sports facility 
Trained - Unclear 
Led by - Unclear 
FSS 
MFIS 
SF 36 
TUG 
 
Significantly improved 
FSS and SF36 
Improved TUG, not 
analysed for 
significance 
No follow-up 
Unclear intervention 
description 
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McCullagh et al 2008 
Ireland 
RCT (PEDro 5/11) 
12 week follow-up 
30 MS participants (17 intervention,  
13 controls) 
EDSS – Unclear 
Type – RR & SP 
Sex F/M – 24/6 
Age mean – 36 
Years diagnosed mean – 5 
 
Completed study – 24  (due to symptom 
relapse, class times, pregnancy, moving 
home and other personal reasons) 
Choice of 10min x 4 of various 
exercises 
12 weeks twice weekly (plus once 
at home) 
 
Venue - Hospital gym 
Trained – In groups (n=4-6) 
Led- Physiotherapist 
MFIS 
MSIS 
FAMS 
Graded Exercise 
Test 
Significant 
improvements in MFIS, 
FAMS, Graded 
Exercise Test at 3 
months. MFIS  and 
FAMS remained 
improved at 6 month 
follow-up 
Adherence to home 
sessions found poor 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Intention to treat 
Concealed group allocation 
Follow-up 
Mostert and Kesselring 
2002 
Switzerland 
RCT (PEDro 4/11) 
 
59 participants   
26 MS participants  (13 intervention, 13 
controls) 
  
EDSS range– 2.5 – 3.5 
Type – Majority RR 
Sex F/M – 21/5 
Age mean – 45 
Years diagnosed mean - 11 
Completed study – 26 (two dropout s due to 
increased spasticity, two due to symptom 
relapse, three due to poor motivation) 
26 non MS controls (13 intervention, 13 
controls) 
Sex F/M – 21/5 
Age range (mean) – (43) 
Completed study –All 
Aerobic  
Cycling 
3-4 weeks of 5 sessions per week 
30 minute sessions 
Venue- Unclear 
Trained – Unclear 
Led by - Unclear 
Maximum aerobic 
capacity 
SF36 
BAQ 
FSS 
MAS 
Spirometry-FVC & 
FEV1 
Non-significant 
improvement in aerobic 
capacity, BAQ and  
SF36 in MS 
intervention group. 
MS participants were 
less active, had reduced 
aerobic capacity, 
perceived quality of life 
and higher fatigue 
compared with non MS 
controls. 
 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Concealed group allocation 
Intention to treat 
follow-up 
between group comparison 
Unclear intervention 
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Newman et al 2007 
UK  
Experimental 
 
 
19 MS participants 
EDSS – Unclear  
Type – Unclear 
Sex F/M – 13/3 
Age range (mean) – 30-65 (54) 
Years diagnosed; range (mean) – 7-37 (16) 
Completed study -16 (unclear why) 
Treadmill training 
4 weeks thrice weekly, 30 minute 
sessions 
Venue - Hospital gym 
Trained – Individually 
Led by – Physiotherapist or 
assistant 
Peak oxygen 
consumption 
Temporal spatial 
gait parameters 
10MWT 
2MWT 
FSS 
Non-significant 
improved VO2 max, 
gait parameter.  
 
Trend toward improved 
fatigue 
 
Small sample size 
No follow-up 
 
 
O’Connell et al 2003 
Ireland 
RCT (Abstract only) 
11  MS participants  (Intervention – 5 
Control – 6) 
EDSS range – 0-3 
Type -  RR 
Sex F/M - Unclear 
Age  - Unclear 
Years diagnosed – Unclear  
 
Completed study - All 
 
 
Circuit style classes  
12 week, twice weekly, 60 minute 
sessions (plus one independent 
session) 
Venue – Unclear 
Trained – In groups (unclear 
numbers) and Individually 
Led - Unclear 
Graded Exercise 
Test 
50 metre walk 
MSIS 
FAMS 
Significantly improved 
Graded Exercise Test 
and FAMS.   
Small study 
No follow-up 
Unclear demographic data 
Unclear intervention 
 
Petajan et al 1996  
USA 
RCT (PEDro 5/11) 
Measurements at Week 5, 
10 & 15. 
 
46 MS participants (21 intervention, 25 
control ) 
EDSS mean – 3.4 
Type – Unclear 
Sex F/M – 31/15 
Age range mean – 40 
Years diagnosed mean – 11 
 
Completed study – All 
Graded cycle 
15 weeks thrice weekly for 30 
minutes 
Venue – Unclear 
Trained - Individually 
Led by -  Unclear 
POMS 
SIP 
FSS 
Graded Exercise 
test 
 
 
Significantly improved 
Graded Exercise test at 
week 5, 10 and 15. 
 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Intention to treat 
Concealed group allocation 
Intention to treat 
No follow-up 
 
Unclear demographic data 
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Pilutti et al 2011 
Canada 
Experimental  
6 MS participants 
EDSS mean – 6.9 
Type – progressive 
Sex F/M – 4/2 
Age mean – 48.2 
Years diagnosed mean – 11.5 
 
Completed study – All 
 
 
Body weight assisted treadmill 
walking 
12 weeks, thrice weekly 30 minute 
sessions 
 
Venue – Rehabilitation centre 
Trained – University laborarory 
Led by – Exercise scientists 
EDSS 
MSFC 
MSQOL 
MFIS 
Treadmill walking 
speed 
Required body 
weight support 
Significantly improved 
walking speed, required 
body weight support 
and MSQOL.  
Non significant 
improvements in MFIS. 
Small study  
No Follow-up 
Ponichtera-Mulcare et al 
1997 
USA 
CT  
Measurements at 15 weeks 
and 24 weeks 
 
23 MS participants  (9 intervention,  
4  controls) 
EDSS mean- 2.44 
(stratified into EDSS <3.5 and EDSS>3.5) 
 
Type – Unclear 
Sex F/M – 15/8 
Age range (mean) – 31-68 (43) 
Years diagnosed;– Unclear 
 
Completed study -All 
Cycling 
24 week thrice weekly 30 minute 
sessions 
Venue - Clinical research facility 
Trained - Unclear 
Led by - Unclear 
Graded Exercise 
test  
VO2 max 
Non-significant 
improvements in 
Graded Exercise Test  
More so in more 
ambulatory individuals, 
not assessed for 
significance 
Decline in Graded 
exercise noted in 
control group 
Unclear demographic data 
Unclear intervention 
No Follow-up 
 
 
Rampello et al 2007 
Italy 
Crossover RCT (PEDro 
6/11) 
 
 
 
19 MS participants 
EDSS mean – 3.5 
Type – Unclear 
Sex F/M - Unclear 
Age range - Unclear 
Years diagnosed mean - 6 
Completed study – 11 
(symptom relapse, not adhering to protocol) 
Aerobic 
Cycle (+stretching) 
Neurorehabilitation 
Trunk movements, gait re-training 
and breathing techniques) 
8 weeks thrice weekly 1 hour 
Venue – Unclear 
Trained - Individually 
Led by -  Unclear 
MFIS 
MSQOL 
Lung capacity 
-Forced expiratory 
volume (FEV1) 
-Vital capacity (VC) 
FEV1/VC ratio 
6MWT 
Significantly improved 
6MWT, non-
significantly improved 
MSQOL and MFIS 
following aerobic 
exercise intervention. 
 
Both interventions 
improved lung capacity. 
 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Concealed group allocation 
Intention to treat 
Follow-up 
Unclear intervention 
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Rasova et al 2006 
USA 
CT 
 
112 MS participants  
36 aerobic training  
24 neurophysiotherapy 
19 combined (aerobic and 
neurophysiotherapy) 
16 controls 
EDSS mean – 2.7 
Type – unclear 
Sex F/M - Unclear 
Age range - Unclear 
Years diagnosed;– Unclear 
Completed study – Unclear  
Aerobic 
Cycling 
Neurophysiotherapy 
Sensory/motor learning/facilitation 
8 weeks of twice weekly 60 minute 
(neurophysiotherapy) or 30 minute 
(aerobic) sessions 
 
Venue - Hospital gym 
Trained – Individually 
Led by - Physiotherapist 
EDSS 
BI 
ESS 
MSQOL 
MFIS 
BDI 
Spirometry 
parameters on/off a 
bicycle ergometer. 
Non-significant 
improvements in 
fatigue, depression and 
spirometry parameters 
in all intervention 
groups (more so in 
aerobic group) 
EDSS improved in both 
groups receiving 
physiotherapy 
 
Unclear demographic data 
No follow-up 
 
 
Rodgers et al 1999 
Ohio 
Experimental 
 
 
 
18 MS participants 
EDSS mean- 3.6 
Type – Unclear  
Sex F/M – 14/4 
Age range (mean) – (43) 
Years diagnosed– Unclear 
 
Completed study - All 
Aerobic  
Cycling 
24 week thrice weekly 30 minute 
sessions 
Venue - Clinical research facility 
Trained - Individual 
Led by - Unclear 
Gait analysis 
-Ground reaction 
force 
Lower limb passive 
range of movement 
EDSS 
Non-significant 
improved disability 
level (overall sample) 
aerobic capacity, hip 
movement and gait 
parameters. 
 
6 subjects demonstrated 
decline in disability 
level. 
Unclear demographic data 
Unclear intervention 
No Follow-up 
 
Schulz et al 2004 
Germany 
RCT (PEDro 6/11) 
 
39 MS participants (23 intervention  
16 control) 
EDSS mean – 2.3 
Type – unclear 
Sex F/M – 29/10 
Age mean – 41 
Years since onset mean – 11.4 
Completed study - All 
Aerobic  
Cycling 
8 week twice weekly 30 minute 
sessions 
 
Venue - Clinical lab 
Trained – Individually 
Led by - Unclear 
POMS 
HADS 
HQOL 
MFIS 
Co-ordination tests  
-3m plank walk 
-Figure 8 walk 
-Static balance   
 
Biological/immunol
ogical parameters 
assessed will not be 
discussed. 
 
Non-significant 
improved aerobic 
capacity in both groups. 
Significant decline in 
co-ordination in control 
group. 
 
 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Concealed group allocation 
Intention to treat 
Follow-up (after the 8 week 
intervention) 
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EDSS – Expanded Disability Status Scale, F-Female,  M – Male, RR – Relapsing-remitting, SP – Secondary Progressive, Outcome measure abbreviations available in Table 2.4.
Schapiro et al 1988 
Colorado, USA 
RCT (PEDro 6/11) 
50 MS participants  (25 intervention,  
25 controls) 
EDSS mean -3.6 
Low EDSS ≤3.5, n=32 
High EDSS  4-6.5, n=28 
 
 
Type – Unclear 
Sex F/M – 27/23 
Age range (mean) –  27-62 (47) 
Years diagnosed; range (mean) – 0-28 (6) 
 
Completed study – 91 
(Unclear  why) 
Aerobic 
Cycling  plus health lecture 
16 week, 4-5 days per week 
 
Venue – Unclear  
Trained – Individual 
Led by – Self-managed 
Aerobic capacity 
test 
Non-significant 
improved fitness test. 
Lower disability group 
greater fitness capacity  
 
 
No; 
Subject blinding 
Therapist blinding 
Concealed group allocation 
Comparable baseline 
Intention to treat 
Follow-up (after the 16 
week intervention) 
Unclear demographic data 
Unclear intervention 
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2.4.2 Resistance exercise 
Similar to the previous section on aerobic exercise (Section 2.4.1), a focus on studies involving 
resistance training will be made. First however an explanation of the mechanisms underlying 
muscle strengthening follows.  
Resistance training is used to improve strength; which is defined as the greatest amount of force a 
muscle can generate in a single maximum voluntary contraction (MVC) (Lamb D.R. 1984). 
Strength gains are initially due to adaptations in the CNS; within the CNS the motor unit is 
comprised of the neuron, originating in the spinal cord, and the muscle fibers which the neuron 
supplies. 
With resistance training, the adaptations to the CNS lead to improved synchronisation of the motor 
unit, allowing more muscle fibers to be recruited to generate more strength. Following this, 
hypertrophy (an anatomical increase in muscle fiber size) will occur. In a healthy population,  this 
may occur after a minimum of six weeks of training (Broughton 2011), but there is no clear 
timeframe (Kraemer et al 2002). It is important that resistance training should be progressed safely 
at different stages of training to elicit continued improvement; indeed most resistance training 
studies in this literature review adopt a progressive resistance training model.  
Muscle weakness is a common problem in MS and a growing number of studies have included 
resistance exercises as the main component under investigation.  These will be summarised, 
highlighting potential gaps in the literature, with more detail available in Table 2.6. Results varied 
across the studies, hampered by many different outcome measures being used, however strength 
was most frequently assessed. Overall, resistance exercise studies in MS have found improvements 
in strength, mobility, fatigue, disability and quality of life. 
In comparison to aerobic exercise studies fewer resistance exercise studies have included 
participants with an EDSS score of greater than 5 (Filipi et al 2010; Filipi et al 2011). Filipi et al 
(2011) stratified the findings from their 78 participants based on disability level. Those with low 
levels of disability (EDSS of 1-4.5) were able to train at a higher weight/resistance intensity 
compared to those more disabled. In addition those moderately (EDSS of 5-7) and severely 
disabled (EDSS >7.5) had similar upper body strength to one another at baseline. In a much smaller 
study (n=8), Kraft et al (1996) found those less disabled improved mobility more following the 
resistance exercise intervention, whilst those more severely affected improved their walking speed 
more. In general however studies have either not reported the disability level of their participants, 
based on EDSS level, or, only included those less severely affected. Thus, there is a need to 
establish the effect of resistance exercises across the disability range. 
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The form of achieving a resistance training effect varies throughout the literature, with many 
methodologies using resistance machines, some using body weight, and one study using resistance 
bands. From these no single form suggests particular benefits over the other however access to 
resistance machines may be limited for some people with MS due to either geographical location or 
physical ability. Thus, free weights or exercises which use body weight as the form of resistance 
may offer a more practical solution. The studies by Filipi et al (2010; 2011) used a range of 
resistance machines, free weights and body weights as part of circuit based programme. 
Unfortunately however the results are limited, being retrospective, whereby past exercise record-
cards were consulted  and based on only one outcome measure; strength improvement (Filipi et al 
2011) or only based on  preliminary data (Filipi et al 2010).  
The length of interventions undertaken has been between 6 and 24 weeks, with most outcomes 
assessed at baseline and at the end of the intervention. General results suggest longer interventions 
result in more significant changes. For example studies of eight week duration; training at home 
seven days per week (Harvey et al 1999) or training twice weekly (White et al 2004; Gutierrez et al 
2005) resulted in no strength changes. All other studies of a longer duration found gains in 
strength. However a shorter six week (thrice weekly session) intervention resulted in significant 
strength gains, albeit using less conventional outcome measures (e.g. ball throwing and leg lifts). 
Few studies adopted a follow-up approach as part of their methodology. From those that did Dalgas 
et al (2010) found improvements in fatigue and quality of life were maintained 12 weeks after the 
intervention whilst Dodd et al (2011) found that improvements following their 10 week 
intervention were not maintained after 12 weeks. Although expected strength gains, based on time 
are available for a healthy population where strength gains can be seen in 6-8 weeks (Kraemer et al 
2002), further research in this area may establish the effect of time on resistance training in MS. 
This is important, as the initial mechanism of strength changes occur as a result of neural 
adaptation, and as the neural system is already compromised in MS it is of interest whether strength 
changes occur in a similar way to non-MS populations. 
Similar to aerobic exercise studies the frequency of resistance exercise sessions in previous studies 
is either 2 or 3 sessions per week, with some studies following the ACSM’s guidelines on 
progressive resistance training, whereby initially low loads, higher repetitions are progressed to 
higher loads lower repetitions (Kraemer et al 2002). However no studies have compared 
intervention frequency, which may be worthwhile. 
Supervision during the exercise is not always reported, however it has mainly been by either 
exercise professionals or physiotherapists. There are examples of interventions which have utilised 
a group class format successfully, although in all but one of these studies class sizes have not 
exceeded 3 or 4 participants. In Broekmans et al (2011),  Dalgas et al (2009; 2010) and Taylor et 
al’s (2006) studies, groups of three people with MS trained together. More recently Dodd et al 
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(2011) carried out resistance training classes with up to 12 participants supervised by up to three 
trainers (physiotherapists and registered personal exercise trainers). Participants in these studies, in 
general, had low to mild disabilities, although the specific EDSS level was unreported in two of the 
studies (Taylor et al 2006; Dodd et al 2011). However the description given would indicate an 
EDSS of less than 5. Thus it is unknown whether a group/class format is feasible in a more 
disabled group of participants. 
The venue of many of the studies has been hospital or university laboratories, however it is 
possible, and perhaps more conducive for long term continuation of the exercise programme to 
allow study participants to undertake exercise in a community leisure facility. Doing so also fits 
well with government guidelines which encourages community rehabilitation (Scottish Executive 
2007). Taylor et al (2006) and Dodd et al (2011) have shown this is feasible by carrying out their 
interventions in community leisure centres. 
Results varied across the studies, however strength improvement occurred in almost all studies 
which assessed strength, regardless of outcome measure, intervention duration, frequency of 
sessions or modality of exercise. Mobility has been assessed in several studies, with many showing 
improvement due to the intervention, although some have reported no change in mobility. Fatigue, 
disability level and quality of life have been assessed in some resistance exercise studies with the 
majority reporting improvements. Improvements in balance have been found in studies with an 
intervention of 12 weeks or greater, however as few studies assess balance it is inappropriate to 
draw any firm conclusions. No study could be found which assessed physical activity levels in their 
participants. It may be important that a consensus be agreed upon as to what outcomes are assessed 
to allow for the true impact of resistance exercise training to be established. 
No studies reported any adverse effects from any resistance exercises, although in qualitative 
results, linked with Taylor et al’s (2006) study, Dodd et al (2006) found that during the first few 
weeks of the 10-week programme participants experienced muscle soreness or fatigue. However 
there is a risk of authors not reporting on adverse event or negative outcomes.  
The design and quality of all studies was mixed, one carried out a retrospective analysis as 
previously discussed (Filipi 2011). Several adopting an experimental methodology with no control 
group  (Kasser and McCubbin 1996; Kraft et al 1996; Fisher et al 2000; White et al 2004; Gutierrez 
et al 2005; Taylor et al 2006; Ayan Perez et al 2007; Filipi et al 2010; Pryor et al 2011). Another 
study used a “within subjects” controlled design (de Souza-Teixeira et al 2009). The remainder 
adopted a RCT design (Harvey et al 1999; Debolt and McCubbin 2004; Dalgas et al 2009; 
Broekmans et al 2011; Dodd et al 2011; Hughes et al 2011). However, as with the aerobic studies 
there is a risk of bias with studies often not achieving assessor blinding and failing to use an 
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intention to treat paradigm when analysing results. For resistance studies PEDro scores ranged 
from six to nine out of a possible eleven. 
As discussed resistance exercise training can result in improved strength, mobility, fatigue, 
disability and quality of life. However there is a need for further research in this area particularly 
regarding; 
• Including participants across the disability range 
• Establishing the optimal length of time for change to be seen 
• Whether a group class delivery is feasible and effective 
• Establishing the optimal frequency of sessions 
• Standardisation of outcome measures, to allow comparison across studies 
o Utilising outcomes to assess the impact of the intervention on physical activity 
levels. 
• Improved methodology to reduce the risk of bias. 
• Undertaking follow-up to ascertain the longer term effect of interventions. 
• Determining if the venue, where the intervention takes place or the profession of the 
exercise instructor is influential on results. 
 
.  
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Table 2.6 Resistance exercise intervention studies 
Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ 
potential bias 
Ayan Perez 2007 
Spain 
Experimental 
22 MS participants 
EDSS – Unclear 
Type – Unclear 
Sex F/M - Unclear 
Age - Unclear 
Years diagnosed – Unclear 
Completed study – All 
Body weight exercises  
 
6 weeks thrice weekly 30 minutes 
Venue – Unclear 
Trained – Unclear 
Led by – Unclear 
9m zigzag run,  
Clapping test 
Dynamic flexibility 
test 
Explosiveness of 
arms & legs,  
Trunk strength 
Flamingo balance test 
Significant improvements 
in dynamic 
flexibility/trunk strength,  
trunk strength, 
eexplosiveness of arms & 
legs and 9m zigzag run. 
 
Only Abstract available 
thus not PEDro rated. 
Further data available in 
Garrett and Coote (2009). 
Unclear intervention 
Unclear demographic data 
No follow-up 
Broekmans et al (2011) 
Belgium 
RCT (PEDro 7/11) 
36 MS participants  (11 Resistance only, 
11 Resistance + EMS, 14 Controls) 
EDSS mean– 4.3 
Type - Sex F/M – 23/13 
Age  mean – 47.8 
Years diagnosed – Unclear 
Completed study – 33 (Unclear why) 
Resistance  machines. 
20 weeks,  5x 60min session/fortnight  
 
Assessed at baseline, week 10  week 
20 measurements)  
Venue – Unclear 
Trained – In groups (n=3) 
Led by - Physiotherapist 
MVC (knee 
extension/flexion) 
TUG 
T25FW 
2MWT 
Functional Reach 
RMI 
Significant MVC 
improvement in both 
resistance training groups 
compared with control 
groups.  
No difference between 
the two resistance groups. 
No; 
Concealed allocation 
Subject blinding 
Therapist blinding 
Intention to treat 
Unclear intervention 
Unclear demographic data 
No follow-up 
Dalgas et al, 2009; 2010 
Denmark 
RCT (PEDro 7/11) 
12 week follow-up 
 
38 MS participants (19 intervention, 19 
controls) 
EDSS mean – 3.8 
Type – RR 
Sex F/M - 20/11 
Age mean – 48.4 
Years diagnosed mean– 7.35 
 
Completed study – 31  (due to 
musculoskeletal problems, and other 
personal reasons) 
Resistance machines 
12 weeks (twice weekly) 
Venue –Unclear 
Trained – In groups (n=3) 
Led by - Unclear 
Knee strength 
MVC leg press 
Handgrip 
Functional capacity 
10MWT 
6MWT 
FSS 
MDI 
SF-36  
Significant improvements 
in knee extensor strength, 
functional capacity, FSS, 
MDI 
SF-36   
 
Many improvements 
maintained at follow-up. 
No; 
Subject blinding 
Therapist blinding 
Intention to treat 
Follow-up (PEDro 
requires this to be in 85% 
of participants) 
Unclear intervention 
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Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ 
potential bias 
DeBolt and McCubbin 
2004 
USA 
RCT (PEDro 7/11) 
 
 
36 MS participants (19 intervention,  
17 controls) 
EDSS mean - 3.3  
Type - All 
Sex F/M – 29/7 
Age range (mean) – 36-57 (50) 
Years diagnosed; range (mean) – 1-40 
(14.5) 
Completed study – 35 (symptom relapse) 
Body weight exercises 
 
(2 weeks supervised then) 8 weeks 
thrice weekly 1 hour sessions 
Venue - Participants home  
Trained – Individual 
Led by - Self-managed 
Static Balance  
 Anteroposterior 
sway  
 Mediolateral sway 
 Sway velocity 
TUG 
Leg extensor power 
rig 
MAS 
Significant increase in leg 
strength 
 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Intention to treat 
No follow-up 
Dodd et al 2011 
Australia 
RCT (PEDro 9/11) 
12 week follow-up 
71 MS participants  (36 intervention 
35 control ) 
EDSS – Unclear (mild to moderate 
walking disability) 
Type – RR 
Sex F/M – 52/19 
Age mean -49.05  
Years diagnosed – Unclear 
Completed study - All 
Resistance machines 
 
10 week twice weekly, 45 minute 
(plus 30 minute social cool down) 
sessions 
Control group; Usual care + 10 1 hour 
social sessions (e.g. massage, 
luncheons, educational sessions) 
2MWT 
1MVC lower body 
50% if 1MVC for 
muscular endurance 
MFIS 
WHOQOL 
MSSS-88 
 
 
Significant difference 
between groups for 
MVC, MFIS and 
WHOQOL at week 10  
At 22 week follow-up No 
between group 
differences 
With all outcomes 
returning toward baseline 
scores. 
No; 
Subject blinding 
Therapist blinding 
Unclear demographic data 
 
Filipi et al (2010) 
USA 
Experimental 
(Preliminary Data) 
 
33 MS participants  
EDSS – 1-6.5 (mean) 
Type – All 
Sex F/M – 22/11 
Age range (mean) – 24-54 (38.8) 
Years diagnosed – Unclear 
Completed study – All  
Resistance machines, free weights & 
body weight 
6 months, twice weekly, 50 minutes 
Venue – Unclear 
Trained - Individually 
Led by – Exercise trainers 
MFIS 
MFES (Modified Fall 
Efficacy Scale) 
BBS 
TUG 
MSFC 
Neurocom Balance 
Master 
Gait analysis with 
Force plate 
Outcomes at BL, 3 
months, 6 months 
Non-significant  
improved MSFC, MFES 
and muscular power 
generation with gait 
analysis. 
Only preliminary data 
reported 
Unclear demographic data 
No follow-up 
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Filipi et al (2011) 
USA 
Retrospective analysis 
67 MS participants  
EDSS range – 1-8 
Low disability;  
EDSS 1-4.5, n=27,  
Mild-moderate disability; EDSS 5-7,n=23, 
EDSS≥7.5, n=17 
Type – All 
Sex F/M – 49/18 
Age range (mean) – 24-75 (49.5) 
(Years diagnosed; range (mean)1-45 
Unclear 
 
Completed study – All 
Resistance machines  
Progress resistance to address balance 
and muscle strength (whole body 
approach) 
Resistance machines and free weights 
included (+ balance) 
24 week, twice weekly, 50 minutes 
sessions 
Instructed by exercise trainers 3:1 
subject to trainer ratio. Protocol 
reviewed by physical therapists for 
safety 
Venue – University sports facility 
Trained - Individually 
Led by – Exercise trainers 
Retrospective 
analysis of training 
records during 
resistance exercise 
programme. 
Strength MVC 
of the following; 
Leg curls 
Back rows 
Leg extensions 
Lat' pull downs 
Shoulder Press 
Chest Press 
Triceps ext 
Arm curls 
Abs crunch 
Back extension 
Shoulder raises 
Wrist curls 
Significantly improved 
MVC on all exercises 
except Abs crunch. 
Lower disability group 
could train at a higher 
weight intensity. 
Upper limb strength 
similar in mild-moderate 
and more severe group. 
 
No follow-up 
Fisher et al (2000) 
(Abstract only) 
USA 
Experimental 
16 MS participants  
EDSS – <6.5 
Type – Unclear 
Sex F/M - Unclear 
Age range – Unclear 
Years diagnosed –Unclear 
 
Completed study – Unclear 
 
Resistance  
(unclear details on intensity/progress) 
16 week, thrice weekly 60 minute 
sessions 
Venue –Unclear 
Trained – Unclear 
Led by - Unclear 
Muscle strength and 
power (outcome 
measures unclear) 
Reported improvements 
in upper and lower limb 
strength (unclear) 
Only Abstract available 
Unclear demographic data 
Unclear intervention No 
follow-up 
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measure 
Findings Limitations/ 
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Gutierrez et al 2005 
USA 
Experimental 
 
8 MS participants 
EDSS mean – 3.7 (self reported) 
Type – RR 
Sex F/M – 7/1 
Age range (mean) – 25-55 (46) 
Years diagnosed  – Unclear 
Completed study -All 
Resistance machines 
8 weeks twice weekly 30 minute 
sessions 
Venue - Biomechanics laboratory 
Trained - Unclear 
Led by – Exercise professionals 
Gait parameters: 
Knee & ankle muscle 
strength test 
3-minute step test 
MFIS 
Self assessed EDSS 
Significant improvement 
in some gait parameters, 
knee extension strength, 
MFIS and self-reported 
EDSS 
Non-significant 
improvement in 3-minute 
step test.  
Small sample size 
Unclear demographic data 
Unclear intervention No 
follow-up 
 
Harvey et al 1999 
UK 
RCT (PEDro 7/11) 
 
19 MS participants  (6 resistance 
intervention 6 mobility  intervention 
5 controls)  
EDSS – Unclear 
Type – Unclear 
Sex F/M – 14/3 
Age range (mean) – 36-55 (47) 
Years diagnosed; range (mean) – 1-15 (7) 
Completed study – 17 (one dropout  due 
to longstanding back pain, one due to 
symptom relapse) 
Free weights 
General Mobility 
Individual programme of stretching, 
balance, mobility, swimming, cycle 
sessions 
8 weeks of daily exercises  
 
Venue - Participants home 
Trained - Individually 
Led by – Self-managed 
50m timed walk 
10MWT 
Electromyography of 
quadriceps 
MVC of quadriceps 
Timed transfer 
Non-significant improved 
transfer in both 
intervention groups. 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Intention to treat 
Unclear demographic data 
Unclear intervention 
No follow-up 
Hayes et al 2011 
USA 
RCT (PEDro 6/11) 
 
 
20 MS participants (10 resistance + 
standard exercise, 10 standard exercise 
only.)  
EDSS - mean 5.2   
Type – Unclear 
Sex F/M – 11/8 
Age mean – 49 
Years diagnosed mean 12 
Completed study – 19 (symptom relapse) 
 
Eccentric resistance based work 
Leg resistance using custom built 
eccentric ergometer (seated stepper) 
Standard exercise included aerobic 
training, stretching and balance 
exercises. 
 
12 weeks of thrice weekly  <60 
minute sessions 
Venue  – Unclear 
Trained – Unclear 
Led by – Unclear  
MVC of 5 lower limb 
muscles 
TUG 
10MWT 
6MWT 
Stair ascent (SA) 
Stair descent (SD) 
BBS 
FSS 
(BMI) 
Standard exercise only 
group improved in SA, 
SD and BBS. 
No significant differences 
between groups or over 
time for other outcomes 
Overall strength  greater 
in resistance group after 
12 weeks 
No; 
Concealed allocation 
Subject blinding 
Therapist blinding 
Assessor blinding 
Intention to treat 
Unclear intervention 
No follow-up 
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Hughes et al 2011 
Ireland 
RCT (Abstract only) 
37 MS participants 
EDSS – Unclear 
Type – Unclear 
Sex F/M –  
Age range (mean) – Unclear 
Years diagnosed; range (mean) – Unclear 
 
Completed study – 25 (unclear why) 
Resistance body exercise 
(squats, calf raises, step-ups, side 
steps, sitting knee extension) 
12 weeks of lower limb strengthening 
exercises 
(Intervention group also wore EMS) 
Venue  – Home 
Trained – Individually 
Led by – Self-managed 
BBS 
MSWS 
MSIS 
Improvements in all 
outcome measures across 
all participants after 12 
weeks 
No significant differences 
between groups or over 
time for other outcomes 
 
Only Abstract available 
thus not PEDro rated. 
Unclear demographic data 
No follow-up 
 
 
Kasser and McCubbin 
1996 
Cited in Dalgas et al 2008 
Experimental 
8 MS participants 
EDSS – Unclear 
Type – Majority RR 
Sex F/M – Unclear 
Age range (mean) – Unclear 
Years diagnosed; range (mean) – Unclear 
Completed study – Unclear 
Unclear form 
Whole body approach 
10 week, twice weekly 
Venue - Unclear 
Trained - Unclear 
Led by – Unclear 
MVC  Non-significant  
 improvements in leg, 
elbow and shoulder MVC 
Only Abstract available  
Small sample 
Unclear demographic data 
Unclear intervention 
No follow-up 
 
Kraft et al 1996; Kraft et 
al 1996a (Abstract only) 
USA 
Experimental 
 
8 MS participants 
EDSS – Unclear 
Type – Unclear 
Sex F/M - Unclear 
Age  -Unclear 
Years diagnosed - Unclear 
 
Completed study - Unclear 
Unclear form 
Progressive upper and lower body 
resistance training 
12 weeks thrice weekly (time unclear) 
Venue – Unclear 
Trained - Unclear 
Led by - Unclear 
 
Walking speed 
Stair climbing speed 
TUG 
SIP 
Muscle strength 
Non-significant 
improvements in: 
walking speed, stair 
climbing speed and 
strength. 
Only Abstract available 
 
Small sample size 
Unclear demographic data 
Unclear intervention 
No follow-up 
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Findings Limitations/ 
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Pryor et al 2011  
USA 
Abstract only  
Experimental 
19 MS participants 
EDSS – 3.7 
Type – RR 
Sex F/M – Unclear  
Age range (mean) –(48.2) 
(Years diagnosed; range (mean) Unclear 
Completed study – Unclear 
Unclear form 
Progressive intervention (unclear) 
16 76week thrice weekly 
Venue – Unclear 
Trained - Unclear 
Led by - Unclear 
Self- assessed 
Disability and fatigue 
assessed with 
questionnaire 
(unreported) 
T25FW 
6MWT 
Non-significant 
improvements in 
disability, fatigue, 
T25FW and 6MWT 
 
Only abstract available 
Unclear demographic data 
Unclear intervention 
No follow-up  
 
 
de Souza-Teixeira et al 
2009 
Spain 
Within subjects 
controlled study 
 
13 MS participants (acted as own control) 
EDSS mean 3.4 
 Type –  unclear 
Sex F/M – 9/4 
Age range  - 43 
Years diagnosed – Unclear 
Completed study – All 
Resistance machines 
 
8 week twice weekly, circuits of 40-
70 MVC increasing set, and reps 
Control time – no training (before 
intervention) 
Venue – Unclear 
Trained – Individually 
Led by – Exercise Specialists 
MRI of thighs 
Quadriceps MVC  
Quadriceps 
endurance (40% 
MVC) 
TUG 
 
After exercise  significant 
improvement of all 
outcomes.  
Unclear demographic data 
Unclear intervention 
No follow-up 
de Souza-Teixeira et al 
2011 
Spain 
Experimental 
16 MS participants  
 
EDSS – 3.3 
Type – Unclear 
Sex F/M – 8/8 
Age range (mean) – 33-56 (44) 
Years diagnosed – 9.4 
 
Completed study – 12 (Unclear why) 
Resistance  
Resistance bands 
6 week thrice weekly <60 minute 
sessions 
Venue – Unclear 
Trained – Unclear 
Led by – Unclear 
Quadriceps MVC 
low load (49N) and 
high load (98N) 
Quadriceps EMG 
FSS 
TUG 
Significantly improved 
MVC low load (49N) and 
high load (98N) and TUG  
Unclear intervention 
No follow-up 
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Taylor et al 2006 
Australia 
Experimental 
 
8 MS participants  
EDSS – Unclear 
Type – Unclear 
Sex F/M – 7/2 
Age range (mean) – 27-61 (45) 
Years diagnosed mean– 9 
Completed study -All 
Resistance machines 
10 week, twice weekly 60 minute 
sessions 
Venue – Community gymnasium 
Trained – In groups (n=3) 
Led by – Physiotherapist and Exercise 
Professional 
MVC lower limb 
Repetitions at 1/2 
MVC lower limb 
Walking speed over 
10m 
2MWT  
Timed stair test 
MSIS 
Significant improvement 
in  both MVC and 
repetition MVC scores 
Non significant 
improvement in other 
outcomes 
Small sample size 
Unclear demographic data 
No follow-up 
White et al 2004 
USA 
Experimental 
 
8 MS participants 
EDSS mean – 3.7 (self reported) 
Type - RR 
Sex F/M – 7/1 
Age range (mean) – 25-55 (46) 
Years diagnosed – Unclear 
Completed study - All 
Resistance machines 
Lower limb strengthening 
8 weeks twice weekly 30 minutes 
Venue – Unclear 
Trained – Individually 
Led by - Unclear 
MRI (of the thigh) 
T25FW 
3-minute Step Test 
MFIS 
Self-assessed EDSS 
Non-significant 
improvement on MRI 
assessment and MFIS 
Small sample size 
Unclear demographic data 
Unclear intervention 
No follow-up 
EDSS – Expanded Disability Status Scale, F-Female,  M – Male, RR – Relapsing-remitting, SP – Secondary Progressive, Outcome measure abbreviations available in Table 2.4 
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2.4.3 Combined exercise 
In this section, combined exercise training will be discussed, as will studies directly comparing 
types of exercise. With combined exercise, training includes a combination of aerobic, resistance or 
balance exercise; no one type of exercise plays a dominant role in the intervention. Thus, to add to 
the relevant explanations of aerobic and resistance exercise in Sections 2.4.1 and 2.4.2 respectively, 
an explanation of the mechanisms underlying balance will be made, with further depth of detail 
available in Sections 3.9.5 and 3.9.6.  
Balance and the ability to maintain ones balance relies on the peripheral sensory systems ability to 
react to the environment. Vestibular, visual and proprioceptive feedback to and from the CNS is 
required (Ruhe et al 2010). As discussed in Section 2.2.1, the damage to the CNS of those with MS 
affects motor and sensory systems with feedback to and from the motor and sensory systems via 
the CNS being altered (Compston and Coles 2008). Thus, due to damage throughout the CNS of 
those with MS, visual feedback may be limited, with an altered sensory system unable to provide 
accurate proprioceptive feedback, leading to balance impairment. Other clinical symptoms of MS, 
including muscle weakness and fatigue may contribute to increased balance impairment in MS 
(Motl et al 2008b). Therefore, strategies to improve balance are important in MS management, and 
combined exercise programmes. 
Results from studies which have used a combined exercise intervention have found positive results 
for a variety of impairments found in MS; mobility, fatigue, aerobic endurance, disability and 
balance. Details on the studies discussed in this section are provided in Table 2.7, with potential 
gaps in the literature highlighted. In addition, as the combined exercise doctrine of these studies is 
similar to that included in this thesis they will be described in more detail where appropriate.  
Of the papers reviewed all but one study (Cattaneo et al 2007a) included either an aerobic exercise 
or resistance exercise component. From these studies only Freeman and Allison (2004) did not 
incorporate aerobic exercise instead they utilised Pilates and resistance training only. In addition to 
aerobic and resistance training, balance exercise has been included in some studies (Cakt et al 
2010; Vore et al 2011; Motl et al 2012), as has Yoga (Oken et al 2004)  and hydrotherapy 
(Romberg et al 2004; Romberg et al 2005). Flexibility training is often included in the warm-up 
and cool-down part of the interventions, however Carter and White (2003) and Fragoso et al (2008) 
made flexibility exercises part of their main intervention. The variety of exercise included in the 
studies may demonstrate that many exercise different exercise types are feasible for those with MS, 
however further work is required to confirm this. 
The disability level of participants in the majority of combined exercise studies is towards the 
milder disability level, indicating a need to include those more disabled by MS in future studies of 
combined exercise. Recently Motl et al (2012) assessed a combined therapeutic exercise 
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programme in 13 people with MS who had a mean EDSS of 5.6, as will be discussed later in this 
section, many improvements in mobility were found. 
The studies ranged in duration from three (Cattaneo et al 2007a) to 24 weeks (Oken et al 2004; 
Romberg et al 2004), with outcome measures being taken before and after the intervention. The 
frequency of the interventions ranged from one to three times per week, with no study comparing 
different frequencies of exercise. Only one study carried out a follow-up of four weeks (Freeman 
and Allison 2004), finding that, on average, after a 10 week, weekly balance and Pilates exercise 
intervention, improvements in balance (Berg Balance Scale - BBS) and mobility/endurance (Six-
minute Walk Test -6MWT) were maintained. Therefore there is scope to fill gaps in the literature 
and by including a follow-up period in future studies. 
It is not always reported whether participants trained individually or in groups, however some 
combined exercise studies have acknowledged that participants trained in groups of 6 (Bjarnadottir 
et al 2007), 9 (Charlton et al 2010), 10 (Freeman and Allison 2004) or in groups of unreported sizes 
(Oken et al 2004; Cakt et al 2010). These studies have close similarities to the main intervention 
included in this thesis, and thus will be discussed individually. 
Charlton et al (2010) evaluated a combined aerobic and resistance intervention over 16 weeks, in 
twice weekly 45 minute sessions. Fourteen participants with MS took part, however their disability 
level and disease type are unclear, all participants were female and 11 completed the intervention. 
Participants took part in a modified “Jazzercise-lite” intervention where aerobic and resistance 
exercises choreographed to music were completed in a circuit format and routines were adapted for 
those participants more or less able. The class was led by two fitness instructors and held in a 
community hall. Unfortunately no validated outcome measures were used, instead a nine-item self-
designed questionnaire, exploring balance, confidence, coordination, energy, flexibility, mood and  
strength in addition to motivation to continue attending was completed by nine of the participants 
at the end of the programme. Results suggest that the intervention improved mood and energy 
amongst other positive finding. This study is limited by being small, lacking in demographic 
details, not including established outcome measures nor a control group. Although this study had a 
relatively poor methodology, it does highlight the feasibility of a group fitness class for people with 
MS. 
Oken et al (2004) carried out a RCT which included 57 individuals with mild to moderate MS 
symptoms (mean EDSS=3.1), unfortunately other demographic details are unclear. The study 
compared the effects of group cycling classes with yoga classes on cognitive function, mood, 
fatigue and quality of life. The participants were divided into three groups; group A attended group 
cycle classes (n=15), group B attended group yoga classes (n=22) and group C acted as controls 
(n=20) and were advised not to change their physical activity. For six months participants attended 
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classes once per week. Sixty-nine individuals began the study, however 12 dropped out, some 
dropped out for health reasons however six participants dropped out due to being unable to commit 
to attending the class; highlighting potential adherence problems of a long term intervention. The 
fatigue aspect of the quality of life measure (SF-36) and the general fatigue aspect of the Modified 
Fatigue Inventory (MFI) showed significant improvements after six months in both intervention 
groups. Between-group differences were not reported. Despite the limitations of this study, it offers 
more long term data than most studies in supervised group exercise. 
Another RCT (Cakt et al 2010) sought to establish the effect of aerobic cycling on quality of life 
and function. The design incorporated three groups; 1) aerobic cycling and combined strengthening 
and balance exercises performed in small groups twice weekly for eight weeks for 15 participants, 
2) a home exercise programme of combined strengthening and balance exercises only (twice 
weekly for eight weeks) for 15 participants, 3) a control group, not changing their usual habits. A 
total of 33 participants completed the study, with reasons for attrition being symptom exacerbation 
in the aerobic cycling group (n=1), the home exercise group (n=2) and in the control group (n=3). 
A comprehensive battery of outcomes was assessed with the aerobic cycling group showing 
significant improvement in mobility (DGI and 10MWT), balance (FES and functional reach), mood 
(BDI) and aerobic endurance and aerobic capacity (tolerated duration and workload of cycling). 
Those in the home exercise group improved aerobic endurance, aerobic capacity and balance, 
whilst the control group did not show any significant changes. Between groups the aerobic fitness 
group improved significantly more than the home exercise group in all but the 10MWT. The study 
also found adherence was far greater for those in the aerobic fitness class (93% of sessions 
attended) compared with the home exercise group (60% of session completed).  
The ten participants in Freeman and Allison’s (2004) study attended one hour sessions once per 
week for ten weeks. Participants were mildly to moderately disabled by MS (mean EDSS=5), were 
mostly women (80%), aged 29-69 and on average had been diagnosed with MS for 16 years. The 
exercise intervention was described as a 15 minute warm-up and 30 minutes of Pilates-based 
standing and lying stretches. The lack of detail make it difficult to recreate the intervention. No 
control group was included, although all participants completed the study. Measurements were 
taken at baseline, following the intervention, and at 4-week follow-up. After the intervention 
significant improvements in balance (BBS) and mobility/endurance (6MWT and MSWS) were 
found, these continued to improve at follow-up. Although interesting, the results from this small 
study cannot be generalised to other groups of people with MS and provide only preliminary data. 
The results are mainly an audit of a group exercise class already in place. 
In a RCT by Bjarnadottir et al (2007) 16 people with mild MS symptoms (mean EDSS=2) and the 
relapsing remitting form of the disease were included. Six participants took part in the five-week 
intervention, which, in brief, involved cycling for up to 25 minutes and 13 resistance exercises with 
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stretching during cool-down.  The remaining ten acted as controls, and kept diaries recording any 
physical activity lasting longer than 20 minutes. The outcome measures included quality of life 
(SF-36) and oxygen consumption and anaerobic threshold during an exercise test. In the 
intervention group results suggested an improvement in aerobic capacity after the five weeks, with 
a trend toward improvements in quality of life. Unfortunately, the study was limited by recruitment 
problems, with potential participants concerned about participating in physical activity. These are 
important messages as the education of those with MS about the safety and importance of taking 
part in physical activity is necessary if it is to be adopted amongst the MS population. The need for 
quality evidence to inform the clinician and client is very real. 
Motl et al (2012) included eight weeks of thrice weekly exercise sessions of aerobic, resistance and 
balance exercise, delivered in groups of 3 to 4 people. Sessions progressed from initially being 20 
minutes long in week 1, to being 60 minutes long by week 8. Thirteen participants with MS were 
included (EDSS mean= 5.6). The researchers aimed for participants to undertake each exercise type 
for an equal length of time, with the session supervised by two exercise specialists and was 
undertaken in a gymnasium. Outcome measures related to mobility were assessed at the baseline 
and on completion of the intervention, these were Timed 25 Foot walk (T25FW), Timed Up and 
Go (TUG), MS Walking Scale (MSWS) and temporal spatial parameters of gait (functional 
ambulation profile (FAP), cadence, velocity, step length, step time, base of support, double support, 
single support, swing phase). Statistically significant results were found for T25FW, TUG, MSWS 
and some temporal spatial gait parameters (FAP, velocity, step length, single support, swing 
phase). As the study did not include a control group or any follow-up assessments it is limited. 
Furthermore only mobility outcome measures were reported. It does however provide encouraging 
results for a moderately disabled group of participants undertaking a combined therapeutic exercise 
intervention.  
The intervention for the present study was delivered in a group format (Chapter 4). In addition to 
the studies just described, aerobic and resistance studies delivered in a group format are of interest. 
Other group exercise class studies, previously discussed, had a more aerobic basis (O'Connell et al 
2003; McCullagh et al 2008) and resistance basis (Taylor et al 2006; Broekmans et al 2011; Dodd 
et al 2011). All were mainly led by a minimum of two physiotherapists or exercise professionals. 
Bjarnadottir et al (2007), Freeman and Allison’s (2004), Oken et al’s (2004) and Motl et al’s (2012) 
combined-exercise classes were led by two professionals, either physiotherapists, physiotherapy 
assistants or exercise professionals, with many of the interventions designed by physiotherapists. 
Thus , from a safety point of view group classes be supervised by more than one leader.  
The venues where interventions were held varied from study to study; rehabilitation centre/hospital 
gyms and community leisure halls and gyms, suggesting these are all realistic venues to set 
exercise class interventions. The study undertaken by Cakt et al (2010) provides the only known 
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data on a comparison between venue, i.e.  an exercise class or home programme, as well as 
comparison between group and individual exercise, and further investigation here may be 
worthwhile.  
Of interest to any group based intervention, although not evident in the results of these quantitative 
studies involving group exercise classes, is the social support offered by attending a group class. 
This may be a confounding factor, which influences results (discussed more in Section 2.5 
regarding qualitative literature). A novel approach, taken by Dodd et al (2011) to overcome this 
potential source of bias, involved the control group attending a “social program” not expected to 
influence the outcome of interest which was strength (i.e. they attended massage, luncheons and 
education sessions). 
As befits the varying nature of the combined exercise intervention, the outcomes assessed were 
varied; improvements were seen in mobility, fatigue, aerobic endurance and capacity, disability and 
balance across the combined exercise studies. During aerobic intervention studies improvements 
were mainly in mobility and aerobic endurance and capacity (Section 2.4.1), whilst in resistance 
intervention studies (Section 2.4.2), improvements were mainly in strength and mobility. There is 
evidence that all types of exercise improve fatigue, disability and quality of life. It may be that if 
only one intervention is to be utilised, it is logical to suggest a combined intervention may be the 
most beneficial. Furthermore as those with MS suffer from a variety of impairments (including 
deficits in strength, mobility, stiffness and fatigue  (Motl et al 2008b)), a combined intervention 
may address these appropriately. However there is minimal research comparing different types of 
exercise (i.e. an aerobic intervention with a resistance intervention with a combined exercise 
intervention) future research incorporating this design may be beneficial. 
Nevertheless it was partially dealt with in a study by Sabapathy et al (2011) which compared 
aerobic exercise and resistance exercise in an eight week randomised cross-over trial in sixteen 
people with MS (unclear disability level). Neither intervention resulted in significant improvements 
over the other (measurements were taken for grip strength, balance (functional reach), 
mobility/endurance (TUG, 6MWT),  the physiological and psychological impact of disease 
(MSIS), fatigue (MFIS), depression (BDI) and quality of life (SF-36)). However as the cumulative 
evidence suggests aerobic exercise may offer benefits for improved mobility and endurance, whilst 
resistance exercise appears to primarily benefit strength and mobility, thus further comparison 
studies would be welcomed. 
In addition, further work on outcome measures which include balance and physical activity levels 
would also be beneficial. Cattaneo et al (2007a) and Freeman and Allison (2004) found significant 
improvements in balance following a three and ten week intervention, respectively, and it would be 
Literature review 
68 
 
of interest if improvements in balance could be recreated in future studies. No studies in the 
combined exercise literature assessed physical activity levels, a clear gap in the literatue. 
Throughout the included combined exercise studies there was minimal evidence of any adverse 
events, although MS relapses have occurred no study has suggested these were as a direct 
consequence of the intervention. The 24 week study by Romberg et al (2008) found that the control 
group deteriorated in their disability scores (measured using the Multiple Sclerosis Functional 
Composite - MSFC), highlighting the variable nature of MS. When added to the similar evidence 
from the decline seen in Shulz et al (2004) and Ponichtera-Mulcare et al ‘s (1997) declining control 
groups (Section 2.4.1). This indicates the need for the use of therapeutic exercise to provide long-
term symptom maintenance. 
The quality of the literature in combined exercise varies with studies using experimental designs 
(Freeman and Allison 2004; Fragoso et al 2008; Charlton et al 2010; Motl et al 2012) and 
randomised control designs (Carter and White 2003; Oken et al 2004; Romberg et al 2004; 
Bjarnadottir et al 2007; Cattaneo et al 2007a; Cakt et al 2010). As before the risk of bias in the 
RCTs is highlighted by the PEDro scores where the scores vary from five to eight out of a possible 
eleven. Indicating a lack of subject, therapist and assessor blinding, follow-up and a lack of 
utilising intention to treat protocol could be improved upon in future studies.  
Combined exercise training may well offer a rounded approach to exercise training, allowing 
participants to benefit from aerobic exercise, resistance exercise and other forms of exercise such 
as flexibility and balance re-training. Combined exercise studies have found improvement in 
participants mobility, exercise capacity, strength, balance, fatigue and disability levels. However 
there is a need to improve the literature here, particularly regarding 
• Including participants more disabled by their MS symptoms 
• Establishing the optimal length of time for change to be seen 
• Establishing the optimal frequency of sessions 
• Standardisation of outcome measures, to allow comparison across studies 
• Utilising outcomes to assess the impact of the intervention on physical activity levels. 
• Including methodology aimed at improving balance, and relevant outcomes. 
• Improved methodology to reduce the risk of publication bias. 
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• Undertaking follow-up to ascertain the longer term effect of interventions. 
 
  
70
Table 2.7 Combined exercise intervention studies 
Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ potential 
bias 
Bjarnadotter et al 2007 
Iceland 
RCT (PEDro 7/11) 
 
 
18 MS participants (8 intervention,  
10 controls) 
EDSS mean – 2 
Type – RR 
Sex F/M – 11/5 
Age range 37 
Years diagnosed 8 
Completed study – 16 
(symptom relapse) 
Combined aerobic and resistance 
exercise  
 
5 weeks, thrice weekly 60 minutes 
Cycling 
Resistance: 13 exercises for major 
muscle groups 
5 weeks thrice weekly 60 min sessions 
Venue - Rehabilitation centre 
Trained – Unclear 
Led by - Physiotherapists 
EDSS 
SF36 
Peak oxygen 
consumption 
Anaerobic threshold 
(VO2 max) 
Non significant 
improvement in Peak 
oxygen consumption and 
SF36 
No; 
Subject blinding 
Assessor blinding 
Adequate follow-up 
subjects 
Intention-to-treat analysis 
No follow-up 
 
Carter and White 2003 
(Abstract only) 
UK 
RCT 
11 MS participants (6  Intervention 
5  Control) 
EDSS – unclear 
Type – unclear 
Sex – unclear 
Age range – unclear 
Years diagnosed – unclear 
 
Completed study – Unclear 
 
Combined flexibility, aerobic and 
resistance exercise 
 
12 weeks (twice weekly) 
Venue – Unclear 
Trained – Unclear 
Led by - Unclear 
PCI 
MVC (hip flexors, 
knee flexors and ankle 
dorsiflexors)  
Non significant 
improvement in PCI and 
MVC (hip and knee flexor)  
Only abstract available thus 
not PEDro rated 
Small sample size 
Unclear demographic data 
Unclear attrition 
No follow-up 
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Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ potential 
bias 
Cakt et al 2010 
Turkey 
RCT (PEDro – 6/11) 
45 MS participants  (15 aerobic exercise 
training [Group 1], 15 lower limb 
strengthening & balance [Group 2], 15 
control [Group 3]) 
EDSS – Unclear (≤6) 
Type – All 
Sex F/M – 23/10 
Age range (mean)-38.3 
Years diagnosed; range (mean) – 7.33 
 
 
 
Completed study - 33 
Cycling [Group 1] + combined 
strengthening and balance exercises 
8 weeks twice weekly sessions of 
around 60 minutes 
Venue - Unclear 
Trained – Groups (unclear how many) 
Led by – Physiotherapist 
Combined strengthening and balance 
exercises [Group 2] 
8 weeks twice weekly sessions of 
around 30 minutes 
Venue – Participants home 
Trained – Individually 
Led by – Self-managed 
SF36 
TUG 
DGI 
Functional Reach 
FES 
10MWT 
FSS 
BDI 
Tolerated duration of 
cycling 
Tolerated workload of 
cycling 
 
In Group 1 
Significant improvement in 
all outcomes except SF36. 
 
In Group 2 
Significant improvement in 
FES, Tolerated duration of 
cycling, Tolerated 
workload of cycling 
Between Groups 1 & 2  
Group 1 Significantly 
improved in all except 
10MWT 
 
Control group showed no 
change 
No; 
Concealed allocation 
Subject blinding 
Therapist blinding 
Follow-up 
Intention-to-treat analysis 
Cattaneo et al 2007 
Italy 
RCT (PEDro 8/11) 
 
44 MS participants  (20 combined 
intervention, 11balance intervention, 13 
controls) 
EDSS unclear 
Type unclear 
Sex F/M – 29/13 
Age range -46 
Years diagnosed 14 
Completed study – 32 
(discharged early or for other unknown 
reasons) 
Combined 
1] Combined balance and motor/sensory 
2] Balance exercise 
3] Motor/sensory only  
3 weeks of 2/3 30 minute sessions per 
week. 
Venue – Rehabilitation centre 
Trained – Individual 
Led by - Therapists 
BBS 
DGI 
Fall frequency  
DHI 
ABC  
Significantly improved 
balance in groups 1 and 2. 
Significant BBS between 
groups 1 and 3 and groups 
2 and 3. 
Significant difference in 
fall frequency between 
groups 1/2 and 3  
 
No; 
Subject blinding 
Assessor blinding 
Adequate follow-up 
subjects 
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Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ potential 
bias 
Charlton et al (2010) 
Iowa, USA 
Experimental 
14 MS participants  
EDSS – Unclear  
Type - unclear 
Sex F/M – female only  
Age range (mean) – 32-70 (54) 
Years diagnosed; range (mean) – unclear 
Completed study – 11 (9 returned the 
questionnaire) 
Combined aerobic and resistance 
exercise 
16 weeks  twice weekly – 45 minutes 
 
Venue – Community hall 
Trained – In groups (of 9) 
Led by – Exercise professionals 
Self –designed self- 
completed 
questionnaire 
regarding symptom 
improvement and 
enjoyment of the 
programme 
Confidence, mood & 
energy improved.  
 
 
Small sample size 
Unclear demographic data 
No follow-up 
 
Fragoso et al (2008) 
Brazil 
Experimental 
 
10 MS participated 
EDSS – mean 2 
Type – Mainly RR 
Sex F/M –9/1 
Age range (mean) – 
 20-49 (35) 
Years diagnosed – Unclear 
 
Completed study – 9 (drop-out not 
motivated to continue) 
Combined flexibility, aerobic and 
resistance exercise 
20 weeks, thrice weekly 60-90 minute 
sessions 
4 weeks progressive stretching 
10 weeks stretching + progressive free 
weights 
6 weeks stretching + progressive free 
weights + walks/runs. 
Venue – University sports facility 
Trained - Unclear 
Led by – Exercise Professionals 
CFS 
HR before/after 3 
minute step test 
Significantly improved HR 
(before and after step test) 
and    fatigue.  
Small sample size 
Unclear demographic data 
No follow-up 
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Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ potential 
bias 
Freeman and Allison 2004 
UK 
Experimental  
4 week follow-up 
 
10 MS participants  
EDSS mean - 5 
Type – Unclear 
Sex F/M - Unclear 
Age range (mean) – 35-69 (53) 
Years diagnosed; range (mean) – 4-28 (10) 
Completed study - All 
Combined body resistance and Pilates 
exercises. 
 
Whole body floor based exercises and 
Pilates 
10 week once weekly 60 minute 
sessions. 
Venue - Hospital gym 
Trained – In Groups (of 10) 
Led by – Physiotherapist and 
Physiotherapist assistant 
BBS 
6MWT 
PCI 
FIS 
MSIS 
MSWS 
Significant improvement in 
BBS, 6MWT, MSWS 
At follow-up BBS and 
6MWT continued to 
improve. 
Small sample size 
Unclear demographic data 
Non controlled 
 
Motl et al 2012 
USA 
Experimental 
 
 
13 MS participants 
EDSS mean = 5.6 
Type – All 
Sex F/M – 8/5 
Age range (mean) – 23-64 
(55.8) 
Years diagnosed; range (mean) – 2-22 (18.1) 
Completed study – all 
 
Combined aerobic, resistance and 
balance  
8 weeks , thrice weekly (20 min – 60 
min sessions) 
Venue – Accessible gymnasium 
Trained – In Groups (of 3-4) 
Led by – Exercise specialists 
 
T25FW 
TUG 
MSWS 
Temporal spatial gait 
parameters 
 (FAP, cadence, 
velocity, step length, 
step time, base of 
support, double 
support, single 
support, swing phase) 
Significant improvement in 
T25FW, TUG, MSWS, 
FAP, velocity, step length, 
single support, swing 
phase. 
Small sample size 
No follow-up 
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Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ potential 
bias 
Oken et al 2004 
USA 
RCT (PEDro 5/11) 
 
69  MS participants (15 exercise 
intervention, 22 yoga intervention,  
20 control) 
EDSS mean -  3.1 
Type -  Unclear 
Sex F/M - Unclear 
Age range - Unclear 
Years diagnosed  – Unclear  
 
Completed study – 57 (due to symptom 
relapse, unrelated surgery, longstanding 
back pain and poor class attendance) 
Aerobic (exercise group) 
Cycling 
Yoga 
Combination of 19 poses 
24 week once weekly 60 (aerobic) or 90 
(yoga) minute session 
Venue – unclear 
Trained – In Groups (Unclear how 
many/class) 
Led by – Physiotherapist (exercise 
intervention) 
Yoga teacher (yoga intervention) 
POMS 
SAI 
MFI 
SF36 
 
 
Non -significant 
improvements in MFI and 
SF36.  
No clear differences 
between groups 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Intention to treat 
Concealed group allocation 
Intention to treat 
Follow-up 
Unclear intervention 
 
Romberg et al 2004; 2005 
Finland 
RCT (PEDro 7/11) 
 
95 MS participants (47 intervention,  
48 controls) 
EDSS mean – 2.3 
Type – Unclear 
Sex F/M – 61/34 
Age mean - 43 
Years diagnosed; range (mean) – 0-28 (6) 
 
Completed study – 91 
(Unclear  reasons) 
Combined aerobic and resistance 
Hydrotherapy initially and then 
unsupervised aerobic exercise of choice.  
Resistance 
Using resistance bands. 
3 weeks of in-patient training followed 
by 24 weeks of unsupervised home 
based training. 
Venue - Physiotherapy department 
(initially) 
Participants own home 
Trained – Individually 
Led by – Physiotherapist initially. 
T25FW 
500MWT 
MVC  knee muscles 
Upper limb weight 
lifting test 
Graded Exercise test 
EDSS 
FIM 
MSQOL 
CES-D  
Equiscale 
 
Significantly improved 
EDSS, non-significant 
improved MSFC, non-
significantly improved 
T25FW. 
 
 
No; 
Subject blinding 
Therapist blinding 
Assessor blinding 
Concealed group allocation 
No follow-up 
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Author and design Participants Key methods Outcome 
measure 
Findings Limitations/ potential 
bias 
Sabapathy et al 2011 
Australia 
Randomised crossover 
 
18 MS 
EDSS - Unclear 
Type – All 
Sex F/M – 12/4 
Age range (mean) – (55) 
Years diagnosed; range (mean) – (10) 
Completed study – 16 
(illness, and lack of time) 
 
Combined 
Aerobic versus Resistance exercise 
Aerobic whole body aerobic circuits 
Resistance whole body progressive 
 (8 week washout) 
8 week, twice weekly 60 minute 
sessions  
Venue – Community Health Centres 
Trained – Unclear 
Led by – Exercise physiologists 
 
Grip strength 
Functional reach 
Step test 
TUG 
6MWT 
MSIS 
MFIS 
BDI 
SF-36 
Functional reach, step test, 
TUG and 6MWT 
improved over the study in 
both groups 
No significant differences 
between groups  
 
Unclear if washout period 
effective, no control group. 
No follow-up 
Vore et al 2011 
New York, USA 
Experimental 
11 MS participants  
EDSS – Unclear 
Type – Unclear 
Sex F/M –9/2 
Age range (mean) – (55) 
(Years diagnosed; range (mean) – (22)  
 
Completed study – 10 
Combined functional exercise  
Included combined gait/functional 
mobility retraining, balance work,  
aerobic & resistance work 
10 week once weekly 60 minute 
sessions 
Venue – Hospital gym 
Trained – Individually 
Led by – Physiotherapy students  
MSQOL 
ABC 
MFIS 
TUG 
10MWT 
Single leg stance 
Significant improvements 
in TUG, 10MWT, MFIS 
 
Small study sample 
No follow-up 
EDSS – Expanded Disability Status Scale, F-Female,  M – Male, RR – Relapsing-remitting, SP – Secondary Progressive, Outcome measure abbreviations available in 
Table 2.4 
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2.4.4 Summary  
There is a growing body of literature surrounding therapeutic exercise in MS, and this has been 
discussed in relation to aerobic exercise, resistance exercise and combined exercise. The literature 
varies in methodology and quality and has been summarised, and presented in depth in Table 2.5-
2.8. In general therapeutic exercise has been found to be beneficial for those with MS. However, 
further work would add to our knowledge and should attempt to address some of the following 
literature gaps 
• With many trials investigating group exercise in those mild to moderately affected by their 
symptoms, future trials should include those more severely affected. 
• As few trials have assessed  physical activity levels, it is important to monitor this. 
• Follow-up, which would allow for assessment of symptom change after cessation of any 
exercise intervention should be included in future trials. 
• As the majority of trials are small and underpowered, larger statistically powered trials 
should be undertaken.  
• Few trials have investigated participants thoughts and beliefs, which may provide an 
insight into why studies are/are not successful, thus more qualitative methodologies should 
be included to establish participants’ thoughts and beliefs. 
• Undertaking interventions at community leisure sites may allow increased participation, 
and should be included in future work. 
 
Literature review 
77 
 
2.5 Qualitative research on exercise in people with MS. 
As discussed there are a growing number of quantitative studies surrounding the area of 
rehabilitation and therapeutic exercise for those with MS. Unfortunately there have been few 
qualitative studies which collect information from the participants’ perspective. These may offer an 
insight into the advantages and disadvantages of exercise interventions, helping guide both 
researchers and clinicians when establishing exercise related services and interventions. 
Studies have gathered opinions, through semi-structured interviews, on exercise from the general 
MS population and from those with MS who already participated in independent community 
exercise. Kayes et al (2011) explored the views on engaging in physical activity in 10 people with 
MS who had a range of disabilities, and were recruited from the general MS population. Whilst 
Smith et al (2011) interviewed 11 women with MS, who already participated in community based 
exercise, to establish the impact of exercise specifically on fatigue. Findings in these two studies 
were similar; it was reported that participating in physical activity and exercise is related to, 
believing exercise can be beneficial (e.g. the perceived line between benefit and harm) and the 
emotional response to physical activity and exercise (e.g. previous negative experiences, self-
efficacy to control the disease and feeling good whilst exercising). Reported barriers preventing 
people exercising are exacerbating MS symptoms (particularly fatigue) and feeling misunderstood 
by the general public or exercise professionals. 
However, these studies were not linked to an MS specific exercise intervention and gathering the 
views and opinions of those taking part in exercise enables the researcher to establish much more 
than barriers and facilitators. It allows an exploration of the positive and negative outcomes from 
the exercise intervention, and will gather participants’ opinions on improving the intervention.  
Three studies have explored the views on exercise of those participating in exercise interventions 
specifically for people with MS, using semi-structured interviews. The quality of these three 
studies was considered using the CASP qualitative research critical appraisal tool (Section 2.3.3).  
Plow et al (2009b) studied 13 participants who were involved in an individual home exercise 
programme (of stretching, static cycling and resistance exercises) as part of a larger study. Whilst, 
in the study by Dodd et al (2006) the nine interviewees had participated in ten weeks of a twice 
weekly resistance training programme, led by a physiotherapist and exercise professionals in a 
community leisure centre, the quantitative results of which were  reported by Taylor et al (2006). 
Finally, the ten participants in Smith et al’s (2009) study had taken part in an eight week 
individually tailored exercise programme led by a physiotherapist.  
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Disability level was not reported based on the EDSS, although disability descriptions were given. 
Only those participating in Dodd et al’s (2006) study included participants with a disability level 
equivalent to an EDSS score of greater than 5 with the descriptions of participants in the other 
studies indicating they were of low levels of disability. 
Dodd et al (2006) analysed their results using the General Inductive approach similar to that 
described by Thomas (2006). Dodd et al  (2006) explored the positive and negative outcomes of 
group resistance exercise and established facilitators or barriers to participating. Many positive 
outcomes of participating were discussed related to physical, psychological and social outcomes. 
Negative outcomes were related to fatigue and general aches and pains. Extrinsic factors (including 
leadership, group, venue, cost, time) and intrinsic factors (including determination, positive 
attitude, seeing progress, novelty and enjoyment) for completing the programme were discussed. 
The only barrier to participating in exercise was related to the cost of taking part. Participants 
spoke of the encouraging, supportive and knowledgeable aspects of the leaders making the class 
easier to complete and that being in a group, in a gym was also worthwhile (Dodd et al 2006). The 
authors also provided information on the questions they included, which are useful when carrying 
out similar studies.  
The study stood up well to the CASP critical appraisal, however although Dodd et al ( 2006) 
justified the use of qualitative research, they did not acknowledge the possibility of using focus 
groups. The authors did not explain clearly in their articles from the studies what the relationship 
was between the participants and researchers, which may have been influential.  
Smith et al (2009) used an Interpretative Descriptive methodology to analyse their findings. As 
their aim was to explore the impact of an exercise programme on the participants perception of 
fatigue many themes surrounding fatigue and exercise emerged. These included, feeling stronger, 
improved fatigue management and healthy tiredness (improving participants’ sleep). Negative 
impacts of exercise on fatigue were reduced balance and walking ability immediately following 
exercise. Critical appraisal highlighted some areas where the study quality could improve; Smith et 
al (2009) provided minimal rationale of the use of qualitative research and interviews and, based on 
the study’s aim, a questionnaire approach may have gathered sufficient information. Minimal 
explanation was provided on the depth of data analysis; doing so would help inform further 
research. 
Plow et al (2009b) used a General Analytical Induction method to analyse their results and aimed 
to establish views on physical activity dependent on how active participants were; stratifying their 
findings based on current physical activity; either physically active (n=3), sometimes active (n=7) 
or inactive (n=3). Related to these criteria responses were different, with physically active 
participants displaying more self-efficacy to use exercise for symptom management and a better 
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ability to self-regulate daily activities to allow them to exercise. Inactive participants presented 
more barriers to exercise than their more active counterparts. Critical appraisal highlighted that 
although Plow et al (2009b) justified their methodology, no consideration was given to the use of 
focus groups, and importantly the researchers did not explicitly acknowledge ethical considerations 
in their published study. 
The studies discussed in this section present interesting messages for any health professional 
involved in activity prescription for people with MS. They provide an insight into the world of the 
person with MS which quantitative studies do not. In particular the insights that having greater self-
efficacy to control the disease (Plow et al 2009b; Smith et al 2011), being led by knowledgeable 
professionals (Dodd et al 2006) and being aware of symptom improvements (Smith et al 2009) 
encourages uptake and continuation of exercise. Fatigue, negative emotional feelings, social 
situations, inaccurate professional advice and lack of appropriate facilities all emerged as 
potentially having a negative impact on physical activity and exercise adherence (Dodd et al 2006; 
Smith et al 2009; Plow et al 2009b; Smith et al 2011). However participants in Smith et al’s (2009) 
study acknowledged that fatigue does not always have a negative effect on exercise, and that it was 
important that individuals were educated to know when they should be able to exercise.  
These papers mainly include the views of those mildly affected with MS, and all use semi-
structured interviews to gather data. Gathering data using focus groups is, as yet, an unexplored 
methodology in a study specific to exercise in MS. However it has been used to gather the views of 
those with a range of neurological conditions (a small sample of whom had MS) (Dawes et al 
2010). Dawes et al (2010) reported that people with neurological conditions would be keener to 
exercise if they felt it could benefit their symptoms, was provided in a group format (with those of 
similar disabilities) and was delivered by knowledgeable staff (particularly physiotherapists). 
Collecting qualitative data using a focus group methodology, which can be more natural, encourage 
participant interaction, and allow contrasting opinions to be easily explored (Kitzinger 1994; 
Wilkinson 1998) are underused in this area of research, these points warrant further investigation.  
Thus the views related to exercise of those more severely affected with MS (EDSS>5), who have 
taken part in a specific MS group exercise programme have not yet been researched. 
2.5.1 Summary  
Despite the growing area of research related to therapeutic exercise for those with MS there are few 
qualitative studies. These studies not only provide information on the barriers and facilitators 
experienced by people with Multiple Sclerosis when considering exercising, but also what effect 
exercise has on their disease symptoms and other areas of their life, in areas which quantitative 
studies may not. Thus qualitative research can be used to guide quantitative study into issues 
Literature review 
80 
 
deemed to be important to the participant. The views and opinions of those with Multiple Sclerosis 
related to exercise is also of interest to any health or exercising professional responsible for 
organising exercise options for those with MS. 
In general qualitative studies have found positive views on therapeutic exercise and physical 
activity for those with MS, although it has highlighted some problems faced by those with MS 
when participating in exercise and physical activity. Further work would improve our knowledge in 
this area and future work should attempt to address some of the following literature gaps; 
• As most qualitative research surrounding exercise and MS has not reported disability level, 
or has only included those described as having an approximate EDSS level 5, opinions and 
views of those more affected (EDSS greater than 5) should be gathered. 
• As semi-structured interviews have mainly been used in MS specific exercise qualitative 
studies so far, the use of focus groups for gathering data is unexplored. 
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2.6 Summary and conclusion 
There is scope for continued clinically relevant research in therapeutic exercise for those with MS, 
with an improvement in study quality, leading in part, to improved care and better overall treatment 
options for those with MS. In particular the lack of community rehabilitation options and 
qualitative research into MS rehabilitation should be addressed  
The aim of this thesis is to address the gaps in the literature. Such gaps include; a lack of studies 
recruiting those more disabled with their MS symptoms (i.e. an EDSS>5), a lack of follow-up data 
after the exercise and unclear information as to the optimal duration of the intervention. These 
areas will be addressed in the main study explained in Chapter 4. 
To address the dearth of knowledge regarding the views and opinions of participants taking part in 
therapeutic exercise interventions for people with MS, qualitative research was undertaken 
(Chapter 5). These aims will be addressed in the following chapters describing the three studies 
involved in this thesis. 
The following chapter will provide a literature background to the outcome measures used in the 
main study, and will introduce the rationale behind the reliability of outcome measures used in MS, 
which will be explained in Chapter 6. 
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3 Literature pertaining to the methodology.  
There are a number of outcome measures used clinically and in research  to evaluate the 
effectiveness of rehabilitation, symptom management and the reduction of disability in patients 
with MS. Many of these are discussed as part of the literature review in Chapter 2. This chapter 
provides a literature background to the chosen quantitative and qualitative methods used in the 
studies undertaken for this thesis.  
3.1 Introduction  
To answer the research questions of this study (Section 1.5), a mixed methodology approach was 
used. Three investigations were undertaken related to the theme of therapeutic exercise for those 
moderately affected with MS. Study 1) The main investigation, was a 12-week exercise 
intervention, with follow-up assessments 6 and 12 months after the end of the intervention. Study 
2) A focus group analysis of the 12-week exercise intervention. Study 3) An assessment of the 
reliability of the outcome measures used in the main investigation. 
Quantitative data were collected through repeated clinical outcome measurement in Studies 1 
(Chapter 4) and 3 (Chapter 6). Focus groups were used in Study 2 (Chapter 5) to elicit participants’ 
views on areas related to the exercise intervention in Study 1. This chapter discusses the literature 
surrounding the chosen methods and puts into context the chosen outcome measures used to 
achieve the primary aim of establishing the effects of a group exercise class in people with MS of 
moderate disability. To achieve the aims of Study 1 and Study 3, what will now be described as 
clinical (quantitative) measurement was undertaken. This will be discussed prior to an examination 
of the literature which guided the qualitative methods chosen to achieve the aims of the focus 
group. This chapter complements the methodological details presented in Chapters 5, 6 and 7, 
providing the background to the methodology sections of these chapters. 
3.2 The use of mixed methodology 
A mixed methodology gathered both quantitative (Study 1), and qualitative (Study 2) data. This 
allowed the research to overcome limitations of single methodology studies. For example, 
quantitative methodology may focus on numerical data and lack the ability to gather data related to 
understanding the context of participants’ behaviour, whilst qualitative methodology may be seen 
as being subjective and lacking reliability and validity  (Taylor 2005; Creswell and Plano Clark 
2007). 
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Primarily quantitative clinical outcomes were used; with qualitative focus group data collected 
independently of the quantitative results. At the time of collection, one form of data did not 
influence the other, consequently a mixed methodology triangulation design was used (Creswell 
and Plano Clark 2007). On final analysis, results from some of the quantitative results were 
relevant to findings from the focus groups, which in turn complemented some of the quantitative 
findings, resulting in a greater understanding of the results. 
3.3 Gathering clinical measurements 
To objectively measure the impact of disease symptoms or a clinical intervention, quantitative 
measurement is commonly used. There are a number of ways to achieve this, for example, timed 
tests, instrumental tools or questionnaires  (Hammond 2000; Yoward et al 2008). However more 
than simply measuring, outcome measures must demonstrate practical use (feasibility) whilst being 
valid and reliable. As such, there are a number of basic concepts when using clinical outcome 
measures. 
3.4 Basic concepts in clinical measurement 
Measurement is an important component of healthcare: used to establish the impact of treatment 
and monitor change in clinical performance (Streiner and Norman 2008). A reliable and valid 
outcome measure which accurately monitors significant changes is important both in research and 
clinical practice (National Institute for Health and Clinical Excellence 2003).  
Reliability is an indicator that the outcome measure can produce consistent results, while validity is 
an indicator of whether the outcome measure is appropriate for its intended purpose (Bowling 
2005). Furthermore the outcome measure, and, where possible, its established reliability and 
validity, should be relevant and feasible for use within the MS population.   
Establishing test re-test reliability involves repeatedly testing the same variable to determine if a 
similar score is found (Bowling 2005). Within reliability assessment, it may be important that both 
intra-and inter-rater reliability be established. Intra-rater reliability establishes the rate of agreement 
of two, or more, scores taken by the same assessor. Whilst inter-rater reliability establishes the 
agreement of two, or more scores taken by two, or more  different independent assessors (Bowling 
2005). Error may be minimised through training and experience (Richards et al 2000), thus more 
experienced clinicians (with more practice using the outcome measure, correctly) are perceived to 
provide more reliable results (Streiner and Norman 2008). However, if time consuming and costly 
training of a clinician is required for an outcome measure, the clinical applicability of the outcome 
measure may be undermined. 
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Statistical tests measuring correlation are commonly used to estimate the reliability of the outcome 
measure. Simple correlation models are, however, limited as they only examine a linear 
relationship, not reliability. A commonly used, and more appropriate statistical method is 
establishing reliability using the Intraclass Correlation Coefficient (ICC), where scores closer to 
unity (1) are deemed more reliable (Denegar and Ball 1993). 
It is important to establish validity to determine whether an outcome measure is appropriate for its 
intended use. Validity can be established in one of two ways. The most common method compares 
the outcome measure against other established outcome measures (the so called “gold standard”) 
that assess similar attributes. Statistical analysis is used to determine if there is a strong correlation 
between the two results. Alternatively, if no similar outcome measure is available, the outcome 
measure must be compared against relevant hypothetical concepts (Streiner and Norman 2008).  
Other statistical tests similar to the ICC, such as the Pearson correlation (commonly denoted as r), 
may also be used in the literature to describe validity. For both, scores closer to unity (1) suggest a 
stronger correlation between the outcome measure of interest and the established outcome measure, 
indicating they are measuring the same factor (Denegar and Ball 1993).  
Related to the validity of the measurement is the influence of “floor” and “ceiling” effects, terms 
which indicate that scores are either very high or very low resulting in the mean score approaching 
the maximum or minimum score possible (Streiner and Norman 2008). Theoretically any outcome 
measure which has a maximum or minimum score may be vulnerable to a potential “floor” or 
“ceiling” effect. 
A “floor effect”, is deemed problematic if, for example, a participant is unable to achieve the basic 
requirements to score lower than the minimum score on a measurement. A “ceiling effect”, is 
deemed problematic when, for example, a participant achieves a top score on a measurement. For 
both these situations, any change in clinical status may not be clearly captured (Nunnally and 
Bernstein 1994). Thus, the outcome measure will not indicate a true representation of what it is 
attempting to measure. In this case the use of secondary outcome measures may compensate for a 
potential floor or ceiling effect. 
Less well-known properties such as the clinical significance/precision of an outcome measure are 
important. Determining clinical significance will help determine any change in score is clinically 
significant and not due to an error in the measurement. One interpretative value for clinical 
significance, calculated from scores distributed across a group of participants repeating the same 
outcome measure, is Minimal Detectable Change (MDC). MDC is defined as the minimal amount 
of change that is not likely to be due to chance variation or error in the measurement (Haley and 
Fragala-Pinkham 2006), thus it is independent of any change seen on, for example, the EDSS scale.  
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However within the literature similar statistical calculations, such as Minimal Important Difference 
(MID) (Guyatt et al 2002) and Minimally Important Clinical Difference (MICD) (Coleman et al, 
2011) may be used. All are indications of clinical significance. 
In addition it is important to know how precise the measure is, this can be described using the 
Standard Error of Measurement (SEM); calculated from the standard deviation of the distributed 
test scores and the reliability of the measure (Denegar and Ball 1993). 
It is a recommendation that, in addition to reporting results of statistical tests, effect sizes or 
difference of means are also reported (Them and Be 2008). Doing so provides an indicator of the 
effect of the intervention without the requirement to consider the number of participants (Coe 
2002).      
The available MS literature reveals that the reliability and validity of outcome measures is not well 
established. Furthermore, using statistical methods, such as those described above to determine the 
clinical significance and precision of outcome measures used to assess therapeutic exercise is rare. 
3.5 Feasibility in clinical measurement 
When deciding on an outcome measure for either clinical or research purposes the practicalities of 
how it will be used is an important consideration. Indeed the outcome measures used should be 
convenient for the clinician as well as acceptable to the client (Hammond 2000). Past studies 
questioning physiotherapists on what factors they consider when choosing outcome measures 
highlight the importance of them being practical and feasible (Chesson et al 1996; Copeland et al 
2008). Findings suggest that cost, time, patient expectations, service prioritisation, clinical decision 
making, audit requirements and clinicians knowledge of outcome measures are all important 
factors when choosing an outcome measure. With space and patient burden also important 
considerations (Bethoux and Bennett 2011). 
3.6 Outcome measurement in MS 
Both generic and MS-specific outcome measures exist. Generic measures can be used in a wide 
range of disease populations, making the data generated from them comparable across different 
groups. However they will not focus on areas specific to MS, where the recommendation is that, 
where available, MS specific outcome measures should be used in MS therapeutic exercise studies 
(Motl and Gosney 2008).  
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Data can be generated from both assessor rated outcome measures and self-report questionnaires. 
These can be chosen based on whether the outcome of interest can be observed (e.g. walking or 
balance) or whether the outcome is better captured from the patients thoughts and feelings (e.g. 
fatigue and mood). However, data on outcomes which may be readily observed may also be 
captured with self-report measures (e.g. balance). Self-reporting may be difficult for those with 
MS, if for example they have difficulties in manual dexterity or cognitive problems which may 
impact speed of information processing and memory  (Matthews 1998; Bruce et al 2010), 
influencing both the time to complete self-reported outcome measures and the accuracy of the data. 
Similarly, in those with MS, performance may fluctuate throughout the day and from day to day, 
irrespective of any new disease activity (Finlayson and van Denend 2003). Quantitative research 
has been conducted to establish the influence of time of day on symptoms; however, no conducive 
findings have emerged.  With Morris et al (2002) and Feys et al’s (2012) participants reporting 
increased fatigue in the afternoon compared with the morning. Although participants in Crenshaw 
et al’s  (2006) study did not report any significant changes in fatigue throughout the day. Mobility 
was also assessed in these studies, with no indication that fatigue influences mobility, perhaps 
suggesting that time of day may not be influential on mobility. 
3.7 Outcome measures used for study inclusion 
Before a fuller discussion on the outcome measures used in the study, information is provided to 
the reader on the measurement tools used to establish participants’ eligibility to the study. Three 
outcome measures were used; the Mini Mental Status Examination (MMSE), the Expanded 
Disability Status Scale (EDSS) and a Fitness Screening form based on the Physical Activity 
Readiness Questionnaire (PAR-Q). Copies of these are available in Appendix 1 and 2. 
3.7.1 The Mini Mental State Examination   
In MS, cognitive deficiency may be problematic (Compston and Coles 2008). The studies in this 
thesis required a level of comprehension which would allow participants to follow instructions, 
complete questionnaires and attend  scheduled appointments. Thus, determining sufficient 
cognitive functioning was important. To ensure participants were of adequate cognitive function 
the Mini Mental Status Examination  (MMSE)  (Folstein et al 1975) was used.  
The MMSE measures cognitive aspects of mental status, primarily; arithmetic, memory and 
orientation, providing a total score out of 30, with higher scores indicative of better cognition. The 
MMSE has been found to be reliable and valid in populations where cognitive impairment may be 
common  (Folstein et al 1975; Kim and Caine 2002).   In MS its validity and reliability has not 
been fully established. However the MMSE has been used in previous studies  related to 
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therapeutic exercise in MS (Patti et al 2002; Patti et al 2003; Finkelstein et al 2008) where scores of 
24 or greater were used for study inclusion. Therefore, a score of 24 or greater was required for 
inclusion in the present studies. 
The MMSE is not without its limitation, as it can be influenced by age and education level 
(Tombaugh and McIntyre 1992), however it is easy to administer and does not require a high level 
of assessor skill, therefore appropriate to the studies in this thesis.  
3.7.2 The Expanded Disability Status Scale  
Created by Kurtze (1983), the EDSS evaluates neurological impairment in MS, and is used as a 
measure of disability. The scale quantifies neurological impairments, in each of eight neurological 
Functional Systems (FS); pyramidal, cerebellar, brainstem, sensory, bowel and bladder, visual, 
cerebral and other. These are combined with ambulation ability and give a measure of disability on 
a scale from normal (0) to death due to MS (10) (Figure 3.1). 
The EDSS scale has been used in the majority of studies involving therapeutic exercise for those 
with MS, as discussed in Chapter 2. Theoretically, its use allows comparison between or within 
those with MS. It is a widely recognised scale; however problems have been highlighted, such as a 
poor response to change (Sharrack et al 1999) and scores clustered around  3/4 and 5/6 (Whitaker 
et al 1995; Jacobs et al 1999). Grades above three are heavily reliant on mobility, thus at the higher 
end of the scale a newly acquired FS problem may not necessarily modify the EDSS score with the 
scale lacking any sensitivity to cognitive changes. Other acknowledged  restrictions of the EDSS 
are the limitations of a nominal scale, when ordinal scales may be a more valid method (Hobart et 
al 2000). Step changes are not reflective of an equal change in disability and the concentration on 
impairment (for the lower levels of the scale) and mobility (for the higher levels of the scale) 
(Rossier and Wade 2001; Bethoux and Bennett 2011) suggest the scale may not capture true 
disease progression.  
The literature review indicated that there is a literature gap surrounding therapeutic exercise for 
those moderately affected with MS, thus, an Expanded Disability Status Scale (EDSS) of 5-6.5 was 
required for study inclusion. This description of moderate MS has been used in the past by 
researchers undertaking similar MS rehabilitation studies (Freeman et al 1997; Freeman et al 1999). 
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Figure 3.1 Pictorial representation of the EDSS Scale  
                  Level of those in study indicated by arrow (MSActiveSource 2010) 
 
Despite it’s acknowledged limitations the EDSS scale was used in this study as it is the most 
widely accepted measure of disability used throughout the MS literature. At present no consensus 
has been reached as to whether another measure of MS disability should be used, consequently to 
allow for comparison between the results of this study and the work of others the EDSS scale was 
used. 
  
3.7.3 Fitness Screening form 
Study 1 included an exercise intervention, thus it was appropriate to establish potential participants’ 
fitness to exercise. A Fitness Screening form was used based on the Physical Activity Readiness 
Questionnaire (PAR-Q) (Shephard 1988).  
Modified versions of the PAR-Q are common in exercise research and in the exercise industry to 
screen individuals for their suitability to exercise (Warburton et al, 2011). However, there are 
limitations to the use of the PAR-Q, for example, it is vulnerable to false positives and may not be 
used consistently. Despite this it does highlight potential risks to exercise participation e.g. heart 
conditions or pain during exercise.  Unlike the MMSE and the EDSS score there was no cut-off 
score for eligibility. If on completion of the PAR-Q any issues were highlighted which would 
suggest exercise may be contra-indicated this would be discussed with the research team, and the 
potential participant excluded as necessary.   
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3.8 Choosing the outcome measures in this study 
A discussion follows of the main outcome measures used in Study 1 and Study 3. By reviewing the 
literature, acknowledging outcome measures used clinically in rehabilitation and by considering the 
feasibility, reliability and validity of the outcome measure, a range of outcome measures were 
considered and chosen. For practical reasons the availability of equipment was also important when 
choosing the outcome measures. The outcome measures chosen were based on, 1) the research 
aims and 2) the International Classification of Functioning (ICF) (World Health Organization 
2001). The ICF is a framework which can be used to categorise the assessment of different 
components of health, it will be described in more detail in Section 3.8.2. In Study 3, the test re-test 
reliability of four of the outcome measures used in Study 1 was investigated in more detail. 
3.8.1 The outcome measures relevant to the research aims 
To meet the aims of the research, outcome measures were chosen to measure the physiological, 
functional and psychological status of participants. As discussed in Section 2.2 there are many 
clinical features and symptoms found in MS. A decision was made to focus on some of these (such 
as those which have been studied in the past therapeutic exercise literature), in particular, outcomes 
that gathered information on mobility, balance, leg strength, activity participation, fatigue, mood, 
quality of life and body composition, all of which may be compromised in MS. 
Information was gathered using the following outcome measures. Most were gathered by the 
assessor, whilst four were self-completed questionnaires (these are notated by an *).   
Mobility The Timed 25 Foot Walk (T25FW) 
 The Six-minute Walk Test (6MWT) 
Temporal Spatial parameters of gait  
 Timed Up and Go test (TUG) 
Balance The Berg Balance Scale (BBS) 
 Activities Balance Confidence scale (ABC)* 
 Overall Stability (OS) 
Leg strength Strongest  (SLS) and weakest (WLS) leg strength  
Activity participation PhoneFITT (PF) 
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Fatigue Fatigue Severity Scale (FSS)* 
Mood Hospital Anxiety and Depression Scale (HADS)* 
Quality of Life 
Body Composition 
Leeds MS Quality of Life (LMSQOL)* 
Body Mass Index (BMI) 
Some of the above outcome measures will gather data on one, or more, aspect of physiological, 
functional or psychological status. For example, the TUG will provide data on functional balance 
and global leg strength. 
The rationale behind each outcome measure will be explained in the following sections. For 
reference, the data collection sheets, which include all assessor rated outcome measures are 
provided in Appendix 3. The participant rated questionnaires are provided in Appendix 4.  
3.8.2 The outcome measures relevant to the International Classification 
of Functioning 
Outcome measures chosen linked to the International Classification of Functioning (ICF). The ICF 
is a model of describing health related conditions, and their impact on the individual. The concept 
was developed by the World Health Organization (2001) and offers a framework to describe the 
interaction between the different domains of a  health condition; body functions and structures, 
activity and participation and environmental factors. Recently a comprehensive core set of 
categories, based on the ICF have been developed for MS (Coenen et al 2011), helping researchers 
and clinicians monitor MS appropriately.  
Due to the primary focus of the study being a physical intervention, outcome measures in Study 1 
and Study 2 were chosen to measure the impact of the intervention across the domains of body 
functions and structures, activity and participation. Whilst domains related to contextual factors, 
which are Environmental and Personal factors, were not measured, as these relate to areas out with 
the primary focus of this research. The interaction between the problems faced by those with MS, 
the domains of the ICF and the relevant outcome measures used to capture the information in the 
study are displayed in Figure 3.2. These were informed by the ICF guideline (World Health 
Organization 2002) and the core Set for MS (Coenen et al, 2011). Throughout Section 3.9 
examples of the relationship between each outcome measure and the ICF is provided. 
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Figure 3.2 Outcome measures related to the International Classification of Functioning  
T25FW–Timed 25ft Walk, 6MWT–Six-minute walk test, temporal spatial gait paramters, BBS-Berg Balance Scale, TUG-Timed up and Go test, SLS–strongest leg strength, WLS–weakest 
leg strength, PF-PhoneFITT, ABC-Activities Balance Confidence, FSS-Fatigue Severity Scale, HADS-Hospital Anxiety and Depression Scale, LMSQOL-Leeds MS Quality of Life).
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3.9 The outcome measures used in this study 
There are many different outcome measures used to investigate the effect of therapeutic exercise in 
MS, some of which have been discussed in Chapter 2 (Tables 2.6 -2.8). These vary in terms of 
validity, reliability and feasibility. A discussion on the different outcome measures used in the 
present study and, where relevant, other similar outcome measures will follow. The reader is 
referred to Table 2.5 where a list of outcome measures, and references to the original works, where 
available,  can be found.  
3.9.1 Timed 25 Foot Walk 
Altered mobility, and reduced walking speed are common symptoms in MS (Motl et al 2008b). 
Measures of mobility, such as short timed walks are used by physiotherapists in neurological 
rehabilitation (Yoward et al 2008). These can include the 10-metre Walk Test (10MWT) or the 
Timed 25-Foot Walk (7.62m) (T25FW). Both are popular in MS literature and are similar in that 
they require minimal equipment and measure mobility over a set distance. As both need additional 
space for acceleration and deceleration they require more room than is suggested by their name. 
However, the T25FW was chosen in this study as it is accepted as the mobility measure used in the 
Multiple Sclerosis Functional Composite (MSFC) (Kalkers et al 2000), a measure of disability in 
MS. The MSFC includes a mobility component (T25FW) a cognitive and an upper body 
component. In addition, the T25FW is shorter that the 10MWT and due to space limitations the 
10MWT could not be easily carried out within the testing area used for this study. 
The T25FW is a timed walk (measured in seconds (s)) over a marked 25-foot course (7.62 metres 
(m)). The T25FW is also a relevant outcome measure when used independently. The origins of the 
T25FW are difficult to locate, however the study by Cutter et al (1999) is one of the earliest uses of 
the T25FW in MS research. 
The T25FW was chosen for both Study 1 and Study 3 as it has been used commonly in MS 
therapeutic exercise studies (White et al 2004; Romberg et al 2004; Romberg et al 2005; Pryor et al 
2011). In addition, it  has now been proposed, by the European Rehabilitation in MS network 
(RIMS) for best practice and research, as a core outcome measure to assess walking in MS (Gijbels 
et al 2011).  
Feasibility 
The T25FW is a practical tool, easy to perform and relevant for both clinical and research purposes. 
Taking less space than the 10MWT it may be more practical if assessment space is limited. 
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Reliability and validity 
Cohen et al (2000) found intra-rater and inter-rater reliability of the T25FW to be high as part of 
the MSFC. When tested over six testing sessions (two sessions per day) completed over two weeks, 
an intra-rater ICC of 0.93 and an inter-rater ICC of 0.95 were reported.  Schwid et al (2002) looked 
at the reliability of changes in T25FW scores in 63 participants (EDSS 0-6.5), measured over five 
consecutive days, finding the measure reasonably reliable, however they found that scores may 
varied by up to 16%. Coleman et al (2012) looked at the clinical significance of T25FW scores 
during a 14 week clinical trial of Dalfampridine (medication prescribed to those with MS to 
improve walking). They found that in participants (mean EDSS=5.8) who were judged to have 
minimally improved, a 17.2% improvement in T25FW was recorded, for those judged to have 
shown no change a 7% change in T25FW was found. 
The test is discussed as having good validity, and as being the standard for correlation of other 
walking and mobility measures (Bethoux and Bennett 2011). In MS, as part of the MSFC the 
T25FW has been shown to correlate moderately with the EDSS (Rudick et al 2002). 
ICF domain and category 
The T25FW captures data on body functions and structures, such as; muscle function, gait pattern 
functions and structure of the lower extremity. It also captures data on activity and participation, 
such as; walking and moving around (World Health Organization 2002; Coenen et al 2011). 
Strengths and limitations 
The test offers an ordinal score where progress and decline can be monitored on a continuous scale.  
Changes in score have been found to compare with both clinical observation and patients’ 
perception of change (Kaufman et al 2000; Hoogervorst et al 2004). The test has shown good 
validity and feasibility. Furthermore there is a need to clarify instructions for the test, as these may 
impact the assessment (Bethoux and Bennett 2011). 
 Further work required 
There is a need to validate the test in MS when used as a stand-alone measure, outwith the MSFC. 
With more work required to establish the reliability, clinical significance and precision of the 
T25FW in those with MS who are clinically stable. To do so the T25FW was assessed as part of 
Study 3 (Chapter 6). 
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3.9.2 Six-minute Walk test 
As discussed, mobility is often compromised in people with MS and this is not only over short 
distances, such as 25 feet. Measuring walking over longer distances provides information on both 
mobility and aerobic endurance. Longer walking tests, such as the 500m walk test, the Two-minute 
Walk test (2MWT) and the Six-minute Walking Test (6MWT), may measure endurance. The 500m 
walk requires participants to walk the measured distance. Therefore  would only be appropriate for 
those with an EDSS of 4.5 (i.e. EDSS 1- 4.5). The 2MWT, like the 6MWT, is time limited, and 
thus all participants below an EDSS score of 6.5 or less should realistically be able to complete 
these. The 2MWT is shorter than the 6MWT, and may be thought of as having more clinical 
applicability, with less burden on the patient  (Bethoux and Bennett 2011), however this may also 
limit its ability to capture data on aerobic endurance, whereas a test lasting a longer length of time 
may bring participants closer to their aerobic capacity. Furthermore there is limited evidence of the 
psychometric properties of the 2MWT in MS research. As such neither the 500m walk or 2MWT 
were used in this study. 
The 6MWT, common in MS literature and used by 14% of British Neurophysiotherapists (Yoward 
et al 2008) was chosen for this study. It has the ability to capture data on mobility and endurance, 
with recent work suggesting its strength as a measure of endurance in MS (Bethoux and Bennett 
2011). First described by Butland et al (1982), the original use of the 6MWT in respiratory disease 
has expanded into neurological conditions such as MS (Freeman and Allison 2004; Paltamaa et al 
2005; Rampello et al 2007; Coote et al 2009). For the 6MWT participants are asked to walk as far 
as possible, under controlled conditions, in six-minutes. Although different protocols are available, 
the American Thoracic Society (2002) guidelines were used in this study; this involved the 
participant walking a 30m course in a corridor with the assessor providing specific verbal cues and 
instructions to standardise the protocol.  
Feasibility 
With minimal costs and training required the 6MWT is feasible for both clinical use and research. 
Indeed walking for a reasonable length of time is an ubiquitous activity, which may be carried out 
by all ambulatory persons with MS. As such the 6MWT is a highly functional outcome measure, 
which has been found to correlate strongly with community ambulation (Gijbels et al 2010b).  
Reliability and validity 
Paltamaa et al (2005) assessed the inter-rater reliability of the 6MWT in nine participants with MS 
and reported the ICC to be 0.93. In part of the same study, the test re-test reliability was established 
in 19 participants with MS, four of whom had an EDSS score of 4 to 6.5, the ICC was reported as 
0.96. The physiotherapy assessors had different levels of experience using the outcome measure, 
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further supporting the reliability of this outcome measure. The good intra-rater reliability found by 
Paltamaa et al (2005) was confirmed by Fry and Pfalzar (2006) in a study of 12 people with MS 
who had  a mean  EDSS score of 3.6. The ICC was 0.96 when the testing was done one week apart, 
similar to Paltamaa et al’s (2005) study. Goldman et al (2008) carried out three tests over one day 
finding good inter-rater (ICC=0.91) and intra-rater reliability (ICC=0.94) of the 6MWT. 
Although clinical significance has not been statistically determined for the 6MWT in MS, it has 
been established in other conditions. For example in Parkinson’s disease MDC scores for the 
6MWT were reported to be a change of 82m (Steffen and Seney 2008). In Steffen and Seney’s 
(2008) study the mean 6MWT score was 316m (SD 142m), thus the MDC was more than 25% of 
the mean score, suggesting a reasonably large change in score is required, in the Parkinson’s 
disease population, to indicate a clinically significant change. 
In an MS population, Paltamaa et al (2005) found a SEM of 30.65m in an ambulatory MS 
population. With a mean score in this study’s participants being 538m at baseline, the narrow SEM 
score does suggest the 6MWT is precise in those with mild-moderate MS. 
In studies involving MS participants, it has been shown that the 6MWT correlates well with 
disability (measured with EDSS, r=0.73; MSFC r=0.72), quality of life (measured with the Short 
Form–36 (SF-36) r=0.69) and mobility (measured with the MS Walking Scale r=0.81) (Goldman et 
al 2008).  
There are a variety of different 6MWT protocols available in the literature mainly related to 
instructions and length of corridor to be used. Altering these constants does affect the reliability 
and validity of the outcome measure. For research purposes, standardised protocol should be stated 
and followed. 
ICF domain and category 
The 6MWT captures data on body functions and structures, such as; exercise tolerance function, 
muscle function, gait pattern functions and structure of the lower extremity. It also captures data on 
activity and participation, such as; walking and moving around (World Health Organization 2002; 
Coenen et al 2011). 
Strengths and limitations 
In addition to showing good reliability and validity the 6MWT has been found to correlate strongly 
with community ambulation (Gijbels et al 2010a). It offers an assessment of mobility, providing a 
test of endurance, which is feasible in most locations. The literature suggests it may be limited by 
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fatigue and exhaustion (Bethoux and Bennett 2011), however this implies the test is capturing data 
on aerobic endurance. As suggested an open area, or long corridor is required for the test which 
may not be practical for all assessment situations.   
Further work required 
There is reasonably strong evidence as to the psychometric properties of this test in MS, however 
further work on the reliability and validity of the 6MWT across the disability range in MS is 
warranted. To confirm the previous work on reliability and to determine the clinical significance 
and precision of the 6MWT in a population moderately affected with MS, the 6MWT was included 
in Study 3. 
3.9.3 Temporal Spatial parameters of gait  
The T25FW and 6MWT provide good clinically applicable measures of mobility; however with 
specialist equipment it is possible to more accurately measure different components of gait. Doing 
so may provide data on which component of the participants gait is compromised. Measuring gait 
accurately can be done by using motion analysis systems or measuring temporal (e.g. time taken 
per step) and spatial (e.g. distance covered per step) parameters of gait through computerised 
walkways.  
Motion analysis provides comprehensive three-dimensional data on gait kinematics. However as 
expensive and bulky equipment is required, with training and time required to understand the 
complex data produced, computerised motion analysis is limited to use in research laboratories 
(Bethoux and Bennett 2011), and would not be feasible in the clinical surroundings of this study.  
Computerised walkways to measure temporal and spatial parameters of gait are embedded with 
sensors to identify the pressure from footfall. These walkways can be transported easily and taken 
to different study sites. By combining temporal and spatial parameters, a functional ambulation 
profile, provides a quantifiable measurement of gait (Walsh 1995). Consequently, information is 
generated to help identify gait abnormality in individuals. 
One system to measure gait parameters is the GAITRite system (CIR Systems), which is a 4.5m 
carpet embedded with sensors and linked to a computer. More recent MS literature, shows that 
computerised walkways, such as the GAITRite system are becoming more popular  (Smedal et al 
2006; Newman et al 2007; Givon et al 2009; Motl et al 2012). Givon et al (2009) showed that the 
GAITRite system can highlight compromised gait patterns in those with MS who have a very low 
level of disability.   
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For this study, temporal parameters of gait were established including; walking cadence (WCa), 
walking velocity (WVel) and step time. As were spatial parameters of gait; left (LSL) and right leg 
step length (RSL). Gait cycle, single support time and double support time were also recorded 
although not included in this thesis. Finally overall walking performance was established with 
Functional Ambulatory Performance (FAP). The measured parameters are similar to those assessed 
by past authors using the GAITRite system (Newman et al 2007; Givon et al 2009; Motl et al 
2012). A description of each parameter is provided in Table 3.1. 
Table 3.1 Temporal Spatial gait parameter measured with the GAITRite system.  
Variable Description  
Cadence (WCa) Number of steps per minute  
Velocity (WVel) The distance walked divided by the ambulation time 
Step length (left LSL & right 
RSL) 
The distance from the heel point of the current footfall to the heel point 
of the previous footfall in the opposite foot (this would be a negative 
value if the participant does not clear the first foot with the second). 
Step time (left LST & right RST) The distance from first contact of one foot to the first contact of second 
foot  
Functional Ambulation Profile 
(FAP)  
Numerical representation of gait  (overall walking performance)  
(CIR Systems 2010)  
 
 
Feasibility 
Measuring temporal spatial parameters using the GAITRite system presents a quick and easy 
assessment, producing quantitative data on gait patterns which many other walking tests do not. 
The system is quick to set-up and requires minimal analysis. However, its expense and requirement 
for training indicate that the outcome measure is best suited for research purposes. The literature 
does not specify whether shoes should remain on or off for testing (Newman et al 2007; Givon et al 
2009), however consistency is recommended. 
Validity and Reliability 
Limited reliability data on temporal spatial gait parameters, which have been established with the 
GAITRite system, is available.  However in an MS population (n=13, mean EDSS = 6) temporal 
spatial parameters, measured with the GAITRite system, have been found to correlate well with 
both the T25FW and the TUG. Sosnoff et al (2011) found that walking velocity scores correlated 
with the T25FW (ICC=0.93) and the TUG (ICC=0.93) and that FAP scores correlated with the 
T25FW (ICC=0.82) and TUG (ICC=0.88).  
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ICF domain and category 
The data gathered from the temporal spatial gait analysis captures information on body functions 
and structures, such as; gait pattern functions and structure of the lower extremity. It also captures 
data on activity and participation, such as; walking and moving around (World Health Organization 
2002; Coenen et al 2011). 
Strengths and limitations 
In summary, assessing temporal spatial gait parameters provide a comprehensive quantitative gait 
analysis. There is limited data available on the psychometric properties, in comparison with more 
traditional outcome measures, although evidence suggests it correlates well with other short 
mobility outcome measures. The expense and training required for this system may limit its use 
although its use is recommended within the MS literature (Bethoux and Bennett 2011). 
3.9.4 Timed Up and Go 
Mobility is only one aspect of function. Other components of function, such as balance and 
orientation around objects are not collected with straightforward mobility assessments, such as the 
T25FW. Therefore the Timed Up and Go (TUG) test, a functional measure of mobility, global leg 
strength and balance ability was also used in this study. The TUG, is a generic outcome measure 
originally designed for use in the elderly population (Podsiadlo and Richardson 1991). Participants 
are timed standing up from a chair, walking around a cone (placed 3 m from the chair) and sitting 
back onto the original chair. It is reportedly used by over half of surveyed British 
neurorehabilitation physiotherapists (Yoward et al 2008) and is used in MS research (Nilsagard et 
al 2007; Cakt et al 2010; Sabapathy et al 2011; Vore et al 2011).  
Feasibility 
The test is simple and cheap to perform, with minimal training required, although as with all the 
outcome measures it is important to follow standardised protocol. 
Reliability and Validity 
In a test re-test study of 43 participants with MS (EDSS 3-6) (Nilsagard et al 2007), reliability was 
found to be good (ICC=0.91) when tested one week apart. An  ICC of 0.86 was found for the 24 
participants in the study with an EDSS  greater than 4.  Although four physiotherapy assessors 
collected data, the same physiotherapist tested the same participant at both time points. 
Unfortunately, the experience level of the physiotherapists was unreported; this is regrettable as 
experience of assessor may influence results (Richards et al 2000). Clinical significance of the 
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TUG, indicated by the MDC score, has not been determined in the MS literature. However for 
those with Parkinson’s disease the MDS score has been found to be 11 seconds (s) the mean score 
for the TUG was 15s (10s SD) (Steffen and Seney 2008), highlighting that the score required to 
indicate a clinically significant change was very large, relative to the mean score. There are no 
reports of the precision of the TUG, measured with SEM, in the MS literature.  
In an MS population Nilsagard et al (2007) found good correlation (ICC=0.83) between the TUG 
and the 10MWT, which supports the validity of the TUG as a mobility outcome measure. 
ICF domain and category 
The TUG captures data on body functions and structures, such as muscle functions, and control of 
voluntary movement function. It also captures data on activity and participation, for example 
changing body position, walking and moving around (World Health Organization 2002; Coenen et 
al 2011). 
Strengths and limitations 
As stated, the test is simple to perform, and has reasonable psychometric properties. However 
depending on the focus of the TUG’s use, its ability to capture data on both mobility, strength and 
balance can be both a strength and weakness. The TUG may be a good functional measure however 
it may be limited as a measure of individual impairments. 
Further work 
Further work on the reliability, clinical significance, precision and validity of the TUG would 
strengthen the previous findings of other authors. Thus to add to the current knowledge on the 
reliability of the TUG, and to determine clinical significance and precision in a group of people 
moderately affected with MS the TUG was included in Study 3. 
3.9.5 Berg Balance Scale 
The ability to maintain balance during physical activities is important in daily life. It is based 
around an individual’s peripheral sensory system’s ability to react to the external environment and 
provide vestibular, visual and proprioceptive feedback to the CNS and back, via the peripheral 
motor system, to the postural muscles in the body (Ruhe et al 2010). However, as has been 
discussed in Section 2.2.3 a deficit in balance is common amongst the MS population (Frzovic et al 
2000; Cattaneo et al 2007a).  
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There are different outcome measures to assess balance, in this section a focus will be made on 
those which are task orientated, and assess functional dynamic balance.  
Some balance measures to assess functional dynamic balance have been used in the MS therapeutic 
exercise literature, such as the Equiscale. However, the Equiscale, based on other measures of 
balance (the Berg Balance Scale (BBS) and the Tinetti Balance assessment) has been rarely used in 
the MS therapeutic exercise literature. Furthermore as the Equiscale is not freely available, it would 
havelimited clinical applicability. The Tinetti balance assessment (Tinetti 1986), includes nine-
items on balance and eight-items on gait), it is used by 17% of physiotherapists working in 
neurology in the UK (Yoward et al 2008), however it is not common in any MS therapeutic 
exercise studies. Moreover, with a focus on both balance and gait, the Tinetti assessment does not 
focus solely on balance. Since these scales are not commonly used, it would be difficult to compare 
findings, and hence reach conclusions from the study results. 
The more commonly used measure of balance in MS, the BBS, was therefore chosen for this study. 
In the survey of commonly used outcome measures 71% of neurophysiotherapists used the BBS 
(Yoward et al 2008). It is a generic, assessor rated measure of functional balance, originally 
designed for use in the elderly population by Berg (1989). The participant performs 14 tasks (of 
increasing difficulty e.g. “Sitting to standing”, “Standing unsupported”, “Standing unsupported 
with eyes closed”, “Standing on one leg”), measured on a 5-point ordinal scale. A maximum score 
of 56 can be achieved, with higher scores indicating better balance. 
Feasibility 
The BBS is cost effective and requires minimal equipment and training; however it may take 15-20 
minutes to complete, longer than other balance measures (Tyson and Connell 2009). 
Reliability and validity 
In 19 people with MS (EDSS <6.5) test re-test reliability of the BBS measured one week apart was 
found to be good (ICC=0.99), with inter-rater reliability also good (ICC=0.85) (Paltamaa et al 
2005). In Paltamaa et al’s (2005) study, the physiotherapy assessors had different levels of 
experience using the outcome measure. This not only strengthens the findings but also improves 
the clinical applicability of the BBS. 
In a less disabled MS population (where only one third of participants used a walking aid – EDSS 
unclear) similar results were found when two experienced neurorehabilitation physiotherapists, 
assessed the reliability of the BBS 3 days apart. Inter-rater reliability was found to be  high 
(ICC=0.96) (Cattaneo et al 2007b).  
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No studies reporting the clinical significance (MDC) of the BBS could be found in the MS 
literature, however in Parkinson’s disease a clinically significant change of 5 points was indicated, 
with the mean score being 50 points (SD=7) (Steffen and Seney 2008). In a post stroke population 
the MDC for the BBS was 7 points when the mean score was 43 points (Stevenson 2001). Paltamaa 
et al (2005) established precision (SEM) of the BBS to be less than 1 point in a group of people 
moderately (EDSS mean=5.26) affected with MS.  
Cattaneo, Regola and Meotti (2006) validated the BBS with other measures of balance in people 
with MS and found a moderate correlation (r=0.48) with the Activities Balance Confidence scale 
(ABC), although this correlation does suggest the two outcome measures are capturing different 
information. This is of interest as the ABC was also used in this study (Section 3.9.9). The BBS is 
an assessor rated measure, whilst the ABC is a self-rated measure, which may explain the 
correlation. Like any scale with a maximum score, the BBS may be vulnerable to a ceiling effect, 
whereby participants may achieve the top score, and any improvement will not be captured by the 
scale 
ICF domain and category 
The BBS captures data on body functions and structures, such as; vestibular function and 
proprioceptive function. It also captures data on activity and participation, such as; maintaining and 
changing body position (World Health Organization 2002; Coenen et al 2011). 
Strengths and limitations 
The BBS has reasonable reliability and validity and has practical clinical use. 
Further work 
There is a need to clarify the psychometric properties of the BBS across the disability range in MS. 
The reliability of the BBS would strengthen the results found by Paltamaa et al (2005) and 
Cattaneo et al (2007b) and would strengthen results of studies using this outcome measure. As such 
the BBS was included in Study 3 (Chapter 6).  
3.9.6 Assessment of Overall stability 
Overall postural stability is important for maintaining an upright posture and for maintaining 
balance during normal activities of daily living. With deficits in balance, such as those found in 
MS, reducing the body’s ability to maintain a static posture and leading to an increased body sway 
from the centre point (Karlsson and Frykberg 2000).  In this study, static balance is defined as the 
Literature pertaining to the methodology 
 
 
102
ability of the participant to maintain their Centre of Pressure (COP – the central point of pressure 
applied to the foot during contact with the ground (Winter 1995; Ruhe et al 2010)) in static stance. 
When attempting to maintain static stance, any movement by the participant, resulting in 
movement of the COP anteroposteriorly, mediolateraly or an axis between these movements, 
provides an indicator of Overall Stability (OS) (Winter 1995; Arnold and Schmitz 1998).  
This data can be determined using static force-plates or moveable balance plate analysis. Force 
plates are rigid electronic plates, on which the participant stands; the plate records the position of 
the COP when is then, through software packages, used to  calculate the net COP and the 
displacement of the COP from this reference point during the test (Gibbs 1997). However, the use 
of force-plates is somewhat limited as they may not challenge static stance, and hence may not 
provide the best data on OS (Karlsson and Frykberg, 2000).  
However, a moveable balance plate provides an unstable platform on which a participant stands, 
which captures similar data to a force plate. Therefore a balance plate may replicate more 
challenging environments. For example, the moveable platform may mimic the challenge of 
maintaining balance whilst standing on a train or bus. For this reason and due to the availability of 
equipment, a moveable balance plate was used in this study, this collected data on the movement of 
the COP as an indicator of OS. 
In this study, the Biodex Stability System (Version 1.3) balance plate was available to provide an 
objective measure of overall stability (OS). The balance system comprises a freely moving 
platform, connected to a computer, which measures overall stability (Figure 3.3). The participant 
stands on the platform, and attempts to maintain a static posture (and maintain the balance plate in 
a horizontal position), whilst doing so the balance plate and computer calculate any movement of 
the COP from the central point, and record this movement in degrees, providing the OS. Lower 
scores indicate a better ability to maintain the COP, and from this indicate better overall balance 
stability. 
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Figure 3.3 Maintaining static stance on balance plate 
 
The stability of the balance plate can be predetermined to one of eight different levels, the most 
stable test (level 8) permits minimal movement (from horizontal) of the platform. The protocol for 
the static balance assessment in this study was designed based on past literature (Aydog et al 2006; 
Ghoseiri et al 2009) and pilot work (Section 4.2.11).  
Feasibility 
 
Once installed the system is quick to set-up and requires minimal analysis. Its expense and 
requirement for training indicate that this outcome measure is best suited for research purposes.  
In addition to its research use, it can be used as a rehabilitation tool, offering biofeedback on the 
patient’s balance performance, and thus has clinical use. It is suggested that more than two trials be 
performed and that fatigue may impact performance (Cachupe et al 2001). In this study, testing was 
limited to three 20 second trials (further protocol detail can be found in Section 4.2.11). 
 
Reliability and Validity  
 
The Biodex balance system has been found to be reliable in those with Parkinson’s disease 
(Ghoseiri et al 2009) and rheumatoid arthritis (Aydog et al 2006). Unfortunately no formal validity 
study could be found using the Biodex balance system in Multiple Sclerosis. 
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ICF domain and category 
The assessment for OS captures data on body functions and structures, such as; vestibular function 
and proprioceptive function. It also captures data on activity and participation, such as maintaining 
a body position (World Health Organization 2002; Coenen et al 2011). 
Strengths and limitations 
In summary, capturing data on overall stability using the Biodex system provides a continuous 
scale of balance. However there is limited evidence of its past use in MS, this may be due to its 
expense making the outcome measure appropriate mainly for research use.  
3.9.7 Quadriceps strength  
Deficits in strength, particularly in the lower limb are common  in MS (Matthews 1998; Motl et al 
2008b). In addition the deficits may be more evident on one side of the body (Confavreux and 
Vukusic 2008). Assessing strength in MS is made more complicated by other confounding factors 
related to the damage found within the nervous system and physical fatigue. For example, muscle 
tone (spasticity) may be altered in those with MS leading to joint contractures (Tripp and Harris 
1991) causing pain and limiting movement.  
There are a number of different outcome measurement tools used in the MS therapeutic exercise 
literature to assess strength and changes to the properties of participants’ muscles. This makes 
comparison of results difficult. Testing muscle strength using electromyogram (EMG) 
methodology has been used in some studies (Harvey et al 1999; de Souza-Teixeira et al 2009), 
EMG measures the electrical conduction across muscle fibres during a muscle contraction. 
Electrodes are placed on the skin, directly over the muscle of interest with the signal sent to a 
computer. However the quality of the information gathered from this outcome measure can be 
affected by the thickness of the skin and subcutaneous fat and the contact between the skin and 
electrodes (Day 2002). Unfortunately, the equipment required for the EMG method of assessing 
muscle properties was not available for this study. Other therapeutic exercise studies have used 
large-scale resistance equipment (such as the static weight machines found in exercise gyms) 
(Dodd 2011; Filipi 2011; Taylor 200; Dalgas 09/10), or large-scale dynamometers   (Gutierrez et al 
2005; de Souza-Teixeira et al 2009; Broekmans et al 2011; Hayes et al 2011) to assess strength. 
Unfortunately these methods were impractical for the clinical setting of this study.  Instead a Hand-
held Dynamometer (HHD) which would provide an accurate measurement, whilst also being 
practical for the clinical setting, was used in this study.  
In general most studies have used a maximum voluntary contraction (MVC) to assess muscle 
strength deficits, in this study the strength of participants’ quadriceps was assessed using a MVC 
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measured with a HHD. The technique involves positioning the participant and HHD to isolate the 
muscle group of interest. A MVC was assessed using a “make-test”, which is preferred for those 
with neurological conditions where spasticity may be problematic (Bohannon 1995). To ensure 
reliability in all assessments the length of the lever arm was also recorded (from the apex of the 
patella to the anterior of the Medial Malleolus where the HHD was placed), from this, torque was 
calculated, providing a quantitative measure of leg strength.  
In addition, the following points were considered in the design of the protocol. To avoid an 
increase in muscle tone during testing, past literature on strength training in persons with spastic 
hemiparesis was consulted.  Tripp and Harris (1991) compared the reliability of five “make tests” 
using an  isokinetic dynamometer  in 20 people post stroke.  Although this testing was not carried 
out using a hand-held machine the rest period between each trial was of interest. In Tripp and 
Harris’ (1991) study, the rest period was dictated by the readiness of the participant to carry out the 
next trial. This resulted in good reliability across the five trials and no increase in muscle tone.  To 
minimise the risk of increased muscle tone during this study, and allow for the impact of physical 
fatigue the MVC was recorded three times, with a minimum of  30 s rest between each trial, once 
the participant was ready.    
The Lafayette HHD (Model 01163) was used, with higher scores, representing increased strength. 
In MS leg weakness often presents asymmetrically (i.e. unilateral weakness) (Confavreux and 
Vukusic 2008), thus weaker (WLS) and stronger leg (SLS) strength was assessed to allow 
comparison between the two. 
Feasibility 
The Lafayette HHD is portable (Figure 3.4), affordable and requires minimal training. Morris et al 
(2008) suggests that three trials are adequate to establish reliable strength values. An initial cost 
will be involved. However, the HHD can be used both clinically and for research purposes. As with 
all outcome measures strict protocol must be used to ensure good reliability. 
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Figure 3.4 Hand-held Dynamometer  
One pence coin provided to demonstrate scale. 
Reliability and Validity 
Bohannon et al (1995) discussed that HHDs have been found to be reliable in a range of 
neurological conditions, mainly post stroke. Unfortunately there is minimal research on the 
reliability and validity of this method of measuring quadriceps strength in MS. Morris et al (2008) 
assessed reliability of HHD quadriceps testing using the Lafayette model, in a group of patients 
following traumatic brain injury. Test re-test scores were good (ICC = 0.92). The protocol, 
regarding sitting position, used in  Morris et al’s (2008) was adopted in this study (Section 4.2.5) .  
In healthy adults Martin et al (2006) assessed the validity of the Lafayette (model 01163) HHD by 
comparing its performance with the Biodex isokinetic dynamometer, described as the “gold-
standard” of muscle strength measurement in healthy adults. Results suggested that the Lafayette 
HHD correlated well (r=0.91) with results from the Biodex isokinetic dynamometer. 
ICF domain and category 
Measuring quadriceps’ strength  captures data on body functions and structures, such as; muscle 
power functions, muscle tone functions, motor reflex functions and structure of lower extremity 
(World Health Organization 2002; Coenen et al 2011). 
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Strengths and Limitations 
Measuring both weaker and stronger leg quadriceps strength using the HHD provides a good 
measure of strength. The Lafayette model is practical and has diverse application as it can be easily 
carried around and used to measure strength on a number of different muscle groups.  
In general, measuring muscle strength in those with MS is vulnerable to increased muscle tone and 
fatigue affecting results; however an effort was made to allow for this in the assessment protocol. 
There is a need to clarify the best outcome measure to monitor strength in MS with more data 
required on the reliability and validity of this outcome measure in MS research.  
3.9.8 The PhoneFITT 
Monitoring activity is important; with past research suggesting those with MS may be less active 
than the general population  (Mostert and Kesselring 2002; Motl et al 2005; Sandroff et al 2012), 
increasing the risk of health problems associated with inactivity (Motl et al 2011). Different 
methods are available for reporting physical activity behaviour including; activity diaries (Ghione 
et al 1993), physical activity questionnaires  (Mostert and Kesselring 2002) or electronic motion 
detection/accelerometers (Motl et al 2009b; Weikert et al 2010). Despite this, levels of physical 
activity are not well reported in the MS literature.  
Activity diaries may be limited as there are no standardised activity diary formats available, thus 
self-designed diaries would require piloting and validation before being used in an intervention trial 
such as this. Furthermore, they rely on participants’ remembering to complete the diary on a 
regular basis and much time may be required to input/interpret the responses from study 
participants. 
Accelerometers are small (matchbox size) electronic devices, worn on the body to accurately 
measure motion (Hale et al 2008), they are becoming more prevalent in the MS literature   (Hale et 
al 2008; Snook et al 2009; Motl et al 2009b; Weikert et al 2010). They have, for example, been 
used in cross sectional studies lasting seven days (Snook et al 2009; Motl et al 2009b) or in one off 
testing occasions to access their psychometric properties (Hale et al 2008; Weikert et al 2010). 
However, to the author’s knowledge they have not been included in any MS therapeutic 
intervention studies. For this study, which had an intervention of 12 weeks and follow-up of up to a 
year it was not practical to expect participants to wear an accelerometer for this length of time.  
However, self-reporting questionnaires are a simple, cheap method used to report physical activity. 
In MS therapeutic exercise literature the BAECKE Activity Questionnaire (BAQ) was used by 
Mostert and Kesselring (2002). However, this outcome measure may suffer a floor effect by being 
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aimed at a more active population, with many questions about activities at work. Thus was less 
appropriate for the participants in this study. 
The PhoneFITT (PF) (Gill et al 2008) activity questionnaire is a generic outcome measure initially 
designed to be administered easily over the telephone and be applicable to an elderly population. 
Unlike the BAQ it also captures data on basic activities of daily living (such as carrying light loads) 
and exercise activity (such as bicycling), thus is more appropriate in a less active population.  
The PF questions physical activity in relation to Frequency, Intensity, Type and Time (FITT) 
(Franklin et al 2000). Participants recount the time spent, and how often, in a typical week in the 
past month, they undertake particular activities. The option to include other personal activities is 
provided. To establish intensity; participants comment on their breathing during discussed 
activities. An example of a typical question is provided in Table 3.2. For analysis in this study, 
scores were totalled according to the original author’s protocol. In summary, the number provided 
at Q2, plus the number (1-4) chosen at Q3 and the number (1-3) chosen at Q4. The scale has no 
upper limit, and thus it is not vulnerable to a ceiling effect, with higher scores representative of 
more activity. 
Table 3.2 Example of typical PhoneFITT question 
Activity Q1 
Participated 
Q2 Frequency (number 
of times per week) 
Q3Duration Q4 Intensity 
 
(In a typical 
week in the 
past month 
have you 
done) 
Walking for 
exercise 
 
1Yes 
2No 
  
  
11 - 15 min 
216 - 30 min 
331 - 60 min 
41 hour + 
 
 
1Breathing NORMALLY and able to 
carry on a conversation 
2SLIGHTLY out of breath BUT still able 
to carry on a conversation 
3TOO out of breath to carry on a 
conversation 
 
Feasibility 
The questionnaire is administered as an interview, it is a multidimensional scale and some assessor 
training is required on its use.  The scale can be completed in five to ten minutes, and is appropriate 
for both clinical and research purposes.  
Reliability and validity  
 
To the author’s knowledge no data is currently available on the use of the PF in MS. In a 
preliminary study in a group of older adults the PF was found to be moderately reliable (ICC=0.74) 
when tested one week apart (Gill et al 2008). However, much work is required on this relatively 
new outcome measure. 
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ICF domain and category 
The PF captures data on activity and participation, such as; carrying out daily routine, undertaking 
tasks, recreation and leisure and moving around (World Health Organization 2002; Coenen et al 
2011) . 
Strengths and Limitations 
The PF captures data on simple activities of daily living through to exercise based physical activity 
using both a nominal and ordinal score, with the potential to gather information on additional 
participant activities. However, this makes comparison between participants difficult. The 
reliability and validity of the PF requires further research. 
3.9.9 Activities Balance Confidence scale 
In addition to assessor rated (BBS) or instrumented (OS) measures of balance, participants’ self-
reported balance, and their balance confidence whilst undertaking activities of daily living is 
important. Two self-reported measures of balance are used in the therapeutic exercise in MS 
literature, the Dizziness Handicap Inventory (DHI) and the Activities Balance Confidence scale 
(ABC) (Powell and Myers 1995). Cattaneo et al (2006; 2007b) have assessed the validity and 
reliability of both , finding the ABC to have better reliability and validity. The ABC is also shorter 
and gathers information particularly on balance, consequently for this study the ABC was used.  
Fifteen items, related to balance confidence, are included in the ABC questionnaire  (e.g. “How 
confident are you that you will not lose your balance or become unsteady when you... walk up and 
down the stairs”) and asks participants to rate these on a 10-point scale.  The ABC was developed 
by Powell and Myers (1995) and was  initially used in an older adult population. 
Feasibility 
The scale can be completed in five minutes and as such can be used in both clinical and research 
settings  
Reliability and Validity 
In addition to the above work by the original authors Powell and Myers (1995), the test-retest 
reliability has been assessed in a study of 25 individuals with MS who were hospital in-patients 
(Cattaneo et al 2007b), with reliability reportedly good (ICC=0.92) when repeated three days apart. 
In an earlier study with 51 MS participants the ABC was found to correlate moderately (r=0.48) 
with the BBS (Cattaneo et al 2006), as discussed in Section 3.9.5.  
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ICF domain and category 
The ABC captures data on body functions and structures, such as perceptual function. It also 
captures data on activity and participation, for example undertaking multiple tasks and lifting and 
carrying objects(World Health Organization 2002; Coenen et al 2011). 
Strength and limitation 
The reliability and validity of the ABC have been found to be reasonable in an MS population. The 
outcome measure is self-completed and thus vulnerable to patient reporting (for those who may 
have cognitive or manual dexterity problems). 
3.9.10 Fatigue Severity Scale 
Fatigue is an important symptom found in many people with MS (Motl et al 2008b).  Fatigue in 
MS is different to fatigue experienced in a healthy population. Krupp et al (1988; 1989), found that 
fatigue experienced in MS (more so than in the healthy control group in their study) may prevent 
sustained physical functioning, be worsened by heat, have a sudden onset and cause frequent 
problems. Furthermore, quantitative measurement of fatigue in MS can be difficult as descriptions 
of fatigue may vary across the MS population; a single person may have difficulty describing their 
fatigue and report it in a number of ways (Chipchase et al 2003).  
Despite this, self-reporting outcome measures are thought to be one of the best methods of 
gathering fatigue information as it is the respondent’s own report of what they are experiencing. A 
number of different fatigue outcome measures are available. For example the Fatigue Severity 
Scale (FSS), Modified Fatigue Impact Scale (MFIS) or the Multidimensional Fatigue Inventory 
(MFI). The MFIS and the MFI are longer questionnaires and used less frequently in the therapeutic 
MS literature (Andreasen et al, 2011). Thus the Fatigue Severity Scale (FSS), developed for use in 
MS (Krupp et al 1989) was used in this study. Participants rate their agreement to nine items 
related to fatigue on a seven-point Likert scale (e.g. “I am easily fatigued”). Scores are totalled and 
divided by nine, higher scores are indicative of fatigue being more severe. 
Feasibility 
The FSS may be completed in less than five minutes. It requires no training and minimal 
explanation and is therefore feasible for use both clinically and in research.  
Reliability and Validity 
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The FSS has been found to have good test re-test reliability (ICC=0.84) when measured after an 
average of 10 weeks in a sample including those with MS (Krupp et al 1989). The FSS showed 
good discrimination between those with MS and healthy controls with the differences in scores 
highly significant (Chipchase et al 2003).  
There are however, reports of both floor and ceiling effects in an MS population (Kos et al 2003), 
which must be considered when analysing the results of this outcome measure. 
ICF domain and category 
The FSS captures data on body functions and structures, such as; energy and drive functions, other 
specified (fatigue). It also captures data on activity and participation, such as; carrying out a daily 
routine, focusing attention and recreation and leisure (World Health Organization 2002; Coenen et 
al 2011). 
Strengths and limitations 
The FSS has been used often in MS therapeutic exercise literature, and has shown reasonable 
reliability in MS. Although it is a short test, being self completed it may be vulnerable to problems 
with participant self-reporting (for those who may have cognitive or manual dexterity problems). 
Furthermore, the outcome measure may be vulnerable to a floor or ceiling effect. 
3.9.11 Hospital Anxiety and Depression Scale 
Similar to the assessment of fatigue, mood is highly subjective to each individual; thus, self 
reported questionnaires are commonly used. In the therapeutic exercise in MS literature the Beck 
Depression Inventory, CES-D, Coopersmith Self-esteem Inventory, Major Depression Inventory, 
Multiple Sclerosis Self-Efficacy-Scale, Profile of Mood States (POMS) and the State-trait Anxiety 
Inventory have all been used. However, all except the POMS focus on one particular aspect of 
mood. The Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith 1983), which 
was created based on clinical experience, and developed for use in the general population, captures 
information on both depression and anxiety. The HADS has previously been  used in the 
therapeutic exercise in MS literature (Schulz et al, 2004), and has wider application in other MS 
literature (Janssens et al 2003). Containing only 14-items it is shorter, and quicker to administer 
than the 65-item POMS. As such, the HADS was used in this study to quantify mood, more 
specifically levels of anxiety and depression.  
Participants are asked to rate each of the 14-items on a 4-point scale producing a total score of 42. 
Seven items refer to anxiety (e.g. “I get sudden feelings of panic”) and seven to depression (e.g. “ I 
feel cheerful”), with participants asked to rank their agreement, in relation to how they have been 
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feeling in the past week. A score of eight or above for either anxiety or depression has been 
suggested to indicate anxiety disorders or clinical depression respectively (Honarmand and 
Feinstein 2009). 
Feasibility 
The test has previously been found to be easily understood and acceptable to both patients and 
clinicians (Bowling 2005). Taking less than five minutes to complete it is appropriate for both 
clinical and research purposes; however, the measure may be vulnerable to a floor or ceiling effect. 
Reliability and validity  
In MS the validity of the HADS has been assessed against a structured psychiatric assessment and 
found to correlate well (Honarmand and Feinstein 2009). The original authors of the scale claimed 
good reliability when used with hospital inpatients, however further work should be done, 
particularly in relation to MS. 
ICF domain and category 
The assessment for mood using the HADS captures data on body functions and structures, such as 
temperament and personality functions. It also captures data on activity and participation, such as 
handling stress and other psychological demands (World Health Organization 2002; Coenen et al 
2011). 
Strengths and limitations 
There is reasonable evidence of the validity of the HADS, it has been widely used in past MS 
research, being unidimensional and reasonably short the test is easy to understand. However, as the 
HADS is a self-completed outcome measure it may be difficult for those with cognitive or manual 
dexterity problems to complete. Furthermore it may be vulnerable to a floor or ceiling effect, 
although there is no report of this. 
3.9.12 Leeds MS Quality of Life  
Health related quality of life is reportedly studied more in MS than any other neurological 
condition  (Mitchell et al 2005). Although there are a number of quality of life outcome measures 
available it is recommended that an MS specific scale be used in intervention studies (Motl and 
Gosney 2008). The Leeds MS Quality of Life Scale (LMSQOL) was designed specifically for MS 
by Ford et al (2001), and has been used in previous MS studies. Although Motl and Gosney (2008) 
did not include it in their review of quality of life outcome measures, from which they 
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recommended that intervention studies use disease specific quality of life scales (such as the 
MSQOL or the MSIS). They later went on to use it in a number of studies related to quality of life 
and physical activity in MS (Motl et al 2008a; Motl and McAuley 2009; Motl et al 2009a) , 
suggesting their support for this outcome measure in studies related to physical activity.  
For the above reasons and as the LMSQOL is shorter than both the MSQOL (54 items) and the 
MSIS (29 items), the LSMQOL was used in this study. Participants’ rate eight-items, on a 4-point 
scale, related to health and quality of life (e.g. “I have worried about my health”) in relation to the 
past month. Lower scores are indicative of higher quality of life. 
Reliability and validity  
Ford et al (2001) found in people with MS (n=199, EDSS level unclear) that the LMSQOL scale 
showed  good internal consistency and moderate test re-test reliability (ICC=0.75) when tested one 
month apart. The authors also provided evidence of moderate validity with general quality of life 
(measured with the SF-36 where the ICC equalled 0.68). In addition the LMSQOL was also able to 
differentiate between relapsing remitting  MS and more progressive MS (Ford et al 2001).    
ICF domain and category 
This assessment of quality of life captures data on body functions and structures, such as 
temperament and personality functions. It captures data on activity and participation, such as 
carrying out daily routine and relationships (Coenen et al 2011). 
Strengths and limitations 
The scale is unidimensional, and was developed for use in MS, it has not been shown to be 
vulnerable to floor or ceiling effects. However, evidence of the reliability and validity of the 
LMSQOL are limited to the original authors work, unlike that of other MS specific outcome 
measures. The outcome measure is self-completed and thus vulnerable to poor patient reporting. 
3.9.13 Body composition 
Body composition, in particular fat distribution, is an important indicator of health, and risk of 
developing other health problems such as obesity and coronary heart disease, musculoskeletal 
problems and some cancers (World Health Organization 2000). Measuring body composition can 
be difficult, with special techniques required to accurately measure fat mass (Katch et al 2011). 
However BMI is commonly used, calculated from height and weight. Normative values are 
available whereby a BMI of;  
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• <18.5 is underweight with a low disease risk (although at increased risk of other health 
problems) 
• 18.5<25 is normal weight, with an average disease risk 
• 25<30 is overweight, with an increased disease risk 
• >30 is obese with an increasing disease risk between moderate to very severe. 
(World Health Organization 2000) 
Body composition, measured with Body Mass Index (BMI) is rarely reported in MS therapeutic 
exercise literature, when it is acknowledged it is mainly as a demographic descriptor. Few studies 
have reported on the effect of an exercise intervention on BMI in MS, of those that have reported 
BMI before and after an intervention no significant changes have been found (Petajan et al 1996; 
Hayes et al 2011).  
Feasibility 
Measuring BMI is based on participant’s height and weight, which can easily be measured 
clinically. 
Reliability and Validity  
As discussed there is limited evidence of the use of BMI in MS research, thus there is no data on its 
reliability and validity in this patient group. Like all outcome measures, strict protocol and 
calibration of tools (i.e scales and stadiometer) are required to ensure validity and reliability. 
ICF domain and category 
BMI captures data on body functions and structures, such as weight maintenance functions. This 
does not appear in Coenen et al’s (2011) core set for MS, however is an important descriptor of 
health status. 
Strengths and limitations 
BMI is a simple clinical test, which provides a crude representation of body composition. The 
outcome measure has well known limitations in the exercise literature. For example, those with a 
higher bone or muscle mass may be incorrectly classified. Furthermore the numerical value 
provides no information on body proportion (important, as the distribution of fat around the body is 
a predictor of disease risk)  (Katch et al 2011).  
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3.9.14 Goal Attainment Scale 
The Goal Attainment Scale (GAS) (Kiresuk and Sherman 1968) was used to assess achievement of 
participants goals. Although it is not commonly used in research, clinically it can be used to 
compare between individuals and different forms of health services (Playford et al 2009).  A list of 
relevant goals are created, by the researching healthcare professional, from this list the participant 
and researcher consider what goals the participant may like to achieve (commonly three goals). 
Once chosen the participant and researcher discuss and decide the chosen goals in order of 
importance (from 1-3) and weigh the possibility of achievement (from 1-3). The overall goal 
attainment scale score, on completion of the intervention, is calculated using an automated 
Microsoft Excel spreadsheet (Turner-Stokes 2009), which applies a standard mathematical formula, 
as described below; 
 
 
Where:  
wi = the weight assigned to the ith goal (if equal weights, wi = 1)  
xi  = the numerical value achieved ( between –2 and + 2).  
Earlier MS literature has suggested that the GAS should be used alongside other outcome measures 
(Khan et al 2008a), such as those described in this chapter. A modified version was used in this 
study, based on past recommendations to improve the practicalities of its use (Turner-Stokes 2009).  
Reliability and Validity 
Unfortunately no literature on the psychometric properties of the modified GAS could be found, 
however the scale is unique and modifiable to the individual, this may explain the difficulties in 
assessing these properties. Further work is required in this area. 
Feasibility 
The outcome measure requires groundwork on the part of the researcher or clinician to establish 
relevant goals, discussion is also required to establish the unique goals of each participant. Details 
of how the GAS was used in this study are given below.  
In accordance with the methods of Turner-Stokes (2009)  a list of 12 possible goals (with a 13th 
‘personal’ goal) was created related to the outcome measures discussed in this chapter. 
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To establish “Best anticipated outcome” (the +2 score) it was important that achievement of the 
chosen goal was based on the literature or expert clinical judgement. Thus a thorough search of the 
relevant literature was made to establish what changes in each outcome measure would be required 
to indicate clinical improvement. Where possible the “Best anticipated outcome” (the +2 score) 
score was based on MS literature, and/or where reliability studies had been carried out to determine 
relevant clinical change. A discussion with the Consultant MS physiotherapist was carried out to 
provide expert advice on what clinical improvement may be anticipated in the patient population of 
interest. This created the recommended 5-point scale (between -2 and +2) for each goal; 
• +2 Best anticipated outcome 
• +1 More than expected outcome 
•   0 Expected outcome 
• -1 Less than expected outcome 
• -2 Unfavourable outcome 
 
A brief explanation follows as to the rationale from the literature regarding the “Best anticipated 
outcome (+2)” for achievement of the 12 chosen goals. Achievement of the other parameters (+1, 
0, -1 and -2) were chosen through discussion with the Consultant MS physiotherapist, based on the 
+2 score. It is acknowledged that these are limited in many cases by 1) the evidence being in a 
disease population where symptoms and management are different to those experienced in MS, 2) 
the participants in this study presenting with a wide range of disability levels. However, this later 
point was addressed by use of percentage changes in scores for each individual, rather than a finite 
score. 
Establishing the Best Anticipated Outcome (+2 score) 
For the T25FW past studies in MS have suggested a clinical change of 16% would indicate a 
clinically relevant change (Kaufman et al 2000; Schwid et al 2002; van Winsen et al 2010) . As 
such, relevant values were chosen to establish +2 achievement (with lower scores a percentage of 
this), these are provided below. The Best anticipated outcome (+2) score will be provided for the 
other outcome measures discussed overleaf. 
• Best anticipated Outcome (+2 score) - Reduction in time to walk 25 ft by >16%  
• More than expected outcome (+1 score) - Reduction in time to walk 25 ft by 10-15% 
• Expected outcome (0 score) - Reduction in time to walk 25 ft by 1-9% 
• Less than expected outcome (-1 score) - No reduction in time to walk 25 ft 
• Unfavourable outcome  (-2 score) - Increase in time to walk 25 ft 
 
Literature pertaining to the methodology 
 
 
117
For the 6MWT, work done in Alzheimer ’s disease was used (Ries et al 2009), where a 4% 
difference in walked distance implied clinical change. Thus, the +2 achievement score was based 
on this.  
To determine  achievement of improving quadriceps’ strength, (i.e. +2 achievement) a change of 
>26% was found in the Traumatic Brain Injury literature (Morris et al 2008), this was used as a 
basis to determine goal achievement. Achievement of TUG performance was based on work done 
in Alzheimer ’s disease by Ries et al (2009); where an improvement of 17% indicated clinical 
change.  
The Best Anticipated Outcome score for the BBS was established from studies involving 
participants with Parkinson’s disease (Steffen and Seney 2008), where for those requiring walking 
aids a change of 7 points (12.5%) would imply clinical change. Improvement in OS was difficult to 
determine, as minimal literature is available on the outcome measure (Biodex balance system), 
therefore a percentage overall improvement was linked to work done by Steffen & Seney (2008) 
for the BBS, with a 12.5% improvement considered to imply a clinical change.   
For the ABC scale the 13% value to indicate clinical change in a study on Parkinson’s disease was 
used (Steffen and Seney 2008). For the FSS MS literature which involved therapeutic exercise 
(similar to that of this research) was used (Newman et al 2007; Dalgas et al 2010), where an 8% 
improvement may indicate clinical change, and thus the +2 score. Similar rationale was used for 
the HADS, where a physiotherapy exercise intervention for people with MS found a change of 10% 
(Wiles et al 2001). 
To determine if participants had improved in a goal to “improve quality of life” (based on the 
LMSQOL) results from a past physiotherapy study (Miller et al 2011), which  noted an 
improvement of 10%, were used to determine +2 goal achievement. 
A goal related to social interaction was included, as this has been found to be an important outcome 
in group exercise classes (Dodd et al 2006; Smith et al 2009). To determine achievement of this 
goal an arbitrary outcome based on making contact with others outwith the class was chosen as the 
+2 outcome. Finally a goal related to attendance at the exercise programme was based on an 
attendance of 80%, as past studies with similar weekly classes reported class attendance of 80%  or 
more  (Taylor et al 2006; McCullagh et al 2008; Dalgas et al 2009). 
Strengths and limitations 
The GAS captures data on participants’ unique goals and can be used to guide and motivate an 
intervention, it allows for both over and under achievement of goals. 
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Calculation of goal attainment is based on establishing different levels of expected outcomes, this 
requires knowledge and experience. Furthermore, it may be difficult to predict outcomes in a 
heterogeneous disabled population, as each individuals capacity to achieve a goal may be different. 
In this study, goals were linked to outcome measures assessed at baseline and also week 12, where 
achievement of goals was based on percentage changes rather than an actual score. This was judged 
a pragmatic solution to allow for those with different abilities to be compared on a similar scale. 
However, the limitations of this are accepted. 
 
3.10 Focus groups  
A secondary aim of this work was to elicit participants views on exercise and the exercise 
intervention, including; personal goal attainment, positive and negative outcomes associated with 
the intervention, and intrinsic and extrinsic factors to participation in, and completing, the 
intervention. To achieve this aim focus groups were undertaken for the qualitative study (Study 2) 
discussed in Chapter 5. 
3.10.1 Gather the views and opinions from study participants  
There are options available to gather study participants views, questionnaires could be completed, 
or qualitative methodology such as one to one interviews or focus groups could be undertaken. 
Self-designed questionnaires with topics specific to the intervention would be one method to gather 
views and opinions from participants in this study, with a need to pilot and validate the 
questionnaire prior to its use. Questionnaires limit the depth of explanation in a participant’s 
answer, and answers are limited to pre-determined questions only. Furthermore, unless 
questionnaires are returned to the researcher immediately they are vulnerable to respondents not 
returning the questionnaire at a later date. In addition, discussion is not possible meaning there is 
less opportunity to gain insight into different viewpoints (Denscombe 2007). 
One benefit of questionnaire based research is that it can gather concise information from a large 
group of people. However, as small numbers were anticipated for this study, it was felt that 
qualitative methodology should be adopted. There are examples of qualitative research, using one 
to one semi-structured interviews, in the MS therapeutic exercise literature (Dodd et al 2006; Smith 
et al 2009; Plow et al 2009b). The studies by Dodd (2006) and Plow  (2009b) are the qualitative 
part of mixed methodology studies, whereby qualitative data complements other findings (Creswell 
and Plano Clark 2007).   
However one to one interviews are limited in that discussion is restricted to one participant, with 
analysis of other interviews (with different participants) done by the researcher later. In addition 
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they can be time-consuming and may not produce natural responses from participants  (Creswell 
and Plano Clark 2007; Denscombe 2007).     
The intent of the study was to stimulate discussion and debate between participants, as groups were 
already formed from the group nature of the intervention, focus groups were a practical and 
sensible choice to gather the views and opinions of the study participants. Focus groups are a well 
established qualitative method of gathering views and opinions from a group of people (Morgan 
1998).  Undertaking focus groups  had other advantages such as participants being able to relate to 
one another’s views, whilst questioning, challenging or agreeing with each other (Kitzinger 1995). 
Credibility of focus group data 
As with the clinical (quantitative) outcome measures previously described, it is important that rigor 
and validity be preserved when undertaking focus group research. There is much debate in the 
health sociology literature about the relevance of establishing rigor and validity (Rolfe 2006; 
Freeman 2006). At a basic level Fern (2001) discusses that, fundamentally, the methods employed, 
such as; the group composition, the number of groups and participants, the location, the moderator 
(researcher) and the analysis can all impact validity. He also contests that validity is to be judged 
by the reader. Fern’s (2001)  rationale was used when establishing the methodology for Study 2 
(Chapter 5).  
Strengths and limitations 
There are a number of advantages to focus groups. They work well to “focus” the opinions of those 
with a commonality or who are  undertaking a collective activity (Kitzinger 1994), for example 
those with MS who have undertaken a group exercise class together. The well conducted focus 
group can encourage participation from those who are reluctant to partake in one-on-one interview 
or who may feel their views are not relevant (Kitzinger 1995) . They can gather differing views and 
opinions, can help establish motivations, are deemed to be reasonably quick and easy to set-up and 
can be used both to educate the group, and gather opinions on service improvement (Morgan 
1996).  In comparison with one-to-one interviews, focus groups may be more natural; encourage 
participants to interact, exchange anecdotes, whilst questioning and commenting on shared 
experiences (Kitzinger 1994; Wilkinson 1998). Thus Focus Groups were appropriate for the group 
nature of this study. 
Nevertheless, there are also some limitations to focus groups. Unlike other forms of data collection 
confidentiality is compromised with all group members aware of others’ views, once expressed. 
Furthermore the more articulate group member may perhaps silence a less confident participant 
(Kitzinger 1995). The research is difficult to recreate, even with the most skilled moderator leading 
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the group, furthermore the risk of the moderator influencing the group may be regarded as creating 
a bias, which has been described as a “cardinal sin” in qualitative research (Fern 2001). In 
comparison with one-to-one interviews it is difficult to establish depth to participants’ opinions 
(Wilkinson 1998). 
3.11 Summary and conclusion 
By reflecting on the outcome measures used in the therapeutic exercise  studies described in 
Chapter 2, and the outcomes discussed in this Chapter it is clear that there are many available 
outcome measures to assess the range of limitations and consequences of MS. Thus, much 
empirical data can be gathered to guide rehabilitation and exercise prescription.  
For this study, outcomes were chosen which would capture data on the physiological, functional 
and psychological status of participants. Outcome measures which showed the best feasibility, 
reliability and validity in relation to both the study population and the methodology were chosen to 
capture the wide range of areas the intervention sought to address.  
This chapter provided a literature background which focused on the methods chosen to establish 
the aims of the study. An initial discussion on the clinical outcome measures chosen, and why was 
followed by a discussion on the use of focus groups. It was highlighted, however, that there is a 
need to address the lack of data on the strength of outcome measures used in MS therapeutic 
exercise literature, particularly for those who have moderate MS (e.g. EDSS 5-6.5). The next three 
chapters will describe the studies undertaken as part of this thesis. Before a discussion of how all 
three studies may guide future clinical practice and research agendas. 
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4 Study 1 
The effects of a 12-week leisure centre based, group exercise intervention 
for people moderately affected with Multiple Sclerosis 
Three investigations were completed as part of this thesis, the first and main investigation assessed 
the impact of a twelve week combined exercise intervention, for people with moderate MS. 
Participants from the main investigation (described in this Chapter) were also participants in the 
other two studies. Some outcome measures used in the main investigation were assessed for 
reliability, with this work discussed in Chapter 6 of this thesis.    
4.1 Introduction and rationale   
A number of studies have used exercise interventions to manage the clinical symptoms associated 
with MS (Section 2.4). This evidence is mainly in those mildly affected with MS, with less known 
about the effects of therapeutic exercise in those with an EDSS greater than 5. Studies have looked 
at the effects of exercise over several weeks and months, indicating a need to establish if there is an 
optimal length of time to ascertain any effect of an exercise intervention. Furthermore, most studies 
report findings at the end of the intervention period, thus there is a need to look at the effects of 
exercise beyond the end of the formal exercise intervention. Additionally, the majority of past 
studies focus on an aerobic-only or resistance-only approach. Although there is evidence to suggest 
an exercise approach combining aerobic and resistance components may be beneficial, further 
work is required to confirm this.  
To address these gaps in the literature, summarised in Section 2.4.4) the main project in this study 
(Study 1) was designed to establish the effects of a 12-week combined exercise intervention for 
those with moderate MS (EDSS 5-6.5). Assessments were carried out up to one year after the end 
of the intervention. To determine the impact of time on the chosen outcomes, and to determine the 
impact of taking part in an exercise programme on the chosen outcomes over a longer period of 
time. 
Following the main aim, hypothesis and overview of the design a description of the methods, 
results and a discussion of the findings are presented.  
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4.1.1 Study aim 
To deliver and evaluate, over both the short and longer term, the effects of a 12-week community 
based group exercise class for people moderately affected with MS, against controls matched for 
disability level who received usual care. 
4.1.2 Research questions  
What are the short and longer term effects of a 12-week community based group exercise class in 
people moderately affected with MS, compared to controls with MS of a similar age, gender and 
disability level who received usual care? 
Is a 12-week community based group exercise class effective in improving the physiological, 
functional or psychological status of people moderately affected by MS? 
4.1.3 Hypothesis 
The null hypothesis for this study is that there will be no statistically significant difference in any 
of the assessed outcomes between the two groups, and further that there will be no statistically 
significant  difference in assessed outcomes over time. 
4.1.4 Study Design 
A longitudinal single-blind randomised control trial (RCT) was undertaken with each participant 
being involved over 15 months. The study compared two groups, one receiving the intervention 
and one acting as a control group. Thirty-two participants were randomly allocated (refer to Section 
4.2.3) to receive either the group exercise intervention or usual care as part of the control group.  
To determine the short term effect of the intervention, assessments were undertaken at baseline, 
after eight weeks and after twelve weeks of the intervention. After which time all participants were 
free to participate in any form of exercise they would like. To determine the longer-term effect of 
the intervention, follow-up assessments were done six and twelve months after completion of the 
12-week intervention (Figure 4.1).  
 
 
 
Figure 4.1 Symbolic representation of Study 1 design 
Intervention Group  O1 X O2 X O3  O4            O5 
Control group        O1  O2  O3  O4            O5 
   Baseline  8 weeks  12 weeks  36 weeks                  60 weeks   
         6 months                  12 months 
   
O = Observation or measurement assessment 
X = Intervention 
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4.2 Methodology 
4.2.1 Ethical considerations 
Ethical approval was obtained from the West of Scotland Research Ethics Committee in December 
2009 (Appendix 5) and Research and Development approval from NHS Ayrshire and Arran 
Research and Development Management in January 2010 (Appendix 6). 
4.2.2 Recruitment and participants  
The subjects were recruited from the Managed Clinical Network (MCN) for MS within NHS 
Ayrshire and Arran. They were all patients of the consultant in rehabilitation medicine, Douglas 
Grant Rehabilitation Centre, Ayrshire Central Hospital, Irvine. All participants had to have a 
confirmed diagnosis of MS, and fit the inclusion criteria to take part. 
Inclusion criteria 
o Clinically or paraclinically diagnosed MS, based on the most recent additions to the 
diagnostic criteria (Table 2.1). 
o An Expanded Disability Status Score between 5 (ambulatory without aid or rest for about 
200 m) to 6.5 (constant bilateral assistance required to walk about 20m without resting)  
o Stable rehabilitation and drug therapy within the past 30 days. 
o Adequate cognitive function, assessed by achieving a score of 24 or greater on the Mini 
Mental State Examination. 
 
Exclusion criteria 
o An exacerbation of their MS symptoms within the past three months. 
o A rapidly progressive disease 
o A history of cardiovascular, respiratory, neurological or metabolic disease, or any other 
medical condition which may prevent participation in the study. 
o Inability to complete the protocol for the outcome measures or the exercise class, as 
measured by a fitness screening form  
 
Before the onset of the study the number of participants required to achieve the necessary statistical 
power was calculated, based on the previous work of Romberg et al (2004). It was determined that 
to achieve a significant difference at the 5% level and a desired clinical effect of a 20% 
improvement in the Timed 25 Foot Walk outcome measure, 23 participants would be required in 
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each group in order to achieve an estimated  power of  80%. Thus in total for the intervention group 
and the control groups 46 subjects were required. 
4.2.3 Screening for inclusion 
To be accepted into the study participants went through several stages of screening (Figure 4.2). 
Initially a list of all patients on the MCN database for MS in NHS Ayrshire and Arran who lived 
within a commutable distance of Sites A or B (Section 4.2.10) was generated; people on this list 
were sent a letter and participant information sheet inviting them to take part (Appendix 7 and 
Appendix 8). Instruction was provided to contact the main researcher by telephone or email should 
they require further information or would like to take part. Reminder letters were sent after one 
month and healthcare professionals working in the Rehabilitation Centre who dealt with MS 
patients who may qualify for the study were asked to make relevant patients aware of the study.   
Forty-three patients contacted the main researcher. They were asked over the phone if they had any 
further questions and what their availability and transport options were for attending the twice-
weekly class. They were also asked about their current mobility level (Do you use a wheelchair? 
Are you able to walk with/without a walking aid? Are you able to walk without a rest or walking 
aid for 300m or more?). These questions provided a crude screening, as those unable to commit to 
the class time, venue, or who were more or less disabled than the inclusion criteria allowed were 
not invited to the main screening assessment at the hospital rehabilitation unit. At this stage seven 
interested participants were not invited for screening. One was suffering a relapse of symptoms and 
six had mobility problems deemed too mild for inclusion in the study.  
Thus, 36 potential participants were invited for screening, which took place within the 
physiotherapy department of the NHS rehabilitation centre. This screening was done by the 
Consultant MS physiotherapist and included an open discussion about the study and the following 
screening outcome measures (refer to Section 3.7); 
o The Mini Mental State Examination (Folstein et al 1975)  
Subjects answered questions, and performed tasks as part of the examination, and were 
eligible to take part in the study if they scored more than 24 points.  
o The Expanded Disability Status Scale (Kurtzke 1983)  
Subjects were assessed by a the Consultant MS physiotherapist  and EDSS level was 
recorded. Participants were eligible if they were deemed to have an EDSS score of 5-6.5 
o Fitness screening form  
Fitness to exercise, based on the Physical Activity Readiness Questionnaires (Shephard 
1988); to ascertain general levels of fitness with a bias towards cardiovascular and 
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respiratory function. The questionnaire was used as a means to highlight any health 
requirements of participants, thus answering “yes” to any questions did not automatically 
exclude potential participants 
Following screening, thirty-two participants were eligible to take part, with four excluded at this 
stage due to having an EDSS of less than 5, undergoing symptom relapse or now being unable to 
commit the time to take part. A summary of the important stages of recruitment is provided in 
Figure 4.2. This figure includes the patient journey, through to the month 12 assessments, further 
details on attendance and attrition are discussed in Section 4.4.2.   
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n= 18 in study 
Month 6 (week 36) measurements 
taken (n=16) 
1 unable to contact, 1 suffering relapse 
n=11 in study  
Week 8 measurements taken (n=11) 
n=11 in study  
Week 12 measurements taken (n=10) 
1 unable to attend hospital due to 
weather conditions 
 
n=10 in study 
Month 6 (week 36) measurements 
taken (n=10) 
Month 12(week 60) measurements 
taken (n=7) 
1 moved away ; completed 
questionnaires 
2 unable to contact 
Month 12(week 60) measurements 
taken (n=16) 
1 unable to attend due to fractured 
arm 
1  unable to contact 
n= 18 in study 
Week 8 measurements taken (n=17) 
1 missing; unable to attend 
n=18 in study 
Week 12 measurements taken ( n= 15) 
1 suspected Trigeminal neuralgia 
1 suffering flu-like symptoms 
1 increased work commitments  
 Discontinued (n=1) 
Moved away  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Flowchart of recruitment, group allocation and patient journey.  
Reason for discontinuation are explained in italics, please note not all outcome measures collected for all 
participants at all time points due to individual mobility issues, and technical problems. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sc
re
en
in
g 
n= 20 in intervention group 
n= 8 Site A 
n= 12 Site B 
n=20 Baseline measurements taken 
      Discontinued (n=2) 
       1 due to family commitments 
      1 decided to participate in other study 
Discontinued (n=1) 
Unable to commit time for 
assessments 
n=12 in control group (including 2 
first assigned to the intervention) 
n=6 with Site A 
n=6 with Site B 
n=12 Baseline measurements taken 
Telephone discussion 
revealed   
6 minimal mobility problems 
1 suffering relapse 
   Excluded n=2 
   One EDSS≤4.5 
   One suffering relapse 
Excluded n=2 
1 EDSS≤4.5 
1 no free time 
n=159 potential participants 
sent invitation letters 
n= 32 consented to participate 
n=43 expressed interest in 
participation 
n= 36 screened 
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A total of 32 participants consented to take part (Table 4.1). These participants were randomly 
selected (see below) to either receive the intervention or be in the control group. The intervention 
took place at one of two venues (Site A and Site B – see Section 4.2.10), each site had a maximum 
class capacity of 10 to 12 participants. Participants at Site A received the intervention first. 
Fourteen participants were eligible for participation at Site A (i.e. lived within a 15 mile radius of 
Site A); ten of these participants were randomly selected to begin the class. Early in the 
intervention, two participants could no longer commit the time, and were transferred to the control 
group, as they had attended less than 4 classes. Data from these two participants are considered in 
the control group, along with the other original four controls.  
Eighteen participants were eligible for Site B. From these, twelve were randomly selected for the 
class, with six controls.  
It was necessary for those randomised to all begin the intervention at the one time, and it was 
initially felt that more control participants may be sought later, however this was not achieved. 
Table 4.1 Baseline characteristics  of subjects in the longitudinal study. 
Group Number of 
subjects 
Gender 
M:F 
Age (years) 
Mean (SD) 
EDSS 
Mean 
Years since onset 
Mean (SD) 
Intervention 20 
Site A = 8 
Site B = 12 
5:15 51.4 (8.1) 6 13.4 (6.4) 
Control 12 4:8 51.8 (8) 6 12.6 (8.1) 
 
Randomisation method 
Randomisation was achieved with a computer programme (Microsoft Excel, 2007). The following 
example describes the method for Site A (repeated at a later date for Site B). On a blank 
spreadsheet a “Group” column of 10 “I” were placed (denoting the intervention group), followed 
by 4 “C” (denoting control group). In the next “Random number” column the RAND function on 
the computer programme randomly provided a number. The “Random number” column was then 
sorted in ascending order, thus changing the order within the “Group” column. This later column 
was then copied and pasted over to a second spreadsheet containing an alphabetical (by surname) 
list of the potential participants.    
4.2.4 The research team 
The main team consisted of the Chief Investigator (Thesis author), an assessor, fitness instructors 
and the Consultant MS physiotherapist. The Chief Investigator is a physiotherapist and fitness 
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instructor who had some experience in exercise classes for those affected with MS, she co-
ordinated the study and jointly led the exercise classes.  
The assessor was a physiotherapist, recruited in January 2010. To improve the assessor’s 
knowledge of the outcome measures three hours of formal training was given, with relevant articles 
on the outcome measures supplied. Training involved observation, formal practice and discussion. 
An instruction manual for all outcome measures was also provided Appendix 9. The assessor was 
blind to group allocation, to avoid the risk of study bias discussed in the literature (Schulz and 
Grimes 2002; Maher et al 2003).  
Fitness instructors were employed by either East Ayrshire Leisure or KA Leisure. Contact was 
made in August 2009 with leisure staff, and meetings were held to discuss the possibility of classes 
taking place. Commitment to the project was strong with leisure staff aware of a “gap” in the 
service for those with MS. The staff involved in the intervention all had experience leading 
exercise classes with disabled clients. In addition they had completed a training day organised by 
the Chief Investigator and the Consultant MS physiotherapist related to exercise prescription in 
MS. 
4.2.5 Assessment protocol 
The assessor took written consent from those who met the inclusion criteria and agreed to take part. 
Contact details, were also taken at this time (Appendix 2).  
Following screening (Section 4.2.3) each participant underwent baseline assessment; this and all 
follow-up assessments took place within the hospital rehabilitation unit. A private room was used 
and attempts were made to keep the room temperature at or below 22° Celsius. Similar 
methodology to that described below was carried out at all five assessments points. On arrival at 
the rehabilitation unit participants were led to a quiet room where they completed the four self-
rated questionnaires which gathered data on balance (ABC), fatigue (FSS), mood (HADS) and 
quality of life (LMSQOL). On completion of the questionnaires the assessor rated outcome 
measures were completed. 
As discussed in the previous chapter (Section 3.7) eight different assessor rated outcome measures 
were collected by the assessor at each assessment (with the addition of the Goal attainment scale at 
baseline only). These collected data on; mobility (T25FW, 6MWT, Temporal spacial parameters of 
gait and TUG), balance (BBS, OS), strength (SLS/WLS), activity levels (PF) and body 
composition (BMI). Three separate assessment protocols were created (Protocol 1 provided in 
Appendix 3), which varied the order of the outcome measures, altering the order of mobility, 
balance and strength assessments. Participants were randomly assigned a protocol order and 
followed this order for every assessment. This was arranged to minimise the effect of tiredness and 
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fatigue potentially affecting results of the later outcome measures, as well as the overall results. As 
some participants wore functional electrical stimulation devices on their legs, ankle foot orthotics, 
or ankle supports inside their shoes participants kept their shoes on during this process. The 
mobility aid used by the participant was noted for each outcome measure and was kept consistent at 
all assessments. 
Timed 25 Foot Walk test  (T25FW) 
 
The 25FWT (Cutter et al 1999) was repeated three times at each session. More fully described in 
Section 3.9.3 participants were given instructions. These included being told to walk at a normal 
pace and to walk past the cone (cones were placed 25ft apart, Figure 4.3). Participants were given 
the opportunity to rest between walks, if required. The time taken to walk 25 feet was recorded and 
the average of the three walks included in the analyses). To minimise walking participants walked 
across the GAITRite carpet used to assess temporal spatial parameters (Section 4.2.5) 
 
 
Figure 4.3 Diagram of 25foot walk  
 
Temporal spatial parameters of gait 
To determine walking patterns, temporal spatial walking parameters were collected as each 
participant walked over a computerised carpet; the GAITRite system (CIR Systems – Model K648-
D8). Discussed in Section 3.9.3 this instrument is a 4.6 m (15 foot) carpet, embedded with 
electronic sensors positioned in a grid-like fashion through the length of the carpet which is linked 
to a computer with dedicated GAITRite software (CIR Systems – version 3.8A). The sensors detect 
foot-fall and accurate gait parameters are recorded (CIR Systems 2010).  
Three separate walks over the GAITRite were performed by each participant as part of the T25FW 
(Figure 4.3) To ensure steady state gait, approximately three feet at either end of the carpet 
provided an acceleration and deceleration zone. Participants’ leg length was required for the 
temporal spatial measure, and was measured for each leg, in centimetres, from the anterior superior 
iliac spine to the floor at the first assessment.  
Computer analysis of the walks was accomplished with the data transformed and relevant 
parameters saved. This analysis involved using the GAITRite software’s FootFall Editor to erase 
GAITRite carpet 
Acceleration 
Zone (3ft) 25ft (7.62m) timed section Deceleration  Zone (3ft) 
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any “footfalls” from walking sticks or walking frames, ensuring only participants’ footfalls were 
analysed.  Analysed temporal parameters were; walking cadence (WCa), walking velocity (WVel) 
and left (LST) and right step time (RST) (with, gait cycle, single support time and double support 
time recorded, but not included in this thesis). Analysed spatial parameters; left (LSL) and right leg 
step length (RSL) were analysed as was overall walking performance; Functional Ambulatory 
Performance (FAP) (as explained in Section 3.9.3). 
Six-minute walk assessment (6MWT) 
Participants completed a 6MWT (Butland et al 1982) (Section 4.2.5) once per session. The 
guidelines written by the American Thoracic Society  (2002) were used. To summarise, the test 
was carried out in a quiet corridor, with two cones placed 30 m apart. Precisely worded 
encouragement was given every minute and rests permitted if required (Appendix 9).   
Timed Up and Go (TUG) 
The TUG (Podsiadlo and Richardson 1991) assessment was carried out three times at each 
assessment. The test (previously discussed in Section 3.9.4) started and ended with participants 
sitting on a standard chair (seat height 40cm from the floor) with armrests. They were instructed to 
stand up, walk around a cone placed 3 m away, and sit back down in a safe/fast manner. The time 
from their back leaving and returning to the chair was recorded with the average of the three trials 
analysed. 
Berg Balance Scale (BBS) 
To measure balance the BBS (Berg et al 1989) was completed once per session. The BBS is more 
fully described in Section 3.9.5.  The assessor evaluated 14 functional balancing tasks of increasing 
difficulty, on a 5-point scale. Equipment used for this test included a Reebok step 16cm high, and 
two chairs (one with armrests) both height 40cm. 
Overall Stability (OS) 
To assess Overall Stability participants were assessed on the Biodex balance system (Biodex 
Stability System – Version 1.3). More fully described in Section 3.9.6. At the baseline assessment 
participants’ foot position was recorded, and the same position was used for all follow-up 
assessments. At each assessment participants were tested three times (with more than 1 minute rest 
between each test) at stability level eight (the most stable) for 20s. To avoid biofeedback, the 
screen was covered during testing with participants asked to look at and focus on a cross marked on 
the wall in front of them. Participants were instructed to avoid holding onto the support handles 
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during the 20s of each trial. The average, of the three readings for overall stability (OS) index score 
was used for analysis. 
Quadriceps strength 
Quadriceps strength was assessed using a MVC “make-test”  following standardised protocol 
(Bohannon 1997), the method is discussed in more depth in Section 3.9.7. To establish positioning 
for all subsequent assessment, at the first assessment the Lafayette HHD (Model 01163) was placed 
anterior to the participants’ Medial Malleolus, and the distance from here to the apex of the patella 
was measured and recorded (Figure 4.4). This distance constituted the “lever-arm”, and to improve 
reliability was kept the same for all assessments.  
Participants sat on a raised plinth, with their back unsupported and their feet not touching the floor . 
They were asked to cross their arms over their chest to avoid recruiting other muscle groups during 
testing (Figure 4.4). With their knees at 90 degrees, the “lever-arm” distance was marked with a 
semi-permanent marker pen. The HHD was positioned on this mark. The HHD was set to sound a 
beep at the start and end of 3 s (during this time the HHD was recording the force produced by the 
participant). Participant were instructed to “push as hard as you can after you hear the first beep, 
stop pushing when you hear the second set of beeps” (constituting a three second MVC). This was 
repeated with three trials on each leg, with a minimum of 30 s rest between each trial. The average 
of the three readings of each leg was analysed. Torque (Nm) was used to quantify strength; 
calculated for each leg by multiplying the force (kilogram output) by 9.81 and multiplying this by 
the lever arm length. The weaker leg and stronger leg were established from baseline 
measurements, and in all subsequent analysis the weaker leg remained the reference leg (i.e if the 
left leg was deemed the weaker at baseline, all subsequent analysis of the weaker leg was from left 
leg results).  
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Figure 4.4 Image of leg strength assessment.  
Note HHD placement, anterior toMmedial Malleoli, and participant sitting position. 
 
The PhoneFITT (PF) 
To measure functional activities of daily living and leisure activity the PF was used (Gill, Jones, 
Zou, & Speechley 2008). Discussed in Section 3.9.8 this self-report interview questionnaire asks 
for “frequency, intensity, type and time” of six functional activities of daily living and ten exercise 
based leisure activities. Participants provide information on six specific common household tasks 
and eleven particular forms of physical activity in a typical week in the preceding month. They are 
asked to provide details on the time spent doing each activity, how often they undertake each 
activity and provide information on their breathing during each activity. There is the option to 
include other personal activities not included in the questionnaire. 
Activities Balance Confidence scale (ABC) 
To measure participants’ confidence in their balance the ABC (Powell and Myers 1995) was used, 
discussed previously in Section 3.9.9. Fifteen questions related to functional and everyday 
activities which challenge balance were rated on a 10-point Likert scale to determine participants’ 
confidence in performing these activities. This yielded a score of 0-150 which was used for 
analysis, with higher scores indicative of more balance confidence. 
Fatigue Severity Scale (FSS) 
To establish fatigue, the FSS (Krupp et al 1989)  was used, previously discussed in Section 3.9.10. 
Participants self-reported their agreement with nine fatigue-related questions on a seven-point 
Likert scale, based on their experiences in the past week. Producing a mean score between 0 and 7, 
this score was used for analysis, with higher scores suggestive of higher fatigue. 
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 Hospital Anxiety and Depression Scale (HADS) 
To assess mood, more specifically anxiety and depression, the self-reporting HADS (Zigmond and 
Snaith 1983) was used, discussed in more depth in Section 3.9.11. Participants respond to fourteen 
questions; seven related to anxiety, seven related to depression on a 4-point scale, in relation to the 
past week. Thus generating a mean score between 0-42, which was used for analysis. The mean 
scores (0-21) for each aspect; anxiety and depression, were also analysed. Higher scores are 
deemed to suggest more anxiety and depression.  
Leeds Multiple Sclerosis Quality of Life scale (LMSQOL) 
The LMSQOL scale (Ford et al 2001) was used to assess quality of life, previously discussed in 
Section 3.9.12. Participants were are asked  to rate eight health related questions on a four-point 
scale, in relation to the past month. This too was self-reported and resulted in a score 0-24, which 
was used for analysis with lower scores indicative of a higher quality of life. 
Body composition (BMI) 
To gather data on body composition Body Mass Index (BMI weight (kg)/height (m2) was 
calculated based on height and weight, previously discussed in Section 3.9.13. Height was 
measured in metres (m), using a Leicester stadiometer. Weight was measured in kilograms (kg), 
using seated scales on each of the five assessments.  
The Goal Attainment Scale 
To establish what goals participants would like to achieve over the duration of the study the Goal 
Attainment Scale (Kiresuk and Sherman 1968) was used on the first assessment. The rationale for 
the Goal Attainment Scale is discussed in Chapter 3 (Sections 3.9.14). Participants choose three of 
12 possible goals (or a 13th personal goal), which they hoped to achieve by the end of the 12-week 
intervention. They then graded their chosen goals in order of importance (from 1-3). Goals were 
chosen by all 32 participants, as these were discussed prior to participants being  allocated to either 
the intervention or control group. 
The overall Goal Attainment Scale score for each of the participants in the intervention group was 
calculated using an automatic Microsoft Excel spreadsheet, applying a standard mathematical 
formula (Turner-Stokes 2009). 
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4.2.6 The exercise intervention  
It is recommended that for those with MS a well-balanced exercise programme be undertaken to 
improve health and manage symptoms (Mulcare 2003; White and Dressendorfer 2004). Achieving 
this was the main aim of the intervention for the main study, with the following section discussing 
the rationale for the intervention methodology. 
Acknowledgement of special considerations in the MS population (Mulcare 2003) was at the 
forefront of the design of the intervention. As such the following was considered, with a brief 
outline of how they were incorporated provided in parenthesis; 
• possible cognitive deficit (verbal, written and pictorial explanation of each exercise),  
• fatigue (no expectation to complete all exercises, rest sessions provided, intensity monitored),  
• mornings an optimal time (classes late morning),  
• balance problems (option of seated exercises),  
• daily fluctuation in symptoms (no expectation to match or exceed previous classes exercises),  
• variation in symptoms and ability (options provided within each exercise)  
 
Within the MS therapeutic exercise literature interventions vary from three weeks to 24 weeks. As 
yet there are no guidelines as to the optimal length of an exercise intervention. Indeed, change (or 
no change) has been seen regardless of the length of the intervention. In the general exercise 
literature, optimal improvements in fitness variables will result from interventions carried out over 
several weeks, allowing the participant to adapt to the training regime (Pollock et al 1998). For a 
healthy population strength gains from resistance training may take six to eight weeks, although 
this may vary with the individual and type of training  (Kraemer et al 2002; Broughton 2011). It 
was judged that, to compare the results of this study with the therapeutic exercise in MS literature 
and to follow the guidelines for healthy populations the intervention would be undertaken for 12-
weeks. Furthermore, to establish if this length of intervention is required, assessments were taken 
after 8 and 12 weeks.   
The commonly accepted FIIT acronym; Frequency, Intensity, Type and Time of exercise (Franklin 
et al 2000) will now be discussed in relation to the intervention.  
Frequency 
Exercise guidelines suggest that healthy adults undertake a well-rounded exercise programme 
which totals 150 minutes per week. If this cannot be met, benefits can still be achieved from some 
activity (Pollock et al 1998, Garber et al 2011).  
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The frequency of classes varies in the MS therapeutic literature; from one to three sessions per 
week (Table 2.5-6). However, there is no evidence comparing different frequencies, thus the 
optimal number of sessions per week remains unknown. Many 12-week interventions, include two 
sessions per week (Kileff and Ashburn 2005; McCullagh et al 2008; Dalgas et al 2009; Dalgas et al 
2010). This approach remains popular (Collett et al 2011) and is recommended (White and 
Dressendorfer 2004).  
To allow comparison with the therapeutic exercise literature the intervention was carried out twice 
weekly. Furthermore the leisure staff involved in the study could provide a venue and staff twice 
weekly. 
Intensity 
The Borg RPE scale (Borg 1982)  to monitor exercise intensity has been used in the MS literature 
(Bjarnadottir et al 2007; Morrison et al 2008; McCullagh et al 2008; Motl et al 2012), finding it a 
simple way of monitoring exercise intensity.  
During physical activity RPE was first discussed by Borg (1970) as a means to rate perceived 
exertion during activity. Two scales are available; the original with values ranging from 6 to 20, 
chosen to denote heart rate values of 60 to 200 beats/min, the newer scale attempts to offer a 
general ratio scale with values ranging from 0 to10 (Borg 1982). The later scale was chosen in this 
study.  
Participants were asked to maintain a “moderate” (RPE 3) to “somewhat-hard” (RPE 4) intensity, 
as is recommended by White and Dressendorfer (2004).  
In the general exercise literature safe progression of exercise training is recommended to allow for 
continued benefit (Pollock et al 1998; Kraemer et al 2002; Garber et al 2011). This rationale is 
adopted within the MS therapeutic exercise literature, particularly for resistance training 
programmes (Section 2.4.2). There are also examples of progressive exercise training in the 
combined exercise training literature (Fragoso et al 2008; Sabapathy et al 2011). Thus, to allow for 
progression in this study different levels were available for each exercise (Table 4.2), this ensured 
participants were able to work at an intensity appropriate to them. The level chosen was based on 
discussion between the participant and the Chief Investigator or supervising leisure staff. A similar 
approach was adopted by Sabapathy et al (2011). 
Type    
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The study aimed to assess the impact of the intervention on the physiological, functional and 
psychological status of participants.  
Within this study physiological and functional outcomes primarily guided the intervention i.e. 
mobility/aerobic endurance, leg strength and balance. Therefore the type of exercises included were 
designed to improve these areas, consequently the type of exercise was a combination of 
aerobic/mobility, resistance and balance exercises. Hence the type of exercise is described as 
combined exercise.  
The Chief Investigator and the Consultant MS physiotherapist chose the exercises for the 
intervention. These were based on the available literature, their personal knowledge of 
physiotherapy and fitness training and through discussions with neurophysiotherapy colleagues and 
supervisors. The included exercises are described in Section 4.2.7.  A whole body approach was 
adopted, thus although in Section 4.2.7 exercises are defined as primarily aerobic, resistance or 
balance exercises there may be overlap between types of exercise. 
Time  
Classes in past studies, which have used alternating or combined exercises, have been undertaken 
for around an hour at a time (Freeman and Allison 2004; Taylor et al 2006; McCullagh et al 2008). 
As there have been no reports of this being problematic an hour long session was also chosen for 
this study. However, it is acknowledged that two one hour classes does not meet the 150 minutes of 
recommended exercise per week for healthy adults (Pollock et al 1998, Garber et al 2011). It was 
judged that two, one hour, classes per week were a good initiation into exercise for participants, 
many of whom were very sedentary.  
The main circuit component lasted 35-40 minutes and was aimed at improving the participants’ 
aerobic endurance/mobility, strength and balance. The exercises in the circuit each lasted one 
minute, chosen for pragmatic reasons based on pilot work (Section 4.2.11). A similar format has 
been used successfully in the past (Taylor et al 2006). After each minute the participants moved to 
the next exercise station, once the slowest participant was ready the group began a new exercise 
(allowing a minimum of two minutes rest between each exercise). 
4.2.7 The exercises in the programme 
The main exercises were delivered in a circuit component, with everyone completing the same 
exercises as they were able. During the study, prior to each session the Chief Investigator chose 8-
10 exercises from Table 4.2, this varied from session to session.   
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The exercises were chosen to benefit those with moderate MS, with it anticipated that the exercises 
would have a carryover effect on the different outcome measures used in the study. An explanation 
of the exercises and examples of the hypothesised impact each may have on the outcome measures 
follow in the sections explaining aerobic exercises, resistance exercises and balance exercises.  
Cards, with pictures and verbal instructions, for each exercise were placed around the room, 
alongside the relevant equipment. Four levels for each exercise allowed for those with differing 
abilities and progression through the weeks. At week nine, a fifth level was added to some of the 
exercises to offer variety. Progress cards were completed by participants at the end of each 
exercise. An explanation of the chosen exercises will be discussed based on what was judged to be 
the main exercise type, i.e. primarily aerobic, resistance or balance.  
Table 4.2 Circuit components of the exercise class. 
Exercise Main Type Description of each exercise and option at each level. 
Runner’s arms Aerobic Near a chair 
1.Sitting down, moving arms in a running style. 
2. Sitting down, moving arms in a running style, holding weights. 
3. Standing, moving arms in a running style. 
4. Standing, moving arms in a running style, holding weights. 
Shuttle walk Aerobic/ 
Mobility 
Chairs set 10m apart 
1.Rest at each end of the shuttle (having a seat) 
2.Walk continuously without resting at each end 
3.Walk continuously with a small weight in each hand 
4.Walk continuously with a small weight in each hand, swinging arms 
Side steps Aerobic/ 
Mobility 
Near supporting surface 
1. Holding onto a stable surface, take one step to the side, and bring feet together, step back. 
2. Not holding on, take one step to the side, and bring feet together, step back. 
3. As 3, lifting arms out to the side, in time with step. 
4.As 4, but taking two-steps to the side before changing direction 
* 5. Grapevine (two steps crossing one leg behind the other) 
Static bike Aerobic On exercise bike or foot pedals 
1.Sitting down, use pedals only. 
2. Sitting down, use pedals, and lifting arms up and down too. 
3. Sitting on bike pedalling with no resistance. 
4. Sitting on bike pedalling against resistance. 
*5. As above, standing out of saddle 
Step-ups Aerobic/ 
Mobility 
Using 20cm step 
1.Sit down, with step in front, lift alternate legs up/down 
2.Standing, step alternate feet forward and back (not on step 
3.Standing, step alternate feet forward and back onto step 
4. As 3, but lifting opposite arms up to the sky (e.g. right arm/left leg). 
*5. Straddle step 
Calf raises Resistance Near supporting surface 
1.Holding onto a stable surface, lift heels from floor, repeat as able. 
2. Lift heels from floor, not holding on, repeat as able.  
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Exercise Main Type Description of each exercise and option at each level. 
3.Lift heels from floor, holding a light weight, repeat as able   
4. Lift heels from floor, holding a heavier weight, repeat as able. 
Up and go Resistance  Sitting on a chair 
1. In a chair (with arms) stand up fully, and sit down again, repeat as able. 
2. Stand from chair, walk to other chair and sit down, repeat as able.  
3. Stand from chair, walk around other chair, and return to sit in first chair, repeat as able. 
4. As 3, but with arms folded when standing. 
Leg extensions Resistance Sitting on a chair 
1. Straighten leg as best as possible, point your toes to the sky, hold for a second then swap 
legs. Repeat.  
2. As above, hold for a FIVE seconds then swap legs. Repeat as able. 
3. As above, hold for a TEN seconds then swap legs.  Repeat as able. 
4. As above, hold for a FIFTEEN seconds then swap legs. Repeat as able. 
*5. As above, small pulses at the end. 
Squats Resistance Near a chair 
1.Holding on, bending legs half-way to ground   
2.Not holding on, bending legs half-way to ground   
3.As above holding light dumbbells 
4.As above, slightly heavier dumbbells  
*5. As 4, when standing straight, going up on toes 
Side-kicks Resistance Near supporting surface 
1. Holding onto a stable surface, lift one leg out to side (as wide as is safe) swap legs, hold 
for a second swap legs. Repeat. 
2. As above, hold for a FIVE seconds then swap legs. Repeat as able. 
3. As above, hold for a TEN seconds then swap legs. Repeat as able. 
4. As above, hold for a FIFTEEN seconds then swap legs. Repeat as able. 
*5. As above, small pulses at the end. 
Upper body Resistance Near a chair 
1.In sitting, shoulder raises (no dumbbells)  
2.As above, with light dumbbells 
3.In standing, shoulder raises (no dumbbells)  
4.As above, with light dumbbells 
Single leg 
stance 
Balance Near supporting surface 
1.Hold onto a stable surface and stand on one leg (aim to maintain for 10 seconds) 
2.As above, not holding on, with arms out to side for balance 
3. As above, not holding on, with arms into side. 
4. As above, with arms into side, slightly bending supporting leg, and then stand up straight, 
repeat as able. 
Take-off Balance With balance cushion 
1. Sitting on chair (with a back), lean forward (simulating 1st part of standing up), and reach 
forward with arms. 
2. As above sitting on stool. 
3. As above sitting on sit fit, on chair. 
4. As above sitting on sit fit, on chair, lifting one leg (swap legs after 30 secs). 
Tick-tack toe Balance Near supporting surface 
1. Walk between tramlines, using wall if required, turn and repeat as able. 
2.Walk between tramlines, not using wall 
3.Walk on line, using wall if required 
4. Walk on line, not using wall. 
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Exercise Main Type Description of each exercise and option at each level. 
Cushion 
standing 
Balance Near supporting surface 
1.In the corner of the room, try and maintain your balance without holding on. 
2. As 1 standing on a mat. Come off, then go back on, when required. 
3. As 2, standing on sit fit. Come off, then go back on, when required. 
4. As 3, moving straight arms slightly (about 4 inches) at sides. 
*Week 9 onward 
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Primarily aerobic exercises 
Past literature has found aerobic interventions and combined exercise interventions to improve 
mobility and endurance (Section 2.4.1 and 2.4.3), thus to improve mobility and aerobic endurance, 
exercises were chosen which were judged to have an impact on aerobic endurance and functional 
mobility. 
Five exercises were primarily aimed at improving aerobic endurance and mobility, with it 
anticipated that these exercises may have an impact on the 6MWT (Section 3.9.2) and the T25FW 
(Section 3.9.1) outcome measures. The aerobic exercises were continuous and rhythmical, and thus 
demanded effort from the cardiorespiratory system. As the aerobic exercises were undertaken twice 
weekly for the duration of the study it was anticipated that this would be at a training intensity 
sufficient to increase aerobic endurance (Section 2.4.1) and therefore have a positive effect on the 
6MWT. In addition, the “shuttle walk” exercise mimicked the T25FW and therefore it 
was anticipated that this would influence the T25FW outcome measure. 
These exercises were named using “lay terms” to help remind participants of what each would 
involve. Exercises included “Shuttle walks”, “Step-ups”, “Runner’s arms”, “Side-steps” and “Static 
bike”, with exercises chosen based on discussions with neurophysiotheapists and the relevant 
literature. An example of the “Step-ups” exercise is displayed in Figure 4.5. 
There are examples of variation of these exercises in earlier literature. In past studies previous 
authors have described some of the exercises similar to those classified as primarily aerobic 
exercise in this study as being resistance or balance exercises; highlighting the diverse nature of 
whole body exercise, targeting; aerobic, resistance and balance components; 
• “Step-ups” in past studies where they are described as being aerobic (Sabapathy et al 
2011), resistance (Debolt and McCubbin 2004; Hughes et al 2011) or balance exercise 
interventions (Motl et al 2012) 
•  “Side-steps” incorporated into the resistance component of Sabapathy et al’s (2011) and 
Hughes et al (2011) work.  
• A “Static bike” has been used in many past aerobic and combined exercise studies 
(Bjarnadottir et al 2007; Cakt et al 2010; Hayes et al 2011; Motl et al 2012).  
• Treadmill walking has also been included in past aerobic and combined exercise studies 
(van den Berg et al 2006; Newman et al 2007; Pilutti et al 2011; Sabapathy et al 2011; 
Study 1 
 
 
141
Motl et al 2012), but as treadmills were not available at both intervention sites (facilities at 
the two sites varied, Section 4.2.9), the “Shuttle walk” was included.   
• “Runner’s arms” was chosen to achieve an increased aerobic workout, whilst resting the 
legs, and is not dissimilar to the upper body aerobic work utilised in Sabapathy et al’s  
(2011) study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Example of an “aerobic” exercise used during the intervention.  
With instructive pictures and text with options for progression provided. 
Primarily resistance exercises 
As weakness is a common symptom in MS, strength was part of the physiological and functional 
outcomes assessed in this study, thus exercises to improve strength were included. Past literature 
 
 
 
 
 
 
 
 
 
 
 
 
St 
Step-ups.  Levels  
     1.Sit down, with step in front, lift alternate legs up/down 
2.Standing, step alternate feet forward and back (not on step) 
3.Standing, step alternate feet forward and back onto step 
4. As 3, but lifting opposite arms up to the sky. 
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has found resistance interventions and combined exercise interventions improve strength (Section 
2.4.2 & 2.4.3).  
To improve strength six exercises were available, five focused on lower body strength. By 
including resistance exercises twice weekly, for the duration of the programme (12 weeks) it was 
anticipated that adaptations to muscle fibre recruitment, and hence improvements in strength would 
emerge (Section 2.4.2). The main measurement of leg strength was quadriceps strength (Section 
3.9.7); with the “leg extension” exercise assumed to target quadriceps strength specifically.  
In addition, as a pragmatic/functional approach was taken in the design of the exercise programme, 
many different exercises which trained an array of lower body muscle groups were included, some 
of which were similar to the outcome measures. For example the “Up and Go” and “Squats” 
exercises offered specific training which mimicked components of the TUG (Section 3.9.4) and the 
BBS (Section 3.9.5) outcome measures. Thus repeated completion of these two exercises was 
anticipated to affect these outcome measures. Finally, the “side-kicks” exercise whilst primarily 
strengthening abductor muscles of the hip also required participants to stand on one leg, and 
therefore this exercise may have a carryover effect to improve balance, and, if so, would be evident 
in results of the balance outcome measures. 
One upper body exercise was included to provide variety and improve participants’ whole body 
strength. Within the resistance and combined therapeutic exercise literature in MS the intervention 
components are not always provided, with large gym-based machines  often the resistance modality 
chosen The use of machines was inappropriate for this study as the facilities at the leisure sites 
varied (Section 4.2.9). Thus, it was decided that mainly body weight exercises would be utilised, 
with the addition of free-weights and time to increase intensity. 
Some resistance exercises were more functional in nature, such as the “Up and Go”, “Squats” and 
“Calf Raises”. Whilst others focused more on strengthening general muscle groups such as the 
shoulder muscles with “Upper Body”, the quadriceps muscles with “Leg Extensions” and the leg 
abductor muscles with the “Side-kicks”. Variations of these exercises are to be found in past 
literature;  
• “Up and Go” (Debolt and McCubbin 2004; Sabapathy et al 2011),  
• “Squats” (Hughes et al 2011; Sabapathy et al 2011; Motl et al 2012),  
• “Side-kicks”  (Hughes et al 2011; Sabapathy et al 2011), 
• “Upper Body” (Sabapathy et al 2011), 
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•  “Calf Raises” (Cakt et al 2010; Hughes et al 2011; Sabapathy et al 2011)  
•  “Leg extension” (Harvey et al 1999; Hughes et al 2011; Motl et al 2012).  
An example of the “Squats” exercise is shown in Figure 4.6. 
 
 
 
 
 
 
 
 
 
Figure 4.6 Example of a “resistance” exercise used during the intervention,  
Primarily balance exercises 
Using a combined exercise intervention which included exercises for balance was another 
important aim of the study since there is less literature including balance as the main intervention in 
MS therapeutic exercise studies (Cattaneo et al 2007a). Balance exercises have been included in 
combined exercise, or as part of resistance exercise interventions. Similar to aerobic and resistance 
studies, the actual exercises included in the intervention are not always provided in past literature. 
To challenge balance four exercises were available; for safety these were performed either under 
closer supervision or near a wall/chair. Balance impairment in MS may be directly related to the 
underlying pathophysiology of MS; as a result of damage in the CNS the motor and sensory 
systems cannot accurately provide feedback required to maintain good balance (Section 2.4.3). 
Thus, within the 12 week time frame the exercises chosen in the programme were not anticipated to 
have a direct effect on the underlying pathophysiology cause of balance impairment in MS. 
However, it was anticipated that continued challenge to participants balance, through the chosen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Squats; Level 
1. Holding on, bending legs half-way to ground   
2.Not holding on, bending legs half-way to ground   
3.As above holding light dumbbells 
4.As above, slightly heavier dumbbells  
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balance exercises, would improve coping strategies and participants’ confidence in their balance. 
Some of the included balance exercises offered specificity of training as they were designed to 
mimic components of the outcome measures selected to assess balance; with “Cushion standing” 
being similar to the static balance assessment involved in the OS (Section 3.9.6) outcome measure. 
Similarly “Single leg stance” and elements of “Tick-tack toe” are assessed in the BBS (Section 
3.9.5) and thus it was anticipated that continued practice of these exercises may have a carryover 
effect on overall balance as evidenced in the BBS.  
Exercises included “Take-off”, “Single Leg Stance”, “Cushion standing” and “Tick-tack toe”. 
Versions of some of these exercises appear in past MS therapeutic exercise literature;  
• “Take-off” (Cattaneo et al 2007a),  
• “Single Leg Stance (Sabapathy et al 2011; Motl et al 2012),  
• “Cushion Standing” and “Tick-tack toe” (Cakt et al 2010; Sabapathy et al 2011; Motl et al 
2012).  
An example of the Tick-tack toe exercise is shown in Figure 4.7. 
 
 
 
 
 
 
 
Figure 4.7 Example of a “balance” exercise used during the intervention.  
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tick-tack toe; Levels 
1. Walk between tramlines, using wall if required, turn and repeat.  
2.Walk between tramlines, not using wall 
3.Walk on line, using wall if required 
4. Walk on line, not using wall. 
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4.2.8 Education 
There was no formal educational component during the intervention. However, both instructors 
frequently gave general exercise advice during the class and answered any specific questions the 
participants may have had regarding exercise and their symptom management. If any issues were 
raised outwith the skill level of the instructors advice was sought from the Consultant MS 
physiotherapist. 
4.2.9 Warm-up and Cool-down 
A warm-up and cool down is recommended as part of all exercise interventions (Kraeman 2010; 
McKardle et al 2010; Pollock 1998; Garber 2011). Past therapeutic exercise literature has included 
a warm-up and cool down of around 10 minutes in a one hour class (Debolt and McCubbin 2004; 
Freeman and Allison 2004) . Thus, the leisure assistant led a 10-minute group warm up. Aerobic 
(e.g. marching, toe taps) and stretching (e.g. side bends and trunk twists) exercises were done 
sitting or standing. The instructors were free to change the content of the warm-up as appropriate.  
The cool-down followed a similar pattern to the warm up and lasted 5-10 minutes, with aerobic 
components and stretching. Participants were given the option of doing the warm-up or cool-down 
seated or standing.  
4.2.10 Venue 
The exercise classes were held twice weekly (Tuesday and Thursday). Participants did not have to 
pay for classes during the 12-weeks of the study. They were held in one of two venues with classes 
at Site A beginning first, classes at Site B followed the same format one month after completion of 
Site A classes.  
Site A 
Site A was a leisure centre comprising a swimming pool, exercise studios and leisure gym. The site 
had good transport link with local buses. Disabled parking and on street parking were available, 
although minimal. The room used for the venue was upstairs behind the main gym, and participants 
were able to use a lift to access the floor. The room contained no equipment and had mirrors 
around the walls. Chairs, an aerobic step, a static bike (Pulse Spin Cycle) and dumbbells of varying 
sizes (1kg-5kg) were provided. The room temperature was maintained at or below 22° Celsius by 
air conditioning. Music was played throughout the class, and was the choice of the instructor.  
Located 300ft from Site A, a community hall, was used for the first two weeks of classes, due to 
room bookings at Site A.  
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 Site B 
Site B was a local authority leisure centre comprising a swimming pool, exercise studios and adult 
and youth leisure gyms. The site had good transport links with local buses. Disabled parking was 
available. The room used for the venue was on the ground floor of the centre and accessible within 
50m of the car park. The “Shokk” youth gym was used, where scaled-down gym equipment was 
found, but not used for the class. Chairs, an aerobic step, a static bike (Shokk Xtreme spin cycle) 
and dumbbells of varying sizes (1kg-5kg) were provided. The room temperature was maintained at 
or below 22° Celsius by air conditioning.  Music was played throughout the class, and was the 
choice of the instructor.  
4.2.11 Pilot work 
Pilot work was done at the hospital rehabilitation unit before beginning the study. 
Assessment pilot and resultant methodological changes.   
From the pilot work an estimated time to complete the assessment and to establish whether those 
most disabled (EDSS 6.5) would be able to complete the assessment was confirmed.  
Two participants (EDSS 5.5 and 6.5) took part in the pilot for the assessments, neither of whom 
took part in the main study. The study was explained, and consent taken. The participants were 
asked to complete the self-rated questionnaires; the ABC, FSS, HADS and LMSQOL, and it was 
established that this would take approximately 10 minutes. The physical assessments and 
PhoneFITT were then carried out, following protocol order 1 (Section 4.2.5) taking between 50 and 
70 minutes dependant on the participants disability level.  
Following pilot work, protocol changes were made as follows; 
• To avoid difficulties with participants who wore ankle foot orthosis, or a Functional 
Electrical Stimulator (FES) machine on their foot, footwear was to remain on throughout 
all testing. During the main study participants were reminded to wear the same shoes for 
assessments. 
• The initial protocol for the overall stability assessment (perfomed on the Biodex balance 
machine was based on past work in disabled populations, which had found stability Level 8 
to be more appropriate than a more challenging level of stability (Aydog et al 2006)  and 
tested for 20 s (Aydog et al 2006) and 30 s (Ghoseiri et al 2009). Following pilot work the 
stability level remained at level eight (the most stable) and the length of each test was 
shortened from 30 s in the pilot to 20 s. 
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Feedback from the participants was positive regarding the ordering of tests and the difficulty.  
Exercise class pilot and resultant methodological changes. 
Two participants took part in the pilot exercise class; both were included in the main study 
(participants 1 and 9 Table 4.4). It was judged that no training effect would occur sufficient to 
disqualify the pilot participants’ inclusion in the main study; since the one hour exercise pilot was 
done only once, five weeks prior to the start of the exercise class. It is acknowledged that the pilot 
participants may have started with some slight advantage, i.e. prior knowledge of the class content, 
however this would likely become insignificant over the 12-week duration of the intervention.  
The pilot class lasted about one hour, and involved a seated warm up and seated cool down, led by 
one of the fitness instructors. Thirteen exercises were trialled, word-explanations and photographs 
were provided (similar to those in Table 4.2) and discussed with the participants.  
Following pilot work, exercise modifications were made; 
• In the “upper body” exercise Level 1 changed from using small weights, to no weights. 
• In the “cushion-standing” exercise Level 1 changed from standing on a mat, to standing on 
the floor.  
• Name changes were made to some exercises e.g. “Side kick” (originally “Hip Abduction”) 
as their names were deemed too technical. 
Feedback from the participants was positive regarding the format, difficulty/intensity and variation 
in the class. 
4.3 Statistical Analysis 
Data were analysed using Minitab (v. 16) and SPSS (v. 16) statistical packages. Independent 
sample t-tests were used for demographic outcomes found to be parametric (e.g. Body Mass Index) 
and for non-parametric variables (e.g. Age) a Mann-Whitney U test was used. All outcome 
measures were analysed on the basis of Intention to Treat, with all variables summarised and 
comparisons made between groups and over time. When three trials were taken for an outcome 
measure, at each time point, (i.e. T25FW, TUG, SLS, WLS, OS and temporal spatial outcomes) 
intraclass correlations were run to assess for reliability across the three trials. In doing so moderate 
to high reliability was found suggesting the values were consistent, accordingly the mean of the 
three readings was used for analysis.  
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The outcome variable data were analysed using a univariate General Linear Model Analysis of 
Variance (ANOVA) which allowed for missing data and possible interaction effects over time 
(baseline, week 8, week 12, month 6 and month 12) and between groups (intervention and control) 
to be assessed. All tests were at the 5% (p<0.05) level of significance (Norman and Streiner 2007). 
Where results of the ANOVA indicated significance between groups (Group effect), over time 
Tukey’s Post Hoc analysis was carried out, to establish whether, over the five time points, 
significance could be found between particular stages (e.g. between weeks 8 and 12, between week 
8 and month 6 etc.).  
A Kolmogorov-Smirnov test was used to assess the distribution of the data; any results found not to 
be normally distributed were transformed to Natural Logarithms and these are presented.  Baseline 
variables were checked for normality using SPSS (v. 16), and as many of the outcomes were not 
found to be normally distributed, a Mann-Whitney U test was performed to check for significance. 
Normally distributed data was analysed with a two-sample t-test.  
The effect of the intervention was calculated, using Cohen’s d analysis, to establish effect size at 
each time point. This showed the difference between the two groups and provided a numerical 
value used to interpret the size of the effect of the intervention. They were calculated for the 
intervention group only. These values were interpreted as a small effect size (d <0.5), moderate 
effect size (d=0.5<0.8) or a large effect size (d≥0.8) (Tyson and Connell 2009). Unlike tests of 
statistical significance, effect size indicates the size of the difference without confusing  it with 
sample size (Coe 2002). It is found in both meta-analysis of MS therapeutic studies   (Motl and 
Gosney 2008; Snook and Motl 2009) and in primary studies of therapeutic exercise in MS 
(Huisinga and Stergiou 2011)  
Clinical effectiveness was also calculated, independently, for both groups as percentage change for 
all outcome measures at all time-points from baseline. The formulae and worked examples for both 
effect size and percentage change are available in Appendix 11. 
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4.4 Results 
4.4.1 Baseline demographic  characteristics 
Thirty-two participants began the study. Twenty subjects were allocated to the intervention group 
with twelve subjects to the control group. Data will be presented as a whole data set, with those 
attending the intervention at site A and site B being regarded as one intervention group, similarly 
the control participants will be considered as one group.  
The intervention group comprised of five men and fifteen women, with four men and eight women 
in the control group. Demographic details of both groups are given in Table 4.3, including their 
baseline scores for the main outcome measures.  Table 4.3 shows that at baseline there were no 
statistical differences between the two groups in terms of age (p=0.893), years since disease onset 
(p=0.687) or any of the assessed outcome measures. 
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Table 4.3 Demographic and baseline characteristics of participants in Study 1.  
Variable/Outcome 
measure 
Intervention 
group 
Control 
group 
Test p-value 
Number of subjects 20 12 - - 
Gender M:F 5:15 4:8 FE 0.696 
Age (years) 51.4 (8.06) 51.8 (8) MW 0.893 
EDSS 6.1 (0.36) 5.8 (0.5) MW 0.387 
Years since onset 13.4 (6.4) 12.6 (8.1) MW 0.687 
T25FW (sec) 22.1 (21.8) 16.1 (13) MW 0.289 
6MWT (m) 191.1 (102.2) 221.2 (120) MW 0.431 
WCa (steps/min) 84.3 (24.4) 123.5 (102.5) T-test 0.068 
WVel (cm/sec) 67.4 (24.2) 105.9 (69.2) T-test 0.251 
FAP 69.8 (14.4) 78.6 (15.6) T-test 0.506 
LSL (cm) 40.85 (14.9) 47.97 (19.7) T-test 0.559 
RSL (cm) 
 
44.33 (15.9) 
 
48.4 (20.2) T-test 0.663 
TUG (sec) 6.3 (8.4) 4.8 (3.3) MW 0.723 
BBS 41.4 (11.8) 44.7 (11.1) T-test 0.822 
OS 6.3 (8.4) 4.8 (3.3) T-test 0.506 
SLS (Nm) 84.3 (24.4) 123.5 MW 0.187 
WLS (Nm) 67.4 (24.2) 105.9 (69.2) T-test 0.106 
PF 53.3 (20.6) 54.6 (26.6) T-test 0.155 
ABC  56.2 (16.6) 51.8 (23.5) MW 0.578 
FSS 5.3 (1.7) 5.7 (1.2) T-test 0.108 
HADS 15.9 (6.5) 15.8 (9.3) MW 0.578 
LMSQOL 12.9 (4.9) 14.1 (3.9) T-test 0.481 
BMI  41.4 (11.8) 44.7 (11.1) MW 0.289 
               
Mean, (standard deviation) and significance details are presented where appropriate 
FE – Fisher’s Exact, MW – Mann-Whitney, T-test – Independent samples t-test, EDSS-Expanded disability 
Status Scale, T25FW – Timed 25ft Walk, 6MWT – Six-minute walk test, BBS, Berg Balance Scale, TUG-
Timed Up and Go test, SLS-strongest leg strength, WLS-weakest leg strength, BMI-Body Mass Index, PF-
PhoneFITT, ABC-Activities Balance Confidence, FSS-Fatigue Severity Scale, HADS-Hospital Anxiety and 
Depression Scale, LMSQOL-Leeds MS Quality of Life, OS-Overall stability, WCa-walking cadence, WVel-
walking velocity, FAP – Functional Ambulatory Perfomance/Overall walking performance. LSL – Left leg 
Step Length, RSL – Right leg Step Length. 
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4.4.2 Attendance and attrition.  
Baseline data were taken for 32 subjects who began the study. Attendance and attrition is 
summarised in Figure 4.3. Reasons for attrition will be explained, with relevant participants 
identified in parenthesis based on participant number provided in Table 4.4.   
At the week eight assessments three subjects discontinued participation (7, 8 & 32), with missing 
data for a further three continuing subjects (5, 25 & 31). At week twelve one other subject 
discontinued participation (45), with four participants unable to attend for assessment, although 
they remained in the study (25, 24, 6 & 28). At month six, one participant had moved away and 
discontinued participation (14), one could not be contacted (26) and one was suffering increased 
mobility problems and was unable to attend (24). At month twelve another participants had moved 
away from the area, however they completed the questionnaires at home (12), three could not be 
contacted (1, 10 & 13) and one had fractured her dominant arm and could not attend or self 
complete the questionnaires (4).  
Over the course of the study there was missing data for some outcome measures. If the assessing 
physiotherapist or Chief Investigator deemed it clinically unsafe to perform the outcome measure, 
for example balance or mobility outcome measures, the outcome measure was not completed; with 
a 0 score recorded for missing data. This occurred on different occasions with two of the 
participants (25 and 29), who had an EDSS score of 6.5. 
Attendance at the exercise class was taken for the intervention groups. Attendance rates were 
calculated to include attendance of those who discontinued participation. Overall attendance at the 
intervention was 71%, 340 out of a possible 480 sessions (Site A 62%, Site B 80%). Other studies 
who report attendance rates often exclude those who discontinued study participation (Taylor et al 
2006; McCullagh et al 2008; Dalgas et al 2010), thus for this study if attendance from those who 
officially discontinued participation (n=3) is excluded, overall attendance was 77% (Site A 72%, 
Site B 81%).  
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Table 4.4 Demographic details of all subjects at baseline 
Participant Site Group 
Age 
(years) Sex 
Years since 
onset EDSS 
1 A I 45 M 14 6 
2 A I 58 F 11 6 
3 A I 48 F 18 6 
4 A I 58 F 16 6.5 
5 A I 62 F 15 6 
6 A I 49 F 18 6 
7 A I 40 F 7 6.5 
8 A I 43 F 2 6 
9 A C 54 F 16 5.5 
10 A C 45 F 16 6.5 
11 A C 45 M 12 6.5 
12 A C 54 M 8 6 
13 A C 53 F 13 6 
14 A C 52 F 27 5 
15 B I 68 M 33 6 
16 B I 40 F 12 6 
17 B I 58 F 15 6 
18 B I 41 F 4 6.5 
19 B I 53 M 17 6.5 
20 B I 49 F 16 6 
21 B I 54 F 12 6 
22 B I 53 M 10 5 
23 B I 49 M 15 6.5 
24 B I 47 F 16 6.5 
25 B I 63 F 12 6.5 
26 B I 45 F 7 6 
27 B C 64 F 22 5.5 
28 B C 58 M 1 6 
29 B C 59 M 7 6.5 
30 B C 34 F 5 6 
31 B C 51 F 6 6 
32 B C 58 F 2 6 
Site refers to site which before randomisation subjects could have been allocated to attend had they been 
selected to the intervention group. I-Intervention, C-Control group, M-Male, F-Female. 
 
Study 1 
 
 
153
4.4.3 Overall results and trends 
Mean data from the assessed outcome measures at baseline, week eight, week twelve, month six 
and month twelve is presented in Table 4.5. 
The mean scores varied for all outcome measures across the different time-points of the study. 
These will be discussed in more depth in the next section of this chapter. Results showed large 
standard deviations throughout the whole data set, for example in the intervention group baseline 
mean scores for the T25FW were 22.1 s with standard deviation being 21.8 s.  
Although there was no statistically significant differences between any outcome measures (Table 
4.5), better baseline scores were seen for the control group in all assessor rated mobility and 
balance measures (Table 4.5). 
At baseline there was no difference in leg strength between the intervention and control group. 
Across the sample as a whole, for 14 of the participants their left leg was stronger, whilst the right 
leg was stronger for the remaining 18 participants tested at baseline. T-test analysis was performed 
to determine whether there was a difference between weaker and stronger leg strength. A 
statistically significant result emerged (p<0.01). 
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Table 4.5 Group means (SD) for the main outcome measures.  
Outcome 
Measure 
Baseline Week 8 Week 12 Month 6 Month 12 
T25FW (sec) 
Intervention 
Control 
 
22.1 (21.8) 
16.1 (13) 
 
14.8 (9.3) 
15.4 (10.1) 
 
14.9 (13.6) 
13.1 (8.6) 
 
21.7 (22) 
12.79 (8.5) 
 
16.4 (18.1) 
23.6 (26.9) 
6MWT (m) 
Intervention 
Control 
 
191.1 (102.2) 
221.2 (120.1) 
 
228.6 (118.7) 
260 (128.9) 
 
262.2 (127.4) 
215.8 (175.7) 
 
226.5(134.4) 
233.89(98.1) 
 
252.3 (115) 
260.3 (159.2) 
WCa (steps/min) 
Intervention 
Control 
 
84.3 (24.4) 
123.5 (102.5) 
 
91.7 (25.6) 
100 (18.1) 
 
97.2 (28.7) 
93.3 (22.9) 
 
89.1 (26.8) 
82.1 (33.2) 
 
92.8 (27.7) 
93.4 (32.2) 
WVel (cm/sec) 
Intervention 
Control 
 
67.4 (24.2) 
105.9 (69.2) 
 
77.6 (33.9) 
87.7 (28.8) 
 
85.4 (35.4) 
98.8 (71.6) 
 
77.1 (32.2) 
68.7 (32.6) 
 
80.4 (31.2) 
80.7 (38.8) 
FAP 
Intervention 
Control 
 
69.8 (14.4) 
78.6 (15.6) 
 
73.7 (17.3) 
81.1 (13.3) 
 
78.1 (17.3) 
74.7 (17.4) 
 
76.87 (15.4) 
77.8 (11.6) 
 
79.5 (14.9) 
71.9 (15.1) 
LSL (cm) 
Intervention 
Control 
 
40.9 (14.9) 
48 (19.7) 
 
42.7 (17.1) 
52.7 (10.3) 
 
49.9(12.6) 
42.9 (8.6) 
 
49.6 (10.1) 
46.9 (9.7) 
 
49.6 (9.3) 
49.2 (11.8) 
RSL (cm) 
Intervention 
Control 
 
44.3 (15.9) 
48.4 (20.2) 
 
47.5 (18.2) 
52.4 (10.1) 
 
53.7 (11.7) 
45.9 (6.9) 
 
50.3 (11.2) 
47.9 (9) 
 
51.4 (10.2) 
47.3 (11) 
LST (s)  
Intervention 
Control 
 
0.8 (0.6) 
0.61 (0.3) 
 
0.71 (0.5) 
0.62 (0.22) 
 
0.73 (0.6) 
0.67 (0.2) 
 
0.81 (0.59) 
0.67 (0.2) 
 
0.84 (0.8) 
0.76 (0.4) 
RST (s) 
Intervention 
Control 
 
0.78 (0.5) 
0.61 (0.3) 
 
0.73 (0.5) 
0.61 (0.14) 
 
0.76 (0.53) 
0.69 (0.2) 
 
0.81 (0.52) 
0.68 (0.2) 
 
0.8 (0.6) 
0.77 (0.4) 
TUG (sec) 
Intervention 
Control 
 
22.3 (16.9) 
19.7 (14.93) 
 
19.7 (14.6) 
19.5 (12.1) 
 
18.4 (15) 
16.2 (11) 
 
27.2 (26.3) 
16.03 (11.5) 
 
20.9 (20) 
28.7 (29.8) 
BBS 
Intervention 
Control 
 
41.4 (11.8) 
44.7 (11.1) 
 
47.4 (9.7) 
47.9 (8.1) 
 
46.7 (10.6) 
40.9 (15.2) 
 
46 .4(10.8) 
43.3 (16.7) 
 
40.3 (17.2) 
42.4 (16.3) 
OS 
Intervention 
Control 
 
6.3 (8.4) 
4.8 (3.3) 
 
4.1 (2.9) 
4.1 (2) 
 
3.7 (2) 
4.6 (1.9) 
 
4.4 8 (2.2) 
5.38 (5.86) 
 
4.4 (2.2) 
4.1 (2.2) 
SLS (Nm) 
Intervention 
Control 
 
42.4 (21.6) 
45.5 (14.4) 
 
40.2 (18.4) 
48.6 (15.8) 
 
67.7(41.3) 
41  (38.4) 
 
73.6 (42.9) 
86.8 (27.5) 
 
75.5 (43.2) 
95.2 (25.5) 
WLS (Nm) 
Intervention 
Control 
 
27.9 (16.1) 
28.3 (14.7) 
 
36.3 (20) 
33.6 (16.5) 
 
54.5 (49) 
34.3 (24.6) 
 
70.2 (39.6) 
66.2 (35.2) 
 
71.6 (37.9) 
70.6 (35.6) 
PF 
Intervention 
Control 
 
53.3 (20.6) 
54.6 (26.6) 
 
69.7 (23.6) 
38.3 (23.1) 
 
78.2 (35.5) 
54.6 (16.7) 
 
61.08 (34.8) 
47.3 (30.4) 
 
60.7 (34.1) 
48.8 (24.2) 
ABC 
Intervention 
Control 
 
56.2 (16.6) 
51.8 (23.5) 
 
69.7 (23.6) 
58.7 (35.6) 
 
79.8 (28.3) 
60.9 (35.6) 
 
62.56 (32) 
57.8 (41.2) 
 
54.1 (30.6) 
57.4 (41.2) 
FSS 
Intervention 
Control 
 
5.5 (1.7) 
5.7 (1.2) 
 
5 (2) 
5.7 (2.1) 
 
5 (1.8) 
6.2 (0.7) 
 
5.07 (1.7) 
5.28 (1.56) 
 
5.4 (1.4) 
5.33 (1.7) 
HADS 
Intervention 
Control 
 
15.9 (6.5) 
15.8 (9.3) 
 
11.6 (5.4) 
14.2 (7.9) 
 
11.7 (5.9) 
13.8 (6.6) 
 
12.13 (2.7) 
13.4 (4) 
 
12.8 (6.6) 
18.9 (9) 
HADS Anx 
Intervention 
Control 
 
7.95 (4.1) 
7.92 (5.2) 
 
5.6 (3.5) 
8.4 (5.1) 
 
6.2 (3.3) 
6.5 (4) 
 
6.3 (3.1) 
7.5 (4.4) 
 
5.9 (4) 
9.4 (5.1) 
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HADS Dep 
Intervention 
Control 
 
7.4 (3.7) 
7.9 (4.9) 
 
6 (2.4) 
8 (4.6) 
 
5.5 (3.4) 
7.3 (3.5) 
 
8.2 (3.5) 
6.8 (4.7) 
 
7 (3.6) 
9.5 (3.6) 
LMSQOL 
Intervention 
Control 
 
12.9 (4.9) 
14.1 (3.9) 
 
11 (4.22) 
12.3 (4.1) 
 
10.9 (3.9) 
12.4 (3.1) 
 
12.13 (2.7) 
13.4 (4) 
 
12 (3.3) 
15.4 (4) 
BMI (kg/m2) 
Intervention 
Control 
 
28.7 (5.1) 
31.4 (5.9) 
 
27.9 (5.1) 
30.7 (6.7) 
 
27.5 (6) 
29.6 (6.2) 
 
27.6 (4.3) 
29.9 (5.5) 
 
45.3 (8.7) 
53.6 (9.9) 
 
T25FW – Timed 25ft Walk, 6MWT – Six-minute walk test, BBS, Berg Balance Scale, TUG-Timed Up and 
Go test, SLS-strongest leg strength, WLS-weakest leg strength, BMI-Body Mass Index, PF-PhoneFITT, 
ABC-Activities Balance Confidence, FSS-Fatigue Severity Scale, HADS-Hospital Anxiety and Depression 
Scale, HADS Anx-Hospital Anxiety and Depression Scale Anxiety; HADS Dep-Hospital Anxiety and 
Depression Scale depression LMSQOL-Leeds MS Quality of Life, OS-Overall stability, WCa-walking 
cadence, WVel-walking velocity, FAP – Functional Ambulatory Perfomance/Overall walking performance. 
LSL – Left leg Step Length, RSL – Right leg Step Length. 
4.4.4 Results of the study 
The results of the study were calculated in three ways;  
• To compare results between groups and over time a General Linear Model Analysis of 
Variance was performed (ANOVA).  
• Effect sizes were calculated for all outcome measures for the interventions group (Table 
4.6).  
• Percentage change, from baseline, was also calculated, for all outcome measures in both 
groups.  
The primary outcome measure, the T25FW is explained in the Section 4.4.5. Results of the 
ANOVA (Section 4.4.6), Effect sizes (Section 4.4.7) and clinical effectiveness (Section 4.4.8) for 
the secondary outcome measures are discussed in respective sections. 
4.4.5 Primary outcome measure results 
The primary outcome measure was the T25FW, however ANOVA results of the T25FW 
demonstrated no statistically significant difference over time (Table 4.6). Effect sizes were 
calculated based on Cohen’s d. For the T25FW small effect sizes occurred at all time points. 
However, after the twelve weeks of the intervention the mean scores improved by 7.2 s (a 
percentage change of 33% - Table 4.7) compared with the 3 s (19%) in the control group. At 
follow-up however, there was no similar pattern. Six months after the intervention the mean scores 
for the T25FW in the intervention group had regressed back toward baseline scores (1.8% clinical 
change),  a further six months (12 months) after the intervention the intervention group showed a  
clinical improvement of 20.6%. 
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In the control group a clinical improvement of 20.5% was seen at 6 months. This compared with 
scores at 12 months where values were less than baseline (-46.5%), suggesting deterioration over 
time. It is important to note that large standard deviations across the sample were present in both 
groups (Table 4.5), leading to considerable variability within the results.  
In summary, the intervention did not lead to any statistically significant findings or significant 
effect sizes in the primary outcome measure, the T25FW. Although there was evidence of positive 
percentage change scores.  
 
Table 4.6 Differences between group and over time, including effect sizes and clinical effect. 
Outcome 
Measure 
Group 
effect 
p-value 
Time 
effect 
p-value 
Group/time 
interaction  
p-value 
Effect size at; 
Week 8  Week 12 Month 6 Month 12 
T25FW * 
 
0.645 0.948 0.702 0.30 0.23 0.22 0.1 
6MWT  0.422 0.684 0.747 
 
0.02 0.68 0.01 0.69 
WCa*  
 
0.820 0.392 0.134 0.49 0.68 0.72 0.65 
WVel *  
 
0.102 0.267 0.565 0.61 0.54 1.01~ 0.65 
FAP * 0.146 
 
0.846 0.696 0.1 0.81~ 0.52 1.09~ 
LSL * 
 
0.077 0.821 0.183 0.16 0.81~ 0.57 0.43 
RSL*  
 
0.135 0.906 0.295 0.05 0.65 0.35 0.45 
LST 
 
0.324 0.217 0.663 0.22 0.28 0.22 0.15 
RST 
 
0.2 0.376 0.722 0.18 0.15 0.1 0.35 
TUG * 
 
0.541 0.922 0.938 0.15 0.03 0.62 0.19 
BBS 
 
0.255 
 
0.985 0.352 0.25 0.80~ 0.5 0.69 
OS* 
 
0.177 0.764 0.699 0.32 0.7 0.48 0.63 
SLS* 
 
0.255 <0.001^ 0.302 0.23 1.65~ 0.69 1.32~ 
WLS * 
 
0.717 <0.001^ 0.613 0.20 1.33~ 1.9~ 0.72 
PF 
 
<0.001^ 0.531 0.079 1.37~ 1.05~ 0.55 0.86~ 
ABC 
 
0.006^ 0.194 0.539 0.33 0.94~ 0.77 0.28 
FSS 
 
0.601 0.889 0.219 0.30 0.67 0.01 0.2 
HADS 
 
0.01^ 0.254 0.683 0.02 0.08 0.38 0.52 
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HADS 
Anx 
0.019^ 
 
0.223 0.462 0.62 0.07 0.28 0.31 
HADS 
Dep 
0.011^ 
 
0.545 0.936 0.34 0.31 0.28 0.49 
LMSQOL 
 
0.002^ 0.128 0.759 0.34 0.27 0.21 0.19 
BMI  
 
0.065 0.791 0.893 -0.02 0.17 0.11 0.05 
T25FW – Timed 25ft Walk, 6MWT – Six-minute walk test, BBS, Berg Balance Scale, TUG-Timed Up and 
Go test, SLS-strongest leg strength, WLS-weakest leg strength, BMI-Body Mass Index, PF-PhoneFITT, 
ABC-Activities Balance Confidence, FSS-Fatigue Severity Scale, HADS-Hospital Anxiety and Depression 
Scale, LMSQOL-Leeds MS Quality of Life, OS-Overall stability, WCa-walking cadence, WVel-walking 
velocity, FAP – Functional Ambulatory Perfomance/Overall walking performance. LSL – Left leg Step 
Length, RSL – Right leg Step Length. *Data transformed to Natural Logarithm for group effect, time effect 
and group/time interaction. ^ p<0.05, ~ d ≥0.8,  
4.4.6 Analysis of Variance statistical test results 
There was no significant differences between the groups in any of the outcome measures at 
baseline. Overall the ANOVA results did not reveal statistically significant results for many 
outcome measures. However, significant differences between groups was found for perceived 
activity levels (PF), perceived balance confidence (ABC), mood (HADS) and quality of life 
(LMSQOL).  
Regarding activity levels (PF) the ANOVA revealed a statistically significant difference between 
the groups (p<0.001), there was no evidence of a time effect (p=0.53). However group behaviour, 
over time, demonstrated a trend towards significance (p=0.079). Post hoc analysis, did not reveal 
any statistically significant differences, between time points.    
The ANOVA results for perceived balance confidence (ABC) revealed a statistically significant 
difference between the groups (p=0.006), however  no significant time effect (p=0.194) or group 
time interaction (p=0.539)  emerged.  
Similarly the ANOVA revealed a significant difference in mood (HADS) (p=0.01); both anxiety 
(HADS Anx) and depression (HADS dep) (p=0.019 and p=0.011 respectively). However ,no 
significant time effect or group time interaction was found for this outcome measure (Table 4.6). 
The ANOVA results revealed a statistically significant difference (p=0.002) between the groups for 
perceived quality of life (LMSQOL). No significant time effect (p=0.128) or group time interaction 
(p=0.759) emerged. 
As group time interactions were not suggestive of any interaction post hoc analysis was not run for 
the ABC, HADS or LMSQOL results.  
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A significant difference between time points was seen for leg strength (as measured by torque) of 
both the stronger (p<0.001) and weaker (p<0.001) leg. As the group behaviour over time was not 
significant (Table 4.6), results imply this was over the sample as a whole, with no clear difference 
between groups. Furthermore no significant group time interaction emerged for either stronger 
(p=0.302) or weaker leg strength (p=0.613). Despite this ICCs were run post hoc, however no 
significant difference was seen between time points, implying at no single time point were strength 
results statistically improved.  
In summary, there was no evidence from the results of the ANOVA that the intervention had any 
statistically significant effect on the other outcome measures assessed in the study (Table 4.6).  
4.4.7 The effect of the intervention  
It is recommended that statistical analysis (ANOVA results) and the effect of the intervention 
(effect sizes) be considered together (Them and Be 2008). The key findings from the ANOVA 
(Section 4.4.6) and the effect sizes are important descriptors of the overall study results. To 
ascertain the effect of the intervention effect sizes were calculated, in the intervention group only, 
based on Cohen’s d (Table 4.6). This calculation uses means from both the intervention and control 
group (Appendix 11). Thus, as positive effect sizes emerged for all outcome measures (with the 
exception of BMI at week 8) these results suggest the intervention group improved more than the 
control group over all outcome measures. 
After eight weeks, a good effect was seen for perceived physical activity (PF; d = 1.37), with 
moderate effects seen for anxiety scores and walking velocity. 
On completion of the intervention, i.e. week 12, a large effect size was found for dynamic balance 
(BBS; d=0.8), stronger (SLS; d=1.65) and weaker (WLS; 1.33) leg strength, perceived physical 
activity (PF; d=1.05), balance confidence (ABC; d=0.94), overall walking performance (FAP; 
d=0.81) and left leg step length (LSL; d=0.81). Moderate effect sizes were seen for walking 
endurance (6MWT), fatigue levels, stability, walking cadence and walking velocity. 
Six months after completion of the intervention large effect sizes were seen in the intervention 
group for weaker leg strength (WLS; d=1.9) and walking velocity (WVel; d=1.01). Moderate 
effect sizes were seen for dynamic balance, mobility (TUG), stronger leg strength, perceived 
physical activity, perceived balance confidence, walking cadence, overall walking performance and 
left step length.  
Twelve months after the intervention, large effect sizes were seen for stronger leg strength (SLS; 
d=1.32), perceived physical activity (PF; d=0.86) and overall walking performance (FAP; d=1.09). 
Moderate effect sizes emerged for walking endurance (6MWT), dynamic balance, weaker leg 
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strength, mood, stability, walking cadence and walking velocity. Results of this for the main 
outcome measures appear in Table 4.6, further temporal spatial results are available in Appendix 
12.  
Over all four time-points (following baseline) no clear pattern emerged to demonstrate a good 
effect was maintained. Some outcomes showed the greatest effect size after 8 weeks (T25FW, PF, 
HADSAnx & LMSQOL), whilst for other outcome measures the greatest effect size was after 12 
weeks (BBS, SLS, ABC, LSL & RSL) or after a further 6 months (TUG, WLS, FSS, WCa, WVel) 
and some on completion of the study (6MWT, HADS, HADS depression, FAP). In addition, at 
week 12, month 6 and month 12 moderate or large effect sizes were seen for measures of leg 
strength, balance and perceived physical activity.  
4.4.8 Percentage change results 
Percentage change was calculated, from mean baseline scores, for the outcome measures at all the 
time-points independently for both groups (Table 4.7). Overall more improvement was seen in the 
majority of the outcome measures in the intervention group, which supports the positive effect 
sizes discussed in Section 4.4.7.  
The improvement seen was particularly true for the assessments taken during and immediately 
following the intervention (Week 8 and 12). At the follow-up assessments the control group 
appeared to improve more in some of the outcome measures (such as stronger leg strength, 
perceived balance confidence and fatigue levels) although the intervention groups still improved to 
a greater extent in most outcome measures.  
In addition, the results of percentage change indicate where participants performance on the 
outcome measures worsened when compared with the initial baseline scores. This was most 
common in the control group, where at month 6 dynamic balance (BBS), perceived physical 
activity (PF), stability (OS), mood (HADS and HADS Anx), walking cadence (WCad), velocity 
(WVel) and overall walking performance (FAP) had lower scores. This regressive pattern 
continued at month 12 for these outcome measures and mobility (T25FW & TUG), body 
composition (BMI), anxiety and depression (HADS). In the intervention group a regression to 
scores below baseline was seen at month 6 for mobility (TUG) and at month 12 for dynamic 
balance (BBS) and body composition (BMI). 
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Table 4.7 Percentage change in intervention and control group.  
Outcome 
Measure 
Intervention group Control group 
Week 
8 
Week 
12 
Month 
6 
Month 
12 
Week 8 Week 
12 
Month 
6 
Month 
12 
T25FW  24% 33% 1.8% 26% 4.2% 19% 20.6% -46.5% 
6MWT  19% 37% 18.5% 32% 18% -2.4% 5.7% 17.7% 
WCa 9% 15% 5.7% 10% -19% -24% -33.5% -24.4% 
WVel 14.3% 26.6% 14.4% 20.3% -17.3% -6.7% -35% -23.8% 
FAP 5.6% 12% 10.1% 13.9% 3.2% -5% -1% -8.5% 
LSL *˚ 4.6% 22% 22% 22% 9.8% -10.6% -2.3% -2.5% 
RSL* ˚ 7.2% 21% 13.5% 16.7% 8% -5.2% -0.5% -2.3% 
LST 11% 8.7% -2.3% -3.8% -1.6% -9.8% -9.8% -26% 
RST -6.4% -2.6% -3.8% -2.6% 0 -13% -12% -26% 
TUG  12% 17% -22.1% 6.2% 0.8% 17% 18.5% -46% 
BBS 15% 12% 12.1% -2.6% 7% -8.5% -3.1% -5.1% 
OS 8% 12% 28.9% 30.2% 6% 2% -12.1% 14.6% 
SLS 5.2% 60% 73.5% 78% 68% -10% 86.8% 95.2% 
WLS  29% 95% 152% 157% 19% 21% 90.7% 109% 
PF 31% 47% 14.6% 13.9% -29% 0.2% -13.4% -10.6% 
ABC 24% 42% 11.3% 3.7% 13% 8% 11.5% 11.3% 
FSS 7.9% 9.2% 3.6% 1.8% -0.5% -8.2% 7.4% 6.5% 
HADS 27% 26% 23.7% 19.5% 10% 13% 15.2% -19.6% 
HADS A 29% 22% 21% 26% -6% 17.9% 5.3% -18.7% 
HADS D 19% 26% 10% 5% <-1% 7.5% 14% -20% 
LMSQOL 15% 16% 6% 7% 13% 12% 5% -9.2% 
BMI  2.7% 3% 3.8% 3.9% 2.2% 5.9% 4.8% -<1% 
Grey shading represents better improvement compared with the other group. 
T25FW – Timed 25ft Walk, 6MWT – Six-minute walk test, BBS, Berg Balance Scale, TUG-Timed Up and 
Go test, SLS-strongest leg strength, WLS-weakest leg strength, BMI-Body Mass Index, PF-PhoneFITT, 
ABC-Activities Balance Confidence, FSS-Fatigue Severity Scale, HADS-Hospital Anxiety and Depression 
Scale, HADS A-Hospital Anxiety and Depression Scale anxiety; HADS Dep-Hospital Anxiety and 
Depression Scale depression; LMSQOL-Leeds MS Quality of Life, OS-Overall stability, WCa-walking 
cadence, WVel-walking velocity, FAP – Functional Ambulatory Perfomance/Overall walking performance. 
LSL – Left leg Step Length, RSL – Right leg Step Length. 
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4.4.9 Fatigue Severity Scale, possible ceiling effect 
As discussed in Section (3.9.10) the FSS has previously been found to be vulnerable to a ceiling 
effect. There was evidence of this during the present study, the FSS at baseline are displayed in 
Figure 4.8. A good distribution of scores was found, however five participants recorded the 
maximum score, indicated a ceiling effect. 
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Figure 4.8 Scatterplot of FSS at baseline 
(Participant number refers to number in Table 4.4) 
 
There was no indication of either a floor or ceiling effect from the results of any other outcome 
measure.  
Intervention  ♦ 
Control   x 
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4.4.10 Goal attainment  
All participants were asked to choose three goals which they would like to achieve by the end of 
the intervention period (Table 4.8). Improving fatigue scores and balance stability was the priority 
goal for most participants (n=7 for both), with improving mobility endurance (n=6) and dynamic 
balance (n=5) also common. Many participants choose to improve the strength of their weaker leg 
(n=17) and improving fatigue scores (n=16).  
Table 4.8 Goals (and related outcome measures) chosen by the participants 
Related outcome Goal 1 Goal 2 Goal 3 Total 
Fatigue (FSS) 7 4 5 16 
Balance stability 
(OS) 
7 3 2 12 
Mobility/endurance 
(6MWT) 
6 2 5 13 
Dynamic Balance 
(BBS) 
5 7 1 13 
Attend class 2 5 4 11 
Mobility (T25FW) 2 1  3 
Leg strength 
(WLS) 
1 8 8 17 
Balance (ABC) 1 1 2 4 
Quality of life 
(LMSQOL) 
 1 1 2 
Mobility/function 
(TUG) 
1  1 2 
Anxiety and 
depression 
(HADS) 
  1 1 
Single leg balance**  1 1 
Weight loss**  1 1 
No participant chose the goal related to social interaction. 
FSS-Fatigue Severity Scale, *S-Overall Stability), 6MWT – Six-minute walk test, BBS- Berg Balance Scale, 
Timed 25ft Walk, WLS-weaker leg strength, ABC-Activities Balance Confidence, LLMSQOL-Leeds 
Multiple Sclerosis Quality of Life, TUG-Timed Up and Go test, HADS-Hospital Anxiety and Depression 
Scale, **Personal (12th) goal. 
 
Achievement of chosen goals was calculated for those in the intervention group, using the formulae 
described in Section 3.9.14. The basic results are presented in Figure 4.9. This result considers all 
three of the chosen goals. In this figure scores further from the fulcrum are larger, thus it can be 
seen that for all but two of the participants, their GAS score was larger at the end of the 
intervention, indicating a move towards achieving their goals. However t-test analysis did not 
reveal any significant difference (p=0.7) between the mean scores at baseline and following the 
intervention.  
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Figure 4.9 Radar diagram of intervention group GAS scores 
Larger scores are indicative of improvement. P – Participant number (Participant number refers to number in 
Table 4.4) 
 
 
4.4.11 Summary of results 
Results from this study suggest that there was no statistically significant results or large effect sizes 
for the primary outcome measure (T25FW), despite this, percentage changes were seen. Of the 
secondary outcome measures, statistically significant differences emerged between groups for the 
perceived physical activity, perceived balance confidence, mood and quality of life. However, no 
interactions were found for any outcome measures, thus, there was no indication, from the 
ANOVA results, that the intervention had a significant effect. The calculated effect sizes at each 
time point provided evidence that the intervention had a large effect on many of the assessed 
outcome measures, furthermore there were many more clinical improvements seen in the 
intervention group compared with the control group. In addition, results suggest that most 
participants improved in outcome measures related to goals they chose to improve. 
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4.5 Discussion 
The aim of the study was to deliver and evaluate, for up to one year, the effects of a 12-week 
therapeutic exercise class, against a control group matched for disability level who received usual 
care, and establish the effects of participation after a further six and twelve months. In doing so, the 
following results emerged: 
A 12-week community based group exercise class for people moderately affected with MS results 
in many physiological (strength, mobility, fatigue and body composition), functional (mobility, 
balance and activity participation) and psychological (mood and quality of life) improvements in  
those who take part. However, there was no statistically significant difference in these outcomes  
for those undertaking the 12-week exercise intervention when compared to a control group of 
people moderately affected with MS not taking part in the exercise intervention. 
4.5.1 General findings  
There was no evidence that the therapeutic exercise intervention had any statistically significant 
effect on the primary outcome measure the T25FW, thus confirming the null hypothesis for the 
primary outcome measure (Section 4.1.3). Small effect sizes were also found for the T25FW. 
However positive percentage change was seen, with those in the intervention group improving 
more so than the control group at three of the four time-points. Within the MS therapeutic exercise 
literature, similar non significant improvements in T25FW times have also been found in less 
disabled MS populations; undertaking 16 weeks of resistance training (Pryor et al 2011), and 
undertaking 24 weeks of home based combined aerobic and resistance training (Romberg et al 
2004; Romberg et al 2005). However Motl et al (2012) found that after eight weeks of thrice 
weekly combined (aerobic, resistance and balance) therapeutic exercise T25FW scores 
significantly improved in study participants (n=13, EDSS mean=5.6). Although similar, their 
participants were slightly less disabled than the participants in this study (EDSS mean (intervention 
group) = 6.1). In addition, the intervention took place three times a week, which may have 
encouraged greater change. 
For the secondary outcome measures, the results of the ANOVA did not indicate any statistically 
significant improvements due to the intervention (i.e. there was no statistically significant 
difference between groups over time), and thus the null hypothesis (Section 4.1.3) cannot be 
rejected. However, the ANOVA indicated that statistically significant changes in perceived 
physical activity levels (PF), perceived balance confidence (ABC), mood (HADS) and perceived 
quality of life (LMSQOL) did occur, but it was not clear that this was in one particular group only. 
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Effect sizes, were also considered as part of this study, although these are not as powerful as the 
ANOVA statistical tests they are recommended to provide a clearer explanation of the data  (Coe 
2002; Them and Be 2008). From the effect sizes it emerged that the intervention group improved in 
all outcome measures; physical, functional and psychological. However, no clear pattern emerged 
to demonstrate that a particular physiological, functional or psychological improvement resulted at 
a particular time point. Moderate or large effect sizes were seen in the intervention group, for 
measures of leg strength, balance and perceived physical activity at all time-points following 
completion of the intervention .  
Finally, at each time-point percentage change was calculated separately for each group, as the 
change from baseline. Overall, those in the intervention group improved more at all time points in 
most outcome measures. The results also highlighted that the control group regressed below 
baseline at varying time-points for measures of mobility, balance, activity levels, body composition 
and fatigue. This observation may be an indication of the potential symptom deterioration seen in 
MS. 
In summary, the results were analysed using an ANOVA statistical test. The ANOVA did not 
indicate that any improvements emerged as a direct result of being in the intervention group. In 
addition to the ANOVA, effect sizes were calculated as was percentage change (from baseline). 
There was an indication from the results of the calculated effect sizes that many outcome measures 
improved in the intervention group. Percentage change results indicated the majority of outcomes 
improved more in the intervention group than in the control group. The following sections will 
discuss these results for each outcome measure. 
4.5.2 Physical activity levels 
Amongst the key findings from this study is that of improved physical activity levels (as measured 
by the PF (Gill et al 2008) which considers a variety of activities of daily living and exercise 
activities). Improved physical activity from participating in the intervention is suggested by results 
from the ANOVA, where a trend towards a significant difference between groups over time 
emerged. The moderate (month 6) and large (week 8, 12 and month 12) effect sizes seen in the 
intervention group also support the premise that physical activity improved as a result of 
participating in the intervention. Furthermore, the intervention group displayed a positive 
percentage change at all time-points, whilst the control group either maintained their levels of 
activity (week 12) or displayed less physical activity (week 8, month 6 and 12). This result, in the 
intervention group at least, may be unsurprising as participants were taking part in an intervention. 
However, there was no obligation to continue remaining active post 12-week intervention, and thus 
it is encouraging that taking part in the exercise class promoted a long term increase in physical 
activity, despite this being less than during the period of the intervention. Results, of percentage 
change, in the control group imply that, despite having the opportunity to engage in the same 
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physical activity options following the initial 12-weeks, the majority of the control group were not 
able to maintain those physical activity levels.  
As previously discussed (Section 1.1), therapeutic exercise is one aspect of physical activity, thus 
the improvements in physical activity levels noted are interesting, as only one past study could be 
found in the therapeutic exercise MS literature, which assessed physical activity levels (Mostert 
and Kesselring 2002). Mostert and Kesselring (2002) used the Baecke Activity Questionnaire 
(BAQ) to investigate the effect of aerobic exercise on activity levels. In their study, activity levels 
increased by, on average, 4%, less than in the present study (where at week 12 a 47% increase was 
seen, and at month 12 a 13.9% increase from baseline was still maintained). It is important to 
remember, however that comparisons between different outcome measures are limited.  
As discussed in Section 3.6 there are limitation in using self-report outcome measures, this may be 
particularly problematic for those with MS, who may have minor cognitive problems which may 
influence the accuracy of data, a potential limitation of this key finding. The author does 
acknowledge the growing trend in monitoring activity using electronic motion detection or 
accelerometers in those with mild MS (Weikert et al 2010; Weikert et al 2011), using these 
technologies or  monitoring attendance at activities may, dependant on the study design, be utilised 
in future studies. 
An increase in physical activity may be beneficial to those with MS, as people with MS have 
previously been found to be more sedentary than the general population (Mostert and Kesselring 
2002; Stuifbergen et al 2003). It is important to not only encourage exercise, but also encourage 
general daily physical activity in people with MS. Increasing physical activity may go some way to 
improving MS-related symptom deterioration, such as muscle weakness and reduced balance, 
whilst also aiding prevention of other co-morbidities associated with inactivity, including reduced 
aerobic endurance, cardiovascular problems, obesity, diabetes, psychological ill-health and cancer 
(Chief Medical Officers 2011). Future studies could aim to move beyond establishing the impact of 
therapeutic exercise on symptom management in MS and look at the wider implications on overall 
physical activity and health. 
4.5.3 Balance 
Improving balance was an important goal for many participants in the study (Table 4.8), thus it is 
important, not least from the patients’ perspective that positive improvements in balance emerged 
during the study. Statistically significant improvements in balance confidence (ABC) emerged 
from the ANOVA results of this study, although this was in both the intervention and control 
group. Statistically significant differences were not seen for the other two balance outcome 
measures (BBS and OS). However, moderate to large effect sizes were seen at the end of the 
intervention for all measures of balance, the positive effect was maintained at month 6 and month 
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12 follow-up. After eight weeks, only small effect sizes were seen across the balance outcome 
measures, this finding may imply that a longer exercise intervention is required to modify changes 
to balance in those with moderate MS .  
In this study the ANOVA results from the ABC, found a statistically significant difference between 
the groups (p=0.006), Despite this, in the intervention group a large effect size at week 12, and a 
moderate effect size at month 6 (Table 4.6) was found. The percentage change results indicated that 
for the intervention group the greatest percentage change was seen after 12 weeks, however 
percentage change differences were higher for the control group at months 6 and 12 than the 
intervention group. Overall, these results imply that the intervention had positive benefits for 
balance confidence, and that 12 weeks may be required to achieve better results, which may not be 
maintained long term after the end of an exercise intervention. In Cattaneo et al’s (2007a) study, 
participants followed a three-week, thrice weekly inpatient programme; no significant differences 
in ABC scores were found. As the ABC includes many questions related to everyday experiences 
(e.g. get into or out of a car”), it may not have been appropriate outcome measure for the 
methodology of Cattaneo et al’s (2007) study. As the participants were inpatients during the study, 
they would not have had the chance to experience getting into or out of a car, for example, between 
answering the questions at baseline and then again at follow-up.  
Despite no statistically significant finding emerging for the BBS in this study, a large effect size 
was seen at week 12, whilst moderate effects were maintained at months 6 and 12. Percentage 
change was similarly positive after week 8, week 12 and month 6, however BBS scores regressed 
towards baseline at the month 12 follow-up. Indeed those in the control group showed a higher 
percentage change at month 6 and 12 than the intervention group.  
Relevant past studies, which have used the BBS, have found significant improvements. Freeman 
and Allison (2004) found a significant improvement in BBS results (p=0.02) at the end of their 10 
week, once weekly combined exercise programme in a single cohort of patients with lower 
disability levels (mean EDSS=5) than participants in the present study. Hughes et al (2011) found a 
significant improvement in BBS scores (p<0.001) after a twelve week home exercise programme in 
participants who all used walking aids. When Hayes et al (2011) studied two cohorts of participants 
(mean EDSS=5.2) for 12 weeks of thrice weekly combined training (one group undertaking 
combined exercise, one  undertaking combined exercise plus intense resistance training), they 
found a significant difference in BBS between groups (p=0.049). Those in the “combined 
intervention group only” improved whilst those in the other group regressed in their BBS scores. 
Results from these studies, alongside results from the present study, may suggest longer 
interventions are needed for balance improvements. However, this combined evidence also 
suggests, training stimulus, disability level and type of exercise may be influential to the outcome 
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of an intervention. Therefore,  no strong conclusions can be drawn and further research on balance 
in those with MS is warranted. 
As with the BBS, no statistically significant results emerged for balance stability (OS), although 
moderate effect sizes were seen at all time points (week 12, month 6 and month 12) after the 
intervention. Furthermore, in the intervention group, a positive clinical change was seen at all time 
points, improving at each subsequent assessment; more so than in the control group. Thus, similar 
to the discussion on the BBS above the duration of the therapeutic exercise intervention may be 
important in influencing balance results. However, as no past studies in the therapeutic MS 
literature were found which utilised a stability balance plate similar to that used in this study, 
results cannot be compared with past research.  
4.5.4 Mood 
There is evidence of increased anxiety and depression amongst those with MS, compared with a 
healthy control group (Zorzon et al 2001). In this study the ANOVA results indicated a statistically 
significant difference in mood, measured with the HADS, as a result of participating in the study, 
although it was not evident that this was as a result of the intervention. The intervention group 
improved more than the control group; as represented by the positive effect size and the results of 
percentage change for the HADS. Some aspects of mood declined in the control group, particularly 
at the month 12 follow-up. 
In other studies researchers who have used different outcome measures to capture data on anxiety 
and depression have found statistically significant results due to the a aerobic exercise intervention. 
Petruzzello et al (2009)  found a  statistically significant improvement in anxiety (measured using 
the STAI) after a single 20 minute session of aerobic exercise. On completion of the eight week 
aerobic cycling exercise programme a significant improvement in depression (measured with the 
BDI) emerged (p<0.05). However in the same study, the comparison group, undertaking a 
resistance/balance intervention, did not show a significant change in depression scores Cakt et al 
(2010). Yet the 12-week resistance intervention in Dalgas et al’s (2010) study resulted in a 
significant improvement in depression (measured with the MDI), with scores being maintained at 
the 12 week follow-up.  
There are other examples of aerobic-based exercise interventions having a positive effect on mood 
(Petajan et al 1996; Schulz et al 2004; Rasova et al 2006), but the results were less significant. 
Accordingly further work is required to ascertain the potential effect of exercise on mood in MS. 
Study 1 
 
 
169
4.5.5 Quality of Life 
Quality of life is reportedly lower in those with MS than their healthier peers (Mostert and 
Kesselring 2002). Statistically it was found by the ANOVA that perceived quality of life results, as 
measured by the LMSQOL (Ford 2001), were significantly different (p=0.002) between groups 
across the duration of the present study. Despite only small effect sizes at each time point the 
percentage change results indicate that the intervention group improved more so than the control 
group.  
The LMSQOL is an MS specific quality of life measure. It has been used in a home based MS-
specific physiotherapy intervention (Miller et al 2011), and a number of studies have shown an 
association between physical activity and quality of life measured with the LMSQOL (Motl et al 
2008a; Motl and McAuley 2009; Motl et al 2009a). 
Past literature in therapeutic exercise in MS, has measured quality of life using MS specific quality 
of life scales, such as the MSIS (O'Connell et al 2003; Freeman and Allison 2004; Taylor et al 
2006; Sabapathy et al 2011) or the MSQOL scale (Romberg et al 2005; Rasova et al 2006; 
Rampello et al 2007; Vore et al 2011; Pilutti et al 2011). With more generic quality of life scales, 
such as the SF-36   (Ware and Sherbourne 1992; Sabapathy et al 2011; Dalgas and Stenager 2011) 
and the WHOQOL (Skevington et al 2004) used in other MS therapeutic exercise studies. The 
number of different quality of life scales used makes comparison difficult, not only with results in 
this study, but between results of past studies.  
In general, results have found small improvements in quality of life following therapeutic exercise 
interventions for those with MS. Pilutti et al (2011) showed a significant change in quality of life 
following a 12 week, thrice weekly aerobic based study, however the lack of control group in this 
study limits the impact of these results. Dalgas et al (2010) found that improved quality of life was 
maintained three months after completion of their resistance training programme. Conversely Dodd 
et al (2011) found that three months after their resistance training programme quality of life 
improvements were not maintained. Thus, the significance of the findings in this study, that 
improvements in quality of life were found and were maintained at the follow-up assessments 
suggest there is a need to establish the impact of exercise interventions on quality of life further.  
4.5.6 Muscle strength 
Reduced strength is a common  symptom for those with MS  (Matthews 1998), furthermore for 
participants in this study improving strength was an important goal  (Table 4.8).  This study’s 
results suggest that a statistically significant difference over time emerged for leg muscle strength, 
when both groups were considered together, for both stronger leg (p<0.001) and weaker leg 
(p<0.001). Large effect sizes were seen in the intervention group after 12 weeks of the intervention, 
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with moderate and large effects seen at the six and 12-month follow-up assessments. Looking at 
percentage change in each group, both groups improved, with the intervention group improving 
most at the 12 week time-point whilst the control group improved more at other time-points. It is 
difficult to explain this finding, although, as indicated in Section 4.5.2, control participants were 
free to increase their physical activity levels, and doing so may have improved their leg strength. 
Improvements in strength initially occur because of neural adaptation (increased recruitment of 
motor units originating in the spinal cord and stimulating muscle fibers), which is followed by 
muscle hypertrophy (Section 2.4.2). In healthy individuals these neural adaptations may take place 
within the first 6 weeks of training, before hypertrophy is seen, although the time for improvements 
in strength to emerge does vary in the literature (Kraemer et al 2002). In an already altered neural 
system, as is found in MS, adaptations required for improvements in strength may be different to 
those of  a healthy population. This may explain why strength gains were not found at week 8, yet 
were found at all subsequent time-points, and perhaps why improvements were found long term in 
the control group. Establishing the influence of neural adaptations on strength gain would add an 
interesting perspective to the therapeutic resistance exercise literature, and provide worthwhile 
clinical guidance to the length of training required. 
In this study a maximum voluntary contraction (MVC), for 3 s, was assessed, using a “make-test” 
where the assessor matched (but did not “break”) the force generated by the participants’ 
quadriceps muscles (Bohannon 2001). In other studies, different methodologies have been used to 
assess strength; making comparison with others results difficult. In past literature strength gains in 
participants’ leg muscles are found by almost all studies where resistance training was the main 
intervention (Section 2.6.2). In these mainly resistance training studies the intervention 
methodology is different to the combined exercise nature of the present study. Only one third of the 
intervention in this study was primarily resistance based, thus training specificity may have an 
important role in outcome. Therefore, the findings from resistance only studies are acknowledged 
but not directly relevant.  
In the combined therapeutic exercise literature in MS, strength is not commonly assessed, making 
comparison difficult. However Romberg et al (2004)  used a MVC (5 s) to measure quadriceps 
strength using a dynamometer (a different model to that of this study). Similar to in this study, no 
statistically significant results occurred in their intervention group following their six-month home 
based exercise study. Further work in establishing the effects of a combined exercise programme 
on participants strength is warranted. 
In addition, all previous studies, to the author’s knowledge have reported strength differences based 
on either left leg or right leg scores. This however does not reflect that weakness may be more 
evident in one lower limb compared with the other, in those with MS, i.e. monoparesis 
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(Confavreux and Vukusic 2008). The approach in the present study, which reported weaker leg and 
stronger leg strength differences (based on leg strength at baseline) is novel and revealed 
statistically significant differences between weaker and stronger leg, at baseline. As a proposal, 
future authors may be interested in adopting this approach. 
4.5.7 Fatigue 
Fatigue is amongst the top five most commonly experienced symptoms experienced by people with 
MS (Mathews, 1998), and in this study improving fatigue was the main goal (alongside improving 
balance stability), which participants wanted to achieve by the end of the intervention (Table 4.8). 
For many years those with MS were advised not to undertake exercise, as it has been suggested that 
exercise may worsen symptoms of fatigue (Sutherland and Andersen 2001). In this study no 
statistically significant changed in fatigue levels emerged, measured using the FSS, over time or 
between groups. Thus, there was no evidence of increased fatigue from participating in exercise. 
A small effect size (d=0.3) was seen at week 8 whilst a moderate effect size (d=0.67) was seen at 
week 12. This compares to the small effect size (d=0.43) reported by Huisinga et al (2011) after 6 
weeks of aerobic exercise training. In the present study, percentage change indicated that fatigue 
levels improved most during the intervention time (week 8 and 12). At the follow-up assessments 
these improvements in fatigue regressed back towards baseline. This compares to one previous 
study where the FSS follow-up results three months after the end of resistance training 
interventions remained improved (Dalgas et al 2010), although  they regressed back towards 
baseline in Dodd et al’s (2011) study.  The relationship between exercise and fatigue is unclear, 
however if exercise has a positive carryover effect on other areas of participants lifestyle, fatigue 
management may be improved, with further investigation required related to exercise and fatigue in 
MS.  
When Andreasen et al (2011) carried out a meta-analysis of therapeutic exercise in MS, two 
relevant conclusions emerged. The FSS is the most commonly used outcome measure for fatigue in 
the relevant literature and therapeutic exercise has the potential to improve fatigue. Although, from 
this study there is no statistically significant results to support the latter point, it is noted that 
fatigue levels improved most during the intervention phase of the study, with no evidence that 
exercise had a detrimental effect on fatigue levels. 
In the literature, mainly aerobic based therapeutic exercise studies have assessed fatigue using the 
FSS. Statistically significant changes have been found  (Huisinga and Stergiou 2011), while some 
authors reported improvements which failed to reach significance (Kileff and Ashburn 2005; 
Newman et al 2007). Other authors have reported no change in FSS scores following a therapeutic 
exercise intervention change (Petajan et al 1996; Geddes et al 2009; Collett et al 2011). In the 
resistance and combined exercise literature both Cakt et al  (2010) and Dalgas et al (2010)  found 
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statistically significant improvements in fatigue in studies lasting 8 weeks and 12 weeks 
respectively. Further suggesting there is a need for more research in this area.  
Past MS literature found the FSS to be vulnerable to a floor and ceiling effect; in a study of 51 
women with MS (EDSS mean 6.5) 1 participant recorded the lowest possible score (demonstrating 
a floor effect), whilst 1 participant recorded the highest score (demonstrating a ceiling effect) (Kos 
et al 2003). In the present study, there was no indication of a floor effect, however a ceiling effect 
was demonstrated, particularly at baseline, when five participants recorded the highest possible 
score. Thus the FSS, for these five participants, may not be recording a true reflection of their 
fatigue, limiting results. Future studies monitoring fatigue, in a group of people moderately affected 
with MS must be aware of a potential ceiling effect with the FSS, and perhaps utilise a different 
fatigue outcome measure. 
4.5.8 Mobility 
Mobility problems are common in those with MS (Motl et al 2008b). In this study mobility was 
assessed in a number of ways; over a short distance (T25FW), over a longer distance to gauge 
endurance (6MWT), functionally (TUG) and by measuring temporal and spatial parameters of gait. 
No statistically significant findings emerged, despite past MS therapeutic exercise studies reporting 
significant improvements in mobility following their intervention (Freeman and Allison 2004; 
Kileff and Ashburn 2005; Newman et al 2007; de Souza-Teixeira et al 2009; Cakt et al 2010; Vore 
et al 2011). 
Results of the T25FW, which showed non-significant improvements have been discussed in 
Section 4.5.1. It emerged from the ANOVA that none of the other mobility outcome measures 
showed statistically significant changes. Moderate effect sizes were seen for the 6MWT (Week 12 
and Month 12), the TUG (Month 6) and for various temporal spatial parameters throughout the 
time-points, this provides some indication of a positive effect, on mobility, from participating in the 
study. 
Past MS therapeutic exercise studies have found significant improvements in 6MWT times. With 
Kileff and Ashburn’s (2005) 12 week, twice weekly cycling intervention and Freeman and 
Allison’s (2004) 10 week, once weekly balance and Pilates-based exercise intervention, both 
showing statistically significant improvements. It seems logical that Kileff and Ashburn’s (2005) 
aerobic intervention would have resulted in increased endurance and the significantly improved 
6MWT. However Freeman and Allison’s (2004) intervention did not have a strong aerobic 
endurance component, yet still produced improvements in endurance measured with the 6MWT. In 
comparison to the present study Kileff and Ashburn’s (2005)  and Freeman and Allison’s (2004) 
studies were smaller, included participants who were less disabled and did not include control 
groups. These findings, combined with the effect sizes noted in the present study suggest further 
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work is required to establish the impact of different types of exercise interventions on walking 
endurance in MS. 
The TUG is common in MS therapeutic exercise literature. Minimal changes in TUG scores have 
been found in some studies (Debolt and McCubbin 2004; Filipi et al 2010; Hayes et al 2011), other 
studies have shown non-statistically significant improvements (Collett et al 2011; Huisinga and 
Stergiou 2011; Sabapathy et al 2011), whilst the following studies have found statistically 
significant improvements. Resistance exercise interventions (de Souza-Teixeira et al 2009; Vore et 
al 2011) and combined exercise training interventions (Cakt et al 2010; Motl et al 2012) have 
resulted in statistically significant changes in TUG scores. The main differences between these 
studies and the present study are that participants’ disability level was lower and the intervention 
was delivered to individual participants (not in a group).  
Finally, temporal spatial gait parameters showed improvement throughout the study, detected by 
effect sizes and percentage change. Results from a recent experimental study (Motl et al 2012) 
found that many temporal spatial gait parameters improved significantly following a combined 
exercise programme, however, as discussed in Section 4.5.1 the intervention was delivered thrice 
weekly. Thus participants in Motl et al’s (2012) study may have both a better training stimulus 
(three times per week) allowing them to improve. In a different study, involving four weeks of 
treadmill training by 16 people with MS (EDSS unreported), statistically significant improvement 
were seen in step length, but improvement in cadence did not reach significance (Newman et al 
2007). The focus on a walking intervention in this older study, which was also delivered thrice 
weekly, may explain the difference in results, as it may be expected that a walking intervention 
may improve gait parameters.  
4.5.9 Body composition 
Body composition is an important indicator of health status and long term disease prevention 
(World Health Organization 2000). In this study BMI was used to indicate body composition. 
Throughout the study, average BMI remained in the overweight to obese category for both groups, 
indicating that the study participants, as a group are at an increased risk of developing other 
diseases. These include obesity and coronary heart disease, musculoskeletal problems and some 
cancers (World Health Organization 2000). Small improvements were seen in both groups BMI 
scores. This is similar to a past 12-week exercise intervention study (Hayes et al 2011).  
Although addressing the impact of therapeutic exercise on long term disease prevention is beyond 
the scope of this thesis it is becoming established, in the literature, that therapeutic exercise can 
have a beneficial effect not only on the symptoms of MS. Therefore, it may now be important to 
establish the impact of therapeutic exercise on disease risk and long term disease prevention for 
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those with MS. This is relevant as those with MS have been found to be at the same risk as the 
healthy population of developing long term health problems (Bronnum-Hansen et al 2004).  
4.5.10 Changes over time 
The study sought to establish whether 8 or 12 weeks of the exercise intervention would result in 
clinical improvement in the assessed outcome measures and whether any improvement would be 
maintained (by assessing at 6 month and 12 month follow-up). As no statistically significant or 
effect size patterns emerged it is difficult to draw conclusions as to recommendations regarding 
duration of a combined exercise intervention. Beyond that, long-term continuation of an exercise 
program may prevent further deterioration, although there is no evidence of this from present 
results.  
Due to the longevity of the study, the opportunity to monitor the natural progression of symptoms, 
in the control group, was realised. In therapeutic exercise MS studies, assessing participants over 
six months provides the opportunity to monitor symptom progression over a reasonable length of 
time. If control groups are advised to not change their usual routine, this will also provide 
information on natural symptom progression. In this study there was no evidence of any clinically 
significant change in any outcome measures in the control group. However the clinical 
effectiveness results (Section 4.4.8) indicated that in the control group some outcomes (related to 
mobility, balance and physical activity) had regressed below baseline by month 6, whilst many 
outcomes (related to mobility, balance, body composition, physical activity and anxiety and 
depression) regressed below baseline at month 12. There are no reports of statistically significant 
regression of symptoms in relevant past studies (Ponichtera-Mulcare et al 1997; Romberg et al 
2005; McCullagh et al 2008) which is similar to the results in this study. However, the results hint 
at the progressive nature of the disease over a period, and may highlight some of the progressive 
symptoms which may be affected in those who have moderate MS (EDSS 5-6.5). Although further 
work which addresses a longer follow-up may be required, particularly as those with a higher 
EDSS (e.g. 6-6.5)  may progress at a different rate to those with a lower  EDSS (e.g. 5-5.5).  
4.5.11 Goal attainment 
The GAS was used to capture data on all participants priority goals, achievement of goals and as a 
motivational tool to encourage achievement of goals (in the intervention group), by the end of the 
12-week intervention. Participants were asked to choose three of a possible 12 goals related to the 
outcome measures and the exercise class, with the option to choose another personal goal. It 
emerged that improving fatigue, balance, mobility/endurance and weaker leg strength were the 
most commonly chosen goals for all participants. Knowledge of the goals of individuals with MS is 
very important, as it could help lead future research agendas, and it is disappointing that there is 
minimal evidence within the literature on the exercise “goals” of those with MS.  
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All but two participants improved in their three chosen goals, thus the majority of those in the 
intervention group improved in the outcomes they chose as goals. There are no previous examples 
within the relevant literature to compare these results; however, it provides a further indication of 
the success of the intervention. 
In order to establish achievement of goals for the study sample it was necessary to base these on 
expected changes. To do so the author sought guidance from the Consultant MS physiotherapist 
and any clinical significance in the relevant literature (Section 3.9.14). The difficulties establishing 
values for relevant clinically significant change scores, by the need to obtain values from both other 
disease populations and exercise interventions is a limitation of this outcome measure, implying a 
need for further work. This finding in part led to the development of Study 3 (Chapter 6) to 
establish what a clinically significant change for common outcome measures used in MS may be. 
Thus although these results and the outcome measure itself is of interest, more work is required to 
ascertain its potential as an outcome measure in MS therapeutic exercise. 
4.5.12 Influence of different EDSS levels 
This study recruited participants with an EDSS of between 5 and 6.5, which translates to four 
different levels on the EDSS scale. Fundamentally, these are categorised based on ability to walk a 
set distance. The results were analysed as a whole data set, i.e. results were not analysed for 
individual disability levels. It was found that, in general, larger standard deviations were seen in the 
more disabled group. However the small number of participants in the less disabled range (i.e. 
EDSS 5 and 5.5, n=4) make it difficult to confirm this. Large standard deviations have been 
reported in past studies of therapeutic exercise in people with MS where studies have recruited 
participants of a similar, or slightly lower, disability level to in this study (Mostert and Kesselring 
2002; Debolt and McCubbin 2004; Freeman and Allison 2004; Freeman et al 2010). Suggesting 
that, even with a narrow EDSS (5-6.5) heterogeneity of the sample is still problematic. Thus, it may 
be necessary for future studies to narrow the EDSS level further. This however limits the 
applicability of the results to a smaller proportion of the MS population. 
Based on results from this study, if narrowing the EDSS to only include participants with an EDSS 
score of 5 to 6, 30 participants would be required in each group to achieve a power of 92% (with 
significance set at p<0.05), for an improvement of more than 2 s on the T25FW to be significant. 
However, narrowing the recruitment levels as such may jeopardise recruitment and make the 
results less relevant to the wider disease population. 
4.5.13 Recruitment, attendance and attrition. 
When recruiting for the study initial interest was minimal, follow-up invitation letters were sent 
and healthcare professionals within the rehabilitation unit were reminded to discuss the study with 
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potential participants at the time of clinic visits. However, although the study failed to recruit a 
large number of participants, leading to both the study being underpowered for statistical 
significance (refer to Section 4.2.2) and fewer participants in the control group, which may have 
influenced results. It is comparable in participant number to many similar studies (Table 2.5-Table 
2.7) The level of recruitment achieved may have been due to the commitment of a 12-week, twice-
weekly exercise programme, the many outcome measures assessed, transport difficulties accessing 
the venue or the invitation letter not inspiring interest in the study. Furthermore as discussed by  
Bjarnadottir et al (2007) potential participants may have had concerns about increasing physical 
activity. Ethical restraints restricted the Chief Investigator being onsite to recruit participants, or 
advertising the study through posters, although doing so may have positively influenced 
recruitment. Ethical restraints also prevented the research team from contacting non-responders to 
establish their reasons for not taking part. 
Attendance at the 12-week class was analysed on an Intention to Treat basis. Attendance was found 
to be 71%. Attendance was similar to another group combined exercise class (67-75%  (Charlton et 
al 2010)), although lower than other aerobic (McCullagh et al 2008) and resistance (Taylor et al 
2006; Dalgas et al 2010) group exercise intervention, where attendance rates were >83%, 94% and 
>80% (in Dalgas et al’s (2010) attendance of <80% resulted in exclusion from the study) 
respectively. This may be explained by the relatively high disability level of participants in the 
present study, with higher disability there may be more effort or logistics involved in attending a 
twice-weekly class. However, attendance rates are more comparable if, in the aforementioned 
better-attended studies, participants who discontinued participation are excluded from analysis. In 
future studies participant retention may be improved by offering transport options and encouraging 
participants to “buddy” with another participant, or indeed encourage able-bodied peers to 
participate to encourage adherence as has been successful in a past study into exercise adherence in 
youths with disabilities (Temple and Stanish 2011). 
Not all participants completed the full study, at week 12 three participants had discontinued 
participation, and data was only collected from 25 individuals with participants unable to attend for 
assessment for a variety of reasons; e.g. adverse weather conditions, increased work commitment, 
relapse or other illness. At the end of the study, one further participant had discontinued 
participation, with data collected from 23 participants. In addition, not all outcome measures were 
assessed in all participants at all time points, as clinical judgement deemed it inappropriate to do so 
with two of the most disabled participants, if for example, a participant was having more severe 
mobility problems. This is a limitation of the study, and highlights the problems of long-term data 
collection. Future studies could seek to increase recruitment, thus allowing for attrition having a 
minimal effect on the results.  
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4.5.14 Appropriateness of a community venue 
There is a move towards healthcare within the community, with many government papers and 
publications promoting activity for those with disabilities in the community (Department of Health 
2005; Scottish Executive 2007). The exercise intervention for this study took place at local 
authority community leisure centres and were part-led by local authority leisure staff. To the 
author’s knowledge only one other study in the UK (Collett et al 2011) has reported on a MS 
therapeutic exercise intervention being carried out in community leisure centres. This and the 
present study show that the community model is feasible and adds to international evidence, that 
organised exercise in community venues is safe and appropriate for many different disability levels 
of MS (Taylor et al 2006; Charlton et al 2010; Dodd et al 2011). 
4.5.15 Limitations 
This study adds unique knowledge to the growing body of research in therapeutic exercise in MS. 
Despite this, it is not without its drawbacks. Study limitations, which have not previously been 
acknowledged, will now briefly be discussed and, when appropriate, potential solutions to 
overcome them will be offered for future research. 
The modest sample size for the study was problematic, perhaps leading, to outcome measures not 
reaching statistical significance. Future studies should be powered appropriately, and utilise 
improved recruitment methods (as discussed in 4.5.13) to increase participation. These future 
studies may utilise more modern forms of communication, when ethically appropriate, to notify a 
wider range of potential participants. Establishing effective methods to both increase initial and 
continued participation would be important for much rehabilitation-based research, and time spent 
on this area would be worthwhile. 
The control group continued usual care, as such they did not receive an “active” intervention. Thus, 
the benefits of the intervention, which may have been influenced by the social dynamic of a group 
exercise programme must be factored into the results. Past literature provides examples of how an 
active control group can be incorporated into the study design, allowing the outcome to be more 
directly identified as being due to the variable of interest (i.e. the therapeutic exercise intervention). 
For example in Dodd et al’s  (2011)  study the control group undertook a “social program” in 
groups. Whilst in Harvey et al’s (1999) study the control group undertook a “general home exercise 
programme”, this is of interest but would not encourage social interaction . 
Although the study provides worthwhile long term data on the effect of a 12 week therapeutic 
intervention. It is a limitation that data were not collected on participants’ exercise behaviours 
following the end of the intervention (i.e. whether they continued to exercise). Doing so would 
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strengthen, and help explain the long term results. Thus future studies should seek to include this in 
their methodology.  
Randomised control trials which incorporate blinding of either assessors, therapists and participants 
is often seen as the sine qua non for clinical trials (Schulz and Grimes 2002) and not doing so 
carries a risk of biased results. Furthermore these aspects of blinding are incorporated into the 
PEDRO criteria to assess the quality of RCTs in rehabilitation (Section 2.3.3). In this study, the 
assessor was blind to group allocation; however, neither “therapists” (those leading the 
intervention) nor the participants were blind to group allocation, leading to a potential bias in the 
results. Achieving triple-blinding would strengthen the findings, although it would be difficult to 
achieve in an active intervention such as therapeutic exercise.  
4.5.16 Critique of methods 
An effort was made to ensure the outcome measures and methodology were appropriate to the 
research, piloting of the outcome measures was done on several occasions prior to the study, with 
the components of the exercise intervention also piloted (refer to section 4.2.11). Despite this, there 
are areas whereby, in retrospect, improvement was possible.  
At baseline all participants successfully completed the outcome measures, however at subsequent 
assessment points some participants were unable to complete some outcomes. For example, the 
mobility level of two participants deteriorated as the study progressed resulting in them no longer 
being able to complete the 6MWT or T25FW, despite two physiotherapists being available to 
provide safe supervision. Thus mobility measures which can be used in a more disabled population 
may be required. 
The temporal spatial walkway was unable to gather data from participants who used a wheeled 
walking frame (as the GAITRite system was unable to differentiate between footfall and wheel 
tracks). This is unreported in the literature, and may present a barrier to using this outcome tool in 
future studies with participants of a higher disability level. 
In general, there is a need to establish the psychometric properties of the chosen outcome measures 
in those moderately affected with MS, as discussed in Chapter 3. This was addressed for the 
T25FW, 6MWT, TUG and BBS in Study 3 (Chapter 6). It is also recommended that further 
outcomes to assess balance, physical activity, body composition and goal attainment in future MS 
research may be beneficial to our understanding of the benefits of therapeutic interventions for 
those with MS.  
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4.6 Summary and conclusion 
Multiple Sclerosis results in many clinical symptoms, and there is increasing evidence that 
therapeutic exercise plays a role in addressing these symptoms. This chapter describes a single-
blinded RCT investigating the short and longer-term effects of a 12-week community based 
exercise class, in people moderately affected with MS, comparing them to a control group 
receiving usual care.  
The study was unique in a number of areas and as such adds substantial knowledge to the literature 
surrounding therapeutic exercise in MS. This study was the first to assess the impact of an exercise 
intervention delivered in community leisure centres, in a group format to those with MS. 
Furthermore it is one of a small number of studies which have delivered a combined (aerobic, 
resistance and balance) exercise intervention to those moderately affected with MS. Despite a lack 
of statistically significant data to suggest the intervention resulted in any changes, there were 
positive results overall. 
Although results from the primary outcome measure, the T25FW, did not show statistically 
significant changes, positive benefits were found, as indicated by the positive percentage change 
scores. No statistically significant results emerged as a result of the intervention, although 
improvements were seen overall. Calculated effect sizes implied the intervention had a positive 
effect on all outcome measures. A single study rarely provides enough evidence to guide clinical 
and research practice, nevertheless the results of this study add to the findings of other studies and 
the systematic reviews discussed in Chapter 2. Therapeutic exercise can improve physical activity 
levels, balance and quality of life, despite, in many cases, using different outcome measures to 
those used in the present study.  
Results from this study, which gathered information on the goals of those with MS, regarding 
participation in a therapeutic exercise programme are, to the author’s knowledge, new, and 
previously unreported. Furthermore, other findings regarding the degenerative nature of the 
physiological, functional or psychological status of people moderately affected with MS, who are 
maintaining their usual routine (i.e. the control group), are of note. During the study group there 
was evidence that the control group deteriorated in clinical outcomes , with some scores regressing 
below baseline scores in areas related to mobility, balance, body composition, physical activity and 
mood) suggesting the need for long term maintenance perhaps utilising therapeutic exercise. 
Like other similar studies, the study did not find that the exercise intervention had a detrimental 
effect on participants fatigue levels, which has important clinical and research implications.  
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Overall no statistically significant changes over time emerged from the results of this study, thus 
further work is required in this area to determine the long-term impact of therapeutic exercise 
interventions for people with MS. 
The results of this study are unique in that they were the first to establish over a year follow-up the 
impact of the intervention on physiological, functional and psychological status of participants. 
The following chapter will describe a qualitative study of the views and opinions from the 
intervention group in the chapter. Before, in Chapter 6, a description of a study to establish the 
reliability of outcome measures used in this chapter’s study.  An explanation of how the three 
studies (Chapters 4, 5 and 6) influence each other and how this may guide future research agendas 
will be done in Chapter 7. 
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5 Study 2 
A qualitative analysis of a 12-week group exercise intervention for people 
with Multiple Sclerosis 
The previous chapter describes the main intervention undertaken as part of this thesis, this involved 
a twelve week exercise intervention, for people moderately affected with MS. This chapter will 
investigate the views and opinions of those who participated in the exercise intervention. Focus 
groups were undertaken after the intervention, which were then analysed using a general inductive 
method. 
5.1 Introduction and rationale 
There is increasing evidence that participating in physical activity and therapeutic exercise plays a 
beneficial role for those with MS (Chapter 2). To strengthen research findings, it is important that 
any therapeutic exercise intervention be analysed using both quantitative and qualitative methods, 
with Dodd et al (2006) acknowledging that doing so in their study allowed data to be gathered 
which would not have been established using a quantitative methodology alone. Using mixed 
methodology is supported in guidance texts on qualitative literature, i.e. by utilising a qualitative 
methodology the views and opinions of study participants can be gathered in a way which 
quantitative methods are unable to achieve (Webb and Kevern 2001). Furthermore, establishing the 
views and opinions of those taking part in research is important to help ensure the relevance and 
quality of research undertaken in healthcare  
As evidenced in Chapter 2 there are a growing number of studies investigating MS therapeutic 
exercise, some of which have utilised a qualitative methodology (Section 2.5). These qualitative 
studies have gathered views on exercise and physical activity in the general MS population (Kayes 
et al 2011). An MS population who habitually participated in exercise (Smith et al 2011), or where 
the participants were undertaking a new therapeutic exercise intervention related to the study 
(Dodd et al 2006; Smith et al 2009; Plow et al 2009a). These studies provide information on 
barriers and facilitators those with MS experience when considering exercise, whilst also providing 
detail on the opinions of how exercise can affect participants’ disease symptoms and other areas of 
their life. All of these previous studies have captured the views on exercise through semi-structured 
interviews. They have found positive views on physical activity and therapeutic exercise from 
those with MS, whilst also gathering details on some problems faced by those with MS related to 
exercising. The studies were, in general, in those who were mildly to moderately disabled by MS, 
although specific EDSS levels were not defined.  
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This chapter will discuss the methodology and results of a study to establish the views and opinions 
of those moderately affected with MS (EDSS 5-6.5) who took part in the exercise intervention as 
part of the main study (Chapter 4). Within the results section consideration will be given to 
important findings. The study will then be discussed to explain the relevance of the results and 
place the research within the context of the main study findings and the relevant past literature. 
Thus, this qualitative study will address the following literature gaps established in Chapter 2; 
• As most qualitative research surrounding exercise and MS have not reported disability 
level, or have only included those described as having an approximate EDSS level of 5, 
opinions and views of those more affected (EDSS greater than 5) should be gathered. 
• As semi-structured interviews have been used in all MS specific exercise qualitative 
studies thus far, the use of focus groups for gathering data is unexplored. 
5.1.1 Study Aim 
To establish the views and opinions on exercise and a therapeutic exercise intervention of those 
who had undertaken a therapeutic exercise intervention.  
5.1.2 Research question 
What are the participants’ views on exercise and a therapeutic exercise intervention? These 
included; personal goal attainment, positive and negative outcomes associated with the 
intervention, and intrinsic and extrinsic factors to participation in, and completing, the intervention. 
5.1.3 Study design 
A qualitative focus group design was utilised. Two focus groups were undertaken, these were 
moderated by the same independent physiotherapist, who used semi-structured questions to 
facilitate the group. The Chief Investigator then transcribed the recorded focus groups and analysed 
the transcripts using a general inductive method. Analysis was verified independently by a second 
physiotherapy researcher, and emergent themes were refined to establish key themes. The specific 
design will be discussed in the following methodology section. 
5.2 Methodology 
The fundamental methodology was based on the guidelines of Fern (2001), who advises on 
ensuring rigor and validity when undertaking focus groups. In his guidelines he highlights five 
main areas which may influence results and thus should be acknowledged. These include; the 
number of groups and participants, the group composition, the moderator, the location and the 
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analysis. An explanation of the rationale of the above five areas is acknowledged within the 
following section.  
5.2.1 Ethical considerations 
Ethical approval was obtained from the West of Scotland Research Ethics Committee in December 
2009, Research and Development approval from NHS Ayrshire and Arran Research and 
Development Management in January 2010. Participants had provided consent to take part in this 
study when consenting for the main study and prior to each focus group discussion participants 
were reminded their comments would be recorded, and subsequently analysed. 
5.3 Recruitment and participants 
Fern (2001) acknowledges that  the Number of groups and participants and the Group Composition 
are areas which must be acknowledged when undertaking qualitative research.  
It is recommended in the literature that the number of focus groups be dictated by the number of 
new themes emerging from the data, known as data saturation (Morgan and Scannell 1998). In this 
study due to participant numbers two focus groups were conducted, one for each intervention site 
(Section 4.2.10) used in the main study. Therefore data saturation may not have been reached. 
Some authors recommend that there be 6 to 10 participants in a focus group (Morgan and Scannell 
1998), however it is not unreasonable for there to be 4 to 8 participants (Kitzinger 1995) with Tang 
and Davis (1995) discussing that anything between 4 and 12 participants is acceptable. Smaller 
groups may allow more in-depth views to be explored with larger groups perhaps providing less 
opportunity for participants to voice their opinions (Carey 1994).  
Practicalities of this study dictated the number of participants. The inclusion and exclusion criteria 
were as previously described (section 4.3), in addition only those who had participated in the 
intervention group of the main study were eligible for this study. Participants in this study had all 
attended the 12-week exercise class, thus a “naturally occurring” group composition was utilised. 
Kitzinger (1995) discusses that a “naturally occurring” group will allow participants to relate to one 
another’s views, while at the same time expressing challenging views, participants may be able to 
contradict what one has said by reminding them of previous experiences together (e.g.“Yes you 
have, you have lost weight”).  By using focus groups, participants will also be able to relate to one 
another, as they have similar problems associated with their MS and all followed the same 12-week 
exercise programme. 
Study 2 
 
 
184
From the 20 people who took part in the intervention group of the main study (Chapter 4) 14 
agreed to take part in the focus groups. All had moderate MS (EDSS 5-6.5), four were men whilst 
ten were women. Five people took part in the focus group at Site A, whilst nine people took part in 
the focus group at Site B (refer to Section 4.2.10). The demographic details of the participants 
along with the site where the focus group took place is displayed in Table 5.1. The qualitative 
analysis will be reported using illustrative quotes from participants within the results section, each 
participant was provided with a number indicated in Table 4.4. 
Table 5.1 Demographic description of participants in Study 2. 
Focus 
Group 
Site 
Number of 
participants  
Mean 
age 
(years) 
Sex 
(M:F) 
Mean years since 
disease onset 
EDSS 
A 5 54.2 1:4 14.8 6.1 
B 9 51 3:7 14.8 6.1 
 
5.3.1 Similarities and differences between the two focus groups 
There were similarities between the two groups. All participants had taken part in the same 
intervention which was delivered at a community leisure site, with the same physiotherapist at both 
sites. In addition, the exercises and format of the class (e.g. length of warm-up, time for each 
exercise, and length of cool-down) were identical at both sites (Section 4.2.6 and 4.2.7). The 
intervention sites differed in ease of access and type of room used (Section 4.2.10).  Fewer 
participants attended the class at Site A, where there were five regular attendees, with one person 
attending less than half of the classes. At site B there were 10 regular attendees, with two people 
attending less than half of the classes.   
All participants were aware that the MS exercise class was funded for the 12-weeks of the 
intervention and that on completion of the class they were all being referred to their local 
authorities exercise referral schemes. The scheme included discounted access to exercise facilities 
and exercise classes aimed at those with disabilities. At Site B, this also included the current 
exercise class which was being maintained once a week, funded by the local authority. 
As indicated in Table 5.1 both focus groups included men and women, with participants being of a 
similar age (Site A mean age= 54.2 years, Site B mean age =51 years) and had been diagnosed for 
a similar length of time (mean time since diagnosis=14.8 years). The EDSS level of participants 
was similar in both focus groups (mean EDSS =6.1).  
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5.3.2 The research team 
Fern (2001) acknowledges the importance of the Moderator in qualitative research. The moderator 
(or researcher) is the linchpin of all focus group methodologies and can influence and structure the 
topics of discussion and spark or stifle debate (Gibbs 1997). An experienced moderator will help 
ensure the quality of the data collected, with Morgan (1998) (p47) attesting that the moderators 
experience “will be most valuable when it is directly relevant to the topics and participants” 
involved in the study.  
The moderator chosen for this study, was otherwise independent from the study, she had 
experience as a physiotherapist, rehabilitating people with MS, and had a special interest in what 
motivates those with MS to exercise. Furthermore, she had several years qualitative research 
experience and had acted as moderator in similar studies.  
In addition, to establish any changes in participants’ body language, a second independent research 
physiotherapist acted as scribe. This researcher also verified topics and themes during analysis of 
the focus groups. This researcher had experience in qualitative research related to exercise 
participation. Neither researcher was known to the participants prior to the focus group. 
5.3.3 Questions 
There is a risk of bias inherent in the role of the moderator, as the moderator can influence the 
discussion. This may be seen as a disadvantage of focus group research. To combat this, a 
interview schedule of semi-structured questions and prompts was developed for this study. 
Questions were determined by the Chief Investigator, based on past qualitative literature in MS and 
exercise studies (Dodd et al 2006; Smith et al 2009), from general literature on focus groups (Webb 
and Kevern 2001) and areas of interest from the more general exercise in MS literature. The 
moderator aimed to stay within these topics, however if participants explored other areas of interest 
the moderator was free to use her judgement to allow this. 
Questions included in the interview schedule are displayed in Table 5.2. Results from the focus 
group at Site A were preliminary analysed prior to the focus group at Site B and, as it was felt that 
areas regarding barriers to exercise and exercising in a group could be explored more, 
modifications were made to the interview schedule for Site B (Table 5.2). 
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Table 5.2 Focus group interview schedule 
Site Questions 
Site A & B Can you tell me about any positive benefits from attending the classes? 
Can you tell me about any problems you had attending the classes? 
What did you think about the exercises themselves? 
What motivated you to participate in the study/classes? 
What motivated you to complete the classes? 
Tell me how you felt about exercising in a group?  
What would you change to make the classes better? 
Do you feel you have achieved the goals you set out at the start of the programme 
of exercise? 
Tell me what you thought about the instructors taking the classes? 
 
Site B 
(additional 
questions) 
Can you tell me what your views on exercise were before beginning the study? 
Have these views changed? 
Can you tell me about anything you have learned about how exercise can help? 
How do you feel about exercising with those without Multiple Sclerosis, who may 
have similar disabilities?  
How do you feel about exercising with those without Multiple Sclerosis, who have 
no disabilities?  
 
5.3.4 Location  
The Location  where the focus group takes place is deemed to be of importance to the results of 
qualitative research  (Fern 2001). The value of an easily accessible venue is important both for the 
researcher and the participants  (Morgan 1996).  For the research team a quiet room where all the 
views of participants are heard, with participants and the moderator sitting in a circle to allow good 
communication would be recommended; for participants an impartial, accessible venue, with 
refreshments may be helpful  (Kitzinger 1995; Morgan and Scannell 1998).  
These points were considered in arranging the location of the focus groups. Both focus groups took 
place in the final week of the 12-week intervention. The focus groups were undertaken in a private 
room at the intervention site, 20-30 minutes after completion of the exercise class. Participants, 
moderator and scribe were provided with refreshments and all sat around a large table. The focus 
groups were recorded on an Olympus WS-321M Digital Voice recorder.  
5.3.5 Analysis of focus groups 
After the focus group has been completed, Analysis is performed. This is the final area of 
methodology which Fern (2001) deems of high importance in focus group methodology. It is 
acknowledged that the use of traditional qualitative interview analysis may be inappropriate for 
focus group analysis (Myers and MacNaghten 1999; Webb and Kevern 2001). It is recommended 
that the focus group be analysed like a conversation, as the groups’ views come in bits and pieces; 
participants are interrupted by others, respond to different views and refer back to others’ answers 
(Webb and Kevern 2001; Krueger 2006). Although an analytical approach to data analysis is 
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encouraged, no specific method of analysis is advocated in the relevant MS exercise literature.  
Authors conducting similar studies  have used a general inductive approach (Dodd et al 2006).  
Thus, in this study the data was analysed using a general inductive approach similar to that 
described by Thomas (2006), and processed following the recommendations of Kitzinger (1995) 
and Webb and Kevern (2001) with the following steps taken; 
1. The two focus groups were initially analysed independently from each other. 
(i) Areas of interest emerging from Site A, not questioned on the interview 
schedule, were added to the interview schedule for Site B (Table 5.2) 
2. The main researcher listened to the recording of the focus groups, read the transcripts 
several times and cross referenced data with the scribed notes. 
3. The data was coded to identify initial topic areas. 
4. A further level of analysis was incorporated to refine the coding framework.  
5. Emerging themes were identified with representative quotations.  
6. In order to improve the reliability of coding and identified themes a second physiotherapy 
researcher independently read the transcripts and identified codes and themes.  
7. Both researchers discussed emergent themes. These were refined to identify similar coding 
and themes, leading to the presented themes and subthemes. 
 
5.4 Results 
5.4.1 Demographic characteristics 
Of the 32 people who participated in the main study, 20 were randomly allocated to the 
intervention group and from this group 14 participants took part in Study 2. The study sample 
consisted of four men and 10 women, a demographic description of the sample is provided in Table 
5.1.  
5.4.2 General findings 
At both focus groups participants interacted well. However, there were differences noted between 
the two groups in terms of response to questions and interaction with each other.  
At Site A participants took it in turns to speak, with an even spread of comments from all five 
participants. A close group dynamic was evident as participants often completed one another’s 
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sentences and expanded on each other’s comments, speaking at length on the importance of the 
social aspects of the exercise intervention.  
At Site B more dominant members of the group dictated the answer to many of the questions, thus, 
some participants did not comment very often. However, the participants at Site B also spoke at 
length of the importance of the social aspects of participating in the intervention. 
During both focus groups the moderator did not have to ask all the questions on the interview 
schedule, as many areas were addressed naturally. However the moderator had more impact during 
Site B’s focus group, this was in response to the dominant group members’ behaviour, as the 
moderator made an effort to include all participants in the discussion.  
As has been discussed additional questions were added to Site B’s interview schedule, which 
covered some areas discussed at Site A which were not part of Site A’s interview schedule. No new 
themes emerged from Site B suggesting that data saturation may have been achieved. The duration 
of both focus groups was approximately one hour, with both coming to a natural completion with 
the moderator feeling all areas had been covered. 
5.4.3 Emergent themes 
Similar themes emerged in both groups, and thus results are presented from both focus groups 
together. Three key themes were identified from the two focus groups, and were; 
• Benefits of the class 
• The exercise class 
• Barriers to exercise 
The three key themes emerged from a number of different subthemes, themes and subthemes were 
interdependent as can be seen in Figure 5.1. Findings are summarised in Table 5.3 and will be 
discussed under the three key themes. Overall, the exercise class emerged as a bridge to allow 
participants to overcome barriers to exercise and benefit from the class.  
Illustrative quotes will be used to report findings, with the study site and individual participant 
number provided in parenthesis (refer to Table 4.4). Conversations between participants are 
represented with quotes with minimal line spacing between. Individual quotes are separated from 
one another with larger line spacing 
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Figure 5.1 Main themes and subthemes emerging from the focus groups. 
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Table 5.3 Key themes and subthemes emerging  from the focus groups  
Theme Subtheme Topic area 
Benefits of the 
exercise class 
Symptom change 
 
Balance 
Mobility 
Fatigue 
Sleep 
Activities of daily living 
Healthy lifestyle behaviours 
Goal attainment Improvements in some areas 
Social support Meeting others  
Working in a group 
Education Appropriate exercise 
Positive views of exercise now 
Inspired to continue 
The exercise class Instruction Knowledgeable 
Motivating 
Non-stigmatic 
Venue Accessibility 
Class structure Length of class 
Length of each exercise 
Level of difficulty 
Type of exercise 
Barriers to exercise Psychosocial 
factors/Social stigma 
Inappropriate professional advice 
Exercising with able-bodied people 
Attitudes of general public 
MS Symptoms 
 
Unable to do the same as before 
Progressively more disabling symptoms 
Symptom change Fatigue 
Lack of service Few other exercise options for people 
moderately affected with MS 
Venue Accessibility 
 
. 
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5.4.4 Benefits of the exercise class 
 
Symptom change 
It emerged from both focus groups that one of the most positive outcomes from participating in the 
class was the improvement of many of the participants’ symptoms. The participants commented on 
improvements in their balance, mobility/walking and management of their fatigue. In addition the 
participants remarked that the therapeutic exercise helped to improve their sleeping patterns, 
activities of daily living and had a positive influence on healthy lifestyle behaviours. 
“..for the last couple of weeks I’ve been coming up the stairs and down the stairs.” 
(A1) 
“I feel a lot more energetic...really I feel much more alert, my head feels 
clearer I can think things through better.” (A2) 
“I can use a dust pan and brush, I couldn’t do that before.” (B24) 
“Yes you have, you have lost weight” (A5 to A1) 
However, although some participants made positive comments about their levels of fatigue, some 
participants noted suffering from post-exertional fatigue immediately after the class. This was seen 
by some as a negative outcome, but not by all participants. 
“My fatigue’s got worse, but my balance has improved” (B22) 
“I think it’s helped me, because the different exercises that you’re doing is helping 
me to do things round about the house…but like [B22] was saying, sometimes you 
go home and you just want to go to sleep or something, you don’t want to do the 
housework” (B24) 
“I do feel the benefit, and ... I go home and I fall asleep for an hour or two” (A1) 
Goal attainment 
At the start of the main study (Chapter 4) participants were asked to choose three goals which they 
would like to improve by the end of the intervention. The participants were asked whether they felt 
they had achieved these, or any other personal goals. Some participants felt they had done so. 
“My confidence is getting better as well, and my balance is getting better. The 
goals I set myself… I’m achieving some of them” (A1) 
“My balance has got a lot better. That was one of mine [A5’s goals], my balance” 
(A5) 
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“ Well I personally feel I’ve reached my goal to a point”. (B17) 
Participants in both groups were keen to continue exercising and participants commented that they 
would still like to work toward achieving their goals. 
“We could all do better yet….” (A3) 
The focus group format allowed participants to explore each other’s views, this was apparent when 
participants were discussing improvement. In doing so participants were able to appreciate the 
variation in their symptoms from day to day. 
“..we all improved a lot. Even our balance and thing”(B15) 
“I don’t think I have, I think I’ve got worse” (B21) 
“Do you not?”(B15) 
“I think I’ve got worse”(B21) 
“I don’t think my balance has got better”(B23) 
“I think generally we have”(B15) 
“But I think you can get good days”(B17) 
“I think I’m just having a bad day today” (B21) 
Social support 
All of the participants spoke favourably about participating in a group exercise class. It became 
apparent that the class format, with all participants having similar symptoms provided an 
environment that allowed participants to support and encourage one another, helped to motivate 
and improve participants attitudes surrounding their own disability and MS symptoms. It also 
provided an environment which facilitated new friendships. Thus providing both extrinsic (meeting 
other people) and intrinsic (motivation, enjoyment, acceptance) factors to facilitate participation. 
"I think because everyone is in the same boat, it stops you from feeling sorry 
for yourself, feeling oh I can’t do this, you see everybody else getting on with 
it and it inspires you to try harder” (B24) 
It was suggested, by the quality of the interactions between the participants in the Site A focus 
group, that a better “group-dynamic” was evident in Site A’s focus group. For example, during Site 
A’s focus group participants strongly agreed about the importance of group exercise with those 
who have similar experiences. 
“Good to get out and about and meet people...We’re all the same, there is nobody any 
different, which was a bonus, because sometimes it’s quite, when you see super fit 
people, it’s a wee bit...” (A4) 
“Depressing, maybe?” (A5) 
“quite nice to come in and do it all together, which has been a good group” (A2) 
“it’s been great, hasn’t it?” (A5) 
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In addition, some participants had never met others with MS. The opportunity to do so, by taking 
part in the exercise intervention was deemed to be a positive benefit of group exercise in a disease 
specific class. 
“I’ve had Multiple Sclerosis for 16 years …this is the first time, we’ve had, well, I’ve 
had this opportunity to come, and meet, and be..” (A2) 
“with others” (A4) 
“as a group” (A2) 
“[when comparing with before the class] I hadn’t met anyone on a similar sort of level 
of MS”  (B18) 
Education  
The participants acknowledged that many of them had learned new things during the 12-weeks of 
therapeutic exercise.  
 “I’ve found it really enjoyable, and I’ve been shocked that an improvement could be 
made by exercising at a much gentler level” (B20) 
 “They [the instructors] were saying, don’t do it like that, do it like this because that’s 
getting the air into your lungs and you know, while you were doing it.. They’re telling 
you well, that’s good for your lungs...Good for your heart” (A4) 
Some participants described how they used what they had learned in the class and applied it 
elsewhere, 
“.. in the kitchen when you’re at the work top, again you can add a wee exercise” 
(B17) 
 “... they [the instructors] explained it, and then when you got home you would do 
them [the exercises] a wee bit” (A4) 
 
5.4.5 The exercise class 
Instruction 
Partly linked with the previous results surrounding education, the participants felt that having 
exercise instructors who were specifically trained to teach those with MS, as was the case in this 
study, allowed them to feel safe and understood. It emerged that this extrinsic factor to 
participation helped the participants to enjoy and benefit from the class.  
“[the instructors] have been very professional and their knowledge has been 
outstanding…. always there for moral support” (A1) 
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Venue 
Some of the participants acknowledged that they had no problems accessing the venue where the 
exercise intervention took place. However, others commented on the lack of disabled parking 
spaces or mentioned that lack of personal transport may have been problematic. These discussions 
provided an insight into the external barriers which may prevent people who are moderately 
affected with MS from taking part in exercise. 
“Well I would have had transport problems but [another participant] lives around the 
corner from me and...he brings me down” (B24) 
Class structure 
 
There was positive feedback regarding the range of exercises included in the exercise class, which 
included a range of aerobic, resistance and balance exercises, these could be performed at differing 
levels of difficulty. The participants liked the varied levels of difficulty available for each exercise. 
“I was really impressed with the fact that there were [exercise] options for different 
levels of difficulty and because you were writing things down [progress cards] at what 
level you had been exercising at. It was encouraging because after a few weeks you 
could look back and see, oh, yes I am getting better” (B20)  
 
Some of the participants discussed that they felt ready to progress to different types of exercises, it 
emerged that this was to both alleviate boredom but also allow participants to challenge themselves 
further.  
“...I’d quite like a Pilates class for people with MS; I think that would be quite good 
because it is concentrating on your core muscles” (B11)  
As discussed in Section 4.2.6 the exercise class lasted around one hour, including a warm-up, the 
main circuit component (one minute of each exercise) and a cool down. This was discussed during 
the focus group with participants suggesting that this format could be improved by including a 
longer cool down section and/or a longer duration on some of the exercises. However, these views 
were not shared by all participants as some felt that the class timings were appropriate. 
“The minute on the bike for me is quite good at the moment, but for doing the shuttle 
walks and the upper body strength or the running arms. Things like that, I feel as if I 
could go on” (A1) 
“I think the hour is actually just long enough.” (A2) 
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5.4.6 Barriers to exercise  
Psychosocial factors/Social stigma 
A strong theme, which emerged frequently throughout both focus groups, was the attitude of other 
people (as perceived by the participants) towards the participants, as people with MS. This was 
judged to be an extrinsic barrier to participation (the attitudes of others).  
There was discussion on previous experiences with exercise instructors which had been less 
successful than the instruction in the present study. Participants gave examples of negative 
experiences they had previously had with leisure professionals who may have had minimal 
knowledge of MS and exercising with MS. For some participants it emerged that this had prevented 
them exercising in the past  
“I felt that the individual trainers [in previous exercise experiences], although they 
were very sympathetic they didn’t really have an understanding, they were frightened 
as well… they were sort of saying well you can’t do this and you can’t do that. I 
would be like, oh well, I won’t go at all” (B18) 
It was also suggested, by participants’ comments, that health professionals provide them with 
health advice, but perhaps may not be able to provide practical advice on how to achieve 
improvements in their health. 
“when I was at the doctors about my knee, they basically said, you need to lose 
weight…it must be something that every doctor…” (A1) 
“I think that they say that to everyone” (A5) 
“They get it ingrained into their head” (A1) 
When participants discussed exercising in an environment with healthy people, it emerged that this 
could also be a barrier preventing them exercising. Participants discussed that when exercising in 
the past they had felt different from healthy people and that they had to explain their illness or their 
symptoms to others. Some participants did not enjoy having to provide these explanations to 
members of the public.  
“…if you were in with another class you would feel out of the ordinary” (A2) 
“[When exercising previously] I’d get off the exercise bike and quite often stagger 
across the room to the weights machine or whatever and you’d see people sort of 
staring and I’d think “God, am I going to have to say it all again?”” (B10) 
The participants’ understanding of how healthy people act around those with MS may be linked 
with acceptance of their own illness, and thus this may be an intrinsic barrier to participation. Some 
participants discussed avoiding activities where they had to confront their condition; imposing self-
limitations.  
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“I think working in the pool would be good for people” (B21)  
“No I wouldn’t go to that [the pool], I’ve tried things like that before and I know I 
wouldn’t. I’m not being funny or that. I’m just being realistic. I wouldn’t go to 
something that was just all able-bodied people and me.” (B24) 
MS Symptoms 
The participants in the focus groups discussed that the symptoms they experienced due to their MS 
were a barrier to them exercising, in the past many had participated in exercise or had been more 
active than they were now. However, it emerged that the class gave them the confidence and 
opportunity to exercise again, helping overcome this barrier. Furthermore the class gave them the 
opportunity to challenge their imposed self-limitations, and do new things, or exercises they hadn’t 
done for a while. 
“Pre MS, I was fairly fit... I did do a programme of exercise, a lot of swimming and 
sit-ups to build the muscles up. But MS kicked in and I wasn’t able to do any of that 
anymore, well I just kind of stopped doing anything. This has got me coming back and 
doing something, at a much lower level, but it’s something, and even getting up in the 
morning and getting ready to come [to the class] is a reason to get moving” (B13) 
“I’m doing things that I’ve never, that I haven’t been able to do for years.” (A3)  
“Yes, I know I know.” (A5)  
“Like silly things like, standing on one leg.” (A3) 
Lack of services 
There was a general agreement amongst all participants that there was a lack of services and 
opportunities to exercise for those with MS; deemed to be an extrinsic barrier to participation. The 
participants were keen to continue active involvement in the MS exercise class, and other forms of 
exercise after the study. However, they discussed the difficulties in doing so. The comments made, 
surrounding the subtheme of lack of service and participants feeling there are not many exercise 
options for those with MS, link with past comments under the theme of Benefits of the Exercise 
Class (Section 5.4.4). When participants expressed that they enjoyed exercising in a group with 
those with a similar condition.  
“I feel with MS you need it [exercise] all the time, you need it either once a week, or 
once a fortnight. You can’t stop because.. you need to do this, you know all the time. 
[The NHS rehabilitation centre] couldn’t obviously do that for us. This is a wee outlet 
for us all, and I think it would be good for us all if it continued” (A5). 
Fatigue 
As discussed in the section on Symptom improvement (Section 5.4.4) some participants 
acknowledged feeling post-exertional fatigue which had a negative effect on other activities of 
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daily living following the class. This emerged as the main negative outcome from participating in 
the exercise intervention. 
Venue 
There was also negative comments regarding accessing the class, in particular participants 
discussed disabled parking problems and potential transport problems accessing the venue. 
Illustrative quotes have previously been provided in Section 5.4.5. 
5.4.7 Summary of results 
Results from this study suggest that the therapeutic exercise class acted as a bridge to help 
participants overcome barriers to exercise allowing them to benefit from taking part in the exercise 
intervention. Benefits to taking part included symptom improvement and social support. Barriers to 
exercise related to participants symptoms and a lack of exercise services appropriate for the 
participants. 
5.5 Discussion 
This qualitative study aimed to establish the views on exercise and the therapeutic exercise 
intervention, undertaken as part of the main study (Chapter 4), in people moderately affected with 
MS. The following research question was addressed. 
What are the participants’ views on exercise and the therapeutic exercise intervention? These 
include; personal goal attainment, positive and negative outcomes associated with the intervention, 
and intrinsic and extrinsic factors to participation in, and completing, the intervention. 
To answer this question focus groups were undertaken at the end of a 12-week exercise 
intervention study for people with MS (Chapter 4).  The methodology was guided by five main 
areas; number of groups and participants, the group composition, the moderator, the location and 
the analysis (Fern 2001). A general inductive approach to analysing findings was adopted, which 
included verification of emergent themes by two researchers.  
5.5.1 General findings 
The exercise intervention, discussed in Chapter 4, was delivered at one of two sites, at each site a 
focus group was undertaken. Despite there being slight differences between the groups, common 
themes and subthemes emerged from both focus groups.  
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Three key themes emerged, these were 1) Benefits of the exercise class, 2) the Exercise class and 
3) Barriers to exercise.  These will be discussed in relation to the results from the quantitative 
findings of the main study and will be compared with results in similar past research.  
5.5.2 Differences between focus groups  
 
Findings from both focus groups were similar, with participants interacting well with one another 
and being positive about the exercise intervention. However, it seemed that there was a stronger 
group dynamic amongst participants at Site A, evidenced by participants agreeing with each others’ 
views and finishing one another’s sentences more than in the focus group at Site B. In addition 
there was an equal spread of conversation amongst participants at Site A, whilst at Site B more 
dominant members of the group appeared to dictate the conversation, perhaps limiting the views of 
others from being expressed. To elicit views from all participants at Site B the moderator played 
more of a role, in an attempt to include everyone. 
The two groups differed in number of participants (n=5 at Site A; n=9 at Site B).  It is suggested in 
the literature that the moderator may find smaller groups easier to manage (Morgan 1996). Whilst 
Carey (1994)  suggests that the fewer people in a focus group the greater the likelihood that they 
will interact. This was the case in the present study, when the smaller focus group interacted better 
than the larger focus group.  
The difference in group size may have influenced findings in the present study, however each 
group’s size was dictated by the main study, and the numbers participating in the exercise 
intervention. Although, it is acknowledged as a limitation of this study, it is unknown if focus 
groups of a similar size would have altered the discussion between participants. Future research 
which includes more than one focus group may benefit from keeping numbers of participants 
similar. Tang and Davis (1995) suggest four important factors which may help dictate group size. 
These are the number of questions, the time provided for each question, the format of the focus 
group and the duration of the focus group. In summary more time is required for a focus group with 
more participants or if there are more questions or if the format of the focus group is not structured 
with ideas and views being freely discussed. For structured focus groups (e.g. using semi-structured 
questions) they recommend on average 2 minutes per question for each person, but advise pilot 
work is undertaken. 
5.5.3 Emergent themes 
Three key themes emerged from the study, these traversed both focus groups, were interlinked by a 
number of different subthemes and answered the research question. The three themes were; 
Study 2 
 
 
199
• Benefits of the class; symptom change, goal attainment, social support and education.  
This theme addressed the research question on personal goal attainment, positive outcomes 
associated with the intervention and intrinsic and extrinsic factors in participating and 
completing the intervention. 
• The exercise class; instruction, venue and class structure.  
This theme addressed the research question on intrinsic and extrinsic factors to 
participating in, and completing, the intervention. 
• Barriers to exercise; psychosocial factors/social stigma. MS Symptoms, symptom change, 
lack of service and venue. 
This theme addressed the research question surrounding negative outcomes associated with 
the intervention and intrinsic and extrinsic factors in participating and completing the 
intervention. 
Many positive outcomes from participating in the exercise intervention were discussed during the 
focus groups, some positive outcomes were related to participants’ MS symptoms. It emerged from 
the focus groups that participants had found improvements in balance, mobility and fatigue 
management. This was similar to benefits found in past qualitative studies after participants with 
MS had participated in resistance exercises or combined exercise interventions (Dodd et al 2006; 
Smith et al 2009). As different types of exercise were delivered in past studies compared with the 
present study (Section 4.2.6) results suggest that participants taking part in many types of exercise 
perceive symptom benefits. The positive comments from the present study participants on 
symptom improvements also links with the quantitative findings in the main study (Chapter 4); 
where it emerged that  the intervention had a non-significant effect on participants balance, some 
aspects of mobility and fatigue levels (Section 4.7.5).   
Other positive outcomes of the exercise intervention emerged, which were not captured by the 
quantitative outcome measures used in the main study, highlighting the benefits of mixed 
methodology. For example, participants spoke of improvements in their ability to undertake 
activities of daily living, that they were now sleeping better and that there was a positive effect on 
other healthy lifestyle behaviours. Participants in studies which have explored the benefits of 
prescribed therapeutic exercise (including aerobic, balance, resistance and stretching exercises)  
(Smith et al 2009) and independent community exercise (which included cycling, gym 
programmes, swimming or walking) (Smith et al 2011) also commented on improvements in 
activities of daily living and sleep patterns. The similarities in the positive outcomes and benefits 
found in this and past studies, in less disabled MS groups, suggest that benefits from taking part in 
therapeutic exercise can be found across a range of disabilities and, as discussed, are not specific to 
one type of exercise.  
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Goal attainment was briefly discussed during the focus groups, with improving balance a goal that 
had been met by some participants. This links with the goal setting used as part of the main study, 
where improving balance was a priority goal for some participants at the start of the exercise 
intervention (Table 4.8). However, there was disparity amongst participants in the focus group as to 
whether they felt they had attained their personal goals by taking part in the 12-weeks of exercise.  
Some participants felt they had achieved their goals, whilst others were less positive. In addition, 
there was also discussion that participants felt they would improve more if they continued 
exercising. In past MS therapeutic exercise literature there is no discussion on achieving personal 
goals, making it difficult to compare these results. However, Dodd et al (2006) acknowledged that 
participants in their study stated that seeing signs of progress motivated them to continue 
exercising. 
It emerged that the social support dynamic of participating in the exercise intervention was 
important to participants, providing both extrinsic facilitators (meeting new people) and intrinsic 
facilitators (motivation, enjoyment and acceptance). This subtheme of social support may have 
been strengthened by the group nature of both the exercise class and the focus group. Participants 
were all positive about meeting others, and exercising with people who had a similar condition; 
with many new friendships being made. This finding supports that found in similar past studies. 
For example Dodd et al’s (2006) study involved semi-structured interviews, undertaken at the end 
of a group exercise intervention and found that exercising with others with MS instilled a feeling of 
acceptance and understanding. This helped the participant feel “normal”, encouraged an “enjoyable 
environment” and facilitated group “camaraderie”.  
Furthermore, the social benefits of group exercise has been found to encourage maintenance of 
exercise amongst those with MS (Smith et al 2011). Indeed people with a range of neurological 
diseases, including MS,  have previously stated that they would like to exercise with a group of 
people with similar disabilities (Dawes et al 2010). This knowledge may be important for service 
provision. 
It was encouraging that participants reported continuing the exercises learned in the class at home, 
and equally encouraging that all planned to continue exercising and trying new forms of exercise. 
Different levels of each exercise were available, and during the focus groups, participants 
acknowledged that this was good, allowing them to progress with their own routine. In addition 
participants completed progress cards at each session. Using progress cards has been acknowledged 
in past literature as an intrinsic motivator to exercise (Dodd et al 2006). Indeed participants in this 
study deemed them to be encouraging, discussing that it was good that they could chart their 
progress and look back upon it. Being aware of symptom improvement has also acted as an internal 
motivator for participants in other studies (Smith et al 2009; Smith et al 2011) 
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In general participants in the present study were happy with the format of the class although they 
gave examples of how the class could be improved. With some participants ready to move on to 
trying new types of exercise, such as Pilates. This is similar to the participants in Dodd et al’s  
(2006) study who felt that at the end of the intervention they would like to progress to different 
types of exercise and exercise equipment. There is no known qualitative literature on preferred 
types of exercise for people with MS, although a variety of exercise types, have been studied in 
past therapeutic exercise studies (Chapter 2). It may be pertinent that future mixed methodology 
studies in MS therapeutic exercise seek to establish preferred types of exercise. As this knowledge 
may improve adherence and therefore direct service provision effectively.  
The results of the focus groups suggest that some participants may impose self-limitations on 
physical activity due to their MS. This may be considered an internal barrier to participating in an 
exercise intervention, and thus was related to the Barriers to Exercise theme. Furthermore, the 
Barriers to Exercise theme provided details on the impact health professionals and members of the 
general public may have on the willingness of those with MS’ to exercise. Participants also agreed 
that a lack of knowledge regarding MS in health and exercise professionals and members of the 
general public had a negative impact on them. 
The attitudes of others, including health professionals, and participants’ views of exercising with 
able-bodied people were explored under the subtheme of Psychosocial factors/Social stigma. 
During the focus groups participants discussed they had experienced a lack of knowledge, 
regarding MS, by exercise professionals they had encountered in the past, presenting a potential 
barrier to exercise participation. This has also been acknowledged in other MS research undertaken 
in New Zealand (Kayes et al 2011) and in the general neurology research undertaken in the UK 
(Dawes et al 2010), which sought to elicit views on exercise. Thus a lack of understanding and 
knowledge of neurological conditions in exercise professionals may be a problem across different 
geographical locations. Exercise professionals knowledge of working with those with neurological 
conditions should be investigated further. It may be recommended that improved training on the 
part of those involved in delivering exercise for those with neurological disabilities may ultimately 
increase exercise uptake and continuation of exercise for those with MS. 
Regarding self-imposed limitations, it emerged that through exercising during the class, 
participants challenged their thoughts on their own capabilities. This resulted in them trying new 
(and old) things which they had not done before (or for a long time). Therefore, it could be 
suggested that they felt empowered and more confident in their own capabilities. Similar attitudes 
were found in those less severely affected with their symptoms, who habitually participated in 
independent community exercise (Smith et al 2011). This is an important finding as using 
therapeutic exercise to challenge perceived self-limitations may help those with MS take control 
throughout the varying stages of their disease.  
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Linked with how participating in exercise may help MS sufferers become more empowered in their 
symptom management is the importance of education, good instruction and healthcare advice. In 
Thorne, Con, McGuinness, McPherson and Harris’s (2004) qualitative study exploring issues 
surrounding communication between those with MS and healthcare providers it emerged that those 
with MS felt empowered by healthcare providers who offer a supportive and facilitative attitude. 
The quality of the instruction during the exercise class was one of the extrinsic facilitators which 
helped participants in this study take part in, and complete, the exercise intervention. This is similar 
to previous findings; that leadership (which was encouraging, supportive and knowledgeable), 
alongside group classes and venue, may be important (Dodd et al 2006). Quality instruction was 
also important as some participants in the focus groups had felt previous fitness instruction had 
been delivered by non-knowledgeable staff, a view echoed in a previous study (Kayes et al 2011).     
Although there was no formal educational component delivered during the exercise intervention, 
there was an implied educational component, with instructors giving advice on exercise and general 
advice on managing symptoms. It emerged from the focus groups that this resulted in participants 
realising that therapeutic exercise can be gentle and can help improve their mood. Participants 
learned from other participants and instructors, that there is a balance to be found between exercise, 
energy levels/fatigue and activities of daily living. Indeed, in the main study there was quantitative 
evidence that the intervention had a beneficial effect on participants’ levels of anxiety. This 
“wellness-philosophy” has been found by past authors looking at the relationship between fatigue 
and exercise in study participants who habitually exercised independently in their community 
(Smith et al 2011). Thus to help those with MS realise the many positive outcomes from 
participating in an exercise intervention an educational component should be integral to any MS 
exercise service to help participants better understand their symptom management. Indeed, even 
during the focus groups participants were learning from others. Perhaps giving an indication that a 
group workshop (led by an expert tutor, with participants also informing the content), may be a 
potential format for any future educational component. 
The exercise intervention delivered in this study (Chapter 4) was designed by physiotherapists and 
was jointly led by a physiotherapist and an exercise professional. This combination may have been 
beneficial to the success of the programme. There are few examples of previous MS studies which 
have utilised this combination in leading exercise classes for those with MS (Dodd et al 2006; 
Taylor et al 2006; Dodd et al 2011). With most therapeutic exercise interventions being led by 
physiotherapists  (Freeman and Allison 2004; Kileff and Ashburn 2005; Newman et al 2007; 
Bjarnadottir et al 2007; McCullagh et al 2008; Cakt et al 2010; Broekmans et al 2011)  or by 
exercise professionals who had consulted with physiotherapists (Filipi et al 2011). Furthermore, as 
physiotherapy input is preferred by those with MS in exercise and physical activity provision 
(Dawes et al 2010; Kayes et al 2011), specialist physiotherapists and exercise professionals should 
consider working together when developing and initially delivering safe and effective MS exercise 
Study 2 
 
 
203
classes. This collaboration is currently recommended for exercise delivery in other neurological 
diseases such as stroke (Scottish Intercollegiate Guidelines Network 2008). 
From the comments raised during the focus groups barriers to exercise emerged. Some were clearly 
extrinsic (over which the participants may have minimal control), for example a lack of services 
and difficulties accessing the venue. Others could be judged to be both extrinsic and intrinsic (areas 
where participants may not initially feel they have control, however it could be argued that these 
areas may be linked with their acceptance of their own illness), for example the attitudes of others 
and exercising with able-bodied people. Other barriers were more internal (influenced by the 
participant, or symptoms suffered by the participant), for example their MS symptoms. 
A lack of exercise services and the venue where exercise took place was discussed, and emerged as 
potential external barriers to exercise participation. Participants did not feel there was enough 
exercise services available for them to access. This is similar to the findings in Kayes et al’s (2011) 
study, undertaken in the UK, where it was discussed that a lack of potential exercise services 
appropriate for those with neurological conditions may be a barrier to exercise participation.  
In addition, some participants in this study who did not have their own car or were unable to access 
the intervention sites using public transport, stated that they may have had problems attending if 
other participants had not provided transport. Similar findings emerged in Kayes et al’s (2011) 
study, where it was reported that physical activity may be limited by transport options. In addition, 
in Plow et al’s (2009b) study, which took place in America, it was acknowledged that problems 
accessing exercise facilities were barriers to participating in exercise.  
As a range of disability levels were represented in Kayes et al’s (2011) and Plow et al’s (2009b) 
studies, these results suggest that transport options may be an important area for service provision 
for those with MS. It seems that this may be a global issue, both geographically and across the 
disability spectrum found in MS. Thus governments and healthcare providers may be required to 
improve transport provisions for those with MS to help encourage an inclusive society. 
It emerged that participants in this study did not want to exercise with able-bodied people, with 
participants providing examples of when they had felt uncomfortable by the attitudes of others. 
Similarly, participants in the study by Smith et al (2011) commented upon feeling self-conscious 
that their symptoms may be misinterpreted by the general public, resulting in them choosing to 
exercise at quieter times or away from others. This emphasises that being accepted into a social-
network may encourage people with MS to exercise, which should be addressed in future service 
provision.  
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This study found that other intrinsic barriers to participating in exercise for study participants were 
related to their MS symptoms. Participants acknowledged that as their symptoms worsened they 
were unable to do the same type of exercise as before.  However, for some participants taking part 
in the exercise class resulted in them doing exercises and activities which they hadn’t been able to 
do for a long time. There are links here between the implied self-limitations which participants 
discussed imposing on themselves and their symptoms being a potential barrier to exercise and 
consequently highlighting that those with MS may benefit in a number of ways,  both physical and 
psychological, by being given the opportunity to exercise. This strengthens the physiological, 
functional and psychological results found in the main study (Section 4.4).  
There was a discussion that suggested fatigue may be an intrinsic barrier to prevent some 
participants from exercising. This was the only negative outcome which emerged and was only for 
a small number of study participants. Stronger suggestions of the limiting effect of fatigue and 
exercise in MS have emerged from past qualitative studies related to exercise and MS (Dodd et al 
2006; Smith et al 2009; Plow et al 2009b; Smith et al 2011), where fatigue was found to be a 
barrier or negative outcome for some people with MS. However, as in other studies (Dodd et al 
2006; Smith et al 2009), participants in the present study agreed with each other that this may be a 
“healthy tiredness”, helping their fatigue management, with few commenting on the problems of 
fatigue.   
Although fatigue is reportedly problematic for many with MS (Chipchase et al 2003), the present 
results, in a more disabled population than previous studies (Dodd et al 2006; Smith et al 2009), 
provides limited evidence to support this. Researchers are therefore encouraged to adopt qualitative 
methodology and questioning to capture details on other barriers to exercise, to better equip health 
professionals overcome barriers to exercise for people with MS. 
5.5.4 Limitations 
This study adds much to the qualitative research in therapeutic exercise in MS. However it is not 
without its limitations. Where appropriate potential solutions to overcome these limitations will be 
provided to aid future research. 
The number of focus groups, and the number of participants was guided by the main study, in that 
only two focus groups were carried out, one for each site. Thus, the main limitation of this study 
was the small sample size, although it was comparable to past similar studies. Due to this it is 
unknown if true data saturation was reached. However, the same themes emerged in both groups, 
and both researchers who analysed the findings believed that no new themes, related to the research 
questions, were emerging. Future studies may benefit from recruiting more participants and 
undertaking more focus groups to establish if all relevant issues are raised. Similarly the number of 
participants was based on the main study, and no formal method was adopted to establish the 
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optimum number of participants in each group (such as that provided by Tang and Davis (1995)), 
this led, in part, to group numbers not being equal.  
The semi-structured questions used in the focus groups were based on past literature of relevance 
and areas of interest from the wider MS therapeutic exercise literature, and as such were judged to 
be relevant. However, as modifications were made after the first focus group, based on areas of 
interest which had emerged from the first focus group it is acknowledged that the questions chosen 
may have been limited. This does suggest that it is a limitation of the study that pilot work was not 
undertaken as part of this study. Therefore, to establish the appropriate number of participants, 
number of questions and time required and, to establish if questions are appropriate it may be 
advised that pilot work be undertaken. 
Although data analysis was verified by a second researcher, it is a limitation that member checking 
was not carried out, whereby participants are sent a typed transcript of the focus group and asked to 
confirm/verify the discussion. This would have strengthened analysis of the results and should be 
incorporated into future study design. 
Only the views of those who agreed to participate in the focus groups were obtained. Therefore the 
views of those who; did not continue to attend the exercise class, were in the control group of the 
main study (Chapter 4) or, more generally, did not have moderate MS, were not included. Thus 
these findings cannot be generalised. Future work may benefit from getting views from those who 
had not taken part in a formal intervention and from those either more or less severely affected with 
MS. In doing so a greater depth of results may emerge. 
In addition, although focus groups were appropriate for the group nature of the study, in the focus 
group at Site B the more dominant members of the group dictated the discussions, thus the views of 
some group members were not heard. Follow-up one to one interviews may better capture views of 
those who are less comfortable speaking in a group format. 
5.6 Summary and conclusion 
Establishing the views and opinions of those taking part in research is important to help ensure the 
relevance and quality of research undertaken in healthcare. This Chapter described a study which 
utilised focus group methodology and a qualitative analysis of the views and opinions of 
participants in a 12-week exercise study, all of whom were moderately affected with MS. The 
results indicated there were many positive outcomes from participating in the intervention, and also 
established barriers and facilitators to undertaking exercise for those moderately affected with MS.  
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The findings support the quantitative results from the main study, such as improvements in balance 
and fatigue with focus group participants acknowledging they had improved in these areas with 
evidence of psychological benefits emerging in both this study and Study 1. The findings also 
support previous qualitative literature in people with MS, and acknowledge the potential of 
exercise to help people with MS have a positive influence on their disease management. 
Facilitators to exercise participation which were important to the participants included, the social 
support offered by group exercise, an accessible venue, appropriate exercise and knowledgeable 
instruction. Potential barriers to exercise participation also emerged; these were psychosocial 
factors (such as poor instructor knowledge and not feeling comfortable exercising with able-bodied 
people), lack of exercise services, or the participants’ symptoms.  
The results of this study are unique as, they are the first to utilise focus group methodology to 
capture opinions of exercise participation in a group of people moderately affected with MS. 
The following chapter will discuss the results of a test-retest reliability study designed to assess 
four mobility and balance outcome measures used in Study 1 (Chapter 4). In Chapter 7 the over 
conclusion will include clinical and research recommendations emerging from the work. 
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6 Study 3 
Reliability and clinical significance of mobility and balance assessments in 
Multiple Sclerosis 
Chapter 4 describes the main investigation (Study 1) undertaken as part of this thesis, which 
assessed the impact of a twelve week combined exercise intervention, for people with moderate 
MS. This chapter will describe a study investigating the reliability, Minimal Detectable Change 
(MDC) and Standard Error of Measurement (SEM) of four outcome measures used in Study 1. 
6.1 Introduction and rationale 
To ensure that accurate measurement is carried out in healthcare, the use of reliable outcome 
measures, to accurately monitor changes in clinical performance is important for both research and 
clinical practice  (National Institute for Health and Clinical Excellence 2003; Streiner and Norman 
2008). 
In the therapeutic exercise studies reviewed as part of this thesis (Chapter 2) many different 
outcomes are used (Table 3.1). From these a number of different outcome measures to capture data 
on the physiological, functional and psychological status of participants were assessed as part of 
Study 1 (Chapter 4). However, when reviewing the literature regarding the methodology (Chapter 
3), and in particular when developing the Goal Attainment Scale (3.9.14)  it was found that there 
was minimal evidence as to the reliability and clinical significance of many outcome measures used 
in MS rehabilitation. Particularly for those with a higher level of disability (e.g. EDSS>5). 
Thus, from the different outcome measures included in Study 1 (Section 3.9) those that gathered 
data on mobility and balance were assessed further. The primary outcome measure from Study 1 
(T25FW) was assessed in this study, as were the 6MWT, TUG and BBS which are common in the 
therapeutic exercise literature and recommended as practical outcome measures (Crow and 
Harmeling 2002; Gijbels et al 2010b). They were also recommended clinically within the West of 
Scotland MS Physiotherapy Network  (NHS Scotland and  2003) and were used within the NHS 
rehabilitation locality where the study was undertaken, and thus the study had direct clinical 
applicability.  
This chapter will describe the methodology and results from the study assessing the reliability of 
four of the mobility and balance measures used in Study 1; the Timed 25 Foot Walk test (T25FW), 
Six-minute Walk test (6MWT), Timed Up and Go test (TUG) and the Berg Balance Scale test 
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(BBS). A discussion will follow, to place the results within the relevant clinical and research 
context. Accordingly, the study will address the literature gaps, described in Chapter 3, below; 
• There is minimal evidence as to the reliability of mobility and balance outcome measures 
used in MS literature regarding therapeutic exercise. 
• There is minimal evidence as to the clinical significance and precision of mobility and 
balance outcome measures used in MS research. 
In addition, the findings from this study will allow a more accurate analysis of some of the results 
found as part of Study 1 (i.e regarding Clinical Effectiveness Section 4.4.5), where relevant this 
will be highlighted in the results and discussion section of this chapter. 
Important concepts to this chapter are discussed in Chapter 3, which provides the main literature 
pertaining to this study. In particular, the basic concepts in clinical measurement (Section 3.4) and 
the rationale for each outcome measure (Sections 3.9.1, 3.9.2, 3.9.4 and 3.9.5).  Chapter 4 describes 
in more detail the use of each outcome measure in this study (Section 4.2.5). 
6.1.1 Study aim 
The aim of this study was to establish the test re-test reliability, clinical significance and precision 
of commonly used mobility and balance outcome measures (T25FW, 6MWT, TUG and BBS) in 
people moderately affected with MS 
6.1.2 Research question 
What are the reliability, clinically significant minimal detectable change and standard error of 
measurement scores of outcome measures (T25FW, 6MWT, TUG and BBS) used in people with 
moderate MS?  
6.1.3 Study design 
A test re-test reliability study of measurements assessed seven days apart by a single 
physiotherapist assessor was undertaken. Twenty-four people moderately affected with MS (EDSS 
5-6.5) took part. Study 1 involved outcome measures being taken at five different time points 
(Figure 4.1), for this reliability study, participants were asked to return seven days after one of 
these scheduled appointments. On this second occasion, four of the outcome measures were 
repeated. To control the influence of diurnal changes in clinical performance participants attended 
at a similar time of day on both occasions. The outcome measures were performed in the same 
order on both days. To encourage consistency within this reliability study, participants were asked 
to avoid starting a new exercise routine, having an unusually busy day before the second 
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assessment to standardise their clothing, footwear and food and drink consumption on both testing 
days. 
6.2 Methodology 
6.2.1 Ethical considerations 
A substantial amendment to the original ethical application for the main investigation was 
submitted to the West of Scotland Research Ethics Committee and Research and Development 
approval from NHS Ayrshire and Arran Research and Development Management. Approval was 
granted in July 2010.  
Slight amendments were made to the participant information sheet, to reflect the inclusion of the 
reliability study, with the consent form updated to reflect the new version number of the participant 
information sheet. 
6.3 Recruitment and participants 
For this study the inclusion and exclusion criteria were as previously described for Study 1 (section 
4.3). It was verified that participants had read and understood the participant information sheet, and 
all read and completed the consent form. 
Before beginning the study the number of participants necessary to achieve the required statistical 
power was calculated, based on the reliability results of Paltamaa et al  (2005), Fry and Pfalzer      
(2006) and Nilsagard (2007).  All of which found high reliability scores higher (ICC>0.8) for the 
6MWT, TUG and BBS.  Therefore it was determined from power estimation tables for the design 
of reliability studies (Walter et al 1998) that, where good reliability was anticipated (i.e. between 
0.7 and 0.9 ), a sample of 19 was required to achieve a power of 80% at the 5% level of 
significance 
The study recruited 24 participants; with an EDSS 5-6.5 (mean 5.75). The majority (n=17) were 
female, the average age was 51.8 years and the average time since diagnosis was 13.7 years.  The 
demographic details of the participants are displayed in Table 6.1, as is a breakdown of 
demographic details based on disability level. 
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Table 6.1 Demographic description and disability level of participants in Study 3. 
Number of 
Participants 
EDSS Gender 
M:F 
Age  
(SD) 
Years since disease 
diagnosis (SD) 
2 5 1:1 43.5 (13.4) 8 (2.8) 
2 5.5 0:2 59 (7.1) 19 (4.2) 
13 6 5:8 52.7 (7.1) 14.1 (7.6) 
7 6.5 2:5 50.6 (7.9) 13.1 (4.5) 
24  5-6.5 7:17 51.8 (7.9) 13.7 (6.5) 
EDSS – Expanded Disability Status Score. Overall sample indicated in bold. 
6.3.1 Assessed outcome measures 
One physiotherapy assessor measured all outcome measures; having undertaken more than 50 
similar assessments, she was familiar with the protocol. Further details on each outcome measure is 
available in Sections 3.9 and 4.2.5. 
The 25 foot walk (T25FW) 
To measure mobility over a short distance the T25FW (Cutter et al 1999) was assessed following 
the protocol described in Section 4.2.5. 
The Six-minute walk (6MWT) 
To measure endurance and mobility over longer distances participants completed a 6MWT 
(Butland et al 1982)  (described in Section 4.2.5).  
The Timed Up and Go (TUG) 
The TUG (Podsiadlo and Richardson 1991) assessment was carried out following the protocol 
described in Section 4.2.5.  
Berg Balance Scale (BBS) 
To measure balance the BBS (Berg et al 1989) was completed once per session and is more fully 
described in Section 4.2.5.   
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6.3.2 Statistical analysis  
The study aimed to establish reliability, clinical significance (through MDC scores) and precision 
(through SEM) scores for all four outcome measures. Data were analysed using  the SPSS (v.16) 
statistical package. Assumptions of normality were assessed using the Kolmogorov-Smirnov test. 
A paired Wilcoxon rank test was used to assess sequential shift over the two time-points for 
variables found not to be normally distributed (the 25FW, TUG and BBS). Data for the 6MWT was 
normally distributed, thus a paired sample t-test was used to assess sequential shift over time. 
Significance was set at p < 0.05.  For the BBS Cronbach Alpha correlation was used to check for 
internal consistency and α was found to be 0.96, therefore other tests of reliability were appropriate 
to perform.  
To assess test re-test reliability Intraclass Correlations Coefficients (ICC) were calculated for all 
measures, the appropriate intra-rater ICC mixed models were used to compare the variability of 
different scores from the same subject (Denegar and Ball 1993). Scores closer to 1 indicate stronger 
reliability, with a score 0.60 - 0.79 suggesting moderate reliability and a score of greater than or 
equal to 0.8 suggesting good reliability (Tyson and Connell 2009).  
Minimal Detectable Change (MDC) was calculated at the 95% confidence interval, to determine 
what scores would fall outside the measurement error of the assessment tool (based on the test/re-
test reliability scores). To determine this, the Standard Error of Measurement (SEM) was first 
calculated using the equation below (where SD denotes Standard Deviation, ICC denotes Intraclass 
Correlation Coefficient & day 0 indicates the first day of assessment): 
 SEM = SDday 0 x √(1-ICC)           (Streiner and Norman 2008). 
Similarly, MDC was calculated using the equation below: 
 MDC = 1.96 √2 x SEM               (Altman and Bland 2011). 
In addition, the calculated MDC score for each outcome measure was used to determine clinical 
significance in the findings from Study 1. To do so, the MDC score was calculated as a percentage 
of the Study 1 baseline score for the four outcome measures during Study 1. To determine whether 
clinical significance was achieved at the week 8, week 12, month 6 or month 12 follow-up time 
points this percentage MDC was compared to results found in study 1. 
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6.4  Results 
6.4.1 Demographic characteristics 
Of the 32 participants in Study 1, 24 participants took part in this study, this comprised seven men 
and seventeen women, demographic details are described in Table 6.1.   
6.4.2 General findings 
The mean scores, standard deviations and 95% confidence intervals for all four tests on both time 
points are displayed in Table 6.2. 
The study found no significant difference between the scores for each of the outcome measures 
when participants were tested one week apart. The reliability (ICC) analysis revealed a high 
correlation between the Day 0 and Day 7 scores for all four of the outcome measures, values 
ranged from 0.94 to 0.97. Together these two observations suggest good reliability. In addition 
narrow confidence intervals were found for all ICCs, further supporting the strength of the 
reliability results. 
Standard Error of Measurement (SEM) scores were calculated for all outcome measures. These 
provide an indication of the precision of the outcome measure. For the T25FW the SEM was 4.6s, 
for the 6MWT the SEM was 27.5m, for the TUG the SEM was 3.6s and for the BBS the SEM was 
2.4  (a change of score of 3 points). 
By using the above SEM scores the MDC was calculated for each outcome measure with results 
displayed in Table 6.2. It emerged that for the T25FW, a change of 12.6s would be required before 
a change in score would suggest a clinical improvement or decline in a person's walking 
performance across a population of people with MS who had an EDSS of 5 to 6.5. Similarly, the 
following MDC results would suggest a clinical change; 76.2m for the 6MWT, 10.6s for the TUG, 
and 7 points (rounded up from 6.5) for the BBS. These results should be considered alongside the 
mean day 0 scores, displayed in Table 6.2. 
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Table 6.2 Results from each outcome measure assessed for reliability 
Test  Day 0 
mean 
(SD) 
Day 7 
mean 
(SD) 
95% CI  
day 0 
95% CI 
day 7 
p-
value 
ICC 95% 
CI 
ICC 
SEM MDC95 
 
T25FWa 
(s) 
17.98 
(18.6) 
 
19.98 
(28.9) 
 
10.12 – 
25.83 
 
7.78-
32.18 
 
0.1531 
 
0.94 
 
0.86-
0.97 
4.6 
 
12.6 
 
6MWT b 
(m) 
246.88 
(135.7) 
 
238.12(
125.1) 
 
189.56 – 
304.19 
 
185.32– 
290.93 
 
0.2622 
 
0.96 0.91-
0.98 
27.5 
 
76.2 
TUGa(s) 22.01 
(21.6) 
 
24.49 
(29.5) 
 
12.87 -
31.15 
 
12.02 -
36.95 
 
0.2411 
 
0.97 
 
0.93-
0.99 
3.8 
 
10.6 
BBSb 
(score) 
45.92 
(12.4) 
 
46.38 
(13.3) 
 
40.66 – 
51.17 
 
40.76-
51.99 
 
0.1151 
 
0.96 
 
0.92-
0.98 
2.4 
 
6.5 
T25FW- Timed 25 foot walk, 6MWT- Six-minute walk test, TUG-Timed Up and Go,BBS-Berg Balance 
Scale. 
 p-values calculated between mean scores at day 0 and day 7, ICC – Intraclass correlation coefficient, SEM –
Standard error of the measurement, MDC – Minimal Detectable Change.                             
a Intraclass correlation coefficient (2, 3), b Intraclass correlation coefficient (2, 1), 1Results of Wilcoxon 
Ranks test, 2Results of paired samples t-test. 
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6.4.3 Clinical significance related to Study 1. 
The clinical significance (MDC) is relevant to results from Study 1, in particular the scores for 
percentage change (Section 4.4.5). By using the MDC score from the T25FW, 6MWT, TUG and 
BBS (Table 6.2) it was possible to calculate, based on the mean baseline scores taken during Study 
1 (Table 4.5), whether a clinically significant change (MDC) had occurred at the week 8, week 12, 
month 6 or month 12 assessments. To ease comparison with results already described (section 
4.4.5), the MDC was calculated as a percentage of the baseline score in Study 1 (for each of the 
four outcome measures) with results displayed in Table 6.3.  
For example; the MDC for the T25FW was 12.6s, in Study 1 the mean baseline score for the 
T25FW was 22.1s (Table 4.5), therefore any change of 12.6s (57% of the baseline score) or greater 
may indicate a significant clinical change in the whole sample. 
It can be seen in Table 6.3 that no clinically significant change occurred at any time point in either 
the exercise intervention group, or the control group during Study 1. However, improvements at 
week 8 for the BBS and week 12 for the 6MWT in the intervention group were nearing a clinically 
significant change. Conversely, at the 12 month follow-up for the TUG the control group were 
nearing a clinically significant decline in performance. 
Table 6.3 MDC score (%) related to results from Study 1.  
Outcome 
Measure 
Intervention group Control group 
MDC Percentage change MDC Percentage change 
Week 
8 
Week 
12 
Month 
6 
Month 
12 
Week 
8 
Week 
12 
Month 
6 
Month 
12 
 
T25FW  
 
57% 
 
24% 
 
33% 
 
1.8% 
 
26% 
 
78% 
 
4.2% 
 
19% 
 
20.6% 
 
-47% 
 
6MWT  
 
38% 
 
19% 
 
37%* 
 
18.5% 
 
32% 
 
33% 
 
18% 
 
-2.4% 
 
5.7% 
 
17.7% 
 
TUG  
 
48% 
 
12% 
 
17% 
 
-22% 
 
6.2% 
 
54% 
 
0.8% 
 
17% 
 
18.5% 
 
-46%* 
 
BBS 
 
17% 
 
15%* 
 
12% 
 
12.1% 
 
-2.6% 
 
16% 
 
7% 
 
-8.5% 
 
-3.1% 
 
-5.1% 
Data incorporated from Section 4.4.8 
T25FW- Timed 25 foot walk, 6MWT- Six-minute walk test, TUG-Timed Up and Go, BBS-Berg Balance 
Scale. *Nearing a clinically significant change. 
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6.4.4 Standard deviations 
In the present study (Study 3), large standard deviations were seen for all four tests; in particular 
the T25FW test and the TUG test Table 6.2. In general, the higher standard deviations in all 
measures were in the most disabled group (Table 6.4). One of the more extreme examples of this 
emerged in the most disabled group of participants (EDSS= 6.5) for the follow-up T25FW score. 
The mean time to walk 25-foot was 45.28s, with the standard deviation being 46.18s. 
Table 6.4 Mean reliability scores, comparison between EDSS . 
Test  EDSS n Day 0 mean (SD) Day 7 mean (SD) 
T25FW (s) 5 
5.5 
6 
6.5 
2 
2 
13 
7 
8.4 (0.6) 
10 (1.7) 
11 (3) 
35.9 (28) 
8.1 (0.4) 
9.2 (0.9) 
9.8 (2.5) 
45.3 (46.2) 
6MWT (m) 5 
5.5 
6 
6.5 
2 
2 
13 
7 
415 (161.2) 
272.5 (38.9) 
276.6 (76) 
136.3 (168.4) 
358.5 (57.3) 
262.5 (14.9) 
277.9 (74.4) 
123 (156.2) 
TUG (s) 5 
5.5 
6 
6.5 
2 
2 
13 
7 
10.7 (2.9) 
13.1 (0.2) 
13.3 (3.9) 
44 (31) 
11 (1.1) 
13 (1.2) 
13.1 (3.4) 
52.6 (44.9) 
BBS (score) 5 
5.5 
6 
6.5 
2 
2 
13 
7 
55 (1.4) 
50 (5.7) 
50.9 (5.1) 
33 (16) 
55 (1.4) 
51.5 (2.1) 
51.9 (5.3) 
32.3 (17.1) 
T25FW- Timed 25 foot walk, 6MWT- Six-minute walk test, TUG-Timed Up and Go, BBS-Berg Balance 
Scale 
6.4.5 Summary of results  
Results from this study suggest that when the T25FW, 6MWT, TUG and the BBS are assessed by a 
single assessor seven days apart the outcome measures are reliable, producing high ICC scores. 
MDC change scores and SEM scores for each outcome measure were calculated and should be 
considered alongside the SDs which emerged across the study population.  
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6.5 Discussion 
Motivated by a need to establish the clinical significance of changes seen in outcome measures 
used in MS, this study used quantitative analysis to investigate the reliability of four outcome 
measures used in Study 1 (Chapter 4), the T25FW, 6MWT, TUG and BBS. All four outcome 
measures have been used in past MS physiotherapy and therapeutic exercise research (as can be 
seen in Tables 2.5-2.7). The results of this study found good test-retest reliability for the T25FW, 
6MWT, TUG, BBS in a group of 24 clinically stable people with MS who had an EDSS score of 5-
6.5.  
Clinically significant change (MDC) was established for all four outcome measures. For the 
T25FW a change of 12.6s was found to indicate a clinically significant change, similarly for the 
6MWT a 76.2m change would indicate a clinically significant change, whilst for the TUG the 
MDC was 10.6s, and for the BBS the MDC was 7 points. These results allow for more detailed 
analysis of the results found in Study 1 (Chapter 4). 
The precision of the four outcome measures was calculated based on the SEM. For the T25FW a 
SEM of 4.5s emerged, for the 6MWT the SEM was 27.5m, for the TUG the SEM was 3.8s and for 
the BBS the SEM was 3 points. 
6.5.1 Test re-test reliability  
High correlation (ICC) scores were found for all four measures with no significant differences 
between the mean scores, indicating that in a group of people moderately affected with MS (EDSS 
5-6.5), the outcome measures are reliable. This finding is generally similar to other studies that 
have calculated test re-test reliability for the 6MWT, TUG and BBS. However for the T25FW, 
where results indicated good reliability (ICC=0.94) no study could be found testing reliability one 
week apart and thus there are no studies with which to compare results. 
Results from the 6MWT (ICC=0.96) were comparable to the two previous studies which 
established reliability using similar methodology to this study (Paltamaa et al 2005; Fry and Pfalzer 
2006). In people less disabled by their MS symptoms Paltamaa et al  (2005) reported an ICC of 
0.96 (mean participant EDSS=5.26), whilst  Fry and Pfalzer (2006) reported a similar ICC of 0.96 
(mean participant EDSS=3.6). Thus, these combined results indicate the 6MWT is a reliable 
outcome measure across a wide disability range in people with MS. 
The present study indicates that reliability of the TUG appears to be good (ICC=0.97). This finding 
supports the data provided by Nilsagard et al (2007), who found that in those with MS (EDSS>4), 
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test re-test reliability one week apart produced an ICC of 0.88. Taken together these results also 
suggest the TUG appears reliable in a moderately disabled MS population. 
The BBS also appears reliable in people with moderate disability in MS, where the high reliability 
results (ICC=0.96) found in this study add to Paltamaa et al’s findings (ICC=0.85), in a smaller 
group (n=10) of people with MS, who were slightly less disabled than those in this study.  
Taken together with findings from past studies, in a clinically stable MS population of moderate 
disability, the T25FW, 6MWT, TUG and BBS appear reliable when assessed by one 
physiotherapist one week apart. This strengthens the findings from the main investigation (Study 
1), as test-retest reliability is confirmed.  
6.5.2 Clinical Significance (Minimal Detectable Change)  
To determine clinical significance of the four assessed outcome measures, MDC values were 
calculated. MDC values should be considered alongside the mean scores and the resultant standard 
deviation scores (Table 6.2 and Table 6.4). Using the formula described in the methods section 
(6.3.2) it was possible to calculate MDC values from the relevant past literature, as this value has 
not previously been calculated by many authors. Thus, the MDC values found in this study can be 
compared with past literature whilst also indicating the clinical significance (based on baseline 
scores in Study 1 and the MDC) from the results in Study 1 (Chapter 4).   
For the 6MWT the MDC was 73.2m. Clinically this would mean that if a person with moderate MS 
were initially assessed in the clinic using the 6MWT, and then on reassessment the distance walked 
following the 6MWT protocol was 73.2m greater or lesser, this would be an indication that a 
clinically significant change had occurred. This result can be compared with past studies where the 
MDC scores were 85m (Paltamaa et al 2005) and 106m (Fry and Pfalzer 2006). Participants in 
these past studies were less disabled, suggesting that varying levels of disability may influence the 
MDC scores for the 6MWT. 
Relative to the mean 6MWT scores at baseline in Study 1, at no time point did the intervention or 
control group as a whole sample achieve a clinically significant score. The overall finding indicates 
that the exercise intervention in Study 1 did not result in a clinically significant change in 
mobility/endurance measured with the 6MWT, with no clinically significant change seen in the 
control group. 
Results from the BBS found a MDC of 7 points. In comparison, the results of the study by 
Paltamaa et al (2005), in participants who had a mean EDSS of 5.26, were calculated to be lower 
(MDC=3 points). This suggests that further work is required to indicate whether disability level 
will influence MDC scores. A larger change in the BBS may be required to show clinically 
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significant change in those more disabled with MS. In relation to results from Study 1, at no time 
point did the results of the intervention and control groups, as a whole sample, achieve a clinically 
significant change. However, at week 8 the mean change in the intervention group’s BBS score 
was near that which would indicate a clinically significant change. 
Whilst analysing the results for the BBS, a very high Cronbach’s α (α=0.96) was found; indicating 
that some of the items tested with the BBS  may be measuring the same aspect of balance more 
than once (Norman and Streiner 2007).  However further clinical and statistical analysis would be 
required to verify the importance of this finding and to establish which items on the BBS may be 
repetitive.  
For the TUG the MDC was 10.6s. This is high relative to the mean score (22.01s) at day 0.  It was 
calculated in Nilsagard et al’s (2007) study of 43 participants that the MDC was 12.2s. Relative to 
the mean day 0 score (13.9s) for their participants’ TUG score, the MDC is also high. Thus, further 
work is required to determine whether calculating MDC scores for the TUG in a moderately 
disabled group of people with MS are an appropriate indicator of clinical change.  
However, by utilising the MDC score found in this study (10.6s), and comparing it with results 
from Study 1 it was possible to establish if any clinical significant change occurred at any specific 
time point. Overall, at no time point during Study 1 did a clinically significant change in TUG 
score occur in either group, on average, based on the calculated MDC score.  
As has been acknowledged reliability has not been established for the T25FW in the past MS 
research and thus clinical significance results from the present study, which found a high MDC of 
12.6s that cannot be compared with other work. As with the TUG score, the MDC score is high 
considering the mean T25FW score (17.98s) at day 0. In addition, by considering the MDC for the 
T25FW with the results from Study 1 at no time did the mean score, from either the intervention or 
the control groups achieve the MDC score. This suggests that the intervention did not result in a 
clinically significant change, across the whole sample, in mobility measured with the T25FW and 
that there was no clinically significant change in the control group.  
The practicalities of using the MDC score as an indicator of clinical significance may be strongly 
influenced by large standard deviations found across a group of participants; although the 
established MDC scores may be useful when assessing the individual. In this study high standard 
deviations were found which may have led to the high change scores indicated for the T25FW and 
TUG. Large standard deviations may have also led to the lack of clinically significant findings, 
based on the MDC score, from results of Study 1. Using the MDC as an indicator of clinical 
significance has been shown to be problematic in other studies looking across a similarly 
heterogeneous group of disabled children (Haley and Fragala-Pinkham 2006) and people with 
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Parkinson's disease (Steffen and Seney 2008); where high change scores were established for some 
outcome measures, including the TUG. These suggestions coupled with findings from the present 
study suggest it would be advisable therefore, to establish particularly for the T25FW and TUG, 
MDC scores in narrower disability ranges and perhaps seek additional means of determining 
clinical significance. 
6.5.3 Precision (Standard Error of Measurement) 
By calculating the SEM scores, it was possible to suggest the precision of the four outcome 
measures in those with an EDSS of 5-6.5. There has been little work published in this area, making 
comparison difficult. Paltamaa et al (2005) calculated a SEM score for the 6MWT to be 30.7m, 
which is similar to results in the present study; where the SEM was 27.5m. For the BBS, which has 
a total score of 56, Paltamaa et al (2005) found the SEM to be 1 point, similar to the 3 points 
(rounded up from 2.4) in the present study, suggesting the BBS is reasonably precise in those with 
MS who have an EDSS of 5 to 6.5. 
For the T25FW and TUG the SEM was calculated as 4.6s and 3.8s respectively. These results are 
reasonable low, and suggest that the outcome measures are precise in this sample population, 
although further work is required to confirm this. 
6.5.4 Limitations and critique of methods 
This study adds new knowledge to the body of research surrounding outcome measures used to 
monitor the clinical impact and clinical progress in those with MS. The study however is not 
without its limitations. These will now briefly be discussed and, when appropriate, potential 
solutions to overcome these limitations will be suggested for future research. 
The study is limited in that the methodology incorporated a test re-test style, using only one 
assessor. Thus future studies should incorporate inter-rater reliability, similar to the methodology 
adopted by Nilsagard et al (2007) whereby more than one assessor assesses the outcome measure. 
The sample size in this study was relatively small, however, power estimation tables for the design 
of reliability studies (Walter et al 1998) would suggest that, where good reliability was anticipated 
(i.e. between 0.7 and 0.9), a sample of 19 could achieve a power of 80% at the 5% level of 
significance. As the study recruited 24 participants, the study was adequately powered. 
The results can only be applied to those with MS who have an EDSS score of 5 to 6.5, recruiting 
participants with a different EDSS score would improve our understanding of these outcome 
measures in those with MS. In addition, the study participants were recruited from a larger study, 
all of whom had completed the outcome measures previously on a minimum of two occasions. This 
may have had an impact on the results, thus it may be appropriate to assess reliability in a group of 
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participants less familiar with the outcome measures.  In addition the results can only be applied to 
the assessed outcome measures following the standardised protocol (Appendix 9). 
The finding of a high Cronbach’s α for the BBS is a limitation of the BBS. It suggests that some of 
the tasks performed as part of the BBS outcome measure may be capturing similar data to other 
tasks; avoiding duplication when assessing outcome measures is important in a disease population 
known to suffer from fatigue, where succinct outcome measure assessment may minimise the 
impact of fatigue on results. It would be pertinent to investigate this finding further in other groups 
of people with MS. 
6.6  Summary and conclusion 
Accurate measurement of health outcomes is important in both research and clinical practice. This 
Chapter described a test re-test reliability study, where a single physiotherapy assessor assessed 
mobility and balance outcome measures, one week apart, in people moderately affected with MS. 
The results indicate that the assessed outcome measures; the T25FW, 6MWT, TUG and BBS were 
reliable when tested under these conditions. The study also established clinically significant change 
scores for each of the outcome measures alongside establishing the precision of these outcome 
measures in a group of people moderately affected with MS. The calculated MDC scores, from this 
study, for the T25FW, 6MWT, TUG and BBS allowed the results from Study 1 in this thesis 
(Chapter 4) to be more fully described; with no clinically significant changes (using MDC) 
emerging for these four outcome measures at any time during Study 1.  
However, this study also highlighted that using the MDC solely to evaluate the clinical significance 
of the four measures may not be recommended when assessing a heterogeneous MS population. 
For example the heterogeneity of the group, even within the EDSS score 5-6.5 results in much 
variation in balance and mobility, due in part to confounding factors such as gait speed, walking 
aid, or spasticity. 
The results of this study will go some way to help guide future research and clinical practice, and 
add to the current knowledge of outcome measurement in clinical practice and research in people 
with MS. They are unique in that they are the first to describe the reliability, clinical significance 
and standard error of measurement of mobility and balance outcome measures in a group of people 
moderately affected by MS. 
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7 Final conclusions and recommendations 
The aim of this thesis was to investigate the impact of therapeutic exercise on those moderately 
affected with MS. Motivated by the need to establish whether therapeutic exercise had an impact 
on the clinical symptoms and lives of those with MS. Although there is accumulating evidence that 
therapeutic exercise has a beneficial effect in those with MS, there are still unanswered questions in 
this area. The studies in this thesis were designed to address some of these unanswered questions, 
with the following specific aims: 
• To deliver and evaluate, over both the short and longer term, the effects of a 12-week 
community based group exercise class in people moderately affected with MS, against 
controls matched for disability level who received usual care 
• To establish the views and opinions on exercise and a therapeutic exercise intervention 
from those who had undertaken a therapeutic exercise intervention.  
• To establish the test re-test reliability, MDC and SEM of commonly used mobility and 
balance outcome measures (T25FW, 6MWT, TUG and BBS) in people moderately 
affected with MS 
The conclusions of this investigation and recommendations from each study’s findings will now be 
discussed. 
7.1 Overall conclusion 
The study found that participating in a 12-week therapeutic exercise intervention specifically for 
those moderately affected with MS (EDSS 5-6.5) resulted in a number of benefits, although 
compared to a control group of similar participants results were not statistically significant. During 
focus groups, following the 12-week intervention, participants acknowledged that taking part 
helped them to overcome barriers to exercise and benefit in a number of ways.  
Furthermore the study found that the T25FW, 6MWT, TUG and BBS are reliable when assessed by 
the same assessor one week apart in those with MS who have an EDSS score of 5 to 6.5 
7.1.1 Complementary studies 
Both the focus group study (Study 2) and the reliability study (Study 3) complemented the main 
study, the long-term exercise intervention study (Study 1).  
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The findings from Studies 1 and 2, add to the growing evidence that therapeutic exercise is 
beneficial. There was both quantitative and qualitative evidence of the benefits of participating in 
the therapeutic exercise intervention. In Study 1 despite no statistically significant results 
(measured with an ANOVA) to suggest the intervention had a positive effect, other statistical tests 
to quantify a change (effect sizes and percentage change from baseline) provided evidence that the 
intervention had a positive effect. The results from the qualitative study supported some of these 
findings, in that participants felt improvements in balance, some areas of mobility and fatigue, 
whilst also highlighting the importance of the social benefit of the exercise intervention. 
Study 3 established that the four assessed outcome measures (T25FW, 6MWT, TUG and BBS) 
were reliable. Finding that the calculated clinical significance values were large in relation to the 
mean group score for the T25FW and TUG outcomes. In both Study 1 and 2 there was evidence, of 
large standard deviations found for many of the outcome measures. This may explain why no 
statistically significant results emerged in Study 1 and why large clinical significance results 
occurred in Study 3, highlighting the difficulties when undertaking research in a heterogeneous 
disease population such as MS.  
7.1.2 Innovative studies 
All three studies add unique knowledge to the literature and were innovative in a number of ways.  
• Study 1 was different to past studies as it was the first to assess the effect of an exercise 
intervention, delivered in the community, in a group format, to those with MS.  
• Study 2 was the first to capture views and opinions from a group of people with MS using 
focus group methodology.  
• Study 3 was unique as it reported the reliability of mobility and balance outcome measures  
in a group of people with MS all of whom had an EDSS score of 5 to 6.5. Furthermore, it 
was the first to report clinical significance of the four outcome measures, measured by 
minimal detectable change scores, in those with MS. 
The overall investigation contributes unique knowledge to therapeutic exercise for those with MS 
and a number of clinical and research recommendations have emerged.  
7.2 Recommendations from Study 1 
Clinical recommendations 
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• Community leisure centre based group exercise is a feasible option for those moderately 
affected with MS. 
• Combined; aerobic, resistance and balance exercise has a positive effect on people with 
MS, particularly in areas related to physical activity levels, balance, quality of life and 
muscle strength, with no detrimental effect on fatigue. 
Research recommendations 
• Narrowing the EDSS level of study participants in future studies will improve the 
significance of results found in therapeutic exercise studies. This should be based on power 
calculations to determine recruitment. 
7.3 Recommendations from Study 2 
Clinical recommendations 
• Those with MS would like exercise options which would allow them to exercise in an 
environment with others who have similar levels of disability 
• When establishing a therapeutic exercise intervention for those with MS, an educational 
component may help participants. A focus group format may be a potential format for this. 
• A basic understanding of neurological conditions should be expected from those delivering 
exercise interventions to this group of people. 
Research recommendations 
• Adopting qualitative methodology to gather data on the outcome of intervention studies in 
MS will strengthen research findings and offer an insight into new areas which quantitative 
analysis may not capture. 
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7.4 Recommendations from Study 3 
Clinical recommendations 
• When following a standardised protocol the T25FW, 6MWT, TUG and BBS are reliable 
outcome measures to assess mobility and balance in people moderately affected by MS. 
Thus these outcome measures should be used in this patient population. 
Research recommendations 
• Establishing the reliability, clinical significance and precision of these outcomes measures 
across the disability range found in MS should be done.  
• By stratifying participants, based on level of disability, the impact of disability level on the 
clinical significance and precision of these outcome measures may be better established. 
• Standardised methods to calculate both the SEM and MDC should be used in future 
studies. 
7.5 Key recommendations for rehabilitation practice 
• A community based group exercise class should be one service available as part of an 
Integrated Care Pathway for MS. 
• To ascertain what may be required to run such a service, and to establish whether it is a 
feasible option for care pathways in MS consultation between patient representatives, 
physiotherapists and community exercise professionals should be done locally. 
• Personnel involved in service delivery should be trained in exercise delivery to 
neurological populations. 
• Class content should be varied, from a bank of exercise options designed by 
physiotherapists and chosen to benefit each participant’s needs, capabilities and goals.  
• Classes should be available two to three times weekly, for around 60 minutes, be delivered 
by a minimum of two leaders and should be associated with an education component. 
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7.6 Key recommendations for future research 
• Researchers in MS rehabilitation should seek to recruit sufficient numbers of participants 
to enable appropriately powered analyses to be conducted, including allowing for 
stratification of results based on, for example, different levels of disability. 
• Power calculations, to determine recruitment should be based on outcome measures 
appropriate to both the population of interest and the aims of the study. 
• Mixed methodology studies, to include both quantitative and qualitative outcomes would 
enhance understanding of rehabilitation literature in MS.  
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Appendix 1 Expanded Disability Status Scale 
 
0 – Normal neurological exam (all grade 0 in all Functional System (FS) scores*) 
1 – No disability, minimal signs in one FS* (i.e. grade 1) 
1.5 – No disability, minimal signs in more than one FS* (more than 1 FS grade 1). 
2 – Minimal disability in one FS (one FS grade 2, others 0 or 1) 
2.5 – Minimal disability in two FS (two FS grade 2, others 0 or 1) 
3 – Moderate disability in one FS (one FS grade 3, others 0 or 1) or mild disability in three or four 
(three or four FS grade 2, others 0 or 1) though fully ambulatory 
3.5 - Fully ambulatory but with moderate disability in one FS (one grade 3) and one or two FS 
grade 2; or two FS grade 3 (others 0 or 1) or five grade 2 (others 0 or 1) 
4 – Fully ambulatory without aid, self-sufficient, up and about some 12 hours a day despite 
relatively severe disability consisting on one FS grade 4 (others 0 or 1), or combination of lesser 
grades exceeding limits of previous levels; able to walk without aid or rest some 500 metres 
4.5 – Fully ambulatory without aid, up and about much of the day, able to work a full day, may 
otherwise have some limitation of full activity or require minimal assistance; characterised by 
relatively severe disability usually consisting of one FS grade 4 (others or 1) or combinations of 
lesser grades exceeding limits of previous levels; able to walk without aid or rest some 300 metres 
5 – Ambulatory without aid or rest for about 200 metres; disability severe enough to impair full 
daily activities (e.g. to work a full day without special provisions); Usual FS equivalents are one 
grade 5 alone, other 0 or 1; combinations of lesser grades usually exceeding specifications for level 
4. 
5.5 Ambulatory without aid for about 100 metres; disability severe enough to preclude full daily 
activities; (usual FS equivalents are one grade 5 alone, others 0 or 1; or combination of lesser 
grades usually exceeding those for level 4. 
6 – Intermittent or unilateral constant assistance (cane, crutch, brace) required to walk about 100 
metres with or without resting; (usual FS equivalents are combinations with more than two FS 
grade >3) 
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6.5 – Constant bilateral assistance (canes, crutches, braces) required to walk about 20 metres 
without resting; (usual FS equivalents are combinations with more than two FS grade >3) 
7 – Unable to walk beyone approximately 5 metres even with aid, essentially restriced to 
wheelchair, wheels self in standard wheelchair and transfers alone; up and about in wheelchair 
some12 hours a day; (usual FS equivalents are combinations with more than one FS grade >4; very 
rarely pyramidal grade 5 alone) 
7.5 – Unable to take more than a few steps; restricted to wheelchair; may need aid intransfer; 
wheels self but cannot carry on in standard wheelchair a full day. May required motorised 
wheelchair (usual FS equivalents are combinations with more than two FS grade >4) 
8 – Essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed itself 
much of the day; retains many self –care functions; generally has effective use of arm; (usual FS 
equivalents combinations, generally grade >4 in several systems) 
8.5 – Essentially restricted to bed much of the day; has some effective use of arm(s); retains some 
self-care functions; (usual FS equivalents are combinations, generally >4 in several systems) 
9 – Helpless bed patient, can communicate and eat (usual FS equivalents are combinations, 
generally >4 in several systems) 
9.5 – Totally helpless bed patient; unable to communicate effectively or eat/swallow; (usual FS 
equivalents are combinations, generally >4 in several systems) 
10 – Death due to MS 
*Excludes cerebral function grade 1 
Note 1 – EDSS levels 1 to 4.5 refer to patients who are fully ambulatory and the precise level 
number is defined by the FS score. EDSS levels 5 – 9.5 are defined by the impairment to 
ambulation and usual equivalents in FS scores are provided. 
Note 2 – EDSS should not change by 1 level unless there is a change in the same direction of at 
lease one level in a least one FS. 
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Appendix 2 Screening Form 
 
Demographic Data 
 
Today’s date _____________   
Participant ID _______________________ 
Participants name ____________________________________________ 
Date of Birth ______________   Age _________  Sex F_____M____ 
 
Disease diagnosis 007 (please choose only 1) 
Relapsing/Remitting (RR)  ____ 
Primary Progressive (1P)  ____ 
Secondary Progressive (2P)____ 
 
Number of year since original diagnosis (whole years only) _____________ 
 
EDSS Score ___________ MMSE Score ____________
 
(See additional form)  (See additional form) 
 
Eligible for inclusion in study (see page 2)  Yes _______ No ________ 
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Mini Mental State Examination 
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Physical Activity Readiness Questionnaire; Fitness screening form  
 
 Yes No 
Are you physically active at the moment   
Have you suffered from any form of heart trouble?   
Do you frequently have any pains in your heart or chest?   
Do you often feel faint or have spell of severe dizziness?   
Have you fallen more than twice in the past month?   
Has your doctor ever said that your blood pressure was too high or too low?   
Has your doctor ever told you that you have bone or joint problems such as 
arthritis, back problems etc which may be aggravated by exercise? 
  
Are you currently on any prescribed drugs for any heart condition problems or 
blood pressure? 
  
Are you recovering from an illness (other than your MS) or operation   
Do you know of any reason why you should not do any physical activity?   
At this point please remind the participant what the class will involve, and establish if 
they think they will be able to manage it. 
Do you feel you will be able to manage the exercise class for this study?   
 
Comments 
_______________________________________________________________________________
___________________________________________________________________________ 
 
Any advice given 
_______________________________________________________________________________
___________________________________________________________________________ 
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Inclusion Criteria Does this patient have…. Yes No 
Clinically or paraclinically diagnosed MS, based on the most recent additions 
to the diagnostic criteria?   
Primary or secondary progressive MS? 
  
An EDSS score between 5 and 6.5? (See additional sheet) 
 
  
Stable rehabilitation and drug therapy within the past 30 days? 
  
Adequate cognitive function, assessed by the Mini Mental State Examination 
of 24 or over? (See additional sheet)   
Access to either the Galleon Leisure centre or Magnum centre using with own 
transport or patient transport 
 
  
 
If No to any of the above, do not complete the rest of this form. 
 
Exclusion Criteria  Yes No 
Has this patient suffered a recent exacerbation of their MS symptoms within 
the past three months?   
Does this patient  have a rapidly progressing disease? 
  
Does this patient show any signs of severe cognitive deficits? 
 
  
Does this patient have a history of cardiovascular, respiratory, neurological, 
metabolic disease, or any other medical condition which may prevent 
participation in the study? 
  
If other 
what?   
Is this patient unlikely to be able to complete the protocol for the outcome 
measures or the exercise class, as measured by a fitness screening form?   
 
If Yes to any of the above, do not complete the rest of this form. 
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Appendix 3 Assessment form  
 
Protocol & Data collection sheets for Quantitative Assessments 
 
Today’s date _____________   
Participant ID _______________________ Participant Initials ___  ____ 
Date of Birth ___________  Age ___________  Gender___________ 
Weaker Leg left [    ] Right   [    ]  
Height (cm)__________________ Weight (kg)____________________ 
 
Leg Length (cm) (L)_______  (R)_______  
  
Timed 25ft walk test shoes on.  
 
Test  Time  (mins:sec) Time (sec) Comments (not necessary) 
Test 1   
 
 
Test 2 
 
   
Test 3 
 
   
 
Did participant wear AFO          Yes____ No ___ 
Was an assistive device used   Yes ___  No ___ 
If Yes, what?   
Unilateral Assistance  Cane (UCa)_____  Crutch (UCr)  _____ 
Bilateral Assistance   Cane (BCa)  _____ Crutch (BCr) _____ 
Walker/Rollator (WR) _______ 
 
Any other comments (not necessary)____________________________________________ 
 
Temporal Spatial walking assessment. 
 
The participant will walk with shoes on across the Gaitrite carpet whilst they are performing the 25 
ft walk test. Measurements will be recorded on the computer. 
 
Any other comments (not necessary)_________________________________ 
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Overall Stability Assessment using a balance plate Biodex  
with shoes on. 
 
Patient position:  
Left heel    [      ]      Co-ordinates [      ]   Left foot angle    [      ]  
Right heel  [      ]      Co-ordinates [      ]   Right foot angle [      ]  
 
Test 1  
Comments _________________________________________________ 
% Time in zone  
A [        ]    B [       ]   C  [       ]    D [      ] 
% Time in quadrant  
I [        ]    II   [       ]   III  [       ]    IV  [      ]  
 
Stab indx   [        ]   AP Indx    [        ]    ML   [        ] 
Mean Deflect    [       ]  Mean AP def   [       ]    Mean ML def   [       ]  
StDev    [       ]   StDev    [       ]    St Dev        [       ]   
 
Test 2 
Comments _________________________________________________ 
% Time in zone  
A [        ]    B [       ]   C  [       ]    D [      ] 
% Time in quadrant  
I [        ]    II   [       ]   III   [       ]    IV  [      ]  
 
Stab indx   [        ]   AP Indx    [        ]    ML   [        ] 
Mean Deflect    [       ]  Mean AP def   [       ]    Mean ML def   [       ]  
StDev    [       ]   StDev    [       ]    St Dev        [       ]   
 
Test 3 
Comments ________________________________________________ 
% Time in zone  
A [        ]    B [       ]   C  [       ]    D [      ] 
% Time in quadrant  
I [        ]    II   [       ]   III  [       ]    IV  [      ]  
 
Stab indx   [        ]   AP Indx    [        ]    ML   [        ] 
Mean Deflect    [       ]  Mean AP def   [       ]    Mean ML def   [       ]  
StDev    [       ]   StDev    [       ]    St Dev        [       ]   
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Berg Balance Scale 
 
Record the lowest possible score for each item 
In most items, the subject is asked to maintain a given position for a specific time. Progressively 
more points are deducted if: 
• the time or distance requirements are not met 
• the subject’s performance warrants supervision 
• the subject touches an external support or receives assistance from the examiner 
Subject should understand that they must maintain their balance while attempting the tasks. The 
choices of which leg to stand on or how far to reach are left to the subject. Poor judgment will 
adversely influence the performance and the scoring. 
 
Scoring 
 1 SITTING TO STANDING 
INSTRUCTIONS: Please stand up. Try not to use your hand for support. 
( ) 4 able to stand without using hands and stabilize independently 
( ) 3 able to stand independently using hands 
( ) 2 able to stand using hands after several tries 
( ) 1 needs minimal aid to stand or stabilize 
( ) 0 needs moderate or maximal assist to stand 
 
2  STANDING UNSUPPORTED 
INSTRUCTIONS: Please stand for two minutes without holding on. 
( ) 4 able to stand safely for 2 minutes 
( ) 3 able to stand 2 minutes with supervision 
( ) 2 able to stand 30 s unsupported 
( ) 1 needs several tries to stand 30 s unsupported 
( ) 0 unable to stand 30 s unsupported 
If a subject is able to stand 2 minutes unsupported, score full points for sitting unsupported. 
Proceed to item #4. 
 
3 SITTING WITH BACK UNSUPPORTED BUT FEET SUPPORTED ON FLOOR OR ON A 
STOOL 
INSTRUCTIONS: Please sit with arms folded for 2 minutes. 
( ) 4 able to sit safely and securely for 2 minutes 
( ) 3 able to sit 2 minutes under supervision 
( ) 2 able to able to sit 30 s 
( ) 1 able to sit 10 s 
( ) 0 unable to sit without support 10 s 
 
4 STANDING TO SITTING 
INSTRUCTIONS: Please sit down. 
( ) 4 sits safely with minimal use of hands 
( ) 3 controls descent by using hands 
( ) 2 uses back of legs against chair to control descent 
( ) 1 sits independently but has uncontrolled descent 
( ) 0 needs assist to sit 
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5 TRANSFERS 
INSTRUCTIONS: Arrange chair(s) for pivot transfer. Ask subject to transfer one way toward a 
seat with armrests and one way 
toward a seat without armrests. You may use two chairs (one with and one without armrests) or a 
bed and a chair. 
( ) 4 able to transfer safely with minor use of hands 
( ) 3 able to transfer safely definite need of hands 
( ) 2 able to transfer with verbal cuing and/or supervision 
( ) 1 needs one person to assist 
( ) 0 needs two people to assist or supervise to be safe 
 
6 STANDING UNSUPPORTED WITH EYES CLOSED 
INSTRUCTIONS: Please close your eyes and stand still for 10 s. 
( ) 4 able to stand 10 s safely 
( ) 3 able to stand 10 s with supervision 
( ) 2 able to stand 3 s 
( ) 1 unable to keep eyes closed 3 s but stays safely 
( ) 0 needs help to keep from falling 
 
7 STANDING UNSUPPORTED WITH FEET TOGETHER 
INSTRUCTIONS: Place your feet together and stand without holding on. 
( ) 4 able to place feet together independently and stand 1 minute safely 
( ) 3 able to place feet together independently and stand 1 minute with supervision 
( ) 2 able to place feet together independently but unable to hold for 30 s 
( ) 1 needs help to attain position but able to stand 15 s feet together 
( ) 0 needs help to attain position and unable to hold for 15 s 
 
8 REACHING FORWARD WITH OUTSTRETCHED ARM WHILE STANDING 
INSTRUCTIONS: Lift arm to 90 degrees. Stretch out your fingers and reach forward as far as you 
can. (The recorded measure is 
the distance forward that the fingers reach while the subject is in the most forward lean position. 
When possible, ask subject to use both arms when reaching to avoid rotation of the trunk.) 
( ) 4 can reach forward confidently 25 cm (10 inches) 
( ) 3 can reach forward 12 cm (5 inches) 
( ) 2 can reach forward 5 cm (2 inches) 
( ) 1 reaches forward but needs supervision 
( ) 0 loses balance while trying/requires external support 
 
9 PICK UP OBJECT FROM THE FLOOR FROM A STANDING POSITION 
INSTRUCTIONS: Pick up the shoe/slipper, which is in front of your feet. 
( ) 4 able to pick up slipper safely and easily 
( ) 3 able to pick up slipper but needs supervision 
( ) 2 unable to pick up but reaches 2-5 cm(1-2 inches) from slipper and keeps balance 
independently 
( ) 1 unable to pick up and needs supervision while trying 
( ) 0 unable to try/needs assist to keep from losing balance or falling 
 
10 TURNING TO LOOK BEHIND OVER LEFT AND RIGHT SHOULDERS WHILE 
STANDING 
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 INSTRUCTIONS: Turn to look directly behind you over toward the left shoulder. Repeat to the 
right. (Examiner may pick an object 
to look at directly behind the subject to encourage a better twist turn.) 
( ) 4 looks behind from both sides and weight shifts well 
( ) 3 looks behind one side only other side shows less weight shift 
( ) 2 turns sideways only but maintains balance 
( ) 1 needs supervision when turning 
( ) 0 needs assist to keep from losing balance or falling 
 
11 TURN 360 DEGREES 
INSTRUCTIONS: Turn completely around in a full circle. Pause. Then turn a full circle in the 
other direction. 
( ) 4 able to turn 360 degrees safely in 4 s or less 
( ) 3 able to turn 360 degrees safely one side only 4 s or less 
( ) 2 able to turn 360 degrees safely but slowly 
( ) 1 needs close supervision or verbal cuing 
( ) 0 needs assistance while turning 
 
12 PLACE ALTERNATE FOOT ON STEP OR STOOL WHILE STANDING UNSUPPORTED 
INSTRUCTIONS: Place each foot alternately on the step/stool. Continue until each foot has 
touched the step/stool four times. 
( ) 4 able to stand independently and safely and complete 8 steps in 20 s 
( ) 3 able to stand independently and complete 8 steps in > 20 s 
( ) 2 able to complete 4 steps without aid with supervision 
( ) 1 able to complete > 2 steps needs minimal assist 
( ) 0 needs assistance to keep from falling/unable to try 
 
13 STANDING UNSUPPORTED ONE FOOT IN FRONT 
INSTRUCTIONS: (DEMONSTRATE TO SUBJECT) Place one foot directly in front of the other. 
If you feel that you cannot place 
your foot directly in front, try to step far enough ahead that the heel of your forward foot is ahead 
of the toes of the other foot. (To 
score 3 points, the length of the step should exceed the length of the other foot and the width of the 
stance should approximate the 
subject’s normal stride width.) 
( ) 4 able to place foot tandem independently and hold 30 s 
( ) 3 able to place foot ahead independently and hold 30 s 
( ) 2 able to take small step independently and hold 30 s 
( ) 1 needs help to step but can hold 15 s 
( ) 0 loses balance while stepping or standing 
 
14 STANDING ON ONE LEG 
INSTRUCTIONS: Stand on one leg as long as you can without holding on. 
( ) 4 able to lift leg independently and hold > 10 s 
( ) 3 able to lift leg independently and hold 5-10 s 
( ) 2 able to lift leg independently and hold ≥ 3 s 
( ) 1 tries to lift leg unable to hold 3 s but remains standing independently. 
( ) 0 unable to try of needs assist to prevent fall 
Mark these in the following table 
 
(      ) TOTAL SCORE (Maximum = 56) 
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PhoneFITT (Activity monitoring) 
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Timed Up & Go test (following Shumway-Cook, 2000 basic protocol) 
Participants can use any assistive device they normally use. 
 
Test number Time Comments 
Test 1  
 
  
Test 2 
 
  
Test 3 
 
  
 
Assistive device used  _______________________________________  
Any other comments _________________________________________ 
 
 
Assessing lower limb (quadriceps) strength,  
 
 
Distance (cm) 
Patella Apex to Mark 
(1), proximal to M 
malleoli 
Left leg  Right leg  
 
 
                                      
 
                                                             
 
 
 
 
 
 
 
 
Test number Left leg (kg) Right leg (kg) Comments 
Test 1 
 
   
Test 2 
 
   
Test 3 
 
   
 
Any other comments _________________________________________ 
 
Six-minute walking test  
 
 
Assistive device used  _______________________________________  
 
 
Test  Distance Comments 
1 
 
  
  
 
Borg pre-test _________________ 
 
Borg post-test  _________________ 
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The Goal Attainment Scale  
Negotiate 3 of the following options. 
 
Goal 1  [  ] Improve walking speed over 25ft 
Goal 2  [  ] Improve distance walked over 6MWT 
Goal 3   [  ] Improve functional strength (TUG) 
Goal 4   [  ] Improve lower limb strength (HHD) weaker leg 
Goal 5  [  ] Improve lower limb strength (HHD) stronger leg 
Goal 6  [  ]  Improve balance (overall stability) 
Goal 7   [  ] Improve balance (BBS) 
Goal 8    [  ]  Improve balance (ABC) 
Goal 9    [  ] Improve social interaction 
Goal 10  [  ]  Improve perceived quality of life (LMS QoL) 
Goal 11  [  ] Improve perceived levels of anxiety and disability (HADS) 
Goal  12 [  ] Attend the exercise programme 
Goal 13  [  ] Improve perceived levels of fatigue 
Goal 14  [  ] Other (but it is necessary to agree 5 outcomes, see accompanying instructions, and 
complete in second table below) 
  
Each goal is weighted according to its importance to the patient (3-pt scale) either 1 (fairly 
important), 2 (very important), and 3 (extremely important) 
 
Each goal is weighted according to the anticipated difficulty (according to the patient & the 
research team) (3-pt scale) 1 (probable), 2 (possible), or 3 (doubtful). 
 
 
Chosen Goal Importance (1, 2, 3) Perceived difficulty (1,2,3) 
   
   
   
 
  Goal option 14  
Goal Attainment 
Level 
Score  
Best anticipated  
outcome 
+2  
More than 
expected  
outcome 
+1  
Expected outcome 0  
Less than 
expected  
outcome 
-1  
Unfavourable 
outcome 
-2  
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Appendix 4 Questionnaire Outcome Measures 
Instructions for participants  
 
Please complete the following four short questionnaires whilst you await the assessor. There are 
questions on both sides. Please answer all questions. 
 
 
 
Leeds MS Quality of Life Scale Scoring Grid (LMSQoL) 
 
Please read the following questions and circle a score which most describes how you have felt in 
the past month. 
 
 Very much Quite a 
lot 
A little Not at all 
My health has affected my  
relationships with my family 
 
3 
        
 
2 
                     
 
1 
       
 
0 
 
I have felt lonely 
 
3       
              
2 
         
1 
       
0 
        
 
I have felt good about my 
appearance 
 0 
 
1 2 3 
I have worried about my health 
 
3 2 1 0 
I have worried about other 
peoples attitudes about me 
 
3 2 1 0 
I have felt tired 
 
3 2 1 0 
I have had as much energy as 
usual 
 
0 1 2 3 
I have felt happy about the 
future 
 
0 1 2 3 
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Fatigue Severity Scale (FSS) 
Read each statement and circle the number which best indicates how much you agree. Low 
numbers indicate you don’t agree, higher numbers indicate stronger agreement. 
During the past week, I have found that: Score 
1. My motivation is lower when I am fatigued. 1 2 3 4 5 6 7 
2. Exercise brings on my fatigue. 1 2 3 4 5 6 7 
3. I am easily fatigued. 1 2 3 4 5 6 7 
4. Fatigue interferes with my physical functioning 1 2 3 4 5 6 7 
5. Fatigue causes frequent problems for me 1 2 3 4 5 6 7 
6. My fatigue prevents sustained physical functioning. 1 2 3 4 5 6 7 
7. Fatigue interferes with carrying out certain duties and 
responsibilities. 
1 2 3 4 5 6 7 
8. Fatigue is among my three most disabling symptoms. 1 2 3 4 5 6 7 
9. Fatigue interferes with my work, family, or social life. 1 2 3 4 5 6 7 
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Appendix 5 Ethical approval 
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Appendix 6 Research and Development approval 
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Appendix 7 Invitation letter 
 
 
 
  
 
 
 
 
  
Dear Sir/Madam 
I am writing to inform you of a study taking place in association with the Douglas Grant 
Rehabilitation Centre and the University of Glasgow.  Yvonne Learmonth, a Physiotherapist and 
PhD student under my supervision, is organising a study which will investigate the effects of a 
leisure centre based exercise programme on people mildly to moderately affected by MS.  
 
Remaining as active as possible is particularly important for you and your MS symptoms. Past 
studies in those less severely affected by MS have found MS symptoms such as walking difficulty, 
reduced strength, poor balance and fatigue can be improved by exercise. Therefore, we would like 
to investigate if any similar benefits might occur in those more affected with MS-related problems. 
To do this we need participants to take part in a 12-week, twice-weekly exercise class at a local 
leisure centre. We will then monitor participants after 6 and 12 months to see the effects of the 
exercise class in the long term 
 
Please note that as this is a research study we will have two groups of people; one group which 
undertakes the exercise programme and one group who doesn’t and you could be allocated to either 
group.  The group which is not exercising will continue to access any physiotherapy or other care 
they require.  After the 12 weeks all participants will be informed of exercise options available to 
them, and will have access to the local authority exercise referral scheme, which offers expert 
advice in staying as healthy as possible and remaining active.  Part of the scheme also offers 
discounts for leisure activities which may be of benefit.  
 
If you feel you may benefit from participating in this study, then please take the time to read the 
participant information sheet enclosed.  If you have questions and/or are interested in taking part 
then please contact: 
Yvonne Learmonth who is the main researcher - 
Telephone:  0141 330 xxxx or Email:  xxxxxx@xxxxxx 
 
PLEASE CONTACT YVONNE BY THURSDAY 20TH May 2010  
IF YOU ARE INTERESTED IN PARTICIPATING. 
 
In addition should you have any further queries related to the study please do not hesitate to contact 
me.  
 
Yours sincerely 
Dr Paul G Mattison, Consultant Physician in Rehabilitation Medicine 
The Douglas Grant 
Rehabilitation Centre 
Ayrshire Central Hospital 
Kilwinning Road 
IRVINE 
Ayrshire      KA12 8SS 
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Appendix 8 Participant Information Sheet  
   
 
 
 
 
 
For the study entitled: 
The effectiveness of a 12 week community based group exercise class for people moderately 
affected with Multiple Sclerosis. 
 
 
The above study is the first part of a larger project being undertaken by Yvonne Learmonth a 
physiotherapist and PhD student at The University of Glasgow, under the supervision of Dr Lorna 
Paul, University of Glasgow and Dr Paul Mattison, Douglas Grant Rehabilitation Centre, Ayrshire 
Central Hospital.  
 
You will also have received an invitation letter to take part from Dr Mattison, as stated the study is 
to assess the effects of a group exercise class for people with MS living in Ayrshire. The study is 
being undertaken in collaboration with NHS Ayrshire & Arran, the Division of Nursing and 
Healthcare at The University of Glasgow, East Ayrshire Leisure and North Ayrshire Leisure 
services.  
 
Before you decide whether or not to take part it is important for you to understand why the research 
is being undertaken and what it will involve.  Please take time to read the following information 
carefully and discuss it with others if you wish.  Ask us if there is anything that is not clear or if 
you would like more information.   
 
It is important that you are aware that consenting to take part means that you may be randomly 
allocated to either the exercise group or the usual care group, however all participants will be 
offered referral into exercise referral schemes on completion of the study. Thank you in advance 
for taking the time to read this and to decide whether or not you wish to take part. 
 
Part 1: Basic study information  
 
What is the purpose of the study? 
There is evidence to suggest that remaining active and exercising can help prevent many health 
problems and can help people improve their mood and encourage social interaction. This is as true 
for people with MS as for those without. From previous studies in those less severely affected with 
MS symptoms, we know that organised exercise classes can increase strength, mobility, exercise 
tolerance and can have an effect on mood and fatigue. However we don’t know yet what the affects 
are in those more severely affected. This study will look at whether a 12 week, twice weekly 
exercise programme in a local leisure centre is effective in improving mobility, balance, strength, 
fatigue and mood. We will also gather patients’ opinions of the exercise therapy classes, and 
follow-up patients progress after 6 and 12 months.  
 
 
Why have I been chosen? 
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You have been identified by Dr Mattison as someone who has MS and   who may benefit from this 
type of intervention and therefore suitable for inclusion in the study. 
 
 
Do I have to take part? 
Taking part in research is entirely voluntary; therefore it is up to you to decide. We will describe 
the study and then go through the information sheet with you, which you can then keep.  
 
If you are interested in taking part you should phone Yvonne Learmonth (contact details are at the 
end of this sheet), who will explain the study in further detail. 
 
An initial appointment will then be made for you to come to the Douglas Grant Rehabilitation 
Centre where we will explain the study further and you will then be asked to sign a consent form to 
show that you agree to take part. If you decide to take part you are still free to withdraw at any 
time and without giving a reason.  A decision to withdraw at any time, or a decision not to take 
part, will not have any effect on the standard of care you receive. 
 
What will happen to me if I take part? 
The study will aim to recruit 52 people with MS. You will initially be involved for 3 months. 
Because we need to find out whether or not the treatment is effective, or whether any benefits 
would have occurred anyway it is necessary to compare two groups and you may be allocated to 
either group. One group will be invited to attend a twice weekly group exercise class at a local 
leisure centre. The class will be supervised by 2 instructors specifically trained in exercise therapy 
for people with MS and will last approximately 60 minutes. It will take the form of a circuit class, 
where different levels of each exercise will be available to you, aerobic, strengthening and balance 
exercises will all be included. On completion of the 12 week class you will be invited to give your 
views during a recorded focus group. The second group will receive usual-care, and if you require 
any physiotherapy treatment during the study this will be available to you as normal. Group 
allocation will be randomly allocated by a computer 
 
All participants (both groups) will be assessed at the beginning of the study, 8 weeks into the study, 
12 weeks into the study (ie at the end of the exercise class), 6 months and 12 months after the 
classes. The assessments will involve measuring your walking ability, balance and lower limb 
strength. We will also measure your perceived levels of fatigue, mood and quality of life, and we 
will take the opportunity to set realistic goals for you to achieve during the study. These 
assessments will be carried out in the Douglas Grant Rehabilitation centre by a registered 
physiotherapist. Following the initial 12 weeks all participants will be given information on 
exercise and activity options available to them in their local leisure centres and will be offered 
inclusion into the exercise referral schemes, these offer advice on healthy living and discounts on 
local authority leisure facilities.  
 
What do I have to do? 
You will have to attend five appointments at the Douglas Grant Rehabilitation Centre. Patients in 
the exercise group will also have to attend the twice weekly exercise class for the 12 weeks of the 
study. 
Disadvantages/risks of taking part  
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There are no expected risks, side effects or disadvantages expected from taking part in this study. 
However as with all exercise those taking part in the exercise group may notice some soreness or 
tiredness associated with the class. 
 
What are the possible benefits of taking part. 
We cannot promise that the study will help, however the information from this study will help 
improve treatment of other people with MS.  It may be that leisure centres continue the exercise 
class on a long term basis. 
 
Expenses and payment 
The exercises classes will be free during the study, however you will be required to make your own 
travel arrangements to access the classes. There may be a possibility that patient transport 
(ambulances and volunteer drivers) may be organised if are unable to make your own way to the 
hospital for assessment purposes.  
 
What happens when the research study stops? 
On completion of the initial 12 week class, all participants will be given information on exercise 
and activity options available to them in their local leisure centres and will be offered inclusion 
into the exercise referral schemes; offering advice on healthy living and discounts on local 
authority leisure facilities. After the 12 months of access to the exercise referral scheme you will 
still be able to access local authority exercise facilities, however this may no longer be at a 
discounted rate.  
 
Will my taking part in this study be kept confidential? 
Yes, all information collected from you during the study will be kept strictly confidential and 
treated with normal ethical and legal practice for data collection. With your consent we will inform 
your own GP about your involvement in this study. 
 
If the information in Part 1 interests you, and you are considering taking part please read the 
additional Part 2 information. 
 
 
Part 2: Additional Information  
 
What happens if new information becomes available? 
Sometimes new treatment information becomes available. Although this is unlikely should this 
happen during the study the researcher will tell you and discuss whether you should stay in the 
study. If you decided not to continue the researcher will arrange for you to receive usual 
physiotherapy care. If you decide to continue you may be asked to sign an updated consent form. 
You may also be recommended by the researcher to withdraw from the study, we will explain the 
reasons and arrange for you to receive usual physiotherapy care. If the study is stopped for any 
other reason we will inform you, and arrange for you to receive usual physiotherapy care. 
 
What will happen if I don’t want to continue in the study? 
You can withdraw at any time, however we would encourage you to keep in contact with us and let 
us know your progress. The information collected from you will still be used.  
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What if there is a problem? 
 
Should you have a concern about any aspect of the study you should contact the main researcher 
(see contact details below) in the first instance, she will do her best to answer any questions. If this 
does not resolve the issue, and you would like to formally complain you can do this through the 
NHS Complaints Procedure details can be obtained from the Patients, Relations and Complaints 
Office tel: 01292 51xxxx. Independent advice about the study can be obtained from Dr Anna 
O’Neill tel: 0141 330 xxxx. 
 
 
What happens to the results of the research study? 
It is intended that the results of the study be used as part of a PhD student’s thesis and will be 
published in smaller reports, all data will be anonymised before this. Should you wish to know the 
results of the study then we will send you a copy of the main findings once the research is complete.  
 
Who is organising funding the research?  
This study is funded by NHS Ayrshire and Arran 
 
 
Who has reviewed this study? 
All research in the NHS is looked at by the Research Ethics committee, an independent group of 
people who aim to protect patient safety, rights, well being and dignity. This study has been 
reviewed and given favourable opinion by the West of Scotland Research Ethics committee. 
 
Participation, further information and contact details. 
Should you wish to take part in this study or if you require any further information about this 
research study, want further advice as to whether you should participate or have any concerns 
during the study please do not hesitate to contact the main researcher on the number below 
 
Yvonne Learmonth 
PhD Student 
School of Nursing & Healthcare 
The University of Glasgow 
59 Oakfield Avenue 
Glasgow 
G12 8LW 
 
Tel: 0141 330 xxxx 
Email xxx@xxx 
 
 
 
Thank you for taking the time to read this information sheet. 
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Appendix 9 Assessor Instructions 
 
Instructions for Assessor 
Equipment required for every session; 
 
Blank assessment sheets  
Participant assessment folders  
Stopwatch  
Ruler (for Berg balance)  
5 + Cones (for walking assessments/TUG) 
2 x average height chairs (one with arms, one without 
arms, please use the same chairs in all assessments) 
Small step/stool 
Tape (to mark out 6MWT)  
Pen with string  
Card to cover biodex screen  
 
 
3 x Clipboard (Borg on back)  
Biodex system  
Gaitrite System, including PC  
Hand-held dynamometer 
Large Borg scale   
Wheel chair 
Room for the walking assessments, 30m for the 
6MWT 
Felt Pen (for marking on skin)  
Scales (seated) 
Water 
Stand and reach scale  
Height measure 
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Order of testing  
 
Protocol 1 Protocol 2 Protocol 3 
Demographic data Demographic data Demographic data 
Timed 25ft walk 
Gaitrite 
6 MWT Berg Balance 
Balance plate Berg Balance  Balance plate 
Berg Balance  PhoneFITT questionnaire Timed 25ft walk 
Gaitrite 
Leg extensor strength Balance Plate PhoneFITT questionnaire 
PhoneFITT questionnaire Leg extensor strength Timed Up and Go 
Timed Up and Go Timed Up and Go Leg extensor strength 
6 MWT Timed 25ft walk 
Gaitrite 
6 MWT 
 
 
Timed 25ft walk test  
 
o A 25 ft course (7.32m) course will be marked with cones. 
o Place a seat at either end if required 
o The patient will start a few feet before the first cone 
o They will be instructed to walk at their own pace to beyond the second cone. 
o The assessor can walk with the participant, but avoid dictating the pace. 
o The time will be recorded from passing the first cone till passing the second cone. 
This test will be repeated three times  
 
During the test they will walk across the gaitrite carpet. 
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Temporal Spatial assessment 
 
The participant will walk across the Gaitrite carpet with their shoes on whilst they are performing 
the 25 ft walk test. Measurements will be recorded on the computer. 
 
 
6-minute walk test 
 
o A set of cones will be placed 30m apart 
o Tape will be placed along the corridor every 3 m 
o The participant will start in standing, in-line with the first cone (shoes on). 
o At this point they will be asked to rate their perceived dyspnea using the Borg 
Scale (show to participant) 
o They will be asked to walk at their own speed using any walking aid of their choice, 
straight to the next cone, and around it, and then walk straight to the first cone. This pattern 
will be repeated for 6 minutes. 
o Give instruction 1 
o During test Give instructions 2 
 
o The distance walked will be recorded. 
o After the 6 minutes, ask and record their Borg rating (RPE). 
o If they stopped say  
“What, if anything, kept you from walking farther?” 
 
 
 
 
 
 
 
 
 
 
 
Borg 10 Point Scale 
• 0 - Nothing at all  
• 1 - Very light  
• 2 - Fairly light  
• 3 - Moderate  
• 4 - Some what hard  
• 5 - Hard  
• 6  
• 7 - Very hard  
• 8  
• 9  
• 10 - Very, very hard  
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•  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Instruction 1 (for 6MWT) 
“The object of this test is to walk as far as possible for 6 minutes. You will 
walk back and forth in this hallway. Six minutes is a long time to walk, so 
you will be exerting yourself. You will probably get out of breath or become 
exhausted. 
You are permitted to slow down, to stop, and to rest as necessary. You may 
lean against the wall while resting, but resume walking as soon as you are 
able.  
You will be walking back and forth around the cones. 
You should pivot briskly around the cones and continue back the other way 
without hesitation. Now I’m going to 
show you. Please watch the way I turn without hesitation.” 
 
Demonstrate by walking one lap yourself. Walk and 
pivot around a cone briskly. 
 
“Are you ready to do that? I am going to use this counter to keep track of 
the number of laps you complete. I will click it each time you turn around 
at this starting line. 
Remember that the object is to walk AS FAR AS POSSIBLE 
for 6 minutes, but don’t run or jog. 
Start now, or whenever you are ready.” 
Instructions 2 (for 6MWT) 
After the first minute, tell the patient the following (in even tones): “You are doing 
well. You have 5 minutes to  go.” 
When the timer shows 4 minutes remaining, tell the patient the following: “Keep up 
the good work. You have 4 minutes to go.” 
When the timer shows 3 minutes remaining, tell the patient the following: “You are 
doing well. You are halfway done.” 
When the timer shows 2 minutes remaining, tell the patient the following: “Keep up 
the good work. You have only 2 minutes left.” 
When the timer shows only 1 minute remaining, tell the patient: “You are doing 
well. You have only 1 minute to go.” 
Do not use other words of encouragement (or body language 
to speed up). 
If the patient stops walking during the test and needs a rest, say this: “You can 
lean against the wall if you would like; then continue walking whenever 
you feel able.” Do not stop the timer. If the patient stops before the 6 minutes 
are up and refuses to continue (or you decide that they should not continue), wheel 
the chair over for the patient to 
sit on, discontinue the walk, and note on the worksheet the distance, the time 
stopped, and the reason for stopping prematurely. 
When the timer is 15 seconds from completion, say this: 
“In a moment I’m going to tell you to stop. When I do, just stop right 
where you are and I will come to you.” 
When the timer rings (or buzzes), say this: “Stop!” Walk over to the patient. 
Consider taking the chair if they look 
exhausted. Mark the spot where they stopped by placing a bean bag or a piece of 
tape on the floor. 
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PhoneFITT  
 
Ask the questions to each participant, recording the same for all participants and  at each assessment.  
For example: 
For making meals, help them work out an average, if they say all meals, go with 21 in frequency (unless for 
example they are out every Saturday, or visit friends twice a week for dinner) 
For shopping, note the total time out of the house, door-door, not just the time in the shop.  
For Question H (…climbing stairs) if they have stairs in their house, record (on average) how many times 
they go up them in a typical week. 
 
 
 
Timed Up & Go test  
 
Participants can use any assistive device they normally use. 
o A small cone is placed 3m away from the chair the participant is sitting on 
o The participant starts in a seated position, with their back on the chair. 
o The participant is asked to stand up, walk around the cone and sit back down, as quickly 
and safely as possible. 
o This is timed from initially (back leaving chair back) leaving the chair to sitting 
back down (back touching chair back). 
o This test will be repeated three times 
 
 
Leg strength 
 
Assessing lower limb strength, using a Hand-held Dynamometer  
Set the Machine to read KG output. 
 
Baseline testing 
 
o The participant starts in a seated position (with the knee bent at 90 degrees), feet not 
touching the floor, on a raised plinth, without back support. 
o The Hand-held Dynamometer is placed just proximal to the medial malleoli on the anterior 
surface of leg, use the largest pad available. 
o Mark (1) on the leg the position of the top of the dynamometer pad (for 
replication). 
o Measure and record the distance from the Apex (most distal point) of the patella to 
Mark (1), with knees bent at 90 degrees. 
o The participant is asked to cross their arms and straighten their leg against the 
dynamometer. 
o By saying “push as hard as you can after you hear the first beep, STOP pushing 
when you hear the second set of beeps” 
o Repeat the process, by lining up with the above mark. 
o Repeat three times in total, complete the same for the second leg.. 
 
Follow-up testing 
o As above, however to ensure reliability and repeatability measure from the Apex of the 
patella to the distance used in previous testing. Mark (1) 
o During testing line top of HHD pad with Mark (1) 
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Remind them not to move their feet from now on, to try and maintain a stable 
position  and to focus on the point marked on the wall in front of them (use your 
hand to cover the screen), to avoid biofeedback. 
 
“Please now fold your arms across your chest” 
 
 
Berg Balance Assessment  
Complete as per protocol on data collection sheets 
 
Overall Stability  
 
Please set the Biodex balance plate machine as follows): 
 
1. Turn on.  
2. Test Duration: (20 s) 
3. Weight Height (don’t need to enter) 
4. Stability Level (8) 
Read the following 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient position  BOTH FEET 
 
5. Patient position  press START and get the participant to find centre, spend at least 30 s 
acclimatising participant. Press STOP once they are near  the centre. 
6. Patient position  look down at the platform, and add the co-ordinates of how the patient 
is standing..RECORD for follow-up assessments. 
 
 
 
 
 
 
 
 
 
7. Stability test  Press START to release the platform, allow 1 minute for participant to 
acclimatise    Press START to begin test   
8. Perform test three times 
 
 
 
“I am now going to test your balance, in standing, this is a moving platform, 
when you first stand on, it will be stable, then when you are ready it will start 
moving. 
 
Ask the participant to: 
 “stand on the plate please”. 
Participant to stand on biodex (holding on) 
“ Please assume a comfortable position, feet shoulder width apart. (patient can 
hold on at this point), look straight ahead,at the marked cross,when we begin 
testing I will ask you to  and place arms across chest  
(this is the standard position, assessor to note any deviation). 
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Goal Attainment Scale 
 
Goals will be set in collaboration with the participant/assessor.  
 
You will have highlighted the Goal Attainment scale at the start of the assessment, and it is 
anticipated that through the assessment the participant and yourself will have found deficits, and 
areas which could be improved.  
 
Use this knowledge to help the participant choose three realistic goals. Please see Goal options (if 
patient feels strongly about adding personal goal, do so, completing all 5 levels).  
 
The participant is only expected to pick three goals, rate them in order of importance and 
anticipated difficulty. 
 
Each goal is weighted according to its importance to the patient (3-pt scale) either 1 (fairly 
important), 2 (very important), and 3 (extremely important) 
 
Each goal is weighted according to the anticipated difficulty (according to the patient & the 
research team) (3-pt scale) 1 (probable), 2 (possible), or 3 (doubtful). 
 
The patient baseline scores for each goal should be allocated as -1 (unless they cannot be worse, in 
which case they would get a score of -2) 
 
 
 
 
Example of potential Goals using the Goal Attainment Scale  
 
Goal attainment is rated using a 5-point scale where 0 is the expected level of attainment  
• Each goal is weighted according to its importance to the patient (3-pt scale) either 1 (fairly 
important), 2 (very important), and 3 (extremely important) 
• Each goal is weighted according to the anticipated difficulty (according to the patient & the 
research team) (3-pt scale) 1 (probable), 2 (possible), or 3 (doubtful). 
• The patient baseline scores for each goal should be allocated as -1 (unless they cannot be 
worse, in which case they would get a score of -2) 
• Please pick three goals from the below options, if choosing Goal 14 it is necessary to agree 
5 possible outcomes. 
 
  Goal option  1 Goal option 2 Goal option 3 
Goal Attainment Level Score Improve T25FW Improve 6MWT Improve TUG  
Best anticipated  
outcome 
+2 Reduction in time by 
>16% 
Increase in distance 
by >4% 
Reduction in time 
by >17% 
More than expected  
outcome 
+1 Reduction in time by 10-
15% 
Increase in distance 
by 2-4.9% 
Reduction in time 
by 10-17% 
 
Expected outcome 0 Reduction in time by 1-
9% 
Increase in distance 
by 0-2% 
Reduction in time 
by 0-10% 
Less than expected  
outcome 
-1 No reduction in time No increased 
distance 
No increase in 
time for TUG 
Unfavourable outcome -2 Increase in time Decreased distance Reduction in time 
for TUG 
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 Goal option 4 Goal option 5 Goal option 6 Goal option 7 
Score Improve weaker leg 
strength 
 
Improve stronger leg 
strength 
 
Improve OS 
balance 
Improve BBS  
+2 Increase in Nm output  
by >5.35% 
Increase in kg output  by 
>5.35% 
Decrease by 12.5% Increase by >7 
points 
+1 Increase in Nm output 
2-5.35% 
Increase in kg output 2-
5.35% 
Decrease by 1-
12.4% 
Increase by 4-7 
points 
0 Increase in Nm output 
by 0-2.5% 
Increase in kg output by 
0-2.5% 
Decrease by .1-
6.9% 
Increase by 1-3 
point 
-1 No change Nm output 
 
No change kg output 
 
No change in OB 
score 
No change in 
score 
-2  Decrease in Nm 
output 
 Decrease in kg output Decrease in OB 
score 
Reduction in 
score 
 
 
 Goal option 8 Goal option 9 Goal option 10 Goal option 11 
Score Improve ABC 
 
Improve social 
interaction  
Improve LMS QoL 
 
Improve HADS 
 
+2 Increase in overall 
score  by >5% 
Has made positive 
external contact with 
more than one other class 
member (e.g phone call, 
meeting) 
Reduction in score 
by > 2 points 
 
Reduction in 
score by >10% 
 
+1 Increase in overall 
score   2-5% 
Has made positive 
external contact with 
other class member 
Reduction in score 
by >1 point 
 
Reduction in 
score by 5-10% 
 
0 Increase in overall 
score  1-2% 
Plans to make positive 
external contact with 
other class member (s) 
Reduction in score 
by 0-1 points 
 
Reduction in 
score by 0-5% 
 
-1 No change in ABC 
score 
No plans to make 
positive external contact 
with other class member 
(s) 
No change in LMS 
QoL score 
No reduction in 
score  
 
-2 Reduction in ABC 
score 
Not interacting in the 
class with others 
Increase in LMS 
QoL score 
Increase in score 
 
 
 
 Goal option 12 Goal option 13 Goal 14 
 Attend the exercise 
programme 
Improve FSS 
 
Participants own 
+2 Attends > 90% of 
lasses 
Improvement in score by 
>8% 
 
+1 Attends > 80% of 
classes 
Improvement in score by 
4-8% 
 
0 Attends > 70% of 
classes 
Improvement in score by 
0-4% 
 
-1 Attends > 60% of 
classes 
No Improvement in score  
 
 
-2 Attends < 59% of 
classes 
Deterioration in score 
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Appendix 10 Study Consent Form  
 
Patient Identification Number for this study:  
 
 
Title of Project: The effectiveness of a 12-week community based group exercise class for 
people moderately affected with Multiple Sclerosis. 
Name of Researcher: Yvonne Learmonth 
    
Please initial boxes 
 
1. I confirm that I have read and understand the participant information  
      sheet (version 2 dated 24/11/09) for the above study and have had the  
      opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to    
 withdraw at any time, without giving any reason, and without  
 my medical care or legal rights being affected. 
 
2. I understand that data collected during the study may be looked at by  
 individuals from NHS Ayrshire & Arran and The University of Glasgow  
 or from regulatory authorities, I give permission for these individuals to  
 access my records. 
 
4.    I agree to my GP being informed of my participation in this study 
    
 
1. I understand that this is a student project that will result in a PhD thesis  
 that will be marked.  
 
2. I agree to take part in the above study. 
 
3. I understand that agreeing to take part in this study means that I will  
 either be part of the exercise class (intervention) group or the usual care  
 (control) group. 
 
 
 
           
Name of Participant  Date Signature 
 
   
Researcher Date Signature 
 
 
 
*1 copy for participant; 1 copy for researcher and 1 (original) to be kept in medical notes. 
Appendices 
 
267
Appendix 11 Effect size and Percentage (clinical) Change calculations 
Effect sizes (ES) were calculated, using Cohen’s d, analysis (Tyson and Connell 2009). A worked 
example using T25FW data at week 8 (Table 4.4) is shown below. 
 
d=     
( ) ( )
( ) 2/
88
BLSDCBLSDI
CWkBLCIWkBLI
+
−−−
 
 
    d=      
( ) ( )
( ) 2/138.21
4.151.167.161.22
+
−−−
 
 
   d=      
4.17
7.04.5 −
 
 
   d=      0.30 for the T25FW at week 8. 
Where BL – Mean baseline score, Wk8 – Mean week eight score,  I -Intervention group, C- 
Control group, SD – Standard deviation. 
 
Percentage change from baseline was calculated for all time-points. A worked example using 
T25FW data at week 8 (Table 4.4) is shown below. 
Percentage change = 100
8
x
BL
WkBL





 −
  
Percentage change = 100
1.22
7.161.22
x




 −
 
Percentage change = 10024.0 x  
Percentage change = 24% for T25FW in the intervention group at week eight. 
Where BL – Mean baseline score, Wk8 – Mean week eight score 
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Appendix 12 Results of Temporal Spatial walking assessment, not shown in thesis  
Group means (and standard deviations) for temporal special parameters  
Temperal Spacial 
parameter (sec) 
Baseline Week 8 Week 12 Month 6 Month 12 
Left Cycle Time 
Intervention 
Control 
 
2.15 (2.5) 
1.11 (0.7) 
 
1.44 (0.9) 
1.75 (1.9) 
 
2.19 (2.7) 
1.29 (0.53) 
 
1.62 (1.1) 
1.24 (0.5) 
 
1.64 (1.4) 
1.52 (0.8) 
Right Cycle Time 
Intervention 
Control 
 
1.55 (1.1) 
1.21 (0.6) 
 
1.43 (0.9) 
1.73(1.8) 
 
1.52 (1.1) 
1.37 (0.44) 
 
1.62 (1.1) 
1.25 (0.5) 
 
1.64 (1.4) 
1.52 (0.8) 
Left Swing Time 
Intervention 
Control 
 
0.45 (0.2) 
0.4 (0.16) 
 
0.42 (0.2) 
0.4 (0.1) 
 
0.45 (0.1) 
0.51 (0.3) 
 
0.47 (0.2) 
0.42 (0.1) 
 
0.49 (0.2) 
0.48 (0.2) 
Right Swing Time 
Intervention 
Control 
 
0.45 (0.2) 
0.4 (0.2) 
 
0.44 (0.2) 
0.4 (0.1) 
 
0.43 (0.1) 
0.42 (0.1) 
 
0.46 (0.1) 
0.42 (0.1) 
 
0.48 (0.1) 
0.44 (0.1) 
Left Single Support Time 
Intervention 
Control 
 
0.45 (0.2) 
0.41 (0.2) 
 
0.44 (0.2) 
0.4 (0.1) 
 
0.44 (0.1) 
0.42 (0.1) 
 
0.45 (0.1) 
0.42 (0.1) 
 
0.48 (0.1) 
0.39 (0.1) 
Right Single Support 
Time 
Intervention 
Control 
 
0.44 (0.2) 
0.39 (0.16) 
 
0.42 (0.2) 
0.4 (0.1) 
 
0.45 (0.1) 
0.41 (0.1) 
 
0.48 (0.2) 
0.42 (0.1) 
 
0.49 (0.2) 
0.49 (0.2) 
Left Double Support 
Time 
Intervention 
Control 
 
 
0.67 (0.8) 
0.43 (0.3) 
 
 
0.58 (0.7) 
0.43 (0.2) 
 
 
0.64 (0.9) 
0.55 (0.3) 
 
 
0.68 (0.8) 
0.52 (0.4) 
 
 
0.68 (1.1) 
0.6 (0.6) 
Right Double Support 
Time 
Intervention 
Control 
 
 
0.69 (0.9) 
0.43 (0.3) 
 
 
0.1 (0.7) 
0.43 (0.2) 
 
 
0.64 (0.88) 
0.54 (0.35) 
 
 
0.46 (0.33) 
0.52 (0.4) 
 
 
0.66 (1.1) 
0.53 (0.7) 
 
Gait cycle From a first contact of first foot to the next first contact of same foot –lower number 
indicates improvement 
Single support From the last contact of the current footfall to the first contact of the next footfall of the 
same foot – lower number indicates improvement (this is relative to Double support time) 
Double support From the first contact of the current footfall and the last contact of the previous footfall, 
added to the time elapsed between the last contact of the current footfall and the first 
contact of the next footfall – lower number indicates improvement (this is relative to 
Single support time) 
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Appendix 13 T25FW scores at each time point for each level of disability 
Means (SD) scores for the total T25WT scores, comparing EDSS level. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T25FW – Timed 25ft Walk,  EDSS – Expanded Disability Status Score 
*missing 25FWT for 2 participants (refer to section 4.4.2) 
Outcome 
Measure and 
time-point 
EDSS Number 
of 
subjects 
Mean Standard 
Deviation 
T25FW 
Baseline 
 
 
 
Week 8* 
 
 
 
Week 12 
 
 
 
Month 6 
 
 
 
Month 12* 
 
5 
5.5 
6 
6.5 
5 
5.5 
6 
6.5 
5 
5.5 
6 
6.5 
5 
5.5 
6 
6.5 
5 
5.5 
6 
6.5 
 
3 
2 
17 
10 
3 
2 
13 
8 
3 
2 
13 
7 
2 
2 
14 
8 
2 
2 
12 
5 
 
8.74 
9.09 
12.82 
37.3 
8.45 
10.5 
10.96 
25.25 
8.4 
9.59 
10.21 
24.59 
8.93 
10.03 
12.43 
32.86 
7.58 
8.73 
10.74 
46.73 
 
1.95 
0.66 
2.27 
19.84 
1.85 
2.83 
3.54 
12.76 
0.55 
1.02 
2.25 
20.74 
0.23 
1.69 
5.23 
28.2 
1.8 
2.12 
3.21 
29.9 
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Glossary 
 
ABC – Activities Balance Confidence scale 
BBS - Berg Balance Scale  
BMI- Body Mass Index 
CNS – Central Nervous System 
COP - Centre of Pressure 
EDSS - Expanded Disability Status Scale  
EMG - Electromyogram  
FAP – Functional Ambulation Profile 
FITT – Frequency, intensity, type and time 
FSS – Fatigue Severity Scale  
HADS - Hospital Anxiety and Depression Scale 
HHD – Hand -held Dynamometer 
ICC – Intraclass Correlation Coefficient 
ICF – International Classification of Functioning 
kg – kilogram 
LMSQOL – Leeds Multiple Sclerosis Quality of Life scale 
LSL – Left Step Length 
LST – Left Step Time 
m- metre 
MCN – Managed Clinical Network 
MDC - minimal detectable change  
MMSE –Mini Mental Status Examination  
   Glossary  
 
271
MRI – Magnetic Resonance Imaging 
MS – Multiple Sclerosis 
MSFC - Multiple Sclerosis Functional Composite  
MVC – Maximum Voluntary Contraction 
NICE - National Institute for Health and Clinical Excellence  
NHS – National Health Service  
OS – Overall Stability 
PAR-Q – Fitness Activity Readiness Questionnaire 
PF - PhoneFITT  
RCT – Randomised control Trial 
RSL – Right Step Length 
RST – Right Step Time 
s - seconds 
SEM - Standard Error of Measurement  
SLS – Strongest Leg Strength 
TUG - Timed Up and Go 
T25FW – Timed 25 Foot Walk  
VEP - Visual Evoked Potential 
WCa - Walking Cadence 
WLS – Weakest Leg Strength 
WVel – Walking Velocity 
6MWT - Six-minute Walk Test 
Not all abbreviations in Section 2.4 appear in this glossary, they can be found in Table 2.4.
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